Dow Chemical 10-K 1 Feb 23 2022 FY Annual report Financial data

Cover Page

Cover Page - USD ($)	12 Months Ended
	Dec. 31, 2022	Jun. 30, 2022
Entity Information [Line Items]
Entity File Number	001-38646
Entity Registrant Name	Dow Inc.
Entity Tax Identification Number	30-1128146
Entity Current Reporting Status	Yes
Entity Filer Category	Large Accelerated Filer
Entity Incorporation, State or Country Code	DE
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Central Index Key	0001751788
Current Fiscal Year End Date	--12-31
Entity Public Float		$ 37,000,000,000
ICFR Auditor Attestation Flag	true
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Document Information [Line Items]
Document Period End Date	Dec. 31, 2022
Document Type	10-K
Document Annual Report	true
Document Transition Report	false
Entity Shell Company	false
Entity Interactive Data Current	Yes
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	FY
Amendment Flag	false
Auditor Name	DELOITTE & TOUCHE LLP
Auditor Location	Midland, Michigan
Entity Listings [Line Items]
Title of 12(b) Security	Common Stock, par value $0.01 per share
Trading Symbol	DOW
Security Exchange Name	NYSE
Entity Listing, Par Value Per Share	$ 0.01
Entity Common Stock, Shares Outstanding	704,879,920
Entity Addresses [Line Items]
Entity Address, Address Line One	2211 H.H. Dow Way
Entity Address, City or Town	Midland
Entity Address, State or Province	MI
Entity Address, Postal Zip Code	48674
City Area Code	989
Local Phone Number	636-1000
Auditor Firm ID	34
The Dow Chemical Company
Entity Information [Line Items]
Entity File Number	001-03433
Entity Registrant Name	The Dow Chemical Company
Entity Tax Identification Number	38-1285128
Entity Current Reporting Status	Yes
Entity Filer Category	Non-accelerated Filer
Entity Incorporation, State or Country Code	DE
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Central Index Key	0000029915
Current Fiscal Year End Date	--12-31
ICFR Auditor Attestation Flag	true
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Document Information [Line Items]
Document Period End Date	Dec. 31, 2022
Document Type	10-K
Document Annual Report	true
Document Transition Report	false
Entity Shell Company	false
Entity Interactive Data Current	Yes
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	FY
Amendment Flag	false
Entity Listings [Line Items]
Security Exchange Name	NYSE
Entity Listing, Par Value Per Share	$ 0.01
Entity Common Stock, Shares Outstanding	100
Entity Addresses [Line Items]
Entity Address, Address Line One	2211 H.H. Dow Way
Entity Address, City or Town	Midland
Entity Address, State or Province	MI
Entity Address, Postal Zip Code	48674
City Area Code	989
Local Phone Number	636-1000
0.500% Notes due March 15, 2027 [Member] | The Dow Chemical Company
Entity Listings [Line Items]
Title of 12(b) Security	0.500% Notes due March 15, 2027
Trading Symbol	DOW/27
1.125% Notes due March 15, 2032 [Member] | The Dow Chemical Company
Entity Listings [Line Items]
Title of 12(b) Security	1.125% Notes due March 15, 2032
Trading Symbol	DOW/32
1.875% Notes due March 15, 2040 [Member] | The Dow Chemical Company
Entity Listings [Line Items]
Title of 12(b) Security	1.875% Notes due March 15, 2040
Trading Symbol	DOW/40
4.625% Notes due October 1, 2044 [Member] | The Dow Chemical Company
Entity Listings [Line Items]
Title of 12(b) Security	4.625% Notes due October 1, 2044
Trading Symbol	DOW/44

Auditor Information

Auditor Information	12 Months Ended
	Dec. 31, 2022
Document Information [Line Items]
Auditor Name	DELOITTE & TOUCHE LLP
Auditor Location	Midland, Michigan
Auditor Firm ID	34

Consolidated Statements of Inco

Consolidated Statements of Income - USD ($) shares in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Income Statement [Abstract]
Net sales	$ 56,902	$ 54,968	$ 38,542
Cost of sales	48,338	44,191	33,346
Research and development expenses	851	857	768
Selling, general and administrative expenses	1,675	1,645	1,471
Amortization of intangibles	336	388	401
Restructuring and asset related charges - net	118	6	708
Integration and separation costs	0	0	239
Equity in earnings (losses) of nonconsolidated affiliates	268	975	(18)
Sundry income (expense) - net	727	(35)	1,269
Interest income	173	55	38
Interest expense and amortization of debt discount	662	731	827
Income before income taxes	6,090	8,145	2,071
Provision for income taxes	1,450	1,740	777
Net income (loss)	4,640	6,405	1,294
Net income attributable to noncontrolling interests	58	94	69
Net income available for The Dow Chemical Company common stockholder	$ 4,582	$ 6,311	$ 1,225
Earnings per common share - basic	$ 6.32	$ 8.44	$ 1.64
Earnings per common share - diluted	$ 6.28	$ 8.38	$ 1.64
Weighted-average common shares outstanding - basic	721	743.6	740.5
Weighted-average common shares outstanding - diluted	725.6	749	742.3

Dow Inc. Consolidated Statement

Dow Inc. Consolidated Statements of Comprehensive Income Statement - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Statement of Comprehensive Income [Abstract]
Net income (loss)	$ 4,640	$ 6,405	$ 1,294
Other comprehensive income (loss), net of tax
Unrealized gains (losses) on investments	(312)	(45)	40
Cumulative translation adjustments	(579)	(425)	205
Pension and other postretirement benefit plans	2,457	2,225	(778)
Derivative instruments	272	123	(76)
Total other comprehensive income (loss)	1,838	1,878	(609)
Comprehensive income	6,478	8,283	685
Comprehensive income attributable to noncontrolling interests, net of tax	58	94	69
Comprehensive income attributable to Dow Inc.	$ 6,420	$ 8,189	$ 616

Dow Consolidated Balance Sheets

Dow Consolidated Balance Sheets - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Cash and cash equivalents	$ 3,886	$ 2,988
Trade (net of allowance for doubtful receivables - 2022: $110; 2021: $54)	5,611	6,841
Other Receivables	2,144	2,713
Inventories	6,988	7,372
Other current assets	1,848	934
Total current assets	20,477	20,848
Investment in nonconsolidated affiliates	1,589	2,045
Other investments (investments carried at fair value - 2022: $1,757; 2021: $2,079)	2,793	3,193
Noncurrent receivables	666	478
Total investments	5,048	5,716
Property	58,055	57,604
Less: Accumulated depreciation	37,613	37,049
Net property	20,442	20,555
Goodwill	8,644	8,764
Other intangible assets (net of accumulated amortization - 2022: $5,022; 2021: $4,725)	2,442	2,881
Operating lease right-of-use assets	1,227	1,412
Deferred income tax assets	960	1,358
Deferred charges and other assets	1,363	1,456
Total other assets	14,636	15,871
Total Assets	60,603	62,990
Notes payable	362	161
Long-term debt due within one year	362	231
Accounts Payable, Trade	4,940	5,577
Accounts Payable, Other	2,276	2,839
Operating lease liabilities - current	287	314
Income taxes payable	334	623
Accrued and other current liabilities	2,770	3,481
Total current liabilities	11,331	13,226
Long-Term Debt	14,698	14,280
Deferred income tax liabilities	1,110	506
Pension and other postretirement benefits - noncurrent	3,808	7,557
Asbestos-related liabilities - noncurrent	857	931
Operating lease liabilities - noncurrent	997	1,149
Other noncurrent obligations	6,555	6,602
Total other noncurrent liabilities	13,327	16,745
Common stock (authorized and issued 100 shares of $0.01 par value each)	8	8
Additional paid-in capital	8,540	8,151
Retained earnings	23,180	20,623
Accumulated other comprehensive loss	(7,139)	(8,977)
Unearned ESOP shares	0	(15)
Treasury stock at cost (2022: 66,798,605 shares; 2021: 29,011,573 shares)	(3,871)	(1,625)
Dow Inc.’s stockholders’ equity	20,718	18,165
Noncontrolling interests	529	574
Total equity	21,247	18,739
Total Liabilities and Equity	$ 60,603	$ 62,990

Dow Consolidated Balance Shee_2

Dow Consolidated Balance Sheets Parentheticals - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Allowance for doubtful receivables	$ 110	$ 54
Investments carried at fair value	1,757	2,079
Other intangible assets, accumulated amortization	$ 5,022	$ 4,725
Common stock authorized (in shares)	5,000,000,000
Common stock, par value (in dollars per share)	$ 0.01
Common stock issued (in shares)	771,678,525	764,226,882
Treasury Stock, Common, Shares	66,798,605	29,011,573

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Statement of Cash Flows [Abstract]
Net income	$ 4,640	$ 6,405	$ 1,294
Depreciation and amortization	2,758	2,842	2,874
Provision (Credit) for deferred income tax	79	278	258
Earnings of nonconsolidated affiliates less than (in excess of) dividends received	696	(651)	443
Net periodic pension benefit cost	23	39	266
Pension contributions	(235)	(1,219)	(299)
Net gain on sales of assets, businesses and investments	(19)	(105)	(802)
Restructuring, goodwill impairment and asset related charges - net	118	6	708
Other net loss	212	921	318
Accounts and notes receivable	1,187	(2,132)	171
Inventories	347	(1,768)	515
Accounts payable	(1,255)	2,458	(84)
Other assets and liabilities, net	(1,065)	(5)	590
Cash provided by operating activities - continuing operations	7,486	7,069	6,252
Cash used for operating activities - discontinued operations	(11)	(60)	(26)
Cash provided by (used for) operating activities	7,475	7,009	6,226
Capital expenditures	(1,823)	(1,501)	(1,252)
Investment in gas field developments	(190)	(92)	(5)
Purchases of previously leased assets	(7)	(694)	(5)
Proceeds from sales of property and businesses, net of cash divested	32	68	929
Acquisitions of property and businesses, net of cash acquired	(228)	(129)	(130)
Investments in and loans to nonconsolidated affiliates	(148)	0	(333)
Distributions and loan repayments from nonconsolidated affiliates	52	51	7
Proceeds from Sale of Equity Method Investments	11	0	0
Purchases of investments	(1,366)	(1,366)	(1,203)
Proceeds from sales and maturities of investments	747	759	1,122
Other investing activities, net	(50)	(10)	29
Cash provided by (used for) investing activities	(2,970)	(2,914)	(841)
Changes in short-term notes payable	253	(48)	(431)
Proceeds from Short-term Debt, Maturing in More than Three Months	0	144	163
Repayments of Short-term Debt, Maturing in More than Three Months	(14)	(130)	(163)
Proceeds from issuance of long-term debt	1,667	109	4,672
Payments on long-term debt	(1,006)	(2,771)	(4,653)
Purchases of treasury stock	(2,325)	(1,000)	(125)
Proceeds from issuance of parent company stock	212	320	108
Transaction financing, debt issuance and other costs	(24)	(537)	(175)
Employee taxes paid for share-based payment arrangements	(35)	(12)	(27)
Distributions to noncontrolling interests	(83)	(73)	(62)
Dividends paid to stockholders	(2,006)	(2,073)	(2,071)
Cash used for financing activities	(3,361)	(6,071)	(2,764)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(237)	(99)	107
Increase (decrease) in cash, cash equivalents and restricted cash	907	(2,075)	2,728
Cash, cash equivalents and restricted cash at beginning of year	3,033	5,108	2,380
Cash, cash equivalents and restricted cash at end of year	3,940	3,033	5,108
Less: Restricted cash and cash equivalents, included in Other current assets	54	45	4
Cash and cash equivalents at end of year	$ 3,886	$ 2,988	$ 5,104

Consolidated Statements of Equi

Consolidated Statements of Equity - USD ($) $ in Millions	Total	Common Stock	Add'l Paid-in Capital	Retained Earnings	Accumulated Other Comprehensive Loss	Unearned ESOP	Treasury Stock, Common
Beginning balance at Dec. 31, 2019		$ 8	$ 7,325	$ 17,045	$ (10,246)	$ (91)	$ (500)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued/sold			108
Stock-based compensation and allocation of ESOP shares			162			42
APIC, Stock Issued During Period, Value, Treasury Reissued - compensation and benefit plans			0
Other			0	(15)
Net income available for The Dow Chemical Company common stockholder	$ 1,225			1,225
Dividends to stockholders				(2,071)
Settlements and transfers related to separation from DowDuPont Inc.				177
Other comprehensive income (loss)	(609)				(609)
Treasury stock purchases							(125)
Stock Issued During Period, Value, Treasury Stock Reissued - compensation and benefit plans							0
Ending balance at Dec. 31, 2020	$ 13,005	8	7,595	16,361	(10,855)	(49)	(625)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Dividends declared per share of common stock	$ 2.80
Dow Inc.’s stockholders’ equity	$ 12,435
Noncontrolling interests	570
Common stock issued/sold			320
Stock-based compensation and allocation of ESOP shares			236			34
APIC, Stock Issued During Period, Value, Treasury Reissued - compensation and benefit plans			0
Other			0	(22)
Net income available for The Dow Chemical Company common stockholder	6,311			6,311
Dividends to stockholders				(2,073)
Settlements and transfers related to separation from DowDuPont Inc.				46
Other comprehensive income (loss)	1,878				1,878
Treasury stock purchases							(1,000)
Stock Issued During Period, Value, Treasury Stock Reissued - compensation and benefit plans							0
Ending balance at Dec. 31, 2021	$ 18,739	8	8,151	20,623	(8,977)	(15)	(1,625)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Dividends declared per share of common stock	$ 2.80
Dow Inc.’s stockholders’ equity	$ 18,165
Noncontrolling interests	574
Common stock issued/sold			212
Stock-based compensation and allocation of ESOP shares			258			15
APIC, Stock Issued During Period, Value, Treasury Reissued - compensation and benefit plans			(79)
Other			(2)	(19)
Net income available for The Dow Chemical Company common stockholder	4,582			4,582
Dividends to stockholders				(2,006)
Settlements and transfers related to separation from DowDuPont Inc.				0
Other comprehensive income (loss)	1,838				1,838
Treasury stock purchases							(2,325)
Stock Issued During Period, Value, Treasury Stock Reissued - compensation and benefit plans							79
Ending balance at Dec. 31, 2022	$ 21,247	$ 8	$ 8,540	$ 23,180	$ (7,139)	$ 0	$ (3,871)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Dividends declared per share of common stock	$ 2.80
Dow Inc.’s stockholders’ equity	$ 20,718
Noncontrolling interests	$ 529

TDCC Consolidated Statements of

TDCC Consolidated Statements of Income Consolidated Statements of Income - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Net sales	$ 56,902	$ 54,968	$ 38,542
Cost of sales	48,338	44,191	33,346
Research and development expenses	851	857	768
Selling, general and administrative expenses	1,675	1,645	1,471
Amortization of intangibles	336	388	401
Restructuring and asset related charges - net	118	6	708
Business Combination, Integration And Separation Related Costs	0	0	239
Equity in earnings (losses) of nonconsolidated affiliates	268	975	(18)
Sundry income (expense) - net	727	(35)	1,269
Interest income	173	55	38
Interest expense and amortization of debt discount	662	731	827
Income before income taxes	6,090	8,145	2,071
Provision for income taxes	1,450	1,740	777
Net income (loss)	4,640	6,405	1,294
Net income attributable to noncontrolling interests	58	94	69
Net income available for The Dow Chemical Company common stockholder	4,582	6,311	1,225
The Dow Chemical Company
Net sales	56,902	54,968	38,542
Cost of sales	48,332	44,187	33,343
Research and development expenses	851	857	768
Selling, general and administrative expenses	1,675	1,645	1,471
Amortization of intangibles	336	388	401
Restructuring and asset related charges - net	118	6	708
Business Combination, Integration And Separation Related Costs	0	0	239
Equity in earnings (losses) of nonconsolidated affiliates	268	975	(18)
Sundry income (expense) - net	714	(79)	1,274
Interest income	181	56	40
Interest expense and amortization of debt discount	662	731	827
Income before income taxes	6,091	8,106	2,081
Provision for income taxes	1,450	1,738	777
Net income (loss)	4,641	6,368	1,304
Net income attributable to noncontrolling interests	58	94	69
Net income available for The Dow Chemical Company common stockholder	$ 4,583	$ 6,274	$ 1,235

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Loss - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Net income (loss)	$ 4,640	$ 6,405	$ 1,294
Other comprehensive income (loss), net of tax
Unrealized gains (losses) on investments	(312)	(45)	40
Cumulative translation adjustments	(579)	(425)	205
Pension and other postretirement benefit plans	2,457	2,225	(778)
Derivative instruments	272	123	(76)
Total other comprehensive income (loss)	1,838	1,878	(609)
Comprehensive income	6,478	8,283	685
Comprehensive income attributable to noncontrolling interests, net of tax	58	94	69
Comprehensive income attributable to The Dow Chemical Company	6,420	8,189	616
The Dow Chemical Company
Net income (loss)	4,641	6,368	1,304
Other comprehensive income (loss), net of tax
Unrealized gains (losses) on investments	(312)	(45)	40
Cumulative translation adjustments	(579)	(425)	205
Pension and other postretirement benefit plans	2,457	2,225	(778)
Derivative instruments	272	123	(76)
Total other comprehensive income (loss)	1,838	1,878	(609)
Comprehensive income	6,479	8,246	695
Comprehensive income attributable to noncontrolling interests, net of tax	58	94	69
Comprehensive income attributable to The Dow Chemical Company	$ 6,421	$ 8,152	$ 626

TDCC Consolidated Balance Sheet

TDCC Consolidated Balance Sheets - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Cash and cash equivalents	$ 3,886	$ 2,988
Trade (net of allowance for doubtful receivables - 2022: $110; 2021: $54)	5,611	6,841
Other Receivables	2,144	2,713
Inventories	6,988	7,372
Other current assets	1,848	934
Total current assets	20,477	20,848
Investment in nonconsolidated affiliates	1,589	2,045
Other investments (investments carried at fair value - 2022: $1,757; 2021: $2,079)	2,793	3,193
Noncurrent receivables	666	478
Total investments	5,048	5,716
Property	58,055	57,604
Less: Accumulated depreciation	37,613	37,049
Net property	20,442	20,555
Goodwill	8,644	8,764
Other intangible assets (net of accumulated amortization - 2022: $5,022; 2021: $4,725)	2,442	2,881
Operating lease right-of-use assets	1,227	1,412
Deferred income tax assets	960	1,358
Deferred charges and other assets	1,363	1,456
Total other assets	14,636	15,871
Total Assets	60,603	62,990
Notes payable	362	161
Long-term debt due within one year	362	231
Accounts Payable, Trade	4,940	5,577
Accounts Payable, Other	2,276	2,839
Operating lease liabilities - current	287	314
Income taxes payable	334	623
Accrued and other current liabilities	2,770	3,481
Total current liabilities	11,331	13,226
Long-Term Debt	14,698	14,280
Deferred income tax liabilities	1,110	506
Pension and other postretirement benefits - noncurrent	3,808	7,557
Asbestos-related liabilities - noncurrent	857	931
Operating lease liabilities - noncurrent	997	1,149
Other noncurrent obligations	6,555	6,602
Total other noncurrent liabilities	13,327	16,745
Common stock (authorized and issued 100 shares of $0.01 par value each)	8	8
Additional paid-in capital	8,540	8,151
Retained earnings	23,180	20,623
Accumulated other comprehensive loss	(7,139)	(8,977)
Unearned ESOP shares	0	(15)
Dow Inc.’s stockholders’ equity	20,718	18,165
Noncontrolling interests	529	574
Total equity	21,247	18,739
Total Liabilities and Equity	60,603	62,990
The Dow Chemical Company
Cash and cash equivalents	3,886	2,988
Trade (net of allowance for doubtful receivables - 2022: $110; 2021: $54)	5,611	6,841
Other Receivables	2,211	2,712
Inventories	6,988	7,372
Other current assets	1,815	924
Total current assets	20,511	20,837
Investment in nonconsolidated affiliates	1,589	2,045
Other investments (investments carried at fair value - 2022: $1,757; 2021: $2,079)	2,793	3,193
Noncurrent receivables	650	452
Total investments	5,032	5,690
Property	58,055	57,604
Less: Accumulated depreciation	37,613	37,049
Net property	20,442	20,555
Goodwill	8,644	8,764
Other intangible assets (net of accumulated amortization - 2022: $5,022; 2021: $4,725)	2,442	2,881
Operating lease right-of-use assets	1,227	1,412
Deferred income tax assets	960	1,358
Deferred charges and other assets	1,363	1,455
Total other assets	14,636	15,870
Total Assets	60,621	62,952
Notes payable	362	161
Long-term debt due within one year	362	231
Accounts Payable, Trade	4,940	5,577
Accounts Payable, Other	2,349	2,841
Operating lease liabilities - current	287	314
Income taxes payable	334	623
Accrued and other current liabilities	2,613	3,299
Total current liabilities	11,247	13,046
Long-Term Debt	14,698	14,280
Deferred income tax liabilities	1,110	506
Pension and other postretirement benefits - noncurrent	3,808	7,557
Asbestos-related liabilities - noncurrent	857	931
Operating lease liabilities - noncurrent	997	1,149
Other noncurrent obligations	6,415	6,454
Total other noncurrent liabilities	13,187	16,597
Common stock (authorized and issued 100 shares of $0.01 par value each)	0	0
Additional paid-in capital	8,627	8,159
Retained earnings	19,472	19,288
Accumulated other comprehensive loss	(7,139)	(8,977)
Unearned ESOP shares	0	(15)
Dow Inc.’s stockholders’ equity	20,960	18,455
Noncontrolling interests	529	574
Total equity	21,489	19,029
Total Liabilities and Equity	$ 60,621	$ 62,952

TDCC Consolidated Statements _2

TDCC Consolidated Statements of Cash Flows Statement - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Net income	$ 4,640	$ 6,405	$ 1,294
Depreciation and amortization	2,758	2,842	2,874
Provision (Credit) for deferred income tax	79	278	258
Earnings of nonconsolidated affiliates less than (in excess of) dividends received	696	(651)	443
Net periodic pension benefit cost	23	39	266
Pension contributions	(235)	(1,219)	(299)
Net gain on sales of assets, businesses and investments	(19)	(105)	(802)
Restructuring, goodwill impairment and asset related charges - net	118	6	708
Other net loss	212	921	318
Accounts and notes receivable	1,187	(2,132)	171
Inventories	347	(1,768)	515
Accounts payable	(1,255)	2,458	(84)
Other assets and liabilities, net	(1,065)	(5)	590
Cash provided by (used for) operating activities	7,475	7,009	6,226
Capital expenditures	(1,823)	(1,501)	(1,252)
Investment in gas field developments	(190)	(92)	(5)
Purchases of previously leased assets	(7)	(694)	(5)
Proceeds from sales of property and businesses, net of cash divested	32	68	929
Acquisitions of property and businesses, net of cash acquired	(228)	(129)	(130)
Investments in and loans to nonconsolidated affiliates	(148)	0	(333)
Distributions and loan repayments from nonconsolidated affiliates	52	51	7
Proceeds from Sale of Equity Method Investments	11	0	0
Purchases of investments	(1,366)	(1,366)	(1,203)
Proceeds from sales and maturities of investments	747	759	1,122
Other investing activities, net	(50)	(10)	29
Cash provided by (used for) investing activities	(2,970)	(2,914)	(841)
Changes in short-term notes payable	253	(48)	(431)
Proceeds from Short-term Debt, Maturing in More than Three Months	0	144	163
Repayments of Short-term Debt, Maturing in More than Three Months	(14)	(130)	(163)
Proceeds from issuance of long-term debt	1,667	109	4,672
Payments on long-term debt	(1,006)	(2,771)	(4,653)
Proceeds from issuance of parent company stock	212	320	108
Transaction financing, debt issuance and other costs	(24)	(537)	(175)
Employee taxes paid for share-based payment arrangements	(35)	(12)	(27)
Distributions to noncontrolling interests	(83)	(73)	(62)
Dividends paid to Dow Inc.	2,006	2,073	2,071
Cash used for financing activities	(3,361)	(6,071)	(2,764)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(237)	(99)	107
Increase (decrease) in cash, cash equivalents and restricted cash	907	(2,075)	2,728
Cash, cash equivalents and restricted cash at beginning of year	3,033	5,108	2,380
Cash, cash equivalents and restricted cash at end of year	3,940	3,033	5,108
Less: Restricted cash and cash equivalents, included in Other current assets	54	45	4
Cash and cash equivalents at end of year	3,886	2,988	5,104
The Dow Chemical Company
Net income	4,641	6,368	1,304
Depreciation and amortization	2,758	2,842	2,874
Provision (Credit) for deferred income tax	80	278	258
Earnings of nonconsolidated affiliates less than (in excess of) dividends received	696	(651)	443
Net periodic pension benefit cost	23	39	266
Pension contributions	(235)	(1,219)	(299)
Net gain on sales of assets, businesses and investments	(19)	(105)	(802)
Restructuring, goodwill impairment and asset related charges - net	118	6	708
Other net loss	221	927	320
Accounts and notes receivable	1,187	(2,132)	171
Inventories	347	(1,768)	515
Accounts payable	(1,255)	2,458	(84)
Other assets and liabilities, net	(1,043)	157	589
Cash provided by (used for) operating activities	7,519	7,200	6,263
Capital expenditures	(1,823)	(1,501)	(1,252)
Investment in gas field developments	(190)	(92)	(5)
Purchases of previously leased assets	(7)	(694)	(5)
Proceeds from sales of property and businesses, net of cash divested	32	68	929
Acquisitions of property and businesses, net of cash acquired	(228)	(129)	(130)
Investments in and loans to nonconsolidated affiliates	(148)	0	(333)
Distributions and loan repayments from nonconsolidated affiliates	52	51	7
Proceeds from Sale of Equity Method Investments	11	0	0
Purchases of investments	(1,366)	(1,366)	(1,203)
Proceeds from sales and maturities of investments	747	759	1,122
Other investing activities, net	(50)	(10)	29
Cash provided by (used for) investing activities	(2,970)	(2,914)	(841)
Changes in short-term notes payable	253	(48)	(431)
Proceeds from Short-term Debt, Maturing in More than Three Months	0	144	163
Repayments of Short-term Debt, Maturing in More than Three Months	(14)	(130)	(163)
Proceeds from issuance of long-term debt	1,667	109	4,672
Payments on long-term debt	(1,006)	(2,771)	(4,653)
Proceeds from issuance of parent company stock	212	320	108
Transaction financing, debt issuance and other costs	(24)	(537)	(175)
Employee taxes paid for share-based payment arrangements	(35)	(12)	(27)
Distributions to noncontrolling interests	(83)	(73)	(62)
Dividends paid to Dow Inc.	4,375	3,264	2,233
Cash used for financing activities	(3,405)	(6,262)	(2,801)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(237)	(99)	107
Increase (decrease) in cash, cash equivalents and restricted cash	907	(2,075)	2,728
Cash, cash equivalents and restricted cash at beginning of year	3,033	5,108	2,380
Cash, cash equivalents and restricted cash at end of year	3,940	3,033	5,108
Less: Restricted cash and cash equivalents, included in Other current assets	54	45	4
Cash and cash equivalents at end of year	$ 3,886	$ 2,988	$ 5,104

TDCC Consolidated Statements _3

TDCC Consolidated Statements of Equity Statement - USD ($) $ in Millions	Total	Common Stock	Add'l Paid-in Capital	Retained Earnings [Member]	Accumulated Other Comprehensive Loss	Unearned ESOP	The Dow Chemical Company	The Dow Chemical Company Common Stock	The Dow Chemical Company Add'l Paid-in Capital	The Dow Chemical Company Retained Earnings [Member]	The Dow Chemical Company Accumulated Other Comprehensive Loss	The Dow Chemical Company Unearned ESOP	Dow Inc. [Member] The Dow Chemical Company Add'l Paid-in Capital	Dow Inc. [Member] The Dow Chemical Company Retained Earnings [Member]
Beginning balance at Dec. 31, 2019		$ 8	$ 7,325	$ 17,045	$ (10,246)	$ (91)		$ 0	$ 7,333	$ 17,313	$ (10,246)	$ (91)
Issuance of parent company stock													$ 108
Stock-based compensation and allocation of ESOP shares			162			42			162			42
Other			0	15					0	(15)
Net income available for The Dow Chemical Company common stockholder	$ 1,225			1,225			$ 1,235			1,235
Dividends to parent														$ (2,233)
Other comprehensive income (loss)	(609)				(609)						(609)
Ending balance at Dec. 31, 2020	13,005	8	7,595	16,361	(10,855)	(49)	13,569	0	7,603	16,300	(10,855)	(49)
The Dow Chemical Company’s stockholder's equity	12,435						12,999
Noncontrolling interests	570						570
Issuance of parent company stock													320
Stock-based compensation and allocation of ESOP shares			236			34			236			34
Other			0	22					0	(22)
Net income available for The Dow Chemical Company common stockholder	6,311			6,311			6,274			6,274
Dividends to parent														(3,264)
Other comprehensive income (loss)	1,878				1,878						1,878
Ending balance at Dec. 31, 2021	18,739	8	8,151	20,623	(8,977)	(15)	19,029	0	8,159	19,288	(8,977)	(15)
The Dow Chemical Company’s stockholder's equity	18,165						18,455
Noncontrolling interests	574						574
Issuance of parent company stock													$ 212
Stock-based compensation and allocation of ESOP shares			258			15			258			15
Other			2	19					(2)	(24)
Net income available for The Dow Chemical Company common stockholder	4,582			4,582			4,583			4,583
Dividends to parent														$ (4,375)
Other comprehensive income (loss)	1,838				1,838						1,838
Ending balance at Dec. 31, 2022	21,247	$ 8	$ 8,540	$ 23,180	$ (7,139)	$ 0	21,489	$ 0	$ 8,627	$ 19,472	$ (7,139)	$ 0
The Dow Chemical Company’s stockholder's equity	20,718						20,960
Noncontrolling interests	$ 529						$ 529

TDCC Consolidated Balance She_2

TDCC Consolidated Balance Sheets Parentheticals - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Investments carried at fair value	$ 1,757	$ 2,079
Other intangible assets, accumulated amortization	$ 5,022	$ 4,725
Common stock authorized (in shares)	5,000,000,000
Common stock issued (in shares)	771,678,525	764,226,882
Common stock, par value (in dollars per share)	$ 0.01
The Dow Chemical Company
Accounts Receivable, Allowance for Credit Loss	$ 110	$ 54
Other intangible assets, accumulated amortization	$ 5,022	$ 4,725
Common stock authorized (in shares)	100
Common stock issued (in shares)	100
Common stock, par value (in dollars per share)	$ 0.01

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Notes)	12 Months Ended
	Dec. 31, 2022
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Principles of Consolidation and Basis of Presentation The accompanying consolidated financial statements of Dow Inc. and TDCC were prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and include the assets, liabilities, revenues and expenses of all majority-owned subsidiaries over which Dow exercises control and, when applicable, entities for which Dow has a controlling financial interest or is the primary beneficiary. Intercompany transactions and balances are eliminated in consolidation. Investments in nonconsolidated affiliates (20-50 percent owned companies or less than 20 percent owned companies over which significant influence is exercised) are primarily accounted for using the equity method. Dow Inc. owns all of the outstanding common shares of TDCC. As a result of the parent/subsidiary relationship between Dow Inc. and TDCC, and considering that the financial statements and disclosures of each company are substantially similar, the companies are filing a combined report for this Annual Report on Form 10-K. The information reflected in the report is equally applicable to both Dow Inc. and TDCC, except where otherwise noted. Transactions between TDCC and Dow Inc. are treated as related party transactions for TDCC. See Note 24 for additional information. The Company conducts its worldwide operations through six global businesses which are organized into the following operating segments: Packaging & Specialty Plastics, Industrial Intermediates & Infrastructure and Performance Materials & Coatings. Corporate contains the reconciliation between the totals for the operating segments and the Company's totals. See Note 25 for additional information. Except as otherwise indicated by the context, the term "Union Carbide" means Union Carbide Corporation and the term "Dow Silicones" means Dow Silicones Corporation, both wholly owned subsidiaries of the Company. Use of Estimates in Financial Statement Preparation The preparation of financial statements in accordance with U.S. GAAP requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. The Company’s consolidated financial statements include amounts that are based on management’s best estimates and judgments. Actual results could differ from those estimates. Significant Accounting Policies Asbestos-Related Matters Accruals for asbestos-related matters, including defense and processing costs, are recorded based on an analysis of claim and resolution activity, defense spending, and pending and future claims. These accruals are assessed at each balance sheet date to determine if the asbestos-related liability remains appropriate. Accruals for asbestos-related matters are included in the consolidated balance sheets in “Accrued and other current liabilities” and “Asbestos-related liabilities - noncurrent.” See Note 15 for additional information. Legal Costs The Company expenses legal costs as incurred, with the exception of defense and processing costs associated with asbestos-related matters. Foreign Currency Translation The local currency has been primarily used as the functional currency throughout the world. Translation gains and losses of those operations that use local currency as the functional currency are included in the consolidated balance sheets in "Accumulated other comprehensive loss" ("AOCL"). For certain subsidiaries, the U.S. dollar is used as the functional currency. This occurs when the subsidiary operates in an economic environment where the products produced and sold are tied to U.S. dollar-denominated markets, or when the foreign subsidiary operates in a hyper-inflationary environment. Where the U.S. dollar is used as the functional currency, foreign currency translation gains and losses are reflected in income. Environmental Matters Accruals for environmental matters are recorded when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated based on current law and existing technologies. These accruals are adjusted periodically as assessment and remediation efforts progress or as additional technical or legal information becomes available. Accruals for environmental liabilities are included in the consolidated balance sheets in “Accrued and other current liabilities” and “Other noncurrent obligations” at undiscounted amounts. Accruals for related insurance or other third-party recoveries for environmental liabilities are recorded when it is probable that a recovery will be realized and are included in the consolidated balance sheets in “Accounts and notes receivable - Other” or "Noncurrent receivables." Environmental costs are capitalized if the costs extend the life of the property, increase its capacity and/or mitigate or prevent contamination from future operations. Environmental costs are also capitalized in recognition of legal asset retirement obligations resulting from the acquisition, construction and/or normal operation of a long-lived asset. Costs related to environmental contamination treatment and cleanup are charged to expense. Estimated future incremental operations, maintenance and management costs directly related to remediation are accrued when such costs are probable and reasonably estimable. Cash and Cash Equivalents Cash and cash equivalents include time deposits and investments with maturities of three months or less at the time of purchase. Financial Instruments The Company calculates the fair value of financial instruments using quoted market prices when available. When quoted market prices are not available for financial instruments, the Company uses standard pricing models with market-based inputs that take into account the present value of estimated future cash flows. The Company utilizes derivatives to manage exposures to foreign currency exchange rates, commodity prices and interest rate risk. The fair values of all derivatives are recognized as assets or liabilities at the balance sheet date. Changes in the fair values of these instruments are reported in income or AOCL, depending on the use of the derivative and whether the Company has elected hedge accounting treatment. Gains and losses on derivatives that are designated and qualify as cash flow hedging instruments are recorded in AOCL until the underlying transactions are recognized in income. Gains and losses on derivative and non-derivative instruments used as hedges of the Company’s net investment in foreign operations are recorded in AOCL as part of the cumulative translation adjustment. Gains and losses on derivatives designated and qualifying as fair value hedging instruments, as well as the offsetting losses and gains on the hedged items, are reported in income in the same accounting period. Derivatives not designated as hedging instruments are marked-to-market at the end of each accounting period with the results included in income. Inventories Inventories are stated at the lower of cost or net realizable value. The method of determining cost for each subsidiary varies among last-in, first-out (“LIFO”); first-in, first-out (“FIFO”); and average cost, and is used consistently from year to year. At December 31, 2022, approximately 27 percent, 64 percent and 9 percent of the Company's inventories were accounted for under the LIFO, FIFO and average cost methods, respectively. At December 31, 2021, approximately 27 percent, 65 percent and 8 percent of the Company's inventories were accounted for under the LIFO, FIFO and average cost methods, respectively. The Company routinely exchanges and swaps raw materials and finished goods with other companies to reduce delivery time, freight and other transportation costs. These transactions are treated as non-monetary exchanges and are valued at cost. Property Land, buildings and equipment are carried at cost less accumulated depreciation or amortization. Property under finance lease agreements is carried at the present value of lease payments over the lease term less accumulated amortization. Depreciation is based on the estimated service lives of depreciable assets and is calculated using the straight-line method. Fully depreciated assets are retained in property and accumulated depreciation accounts until they are removed from service. In the case of disposals, assets and related accumulated depreciation are removed from the accounts, and the net amounts, less proceeds from disposal, are included in income. Impairment and Disposal of Long-Lived Assets The Company evaluates long-lived assets (property, finite-lived intangible assets and right-of-use assets) for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. When undiscounted future cash flows are not expected to be sufficient to recover an asset’s carrying amount, the asset is written down to its fair value based on bids received from third parties or a discounted cash flow analysis based on market participant assumptions. Long-lived assets to be disposed of by sale, if material, are classified as held for sale and reported at the lower of carrying amount or fair value less cost to sell, and depreciation/amortization is ceased. Long-lived assets to be disposed of other than by sale are classified as held and used until they are disposed of and reported at the lower of carrying amount or fair value, and depreciation/amortization is recognized over the remaining useful life of the assets. Goodwill and Other Intangible Assets The Company records goodwill when the purchase price of a business combination exceeds the estimated fair value of net identified tangible and intangible assets acquired. Goodwill is tested for impairment at the reporting unit level annually in the fourth quarter, or more frequently when events or changes in circumstances indicate that the fair value of a reporting unit has more likely than not declined below its carrying value. When testing goodwill for impairment, the Company may first assess qualitative factors. If an initial qualitative assessment identifies that it is more likely than not that the fair value of a reporting unit is less than its carrying value, additional quantitative testing is performed. The Company may also elect to skip the qualitative testing and proceed directly to the quantitative testing. If the quantitative testing indicates that goodwill is impaired, an impairment charge is recognized based on the difference between the reporting unit's carrying value and its fair value. The Company primarily utilizes a discounted cash flow methodology to calculate the fair value of its reporting units. Finite-lived intangible assets such as developed technology, customer-related, trademarks, tradenames and software, are amortized over their estimated useful lives, generally on a straight-line basis for periods ranging primarily from 3 to 20 years. Asset Retirement Obligations The Company records asset retirement obligations as incurred and reasonably estimable, including obligations for which the timing and/or method of settlement are conditional on a future event that may or may not be within the control of the Company. The fair values of obligations are recorded as liabilities on a discounted basis and are accreted over time for the change in present value. Costs associated with the liabilities are capitalized and amortized over the estimated remaining useful life of the asset, generally for periods of 10 years or less. Investments Investments in debt securities, primarily held by the Company's insurance operations, are classified as trading, available-for-sale or held-to-maturity. Investments classified as trading are reported at fair value with unrealized gains and losses related to mark-to-market adjustments included in income. Those classified as available-for-sale are reported at fair value with unrealized gains and losses recorded in AOCL. Those classified as held-to-maturity are recorded at amortized cost. The cost of investments sold is determined by FIFO or specific identification. Investments in equity securities with a readily determinable fair value are reported at fair value with unrealized gains and losses related to mark-to-market adjustments included in income. Equity securities without a readily determinable fair value are accounted for at cost, adjusted for impairments and observable price changes in orderly transactions. The Company routinely reviews its investments for declines in fair value below the cost basis. When events or changes in circumstances indicate the carrying value of an asset may not be recoverable, the security is written down, establishing a new cost basis. Leases The Company determines whether a contract contains a lease at contract inception. A contract contains a lease if there is an identified asset and the Company has the right to control the asset. Operating lease right-of-use (“ROU”) assets represent the Company's right to use an underlying asset for the lease term, and lease liabilities represent the Company's obligation to make lease payments arising from the lease. Operating lease ROU assets and lease liabilities are recognized at commencement date based on the present value of lease payments over the lease term. The Company uses the incremental borrowing rate in determining the present value of lease payments, unless the implicit rate is readily determinable. If lease terms include options to extend or terminate the lease, the ROU asset and lease liability are measured based on the reasonably certain decision. Leases with a term of 12 months or less at the commencement date are not recognized on the balance sheet and are expensed as incurred. The Company has lease agreements with lease and non-lease components, which are accounted for as a single lease component for nearly all classes of leased assets for which the Company is the lessee. Additionally, for certain equipment leases, the portfolio approach is applied to account for the operating lease ROU assets and lease liabilities. In the consolidated statements of income, lease expense for operating lease payments is recognized on a straight-line basis over the lease term. For finance leases, interest expense is recognized on the lease liability and the ROU asset is amortized over the lease term. Some leasing arrangements require variable payments that are dependent upon usage or output, or may vary for other reasons, such as insurance or tax payments. Variable lease payments are recognized as incurred and are not presented as part of the ROU asset or lease liability. See Note 16 for additional information. Revenue The Company recognizes revenue when its customer obtains control of promised goods or services in an amount that reflects the consideration which the Company expects to receive in exchange for those goods or services. To determine revenue recognition, the Company performs the following five steps: (1) identify the contract(s) with a customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract and (5) recognize revenue when (or as) the entity satisfies a performance obligation. See Note 3 for additional information. Revenue related to the Company's insurance operations includes third-party insurance premiums, which are earned over the terms of the related insurance policies and reinsurance contracts. Severance Costs The Company routinely reviews its operations around the world in an effort to ensure competitiveness across its businesses and geographic regions. When the reviews result in a workforce reduction related to the shutdown of facilities or other optimization activities, severance benefits are provided to employees primarily under the Company’s ongoing benefit arrangements. These severance costs are accrued once management commits to a plan of termination and it becomes probable that employees will be entitled to benefits at amounts that can be reasonably estimated. Income Taxes The Company accounts for income taxes using the asset and liability method. Under this method, deferred tax assets and liabilities are recognized for the future tax consequences of temporary differences between the carrying amounts and tax bases of assets and liabilities using enacted tax rates. The effect of a change in tax rates on deferred tax assets or liabilities is recognized in income in the period that includes the enactment date. The Company uses the portfolio approach for releasing income tax effects from AOCL. The Company recognizes the financial statement effects of an uncertain income tax position when it is more likely than not, based on the technical merits, that the position will be sustained upon examination. The Company accrues for other tax contingencies when it is probable that a liability to a taxing authority has been incurred and the amount of the contingency can be reasonably estimated. The current portion of uncertain income tax positions is included in “Income taxes payable” and the long-term portion is included in “Other noncurrent obligations” in the consolidated balance sheets. Provision is made for taxes on undistributed earnings of foreign subsidiaries and related companies to the extent that such earnings are not deemed to be permanently invested. Earnings per Common Share The calculation of earnings per common share is based on the weighted-average number of the Company's common shares outstanding for the applicable period. The calculation of diluted earnings per common share reflects the effect of all potential common shares that were outstanding during the respective periods, unless the effect of doing so is antidilutive. TDCC Dividends

RECENT ACCOUNTING GUIDANCE (Not

RECENT ACCOUNTING GUIDANCE (Notes)	12 Months Ended
	Dec. 31, 2022
Accounting Standards Update and Change in Accounting Principle [Abstract]
RECENT ACCOUNTING GUIDANCE	RECENT ACCOUNTING GUIDANCE Recently Adopted Accounting Guidance In the first quarter of 2021, the Company adopted Accounting Standards Update ("ASU") 2019-12, "Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes." The amendments simplify the accounting for income taxes by removing certain exceptions to the general principles of Topic 740, "Income Taxes" and improve consistent application by clarifying and amending existing guidance. The adoption of this guidance did not have a material impact on the Company's consolidated financial statements. Accounting Guidance Issued But Not Adopted at December 31, 2022 In September 2022, the Financial Accounting Standards Board issued ASU 2022-04, "Liabilities — Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations," which requires disclosures intended to enhance the transparency of supplier finance programs. The amendments in this ASU require buyers in a supplier finance program to disclose sufficient information about the program to allow a user of financial statements to understand the program’s nature, activity during the period, changes from period to period, and potential magnitude. The amendments are effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, except for the disclosure of rollforward information, which is effective for fiscal years beginning after December 15, 2023. Early adoption is permitted. The amendments should be applied retrospectively to each period in which a balance sheet is presented, except for disclosure of rollforward information, which should be applied prospectively. The ASU only requires disclosures related to the Company's supplier finance programs and does not affect the recognition, measurement or financial statement presentation of supplier finance program obligations. The Company expects to adopt the new disclosure requirements in the first quarter of 2023, with the exception of the annual requirement to disclose rollforward information, which the Company expects to early adopt and present prospectively beginning in the 2023 annual financial statements.

REVENUE (Notes)

REVENUE (Notes)	12 Months Ended
	Dec. 31, 2022
Revenue from Contract with Customer [Abstract]
REVENUE	REVENUE The majority of the Company's revenue is derived from product sales. In 2022, 99 percent of the Company's revenue related to product sales (99 percent in 2021 and 2020). The remaining sales were primarily related to the Company's insurance operations and licensing of patents and technologies. Disaggregation of Revenue Dow disaggregates its revenue from contracts with customers by operating segment and business, as the Company believes it best depicts the nature, amount, timing and uncertainty of its revenue and cash flows. See details in the tables below: Net Trade Sales by Segment and Business 2022 2021 2020 In millions Hydrocarbons & Energy $ 9,414 $ 8,149 $ 4,271 Packaging and Specialty Plastics 19,846 19,979 14,030 Packaging & Specialty Plastics $ 29,260 $ 28,128 $ 18,301 Industrial Solutions $ 5,682 $ 5,139 $ 3,929 Polyurethanes & Construction Chemicals 10,907 11,700 8,080 Others 17 12 12 Industrial Intermediates & Infrastructure $ 16,606 $ 16,851 $ 12,021 Coatings & Performance Monomers $ 4,051 $ 4,050 $ 3,258 Consumer Solutions 6,713 5,622 4,693 Performance Materials & Coatings $ 10,764 $ 9,672 $ 7,951 Corporate $ 272 $ 317 $ 269 Total $ 56,902 $ 54,968 $ 38,542 Net Trade Sales by Geographic Region 2022 2021 2020 In millions U.S. & Canada $ 20,945 $ 19,613 $ 13,582 EMEAI 1 19,631 19,746 12,969 Asia Pacific 10,344 10,043 8,165 Latin America 5,982 5,566 3,826 Total $ 56,902 $ 54,968 $ 38,542 1. Europe, Middle East, Africa and India. Product Sales Product sales consist of sales of the Company's products to manufacturers and distributors. The Company considers order confirmations or purchase orders, which in some cases are governed by master supply agreements, to be contracts with a customer. Product sale contracts are generally short-term contracts where the time between order confirmation and satisfaction of all performance obligations is less than one year. However, the Company has some long-term contracts which can span multiple years. Revenues from product sales are recognized when the customer obtains control of the product, which occurs at a point in time, usually upon shipment, with payment terms typically in the range of 30 to 60 days after invoicing, depending on business and geographic region. When the Company performs shipping and handling activities after the transfer of control to the customer (e.g., when control transfers prior to shipment), these are considered fulfillment activities, and accordingly, the costs are accrued when the related revenue is recognized. Taxes collected from customers relating to product sales and remitted to governmental authorities are excluded from revenues. The Company elected to use the practical expedient to expense cash and non-cash sales incentives, as the amortization period for the costs to obtain the contract would have been one year or less. Certain long-term contracts include a series of distinct goods that are delivered continuously to the customer through a pipeline (e.g., feedstocks). For these types of product sales, the Company invoices the customer in an amount that directly corresponds with the value to the customer of the Company’s performance to date. As a result, the Company recognizes revenue based on the amount billable to the customer in accordance with the right to invoice practical expedient. The transaction price includes estimates for reductions in revenue from customer rebates and right of returns on product sales. These amounts are estimated based upon the most likely amount of consideration to which the customer will be entitled. All estimates are based on historical experience, anticipated performance and the Company’s best judgment at the time to the extent it is probable that a significant reversal of revenue recognized will not occur. All estimates for variable consideration are reassessed periodically. The Company elected the practical expedient to not adjust the amount of consideration for the effects of a significant financing component for all instances in which the period between payment and transfer of the goods will be one year or less. For contracts with multiple performance obligations, the Company allocates the transaction price to each performance obligation based on the relative standalone selling price. The standalone selling price is the observable price which depicts the price as if sold to a similar customer in similar circumstances. Patents, Trademarks and Licenses The Company enters into licensing arrangements in which it licenses certain rights of its patents and technology to customers. Revenue from the majority of the Company’s licenses for patents and technology is derived from sales-based royalties. The Company estimates the amount of sales-based royalties it expects to be entitled to based on historical sales to the customer. For the remaining revenue from licensing arrangements, payments are typically received from the Company's licensees based on billing schedules established in each contract. Revenue is recognized when the performance obligation is satisfied. Remaining Performance Obligations Remaining performance obligations represent the transaction price allocated to unsatisfied or partially unsatisfied performance obligations. At December 31, 2022, the Company had unfulfilled performance obligations of $840 million ($829 million at December 31, 2021) related to the licensing of technology and expects revenue to be recognized for the remaining performance obligations over the next six years. The remaining performance obligations are for product sales that have expected durations of one year or less, product sales of materials delivered through a pipeline for which the Company has elected the right to invoice practical expedient, or variable consideration attributable to royalties for licenses of patents and technology. The Company has received advance payments from customers related to long-term supply agreements that are deferred and recognized over the life of the contract, with remaining contract terms that range up to 18 years. The Company will have rights to future consideration for revenue recognized when product is delivered to the customer. These payments are included in "Accrued and other current liabilities" and "Other noncurrent obligations" in the consolidated balance sheets. Contract Assets and Liabilities The Company receives payments from customers based upon contractual billing schedules. Accounts receivable are recorded when the right to consideration becomes unconditional. Contract assets include amounts related to the Company’s contractual right to consideration for completed performance obligations not yet invoiced. Contract liabilities include payments received in advance of performance under the contract and are recognized in revenue when the performance obligations are met. "Contract liabilities - current" primarily reflects deferred revenue from prepayments from customers for product to be delivered in 12 months or less and royalty payments that are deferred and will be recognized in 12 months or less. "Contract liabilities - noncurrent" includes advance payments that the Company has received from customers related to long-term supply agreements and royalty payments that are deferred and recognized over the life of the contract. Revenue recognized in 2022 from amounts included in contract liabilities at the beginning of the period was approximately $250 million (approximately $295 million in 2021 and $145 million in 2020). In 2022, the amount of contract assets reclassified to receivables as a result of the right to the transaction consideration becoming unconditional was approximately $15 million (approximately $35 million in 2021). Asset impairment charges related to contract assets in 2022 were insignificant (no impairment charges in 2021 or 2020). The following table summarizes the contract assets and liabilities at December 31, 2022 and 2021: Contract Assets and Liabilities at Dec 31 Balance Sheet Classification 2022 2021 In millions Accounts and notes receivable - trade Accounts and notes receivable - trade $ 5,611 $ 6,841 Contract assets - current Other current assets $ 48 $ 34 Contract assets - noncurrent Deferred charges and other assets $ 16 $ 26 Contract liabilities - current 1 Accrued and other current liabilities $ 275 $ 209 Contract liabilities - noncurrent 2 Other noncurrent obligations $ 1,725 $ 1,925 1. The increase from December 31, 2021 to December 31, 2022 was due to the reclassification of deferred royalty payments from noncurrent to current. 2. The decrease from December 31, 2021 to December 31, 2022 was due to the recognition of revenue on long-term product supply agreements and the reclassification of deferred royalty payments from noncurrent to current.

DIVESTITURES (Notes)

DIVESTITURES (Notes)	12 Months Ended
	Dec. 31, 2022
Discontinued Operations and Disposal Groups [Abstract]
DIVESTITURES	DIVESTITURES Divestiture of Rail Infrastructure Operations and Assets On September 30, 2020, TDCC sold its rail infrastructure operations and assets, including existing agreements to provide rail services to unrelated third parties, at six sites in the U.S. & Canada to an affiliate of Watco Companies, L.L.C. for cash proceeds of $303 million, net of costs to sell and other adjustments and subject to customary post-closing adjustments. These assets are located at TDCC’s sites in Plaquemine and St. Charles, Louisiana; Freeport and Seadrift, Texas; and Fort Saskatchewan and Prentiss, Alberta, Canada. Divested operations included property with a net book value of $68 million and goodwill of $2 million ($16 million related to Packaging & Specialty Plastics and $54 million related to Corporate). TDCC retained ownership of the sites and underlying real property where the divested operations are located. TDCC and the buyer entered into mutual long-term service agreements designed to ensure the continuation of rail services for TDCC's existing operations at each site. The rail-service agreements include variable fees that have an initial term of 25 years. TDCC recognized a pretax gain of $233 million on the sale ($48 million related to Packaging & Specialty Plastics and $185 million related to Corporate), included in "Sundry income (expense) - net" in the consolidated statements of income. The Company evaluated the divestiture of the rail infrastructure operations and assets and determined it did not represent a strategic shift that had a major effect on the Company’s operations and financial results and did not qualify as an individually significant component of the Company. As a result, the divestiture is not reported as discontinued operations. Divestiture of Marine and Terminal Operations and Assets On December 1, 2020, TDCC sold certain U.S. Gulf Coast marine and terminal operations and assets, including existing agreements to provide marine and terminal services to unrelated third parties, at three U.S. sites to an affiliate of Royal Vopak for cash proceeds of $600 million, net of costs to sell and other adjustments and subject to customary post-closing adjustments. These assets are located at TDCC's sites in Plaquemine and St. Charles, Louisiana, and Freeport, Texas. Divested operations included property with a net book value of $93 million and goodwill of $8 million ($7 million related to Packaging & Specialty Plastics, $17 million related to Industrial Intermediates & Infrastructure and $77 million related to Corporate). TDCC retained ownership of the sites and the underlying real property where the divested operations are located. TDCC and the buyer entered into mutual long-term service agreements designed to ensure the continuation of marine and terminal services for TDCC's existing operations at each site. The marine and terminal service agreements include fixed and variable fees that have initial terms of up to 25 years. In the fourth quarter of 2020, TDCC recognized a pretax gain of $499 million on the sale ($17 million related to Packaging & Specialty Plastics, $61 million related to Industrial Intermediates & Infrastructure and $421 million related to Corporate), included in "Sundry income (expense) - net" in the consolidated statements of income. The Company evaluated the divestiture of the marine and terminal operations and assets and determined it did not represent a strategic shift that had a major effect on the Company’s operations and financial results and did not qualify as an individually significant component of the Company. As a result, the divestiture is not reported as discontinued operations.

RESTRUCTURING, GOODWILL IMPAIRM

RESTRUCTURING, GOODWILL IMPAIRMENT AND ASSET RELATED CHARGES - NET (Notes)	12 Months Ended
	Dec. 31, 2022
Restructuring and Related Activities [Abstract]
RESTRUCTURING, GOODWILL IMPAIRMENT AND ASSET RELATED CHARGES - NET	RESTRUCTURING AND ASSET RELATED CHARGES - NET The "Restructuring and asset related charges - net" line in the consolidated statements of income is used to record charges for restructuring programs and other asset related charges, which includes other asset impairments. Restructuring Programs 2020 Restructuring Program On September 29, 2020, the Dow Inc. Board approved restructuring actions to achieve the Company's structural cost improvement initiatives in response to the continued economic impact from the coronavirus disease 2019 ("COVID-19") pandemic. The restructuring program was designed to reduce structural costs and enable the Company to further enhance competitiveness while the COVID-19 economic recovery gained traction. This program included a global workforce cost reduction of approximately 6 percent and actions to rationalize the Company's manufacturing assets, which included asset write-down and write-off charges, related contract termination fees and environmental remediation costs ("2020 Restructuring Program"). Severance benefits are provided to employees primarily under Dow's ongoing benefit arrangements and are accrued against the Corporate segment once management commits to a plan of termination. The actions related to the 2020 Restructuring Program were substantially complete by the end of 2021, with the exception of certain cash payments that will continue into 2023. In the third quarter of 2020, the Company recorded pretax restructuring charges of $575 million, consisting of severance and related benefit costs of $297 million, asset write-downs and write-offs of $197 million and costs associated with exit and disposal activities of $81 million. In the fourth quarter of 2020, the Company recorded net favorable pretax restructuring credits of $1 million related to asset write-downs and write-offs and $1 million related to costs associated with exit and disposal activities (related to Performance Materials & Coatings and Corporate). The adjustment to costs associated with exit and disposal activities included curtailment costs associated with a defined benefit pension plan. See Note 19 for additional information. In 2021, the Company recorded pretax restructuring charges of $12 million for asset write-downs and write-offs and $10 million for costs associated with exit and disposal activities. In addition, the Company reduced pretax restructuring charges by $10 million for severance and related benefit costs. The following table summarizes the activities related to the 2020 Restructuring Program: 2020 Restructuring Program Severance and Related Benefit Costs Asset Write-downs and Write-offs Costs Associated with Exit and Disposal Activities Total In millions Packaging & Specialty Plastics $ — $ 11 $ — $ 11 Industrial Intermediates & Infrastructure — 22 — 22 Performance Materials & Coatings — 116 61 177 Corporate 297 47 19 363 Total restructuring charges $ 297 $ 196 $ 80 $ 573 Charges against the reserve — (196) (5) (201) Cash payments (8) — — (8) Reserve balance at Dec 31, 2020 $ 289 $ — $ 75 $ 364 Packaging & Specialty Plastics $ — $ — $ 8 $ 8 Industrial Intermediates & Infrastructure — 1 — 1 Performance Materials & Coatings — 8 2 10 Corporate (10) 3 — (7) Total restructuring charges $ (10) $ 12 $ 10 $ 12 Charges against the reserve — (12) — (12) Cash payments (175) — (21) (196) Reserve balance at Dec 31, 2021 $ 104 $ — $ 64 $ 168 Cash payments (88) — (11) (99) Reserve balance at Dec 31, 2022 $ 16 $ — $ 53 $ 69 At December 31, 2022, $22 million ($112 million at December 31, 2021) of the reserve balance was included in "Accrued and other current liabilities" and $47 million ($56 million at December 31, 2021) was included in "Other noncurrent obligations" in the consolidated balance sheets. The Company recorded pretax restructuring charges of $585 million inception-to-date under the 2020 Restructuring Program, consisting of severance and related benefit costs of $287 million, asset write-downs and write-offs of $208 million and costs associated with exit and disposal activities of $90 million. Asset Write-downs and Write-offs The 2020 Restructuring Program included charges related to the write-down and write-off of assets totaling $196 million in 2020. Details regarding the asset write-downs and write-offs are as follows: • Packaging & Specialty Plastics recorded a charge of $11 million to rationalize its production capacity by shutting down a small-scale production unit. • Industrial Intermediates & Infrastructure recorded a charge of $22 million to rationalize its asset footprint by shutting down certain amines and solvents facilities in the United States and Europe as well as select, small-scale downstream polyurethanes manufacturing facilities. • Performance Materials & Coatings recorded a charge of $116 million for shutting down manufacturing assets, primarily related to small-scale coatings reactors, and also rationalized its upstream asset footprint in Europe and the U.S. & Canada by adjusting the supply of siloxane and silicon metal to balance to regional needs. • Corporate recorded a charge of $47 million related to the write-down of leased, non-manufacturing facilities and the write-down of miscellaneous assets. The 2020 Restructuring Program included charges related to the write-down and write-off of assets totaling $12 million in 2021, which included additional write-down and write-off of assets related to the actions listed above, impacting Industrial Intermediates & Infrastructure ($1 million) and Performance Materials & Coatings ($8 million), and the write-down of an additional non-manufacturing facility impacting Corporate ($3 million). Shut down related activities for impacted facilities were substantially complete by the end of 2021. Costs Associated with Exit and Disposal Activities The 2020 Restructuring Program included charges of $80 million for costs associated with exit and disposal activities in 2020, which included $19 million for contract termination fees related to the asset actions listed above, impacting Performance Materials & Coatings ($9 million) and Corporate ($10 million), as well as $56 million for environmental remediation, impacting Performance Materials & Coatings ($52 million) and Corporate ($4 million) and $5 million related to curtailment costs associated with a defined benefit pension plan, impacting Corporate. The 2020 Restructuring Program included charges of $10 million for costs associated with exit and disposal activities in 2021, which included contract termination fees and environmental remediation, impacting Packaging & Specialty Plastics ($8 million) and Performance Materials & Coatings ($2 million). The Company expects to incur additional costs in the future related to its restructuring activities. Future costs are expected to include demolition costs related to closed facilities and restructuring implementation costs. These costs will be recognized as incurred. The Company also expects to incur additional employee-related costs, including involuntary termination benefits, related to its other optimization activities. These costs cannot be reasonably estimated at this time. Asset Related Charges 2022 Charges In 2022, the Company recorded pretax asset related charges of $118 million due to the Russia and Ukraine conflict and the expectation that certain assets would not be recoverable. These charges included the write-down of inventory, the recording of bad debt reserves and the impairment of other assets. Asset related charges by segment in 2022 were as follows: $8 million in Packaging & Specialty Plastics, $73 million in Industrial Intermediates & Infrastructure, $6 million in Performance Materials & Coatings and $31 million in Corporate. 2020 Charges In 2020, the Company recognized pretax impairment charges of $49 million, including additional pretax impairment charges for capital additions made to a bio-ethanol manufacturing facility in Santa Vitoria, Minas Gerais, Brazil ("Santa Vitoria"), which was impaired in 2017 and divested in 2020, as well as charges for miscellaneous write-offs and write-downs of non-manufacturing assets and the write-down of certain corporate leased equipment. The impairment charges related to Packaging & Specialty Plastics ($19 million), Performance Materials & Coatings ($15 million) and Corporate ($15 million). See Note 22 for additional information. Subsequent Event On January 25, 2023, the Dow Inc. Board approved restructuring actions to achieve the Company's structural cost improvement initiatives in response to the continued economic impact from the global recessionary environment and to enhance its agility and long-term competitiveness across the economic cycle. This program includes a global workforce cost reduction, decreasing turnaround spending, actions to rationalize the Company’s manufacturing assets, which includes asset write-down and write-off charges and related contract termination fees. The Company will record a charge in the first quarter of 2023 for costs associated with these activities. In total, these costs are expected to be in the range of $550 million to $725 million and will consist of severance and related benefit costs ranging from $330 million to $425 million in connection with a global workforce reduction of approximately 2,000 roles; costs associated with exit and disposal activities ranging from $20 million to $50 million; and asset write-downs and write-offs ranging from $200 million to $250 million. Future cash payments related to severance costs, contract termination fees and environmental remediation costs are anticipated to be approximately $450 million to $550 million and will be paid out primarily over the next two years.

SUPPLEMENTARY INFORMATION (Note

SUPPLEMENTARY INFORMATION (Notes)	12 Months Ended
	Dec. 31, 2022
Supplementary Information [Abstract]
SUPPLEMENTARY INFORMATION	SUPPLEMENTARY INFORMATION Sundry Income (Expense) – Net Dow Inc. TDCC In millions 2022 2021 2020 2022 2021 2020 Non-operating pension and other postretirement benefit plan net credits 1 $ 358 $ 332 $ 103 $ 358 $ 332 $ 103 Foreign exchange losses 2 (117) (8) (62) (126) (13) (65) Loss on early extinguishment of debt 3 (8) (574) (149) (8) (574) (149) Gain on sales of other assets and investments 78 105 48 78 105 48 Indemnification and other transaction related costs 4 4 30 (21) — (2) (11) Luxi arbitration award 5 — 54 — — 54 — Gain (loss) on divestitures and asset sale 6 — 16 (15) — 16 (15) Gain on divestiture of rail infrastructure operations and assets 7 — — 233 — — 233 Gain on divestiture of marine and terminal operations and assets 7 — — 499 — — 499 Gain related to Nova legal matter 5 321 — 544 321 — 544 Dow Silicones breast implant liability adjustment 5 60 — 5 60 — 5 Other - net 31 10 84 31 3 82 Total sundry income (expense) – net $ 727 $ (35) $ 1,269 $ 714 $ (79) $ 1,274 1. See Note 19 for additional information. 2. Foreign exchange losses in 2022 relate primarily to exposures in the Argentinian peso. 3. See Note 14 for additional information. 4. Primarily related to charges associated with agreements entered into with DuPont and Corteva as part of the separation and distribution. 5. See Note 15 for additional information. 6. The year ended December 31, 2021 includes post-closing adjustments on a previous divestiture, related to Packaging & Specialty Plastics. The year ended December 31, 2020 primarily relates to a loss on the divestiture of a bio-ethanol manufacturing facility in Brazil, related to Packaging & Specialty Plastics. 7. See Note 4 for additional information. Accrued and Other Current Liabilities “Accrued and other current liabilities” were $2,770 million and $2,613 million at December 31, 2022 and $3,481 million and $3,299 million at December 31, 2021, for Dow Inc. and TDCC, respectively. Accrued payroll, which is a component of "Accrued and other current liabilities" and includes liabilities related to payroll, performance-based compensation and severance, was $650 million at December 31, 2022 and $1,030 million at December 31, 2021. No other components of "Accrued and other current liabilities" were more than 5 percent of total current liabilities. Supplemental Cash Flow Information The following table shows cash paid for interest and income taxes for the years ended December 31, 2022, 2021 and 2020: Supplemental Cash Flow Information 2022 2021 2020 In millions Cash paid during year for: Interest $ 675 $ 801 $ 842 Income taxes $ 793 $ 731 $ 518

INCOME TAXES (Notes)

INCOME TAXES (Notes)	12 Months Ended
	Dec. 31, 2022
Income Tax Disclosure [Abstract]
INCOME TAXES	INCOME TAXES The financial statements for Dow Inc. and TDCC are substantially similar, including the reporting of current and deferred tax expense (benefit), provision for income taxes, and deferred tax asset and liability balances. As a result, the following income tax discussion pertains to Dow Inc. only. Geographic Allocation of Income and Provision for Income Taxes In millions 2022 2021 2020 Income (loss) before income taxes Domestic $ 2,383 $ 1,523 $ (681) Foreign 3,707 6,622 2,752 Income before income taxes $ 6,090 $ 8,145 $ 2,071 Current tax expense (benefit) Federal $ 434 $ (46) $ (176) State and local 82 48 4 Foreign 855 1,460 691 Total current tax expense $ 1,371 $ 1,462 $ 519 Deferred tax expense Federal $ 63 $ 130 $ 184 State and local 1 26 19 Foreign 15 122 55 Total deferred tax expense $ 79 $ 278 $ 258 Provision for income taxes $ 1,450 $ 1,740 $ 777 Net income $ 4,640 $ 6,405 $ 1,294 Reconciliation to U.S. Statutory Rate 2022 2021 2020 Statutory U.S. federal income tax rate 21.0 % 21.0 % 21.0 % Equity earnings effect (1.2) (2.2) 0.2 Foreign income taxed at rates other than the statutory U.S. federal income tax rate (1.4) (1.3) (2.3) U.S. tax effect of foreign earnings and dividends 1.2 1.7 3.9 Unrecognized tax benefits 1.3 4.7 7.3 Divestitures 1 — — (5.1) Changes in valuation allowances (2.8) 2.6 12.6 Federal tax accrual adjustment 2 0.6 (5.3) 0.3 State and local income taxes 2.8 0.2 0.3 Other - net 2.3 — (0.7) Effective tax rate 23.8 % 21.4 % 37.5 % 1. The 2020 impact relates to the divestiture of a bio-ethanol manufacturing facility in Brazil. See Note 5 for additional information. 2. The 2021 impact represents a capital loss incurred on an internal restructuring fully offset by a valuation allowance reported in "Changes in valuation allowances" line item. Deferred Tax Balances at Dec 31 2022 2021 In millions Assets Liabilities Assets Liabilities Property $ 505 $ 3,001 $ 484 $ 3,150 Tax loss and credit carryforwards 1,472 — 1,784 — Postretirement benefit obligations 749 239 1,753 303 Other accruals and reserves 1,497 279 1,487 191 Intangibles 36 415 108 556 Inventory 129 278 33 203 Investments 116 41 31 26 Other – net 999 131 1,093 101 Subtotal $ 5,503 $ 4,384 $ 6,773 $ 4,530 Valuation allowances (1,269) — (1,391) — Total $ 4,234 $ 4,384 $ 5,382 $ 4,530 Operating Loss and Tax Credit Carryforwards at Dec 31 2022 2021 In millions Assets Assets Operating loss carryforwards Expire within 5 years $ 158 $ 240 Expire after 5 years or indefinite expiration 752 817 Total operating loss carryforwards $ 910 $ 1,057 Tax credit carryforwards Expire within 5 years $ 77 $ 227 Expire after 5 years or indefinite expiration 96 103 Total tax credit carryforwards $ 173 $ 330 Capital loss carryforwards Expire within 5 years $ 389 $ 397 Total tax loss and tax credit carryforwards $ 1,472 $ 1,784 Undistributed earnings of foreign subsidiaries and related companies that are deemed to be permanently invested amounted to $6,013 million at December 31, 2022 and $7,769 million at December 31, 2021. Undistributed earnings are subject to certain taxes upon repatriation, primarily where foreign withholding taxes apply. It is not practicable to calculate the unrecognized deferred tax liability on undistributed earnings. The following table provides a reconciliation of the Company's unrecognized tax benefits: Total Gross Unrecognized Tax Benefits In millions 2022 2021 2020 Total unrecognized tax benefits at Jan 1 $ 580 $ 373 $ 319 Decreases related to positions taken on items from prior years (47) (3) (1) Increases related to positions taken on items from prior years 53 187 52 Increases related to positions taken in the current year 46 44 18 Settlement of uncertain tax positions with tax authorities (111) (18) (14) Decreases due to expiration of statutes of limitations — (1) (1) Foreign exchange gain (1) (2) — Total unrecognized tax benefits at Dec 31 $ 520 $ 580 $ 373 Total unrecognized tax benefits that, if recognized, would impact the effective tax rate $ 520 $ 501 $ 285 Total amount of interest and penalties expense (benefit) recognized in "Provision for income taxes" $ (27) $ 359 $ 84 Total accrual for interest and penalties recognized in the consolidated balance sheets $ 498 $ 502 $ 144 The 2022 impacts primarily relate to the settlement of uncertain tax positions in multiple foreign jurisdictions. The 2021 impacts primarily relate to an increase in uncertain tax positions due to controversy in multiple jurisdictions related to various prior year cross-border matters. The Company files tax returns in multiple jurisdictions. These returns are subject to examination and possible challenge by the tax authorities. Open years contain matters that could be subject to differing interpretations of applicable tax laws and regulations as they relate to the amount, character, timing or inclusion of revenue and expenses or the sustainability of income tax credits for a given audit cycle. The ultimate resolution of such uncertainties is not expected to have a material impact on the Company's results of operations. The earliest open tax years are 2004 for state income taxes and 2007 for federal income taxes in the United States and 2011 in foreign jurisdictions.

EARNINGS PER SHARE (Notes)

EARNINGS PER SHARE (Notes)	12 Months Ended
	Dec. 31, 2022
Earnings Per Share [Abstract]
Earnings Per Share [Text Block]	EARNINGS PER SHARE CALCULATIONS The following tables provide earnings per share calculations of Dow Inc. for the years ended December 31, 2022, 2021 and 2020. In accordance with the accounting guidance for earnings per share, earnings per share of TDCC is not presented as this information is not required in financial statements of wholly owned subsidiaries. Net Income for Earnings Per Share Calculations 2022 2021 2020 In millions Net income $ 4,640 $ 6,405 $ 1,294 Net income attributable to noncontrolling interests 58 94 69 Net income attributable to participating securities 1 24 32 9 Net income attributable to common stockholders $ 4,558 $ 6,279 $ 1,216 1. Restricted stock units are considered participating securities due to the Company's practice of paying dividend equivalents on unvested shares. Earnings Per Share - Basic and Diluted 2022 2021 2020 Dollars per share Earnings per common share - basic $ 6.32 $ 8.44 $ 1.64 Earnings per common share - diluted $ 6.28 $ 8.38 $ 1.64 Share Count Information 2022 2021 2020 Shares in millions Weighted-average common shares outstanding - basic 721.0 743.6 740.5 Plus dilutive effect of equity compensation plans 4.6 5.4 1.8 Weighted-average common shares outstanding - diluted 725.6 749.0 742.3 Stock options and restricted stock units excluded from EPS calculations 1 7.6 5.8 14.2 1. These outstanding options to purchase shares of common stock and restricted stock units were excluded from the calculation of diluted earnings per share because the effect of including them would have been antidilutive.

INVENTORIES (Notes)

INVENTORIES (Notes)	12 Months Ended
	Dec. 31, 2022
Inventory Disclosure [Abstract]
INVENTORIES	INVENTORIES The following table provides a breakdown of inventories: Inventories at Dec 31 In millions 2022 2021 Finished goods $ 4,150 $ 4,554 Work in process 1,476 1,615 Raw materials 954 822 Supplies 892 866 Total $ 7,472 $ 7,857 Adjustment of inventories to the LIFO basis (484) (485) Total inventories $ 6,988 $ 7,372 Inventories valued on the LIFO basis represented 27 percent of the total inventories at December 31, 2022 and December 31, 2021.

PROPERTY (Notes)

PROPERTY (Notes)	12 Months Ended
	Dec. 31, 2022
Property, Plant and Equipment [Abstract]
PROPERTY	PROPERTY The following table provides a breakdown of property: Property at Dec 31 Estimated Useful 2022 2021 In millions Land and land improvements 0-25 $ 2,129 $ 2,045 Buildings 5-50 5,045 5,108 Machinery and equipment 3-25 42,131 42,627 Other property 3-50 6,622 6,286 Construction in progress — 2,128 1,538 Total property $ 58,055 $ 57,604 In millions 2022 2021 2020 Depreciation expense $ 1,958 $ 2,063 $ 2,092 Capitalized interest $ 63 $ 59 $ 64

NONCONSOLIDATED AFFILIATES (Not

NONCONSOLIDATED AFFILIATES (Notes)	12 Months Ended
	Dec. 31, 2022
Equity Method Investments and Joint Ventures [Abstract]
NONCONSOLIDATED AFFILIATES	NONCONSOLIDATED AFFILIATES The Company’s investments in companies accounted for using the equity method (“nonconsolidated affiliates”), by classification in the consolidated balance sheets, and dividends received from nonconsolidated affiliates are shown in the following tables: Investments in Nonconsolidated Affiliates at Dec 31 2022 1 2021 1 In millions Investment in nonconsolidated affiliates $ 1,589 $ 2,045 Other noncurrent obligations (144) — Net investment in nonconsolidated affiliates $ 1,445 $ 2,045 1. The carrying amount of the Company’s investments in nonconsolidated affiliates at December 31, 2022 and 2021 was $55 million less than its share of the investees’ net assets, exclusive of additional differences relating to Sadara, EQUATE Petrochemical Company K.S.C.C. ("EQUATE") and AgroFresh Solutions Inc. ("AFSI"), which are discussed separately in the disclosures that follow. Dividends Received from Nonconsolidated Affiliates 2022 2021 2020 In millions Dividends from nonconsolidated affiliates 1 $ 964 $ 324 $ 425 1. Included in "Earnings of nonconsolidated affiliates less than (in excess of) dividends received" in the consolidated statements of cash flows. Except for AFSI, the nonconsolidated affiliates in which the Company has investments are privately held companies; therefore, quoted market prices are not available. Sadara In 2011, the Company and Saudi Arabian Oil Company formed Sadara - a joint venture between the two companies that subsequently constructed and now operates a world-scale, fully integrated chemicals complex in Jubail Industrial City, Kingdom of Saudi Arabia. The Company has a 35 percent equity interest in this joint venture and has been, and continues to be, responsible for marketing the majority of Sadara’s products through the Company’s established sales channels. In 2021, Dow and the Saudi Arabian Oil Company agreed to and began transitioning the marketing rights and responsibilities for Sadara’s finished products to levels more consistent with each partner’s equity ownership, which is being implemented through 2026. This transition will not impact equity earnings, but is expected to reduce the Company's sales of Sadara products over the five year period. The Company’s investment in Sadara was $1,464 million less than Dow’s proportionate share of the carrying value of the underlying net assets held by Sadara at December 31, 2022 ($1,541 million less at December 31, 2021). This basis difference, which resulted from the 2019 impairment of the investment, is primarily attributed to the long-lived assets of Sadara and is being amortized over the remaining useful lives of the assets. At December 31, 2022, the Company had an investment balance in Sadara of $322 million ($416 million at December 31, 2021) included in “Investment in nonconsolidated affiliates” in the Company’s consolidated balance sheets. See Note 15 for additional information related to guarantees. In 2020, the Company loaned $333 million to Sadara that was accounted for as in substance common stock and classified as "Investment in nonconsolidated affiliates" in the Company's consolidated balance sheets. At December 31, 2022 and 2021, the Company's note receivable with Sadara was zero. EQUATE At December 31, 2022, the Company had a negative investment balance in EQUATE of $144 million classified as "Other noncurrent obligations" ($115 million at December 31, 2021 included in “Investment in nonconsolidated affiliates”) in the consolidated balance sheets. The Company's investment in EQUATE was $447 million less than the Company's proportionate share of EQUATE's underlying net assets at December 31, 2022 ($458 million less at December 31, 2021), which represents the difference between the fair values of certain MEGlobal assets acquired by EQUATE and the Company's related valuation on a U.S. GAAP basis. A basis difference of $126 million at December 31, 2022 ($140 million at December 31, 2021) is being amortized over the remaining useful lives of the assets and the remainder is considered a permanent difference. AFSI At December 31, 2022 and 2021, the Company had an investment balance in AFSI of zero. At December 31, 2022, the Company's investment in AFSI was $72 million less than the Company's proportionate share of AFSI's underlying net assets ($96 million less at December 31, 2021). This amount primarily relates to an other-than-temporary decline in the Company's investment in AFSI. At December 31, 2022 and 2021, the Company held a 40 percent ownership interest in AFSI. Transactions with Nonconsolidated Affiliates The Company has service agreements with certain nonconsolidated affiliates, including contracts to manage the operations of manufacturing sites and the construction of new facilities; licensing and technology agreements; and marketing, sales, purchase, lease and sublease agreements. The Company sells excess ethylene glycol produced at manufacturing facilities in the United States and Europe to MEGlobal, a subsidiary of EQUATE. The Company also sells ethylene to MEGlobal as a raw material for its ethylene glycol plants in Canada. Sales of these products to MEGlobal represented 1 percent of total net sales in 2022, 2021 and 2020. Sales of ethylene to MEGlobal are reflected in the Packaging & Specialty Plastics segment and represented 2 percent of the segment's sales in 2022, 2021 and 2020. Sales of ethylene glycol to MEGlobal are reflected in the Industrial Intermediates & Infrastructure segment and represented 1 percent of the segment's sales in 2022, 2021 and 2020. The Company is responsible for marketing the majority of Sadara products outside of the Middle East zone through the Company’s established sales channels. Under this arrangement, the Company purchases and sells Sadara products for a marketing fee. Purchases of Sadara products represented 7 percent of "Cost of sales" in 2022 (9 percent in 2021 and 8 percent in 2020). The Company purchases products from The SCG-Dow Group, primarily for marketing and distribution in Asia Pacific. Purchases of products from The SCG-Dow Group represented 3 percent of "Cost of sales" in 2022, 2021 and 2020. Sales to and purchases from other nonconsolidated affiliates were not material to the consolidated financial statements. Balances due to or due from nonconsolidated affiliates at December 31, 2022 and 2021 were as follows: Balances Due To or Due From Nonconsolidated Affiliates at Dec 31 2022 2021 In millions Accounts and notes receivable - Other $ 307 $ 357 Accounts payable - Other $ 1,083 $ 1,611 Principal Nonconsolidated Affiliates The Company had an ownership interest in 37 nonconsolidated affiliates at December 31, 2022 (37 at December 31, 2021). The Company's principal nonconsolidated affiliates and its ownership interest (direct and indirect) for each at December 31, 2022, 2021 and 2020 are as follows: Principal Nonconsolidated Affiliates at Dec 31 Country Ownership Interest 2022 2021 2020 EQUATE Petrochemical Company K.S.C.C. Kuwait 42.5 % 42.5 % 42.5 % The Kuwait Olefins Company K.S.C.C. Kuwait 42.5 % 42.5 % 42.5 % The Kuwait Styrene Company K.S.C.C. Kuwait 42.5 % 42.5 % 42.5 % Map Ta Phut Olefins Company Limited 1 Thailand 32.77 % 32.77 % 32.77 % Sadara Chemical Company Saudi Arabia 35 % 35 % 35 % The SCG-Dow Group: Siam Polyethylene Company Limited Thailand 50 % 50 % 50 % Siam Polystyrene Company Limited Thailand 50 % 50 % 50 % Siam Styrene Monomer Company Limited Thailand 50 % 50 % 50 % Siam Synthetic Latex Company Limited Thailand 50 % 50 % 50 % 1. The Company's effective ownership of Map Ta Phut Olefins Company Limited ("Map Ta Phut") is 32.77 percent, of which the Company directly owns 20.27 percent and indirectly owns 12.5 percent through its equity interest in Siam Polyethylene Company Limited. The Company’s investment in and equity earnings from its principal nonconsolidated affiliates are as follows: Investment in Principal Nonconsolidated Affiliates at Dec 31 2022 2021 In millions Investment in nonconsolidated affiliates $ 1,116 $ 1,621 Other noncurrent obligations (144) — Net investment in principal nonconsolidated affiliates $ 972 $ 1,621 Equity in Earnings (Losses) of Principal Nonconsolidated Affiliates 2022 2021 2020 In millions Equity in earnings (losses) of principal nonconsolidated affiliates $ 192 $ 918 $ (16) The summarized financial information that follows represents the combined accounts (at 100 percent) of the principal nonconsolidated affiliates. Summarized Balance Sheet Information at Dec 31 2022 2021 In millions Current assets $ 6,241 $ 8,158 Noncurrent assets 22,526 23,681 Total assets $ 28,767 $ 31,839 Current liabilities $ 3,754 $ 3,990 Noncurrent liabilities 18,999 20,039 Total liabilities $ 22,753 $ 24,029 Noncontrolling interests $ 223 $ 174 Summarized Income Statement Information 1 2022 2021 2020 In millions Sales $ 14,026 $ 14,969 $ 9,470 Gross profit $ 1,246 $ 3,219 $ 619 Income (loss), net of tax $ (91) $ 2,013 $ (461) 1. The results in this table include purchase and sale activity between certain principal nonconsolidated affiliates and the Company, as previously discussed in the "Transactions with Nonconsolidated Affiliates" section.

GOODWILL AND OTHER INTANGIBLE A

GOODWILL AND OTHER INTANGIBLE ASSETS (Notes)	12 Months Ended
	Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
GOODWILL AND OTHER INTANGIBLE ASSETS	GOODWILL AND OTHER INTANGIBLE ASSETS The following table shows changes in the carrying amounts of goodwill by reportable segment for the years ended December 31, 2022 and 2021: Goodwill Packaging & Specialty Plastics Industrial Intermediates & Infrastructure Performance Materials & Coatings Total In millions Balance at Jan 1, 2021 $ 5,115 $ 1,100 $ 2,693 $ 8,908 Foreign currency impact (10) (4) (130) (144) Balance at Dec 31, 2021 $ 5,105 $ 1,096 $ 2,563 $ 8,764 Foreign currency impact (5) (3) (112) (120) Balance at Dec 31, 2022 $ 5,100 $ 1,093 $ 2,451 $ 8,644 At December 31, 2022, goodwill was carried by all reporting units except Coatings & Performance Monomers. Goodwill Impairments The carrying amounts of goodwill at December 31, 2022 and 2021 were net of accumulated impairments of $309 million in Industrial Intermediates & Infrastructure and $2,530 million in Performance Materials & Coatings. Goodwill Impairment Testing The Company performs an impairment test of goodwill annually in the fourth quarter. In 2022, the Company performed qualitative testing for all reporting units that carried goodwill. Based on the results of the qualitative testing, the Company did not perform quantitative testing on any reporting units in 2022 and 2021. Quantitative testing was performed for one reporting unit in 2020. The qualitative testing on the reporting units indicated that it was not more likely than not that fair value was less than the carrying value for the reporting units. The quantitative testing conducted in 2020 concluded that no goodwill impairments existed. Other Intangible Assets The following table provides information regarding the Company’s other intangible assets: Other Intangible Assets at Dec 31 2022 2021 In millions Gross Accum Amort Net Gross Accum Amort Net Intangible assets: Developed technology 1 $ 2,651 $ (2,025) $ 626 $ 2,654 $ (1,871) $ 783 Software 1,358 (962) 396 1,396 (945) 451 Trademarks/tradenames 352 (345) 7 352 (344) 8 Customer-related 3,103 (1,690) 1,413 3,204 (1,565) 1,639 Total other intangible assets $ 7,464 $ (5,022) $ 2,442 $ 7,606 $ (4,725) $ 2,881 1. Includes $17 million gross carrying amount in 2022 and 2021 for in-process research and development that has not yet commercialized. The following table provides information regarding amortization expense related to intangible assets: Amortization Expense 2022 2021 2020 In millions Other intangible assets, excluding software $ 336 $ 388 $ 401 Software, included in "Cost of sales" $ 80 $ 90 $ 96 Total estimated amortization expense for the next five fiscal years, including amounts expected to be capitalized, is as follows: Estimated Amortization Expense for Next Five Years In millions 2023 $ 387 2024 $ 368 2025 $ 278 2026 $ 203 2027 $ 170

TRANSFERS OF FINANCIAL ASSETS (

TRANSFERS OF FINANCIAL ASSETS (Notes)	12 Months Ended
	Dec. 31, 2022
Transfers and Servicing [Abstract]
TRANSFERS OF FINANCIAL ASSETS	TRANSFERS OF FINANCIAL ASSETS Accounts Receivable Programs The Company maintains committed accounts receivable facilities with various financial institutions, including in the United States (“U.S. Program”) and in Europe (“Europe Program” and together with the U.S. Program, "the Programs"), which are both set to expire in November 2025. Under the terms of the Programs, the Company may sell certain eligible trade accounts receivable at any point in time, up to $900 million for the U.S. Program and up to €500 million for the Europe Program. Under the terms of the Programs, the Company continues to service the receivables from the customer, but retains no interest in the receivables, and remits payment to the financial institutions. The Company also provides a guarantee to the financial institutions for the creditworthiness and collection of the receivables in satisfaction of the facility. See Note 15 for additional information related to guarantees. In 2022, the Company sold $391 million (zero in 2021) of receivables under the Programs.

NOTES PAYABLE, LONG-TERM DEBT A

NOTES PAYABLE, LONG-TERM DEBT AND AVAILABLE CREDIT FACILITIES (Notes)	12 Months Ended
	Dec. 31, 2021
Debt Disclosure [Abstract]
NOTES PAYABLE, LONG-TERM DEBT AND AVAILABLE CREDIT FACILITIES	NOTES PAYABLE, LONG-TERM DEBT AND AVAILABLE CREDIT FACILITIES Notes Payable at Dec 31 In millions 2022 2021 Commercial paper $ 299 $ — Notes payable to banks and other lenders 63 161 Total notes payable $ 362 $ 161 Year-end average interest rates 6.55 % 5.78 % Long-Term Debt at Dec 31 2022 Average Rate 2022 2021 2021 In millions Promissory notes and debentures: Final maturity 2022 — % $ — 8.64 % $ 121 Final maturity 2023 7.63 % 250 7.63 % 250 Final maturity 2025 5.63 % 333 5.63 % 333 Final maturity 2026 — % — 3.63 % 750 Final maturity 2028 and thereafter 1 5.36 % 10,864 5.15 % 9,363 Other facilities: Foreign currency notes and loans, various rates and maturities 1.16 % 2,562 1.17 % 2,730 InterNotes®, varying maturities through 2052 3.87 % 543 3.37 % 392 Finance lease obligations 2 790 869 Unamortized debt discount and issuance costs (282) (297) Long-term debt due within one year 3 (362) (231) Long-term debt $ 14,698 $ 14,280 1. Cost includes net fair value hedge adjustment gains of $46 million at December 31, 2022 ($47 million at December 31, 2021). See Note 21 for additional information. 2. See Note 16 for additional information. 3. Presented net of current portion of unamortized debt issuance costs. Maturities of Long-Term Debt for Next Five Years at Dec 31, 2022 In millions 2023 $ 362 2024 $ 127 2025 $ 388 2026 $ 78 2027 $ 1,209 2022 Activity In the second quarter of 2022, the Company redeemed $750 million aggregate principal amount of 3.625 percent notes due May 2026. As a result of the redemption, the Company recognized a pretax loss on the early extinguishment of debt of $8 million, included in "Sundry income (expense) - net" in the consolidated statements of income and related to Corporate. In the fourth quarter of 2022, the Company issued $1.5 billion of senior unsecured notes. The offering included $600 million aggregate principal amount of 6.30 percent notes due 2033 and $900 million aggregate principal amount of 6.90 percent notes due 2053. In 2022, the Company issued an aggregate principal amount of $167 million of InterNotes®. Additionally, the Company repaid $121 million of long-term debt at maturity and approximately $3 million of long-term debt was repaid by consolidated variable interest entities. 2021 Activity In the second quarter of 2021, the Company redeemed $208 million aggregate principal amount of 3.15 percent notes due May 2024 and $811 million aggregate principal amount of 3.50 percent notes due October 2024. As a result of the redemptions, the Company recognized a pretax loss of $101 million on the early extinguishment of debt, included in "Sundry income (expense) - net" in the consolidated statements of income and related to Corporate. In the third quarter of 2021, the Company completed cash tender offers for certain debt securities. In total, $1,042 million aggregate principal amount was tendered and retired. As a result, the Company recognized a pretax loss of $472 million on the early extinguishment of debt, included in "Sundry income (expense) – net" in the consolidated statements of income and related to Corporate. In addition, the Company voluntarily repaid $81 million of long-term debt due within one year. In 2021, the Company issued an aggregate principal amount of $109 million of InterNotes®, and redeemed an aggregate principal amount of $31 million at maturity. In addition, the Company voluntarily repaid an aggregate principal amount of $213 million of InterNotes® with various maturities. As a result, the Company recognized a pretax loss of $1 million on the early extinguishment of debt, included in "Sundry income (expense) - net" in the consolidated statements of income and related to Corporate. Additionally, the Company repaid $259 million of long-term debt at maturity and approximately $25 million of long-term debt was repaid by consolidated variable interest entities. 2020 Activity In February 2020, the Company issued €2.25 billion aggregate principal amount of notes (“Euro Notes”). The Euro Notes included €1.0 billion aggregate principal amount of 0.50 percent notes due 2027, €750 million aggregate principal amount of 1.125 percent notes due 2032 and €500 million aggregate principal amount of 1.875 percent notes due 2040. The Euro Notes have a weighted average coupon rate of approximately 1.0 percent. With the net proceeds from the issuance of the Euro Notes, Dow Silicones voluntarily repaid $750 million of principal under a certain third party credit agreement ("Term Loan Facility”). In addition, the Company redeemed $1.25 billion of 3.0 percent notes issued by the Company with maturity in 2022. As a result, the Company recognized a pretax loss of $85 million on the early extinguishment of debt, included in “Sundry income (expense) – net” in the consolidated statements of income and related to Corporate. In the first quarter of 2020, the Company withdrew $800 million under various uncommitted bilateral credit arrangements, which were subsequently repaid in the second quarter of 2020. In August 2020, the Company issued $2.0 billion aggregate principal amount of notes. The notes included $850 million aggregate principal amount of 2.1 percent notes due 2030 and $1.15 billion aggregate principal amount of 3.6 percent notes due 2050 (together, the "Notes" ). With the net proceeds from the issuance of the Notes, Dow Silicones voluntarily repaid the remaining $1.25 billion outstanding principal balance under the Term Loan Facility. In September 2020, the Company also used $556 million of aggregate proceeds from the Notes to fund cash tender offers for certain of its debt securities and certain debt securities of Union Carbide. In total, $493 million aggregate principal amount was tendered and retired. These actions resulted in a pretax loss of $62 million on the early extinguishment of debt included in "Sundry income (expense) – net" in the consolidated statements of income and related to Corporate. In 2020, the Company also issued an aggregate principal amount of $190 million of InterNotes® and redeemed an aggregate principal amount of $180 million at maturity. In addition, the Company voluntarily repaid an aggregate principal amount of $400 million of InterNotes® with various maturities. As a result, the Company recognized a pretax loss on the early extinguishment of debt of $2 million, included in “Sundry income (expense) – net” in the consolidated statements of income and related to Corporate. Additionally, the Company repaid $134 million of long-term debt at maturity and approximately $29 million of long-term debt was repaid by consolidated variable interest entities. Available Credit Facilities The following table summarizes the Company's credit facilities: Committed and Available Credit Facilities at Dec 31, 2022 In millions Committed Credit Credit Available Maturity Date Interest Five Year Competitive Advance and Revolving Credit Facility $ 5,000 $ 5,000 November 2027 Floating rate Bilateral Revolving Credit Facility 300 300 September 2023 Floating rate Bilateral Revolving Credit Facility 1 500 500 November 2024 Floating rate Bilateral Revolving Credit Facility 100 100 March 2025 Floating rate Bilateral Revolving Credit Facility 100 100 March 2025 Floating rate Bilateral Revolving Credit Facility 100 100 March 2025 Floating rate Bilateral Revolving Credit Facility 200 200 September 2025 Floating rate Bilateral Revolving Credit Facility 250 250 September 2025 Floating rate Bilateral Revolving Credit Facility 300 300 November 2025 Floating rate Bilateral Revolving Credit Facility 100 100 March 2026 Floating rate Bilateral Revolving Credit Facility 150 150 November 2026 Floating rate Bilateral Revolving Credit Facility 200 200 November 2026 Floating rate Bilateral Revolving Credit Facility 250 250 March 2027 Floating rate Bilateral Revolving Credit Facility 100 100 May 2027 Floating rate Bilateral Revolving Credit Facility 350 350 June 2027 Floating rate Bilateral Revolving Credit Facility 200 200 September 2027 Floating rate Bilateral Revolving Credit Facility 100 100 October 2027 Floating rate Bilateral Revolving Credit Facility 100 100 November 2027 Floating rate Total Committed and Available Credit Facilities $ 8,400 $ 8,400 1. Assumes the option to extend the bilateral revolving credit facility will be exercised. Letters of Credit The Company utilizes letters of credit to support commitments made in the ordinary course of business. While the terms and amounts of letters of credit change, the Company generally has approximately $600 million of outstanding letters of credit at any given time. Debt Covenants and Default Provisions TDCC’s outstanding long-term debt has been issued primarily under indentures which contain, among other provisions, certain customary restrictive covenants with which TDCC must comply while the underlying notes are outstanding. Failure of TDCC to comply with any of its covenants, could result in a default under the applicable indenture and allow the note holders to accelerate the due date of the outstanding principal and accrued interest on the underlying notes. TDCC's indenture covenants include obligations to not allow liens on principal U.S. manufacturing facilities, enter into sale and lease-back transactions with respect to principal U.S. manufacturing facilities, merge or consolidate with any other corporation, or sell, lease or convey, directly or indirectly, all or substantially all of TDCC’s assets. The outstanding debt also contains customary default provisions. TDCC remains in compliance with these covenants. TDCC’s primary, private credit agreements also contain certain customary restrictive covenant and default provisions in addition to the covenants set forth above with respect to TDCC’s debt. Significant other restrictive covenants and default provisions related to these agreements include: (a) the obligation to maintain the ratio of TDCC’s consolidated indebtedness to consolidated capitalization at no greater than 0.70 to 1.00 at any time the aggregate outstanding amount of loans under the Five Year Competitive Advance and Revolving Credit Facility Agreement ("Revolving Credit Agreement") dated November 23, 2021, equals or exceeds $500 million, (b) a default if TDCC or an applicable subsidiary fails to make any payment, including principal, premium or interest, under the applicable agreement on other indebtedness of, or guaranteed by, TDCC or such applicable subsidiary in an aggregate amount of $100 million or more when due, or any other default or other event under the applicable agreement with respect to such indebtedness occurs which permits or results in the acceleration of $400 million or more in the aggregate of principal, and (c) a default if TDCC or any applicable subsidiary fails to discharge or stay within 60 days after the entry of a final judgment against TDCC or such applicable subsidiary of more than $400 million. Failure of TDCC to comply with any of the covenants or default provisions could result in a default under the applicable credit agreement which would allow the lenders to not fund future loan requests and to accelerate the due date of the outstanding principal and accrued interest on any outstanding indebtedness. Dow Inc. is obligated, substantially concurrently with the issuance of any guarantee in respect of outstanding or committed indebtedness under TDCC's Revolving Credit Agreement, to enter into a supplemental indenture with TDCC and the trustee under TDCC’s existing 2008 base indenture governing certain notes issued by TDCC. Under such supplemental indenture, Dow Inc. will guarantee all outstanding debt securities and all amounts due under such existing base indenture and will become subject to certain covenants and events of default under the existing base indenture. In addition, the Revolving Credit Agreement includes an event of default which would be triggered in the event Dow Inc. incurs or guarantees third party indebtedness for borrowed money in excess of $250 million or engages in any material activity or directly owns any material assets, in each case, subject to certain conditions and exceptions. Dow Inc. may, at its option, cure the event of default by delivering an unconditional and irrevocable guarantee to the administrative agent within thirty days of the event or events giving rise to such event of default. No such events have occurred or have been triggered at the time of the filing of this Annual Report on Form 10-K.

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Notes)	12 Months Ended
	Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENT LIABILITIES	COMMITMENTS AND CONTINGENCIES Environmental Matters Introduction Accruals for environmental matters are recorded when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated based on current law and existing technologies. At December 31, 2022, the Company had accrued obligations of $1,192 million for probable environmental remediation and restoration costs ($1,220 million at December 31, 2021), including $244 million for the remediation of Superfund sites ($237 million at December 31, 2021). This is management’s best estimate of the costs for remediation and restoration with respect to environmental matters for which the Company has accrued liabilities, although it is reasonably possible that the ultimate cost with respect to these particular matters could range up to approximately two times that amount. Consequently, it is reasonably possible that environmental remediation and restoration costs in excess of amounts accrued could have a material impact on the Company’s results of operations, financial condition and cash flows. It is the opinion of the Company’s management, however, that the possibility is remote that costs in excess of the range disclosed will have a material impact on the Company’s results of operations, financial condition or cash flows. Inherent uncertainties exist in these estimates primarily due to unknown conditions, changing governmental regulations and legal standards regarding liability, and emerging remediation technologies for handling site remediation and restoration. As new or additional information becomes available and/or certain spending trends become known, management will evaluate such information in determination of the current estimate of the environmental liability. As part of the Company's 2020 Restructuring Program, in the third quarter of 2020, the Company recorded a pretax charge related to environmental remediation matters. This charge resulted from the Company's evaluation of the costs required to manage remediation activities at sites Dow will permanently shut down as part of its 2020 Restructuring Program. In addition, the Company recorded indemnification assets of $50 million related to Dow Silicones' environmental matters. The Company recognized a pretax charge, net of indemnifications, of $56 million, included in "Restructuring and asset related charges - net" in the consolidated statements of income and related to Performance Materials & Coatings ($52 million) and Corporate ($4 million). See Note 5 for additional information. The following table summarizes the activity in the Company's accrued obligations for environmental matters for the years ended December 31, 2022 and 2021: Accrued Obligations for Environmental Matters 2022 2021 In millions Balance at Jan 1 $ 1,220 $ 1,244 Accrual adjustment 184 159 Payments against reserve (204) (162) Foreign currency impact (8) (21) Balance at Dec 31 $ 1,192 $ 1,220 The amounts charged to income on a pretax basis related to environmental remediation totaled $ 176 million 158 million 234 million Midland Off-Site Environmental Matters On June 12, 2003, the Michigan Department of Environmental Quality ("MDEQ") issued a Hazardous Waste Operating License (the "License") to the Company’s Midland, Michigan, manufacturing site (the “Midland Site”), which was renewed and replaced by the MDEQ on September 25, 2015, and included provisions requiring the Company to conduct an investigation to determine the nature and extent of off-site contamination in the City of Midland soils, the Tittabawassee River and Saginaw River sediment and floodplain soils, and the Saginaw Bay, and, if necessary, undertake remedial action. In 2016, final regulatory approval was received from the MDEQ for the City of Midland and the Company is continuing the long term monitoring requirements of the Remedial Action Plan. Tittabawassee and Saginaw Rivers, Saginaw Bay The Company, the U.S. Environmental Protection Agency (“EPA”) and the State of Michigan ("State") entered into an administrative order on consent (“AOC”), effective January 21, 2010, that requires the Company to conduct a remedial investigation, a feasibility study and a remedial design for the Tittabawassee River, the Saginaw River and the Saginaw Bay, and pay the oversight costs of the EPA and the State under the authority of the Comprehensive Environmental Response, Compensation, and Liability Act. These actions, to be conducted under the lead oversight of the EPA, will build upon the investigative work completed under the State Resource Conservation Recovery Act program from 2005 through 2009. The Tittabawassee River, beginning at the Midland Site and extending down to the first six miles of the Saginaw River, are designated as the first Operable Unit for purposes of conducting the remedial investigation, feasibility study and remedial design work. This work will be performed in a largely upriver to downriver sequence for eight geographic segments of the Tittabawassee and upper Saginaw Rivers. In the first quarter of 2012, the EPA requested the Company address the Tittabawassee River floodplain ("Floodplain") as an additional segment. In January 2015, the Company and the EPA entered into an order to address remediation of the Floodplain. The remedial work is expected to continue as river levels allow. The remainder of the Saginaw River and the Saginaw Bay are designated as a second Operable Unit and the work associated with that unit may also be geographically segmented. The AOC does not obligate the Company to perform removal or remedial action; that action can only be required by a separate order. The Company and the EPA have been negotiating orders separate from the AOC that obligate the Company to perform remedial actions under the scope of work of the AOC. The Company and the EPA have entered into six separate orders to perform limited remedial actions in seven of the eight geographic segments in the first Operable Unit, including the Floodplain. Dow has received from the EPA a Notice of Completion of Work for three of these six orders and the Company continues the long-term monitoring requirements. Dow also has entered into a separate order to perform a limited remedial action for certain properties located within the second Operable Unit. In 2022, the Company implemented the limited remedial action in the second Operable Unit. Alternative Dispute Resolution Process The Company, the EPA, the U.S. Department of Justice and the natural resource damage trustees (which include the Michigan Office of the Attorney General, the Michigan Department of Environment, Great Lakes and Energy, the Michigan Department of Natural Resources, the U.S. Fish and Wildlife Service, the U.S. Bureau of Indian Affairs and the Saginaw-Chippewa Indian Tribe of Michigan) have been engaged in negotiations to seek to resolve potential governmental claims against the Company for natural resource damages related to historical off-site contamination associated with the City of Midland, the Tittabawassee and Saginaw Rivers and the Saginaw Bay. The Company and the governmental parties started meeting in the fall of 2005 and entered into a Confidentiality Agreement in December 2005. On July 20, 2020, the U.S. District Court for the Eastern District of Michigan ("District Court") entered a final consent decree in Civil Action No. 1:19-cv-13292 between the Company and federal, state and tribal trustees to resolve allegations of natural resource damages arising from the historic operations of the Company’s Midland Site. The consent decree required the Company to pay a $15 million cash settlement to be used for long-term maintenance and trustee-selected remediation projects with an additional $7 million to specified local projects managed by third parties. These funds were paid in December 2020. The consent decree further requires the Company to complete 13 additional environmental restoration projects which are valued by the trustees at approximately $77 million, to be conducted over the next several years. In 2022, the first environmental restoration project was opened to the public. The Company continues to work with the trustees on the remaining projects. At December 31, 2022, the accrual for these off-site matters was $92 million (included in the total accrued obligation of $1,192 million). At December 31, 2021, the Company had an accrual for these off-site matters of $104 million (included in the total accrued obligation of $1,220 million). Environmental Matters Summary It is the opinion of the Company’s management that the possibility is remote that costs in excess of those disclosed will have a material impact on the Company’s results of operations, financial condition or cash flows. Litigation Asbestos-Related Matters of Union Carbide Corporation Introduction Union Carbide is and has been involved in a large number of asbestos-related suits filed primarily in state courts during the past four decades. These suits principally allege personal injury resulting from exposure to asbestos-containing products and frequently seek both actual and punitive damages. The alleged claims primarily relate to products that Union Carbide sold in the past, alleged exposure to asbestos-containing products located on Union Carbide’s premises and Union Carbide’s responsibility for asbestos suits filed against a former Union Carbide subsidiary, Amchem Products, Inc. ("Amchem"). In many cases, plaintiffs are unable to demonstrate that they have suffered any compensable loss as a result of such exposure, or that injuries incurred in fact resulted from exposure to Union Carbide’s products. Union Carbide expects more asbestos-related suits to be filed against Union Carbide and Amchem in the future, and will aggressively defend or reasonably resolve, as appropriate, both pending and future claims. Estimating the Asbestos-Related Liability Union Carbide has engaged Ankura Consulting Group, LLC ("Ankura") to perform periodic studies to estimate the undiscounted cost of disposing of pending and future claims against Union Carbide and Amchem through the terminal year of 2049, including a reasonable forecast of future defense and processing costs. Each October, Union Carbide requests Ankura to review its historical asbestos claim and resolution activity through the third quarter of the current year, including asbestos-related defense and processing costs, to determine the appropriateness of updating the most recent study. At each balance sheet date, Union Carbide also compares current asbestos claim and resolution activity, including asbestos-related defense and processing costs, to the results of the most recent Ankura study to determine whether the accrual continues to be appropriate. In December 2020, Ankura completed a study of Union Carbide's historical asbestos claim and resolution activity through September 30, 2020, including asbestos-related defense and processing costs, and provided estimates for the undiscounted cost of disposing of pending and future claims against Union Carbide and Amchem through the terminal year of 2049. Based on the study and Union Carbide's internal review process, it was determined that no adjustment to the accrual was required. In December 2021, Ankura stated that an update of its December 2020 study would not provide a more likely estimate of future events than the estimate reflected in the study and, therefore, the estimate in the study remained applicable. Based on Union Carbide's internal review process and Ankura's response, Union Carbide determined that no change to the accrual was required. At December 31, 2021, the asbestos-related liability for pending and future claims against Union Carbide and Amchem, including future asbestos-related defense and processing costs, was $1,016 million, and approximately 25 percent of the recorded liability related to pending claims and approximately 75 percent related to future claims. In December 2022, Ankura completed a study of Union Carbide's historical asbestos claim and resolution activity through September 30, 2022, including asbestos-related defense and processing costs, and provided estimates for the undiscounted cost of disposing of pending and future claims against Union Carbide and Amchem through the terminal year of 2049. Based on the study and Union Carbide's internal review process, it was determined that no adjustment to the accrual was required. At December 31, 2022, the asbestos-related liability for pending and future claims against Union Carbide and Amchem, including future asbestos-related defense and processing costs, was $947 million, and approximately 23 percent of the recorded liability related to pending claims and approximately 77 percent related to future claims. Summary The Company's management believes the amounts recorded by Union Carbide for the asbestos-related liability, including defense and processing costs, reflect reasonable and probable estimates of the liability based upon current, known facts. However, future events, such as the number of new claims to be filed and/or received each year, the average cost of defending and disposing of each such claim, as well as the numerous uncertainties surrounding asbestos litigation in the United States over a significant period of time, could cause the actual costs for Union Carbide to be higher or lower than those projected or those recorded. Any such events could result in an increase or decrease in the recorded liability. Because of the uncertainties described above, Union Carbide cannot estimate the full range of the cost of resolving pending and future asbestos-related claims facing Union Carbide and Amchem. As a result, it is reasonably possible that an additional cost of disposing of Union Carbide's asbestos-related claims, including future defense and processing costs, could have a material impact on the Company's results of operations and cash flows for a particular period and on the consolidated financial position. Dow Silicones Chapter 11 Related Matters In 1995, Dow Silicones, then a 50:50 joint venture between the Company and Corning Incorporated ("Corning"), voluntarily filed for protection under Chapter 11 of the U.S. Bankruptcy Code in order to resolve Dow Silicones’ breast implant liabilities and related matters (the “Chapter 11 Proceeding”). Dow Silicones emerged from the Chapter 11 Proceeding on June 1, 2004 (the “Effective Date”) and is implementing the Joint Plan of Reorganization (the “Plan”). The Plan provides funding for the resolution of breast implant and other product liability litigation covered by the Chapter 11 Proceeding. As of June 1, 2016, Dow Silicones is a wholly owned subsidiary of the Company. Under the Plan, a product liability settlement program administered by an independent claims office and funded by Dow Silicones (the “Settlement Facility”) was created to resolve breast implant and other product liability claims. Product liability claimants rejecting the settlement program in favor of pursuing litigation must bring suit against a litigation facility (the "Litigation Facility") that is also funded by Dow Silicones. At December 31, 2022, Dow Silicones and its insurers have made life-to-date payments of $1,846 million to the Settlement Facility and Litigation Facility and Dow Silicones is currently making additional payments to fund the Settlement Facility. In accordance with ASC Topic 450 "Accounting for Contingencies," the Company records a liability for breast implant and other product liability claims (“Implant Liability”), which reflects the estimated impact of the settlement of pending claims. The claim filing deadline passed in June 2019. All claims have been received and are being processed. In the fourth quarter of 2022, with the assistance of a third party consultant, Dow Silicones updated its Implant Liability estimate to reflect the reduced uncertainty of the Company's liability for unpaid claims, the decrease in claims filing activity and the passage of time. Accordingly, Dow Silicones decreased its Implant Liability by $60 million, which was included in "Sundry income (expense) - net" in the consolidated statements of income and related to Corporate. Based on the new estimate related to claims filed at and before the claim filing deadline, Dow Silicones estimates that it will be obligated to contribute an additional $16 million to the Settlement Facility at December 31, 2022 ($130 million at December 31, 2021) which was included in “Accrued and other current liabilities” and "Other noncurrent obligations" in the consolidated balance sheets. Dow Silicones believes the recorded liability reflects the best estimate of the remaining funding obligations under the Plan and is not aware of circumstances based on current, known facts that would significantly change the Implant Liability estimate. Other Litigation Matters In addition to the specific matters described above, the Company is party to a number of other claims and lawsuits arising out of the normal course of business with respect to product liability, patent infringement, employment matters, governmental tax and regulation disputes, contract and commercial litigation, and other actions. Certain of these actions purport to be class actions and seek damages in very large amounts. All such claims are being contested. The Company has an active risk management program consisting of numerous insurance policies secured from many carriers at various times. These policies may provide coverage that could be utilized to minimize the financial impact, if any, of certain contingencies described above. It is the opinion of the Company’s management that the possibility is remote that the aggregate of all such other claims and lawsuits will have a material adverse impact on the results of operations, financial condition and cash flows of the Company. Indemnifications with Corning In connection with the June 1, 2016 ownership restructure of Dow Silicones, the Company is indemnified by Corning for at least 50 percent of future losses associated with certain pre-closing liabilities, including the Implant Liability and certain environmental matters described in the preceding sections, subject to certain conditions and limits. The maximum amount of indemnified losses which may be recovered are subject to a cap that declines over time. Indemnified losses are capped at $1 billion between May 31, 2018 and May 31, 2023, and no recoveries are permitted on claims initially submitted after May 31, 2023. The Company had indemnification assets of $98 million at December 31, 2022 ($95 million at December 31, 2021), which was included in "Other current assets" and "Noncurrent receivables" in the consolidated balance sheets. Gain Contingency - Dow v. Nova Chemicals Corporation Patent Infringement Matter In December 2010, Dow filed suit in the Federal Court in Ontario, Canada ("Federal Court") alleging that Nova Chemicals Corporation ("Nova") was infringing the Company's Canadian polyethylene patent 2,106,705 (the "'705 Patent"). Nova counterclaimed on the grounds of invalidity and non-infringement. In accordance with Canadian practice, the suit was bifurcated into a merits phase, followed by a damages phase. Following trial in the merits phase, in May 2014 the Federal Court ruled that the Company's '705 Patent was valid and infringed by Nova. Nova appealed to the Canadian Federal Court of Appeal, which affirmed the Federal Court decision in August 2016. Nova then sought leave to appeal its loss to the Supreme Court of Canada ("Canadian Supreme Court"), which dismissed Nova’s petition in April 2017. As a result, Nova exhausted all appeal rights on the merits, and it was undisputed that Nova owed the Company the profits it earned from its infringing sales as determined in the trial for the damages phase. In April 2017, the Federal Court issued a Public Judgment in the damages phase, which detailed its conclusions on how to calculate the profits to be awarded to the Company. In June 2017, the Federal Court ordered Nova to pay $645 million Canadian dollars (equivalent to $495 million U.S. dollars) to the Company, plus pre- and post-judgment interest, for which the Company received payment of $501 million from Nova in July 2017. Although Nova was appealing portions of the damages judgment, certain portions of it were indisputable and could be retained by the Company regardless of the outcome of any further appeals by Nova. As a result of these actions and in accordance with ASC Topic 450-30 "Gain Contingencies," the Company recorded a $160 million pretax gain in the second quarter of 2017. On September 15, 2020, the Canadian Federal Court of Appeal dismissed Nova's appeal of the damages judgment, thus affirming the trial court's decision in its entirety. In November 2020, Nova filed an application for leave to appeal this decision to the Canadian Supreme Court. In November 2022, the Canadian Supreme Court dismissed Nova's appeal, thereby exhausting all of Nova's appeal rights for the damages judgment. As a result, the Company recorded a pretax gain of $341 million in the fourth quarter of 2022 for the previously disputed portion of the damages judgment, of which $321 million was included in "Sundry income (expense) - net," related to Packaging & Specialty Plastics, and $20 million was included in "Selling, general and administrative expenses" in the consolidated statements of income. At December 31, 2021, the Company had $341 million included in "Accrued and other current liabilities" related to the previously disputed portion of the damages judgment (zero at December 31, 2022). Gain Contingency - Dow v. Nova Chemicals Corporation Ethylene Asset Matter On September 18, 2019, the Court of the Queen’s Bench in Alberta, Canada, signed a judgment ordering Nova to pay the Company $1.43 billion Canadian dollars (equivalent to approximately $1.08 billion U.S. dollars) by October 11, 2019, for damages the Company incurred through 2012 related to the companies’ jointly-owned ethylene asset in Joffre, Alberta, Canada. The Court of the Queen's Bench in Alberta, Canada, which initially ruled in June 2018, found that Nova failed to operate the ethylene asset at full capacity for more than ten years, and furthermore, that Nova violated several contractual agreements related to the Company receiving its share of the asset’s ethylene production. These actions deprived the Company of millions of pounds of ethylene. Nova appealed the judgment, however, certain portions of it are no longer in dispute and can be retained by the Company regardless of the outcome of any further appeals by Nova. As a result and in accordance with ASC Topic 450-30 “Gain Contingencies,” the Company recorded a $186 million pretax gain in the third quarter of 2019. In October 2019, Nova paid $1.08 billion Canadian dollars (equivalent to approximately $0.8 billion U.S. dollars) directly to the Company, and remitted $347 million Canadian dollars to the Canada Revenue Agency ("CRA") for the tax account of one of the Company's subsidiaries. The Company sought a refund of the entire amount remitted to CRA. On March 31, 2020, the Company received the full refund from CRA, equivalent to $259 million U.S. dollars. In preparation for the June 2020 appellate hearing on the case, Nova provided the Court of the Queen's Bench in Alberta, Canada, an updated schedule of the financial impact of the issues on appeal, which explained that even if Nova prevails on all appeal issues, the Company would still be entitled to retain an amount in excess of the gain recognized in 2019. As a result, the Company recorded an $18 million pretax gain in the second quarter of 2020, of which $12 million was included in "Selling, general and administrative expenses" and $6 million was include d in "Sundry income (expense) - net" in the consolidated statements of income and related to Packaging & Specialty Plastics. On September 16, 2020, the Court of Appeal of Alberta issued its decision, affirming the trial court's liability finding, upholding the majority of Dow's damages and requiring the trial court to recalculate a portion of damages. In the fourth quarter of 2020, Nova chose not to petition the Canadian Supreme Court to review the appellate court decision, making additional portions of the ruling in Dow’s favor final and no longer subject to dispute. As a result, the Company recorded a $552 million pretax gain in the fourth quarter of 2020, of which $538 million was included in "Sundry income (expense) - net" and $14 million was included in "Selling, general and administrative expenses" in the consolidated statements of income and related to Packaging & Specialty Plastics. At December 31, 2022, $323 million ($323 million at December 31, 2021) was included in "Other noncurrent obligations" in the Company's consolidated balance sheets related to the disputed portion of the damages judgment. Dow continues to seek an award of additional damages for the period from 2013 through 2018 to account for the ethylene shortfall during those years. The damages hearing began in the trial court in November 2021 that would resolve the impact of the appellate ruling and quantify Dow's damages for the 2013-2018 period. Dow has also filed a new lawsuit in the same Alberta, Canada court to account for damages due to lost ethylene after June 2018. Luxi Chemical Group Breach of Contract Matter In November 2017, an arbitration panel of the Stockholm Chamber of Commerce held that Luxi Chemical Group Co., Ltd. (“Luxi”), based in Shandong Province, China, violated a secrecy and non-use agreement related to the Dow and Johnson Matthey Davy Technologies Limited (“JM”) LP OXO SM Process by using Dow and JM protected information in the design, construction, and operation of its butanol and 2-ethylhexanol plants, awarding damages, fees and costs, plus interest, to both Dow and JM. In September 2021, Luxi paid the arbitration award and interest assessment and, as a result, Dow recorded a pretax gain of $54 million included in “Sundry income (expense) – net” in the consolidated statements of income and related to Industrial Intermediates & Infrastructure. Brazilian Tax Credits In March 2017, the Federal Supreme Court of Brazil (“Brazil Supreme Court”) ruled in a leading case that a Brazilian value-added tax ("ICMS") should not be included in the base used to calculate a taxpayer's federal contribution on total revenue known as PIS/COFINS (the “2017 Decision”). Previously, three of the Company’s Brazilian subsidiaries filed lawsuits challenging the inclusion of ICMS in their calculation of PIS/COFINS, seeking recovery of excess taxes paid. In response to the 2017 Decision, the Brazilian tax authority filed an appeal seeking clarification of the amount of ICMS tax to exclude from the calculation of PIS/COFINS. In May 2021, the Brazil Supreme Court ruled in a leading case related to the amount of ICMS tax to exclude from the calculation of PIS/COFINS, which resolved two of the lawsuits filed by the Company and, in May 2022, a court decision related to the remaining lawsuit, ruling in favor of the Company's Brazilian subsidiary, became final and unappealable. As a result, the Company recorded pretax gains of $112 million in 2022 and $67 million in 2021 for certain excess PIS/COFINS paid from 2009 to 2019, plus applicable interest, which the Company expects to apply to future required federal tax payments, and the reversal of related liabilities. The pretax gains were recorded in “Cost of sales” in the consolidated statements of income. At December 31, 2022, related tax credits available and expected to be applied to future required federal tax payments totaled $126 million ($52 million at December 31, 2021). Purchase Commitments The Company has outstanding purchase commitments and various commitments for take-or-pay or throughput agreements. The Company was not aware of any purchase commitments that were negotiated as part of a financing arrangement for the facilities that will provide the contracted goods or services or for the costs related to those goods or services at December 31, 2022 and 2021. Guarantees The following table provides a summary of the final expiration, maximum future payments and recorded liability reflected in the consolidated balance sheets for guarantees: Guarantees Dec 31, 2022 Dec 31, 2021 In millions Final Maximum Future Payments 1 Recorded Liability Final Maximum Future Payments Recorded Liability Guarantees 2038 $ 1,236 $ 200 2038 $ 1,273 $ 220 1. In addition, TDCC has provided guarantees, in proportion to the Company's 35 percent ownership interest, of all future interest payments that will become due on Sadara’s project financing debt during the grace period, which Dow's share is estimated to be $393 million at December 31, 2022 ($446 million at December 31, 2021). Based on Sadara's current forecasted cash flows, the Company does not expect to be required to perform under the guarantees. Guarantees arise during the ordinary course of business from relationships with customers, committed accounts receivable facilities and nonconsolidated affiliates when the Company undertakes an obligation to guarantee the performance of others (via delivery of cash or other assets) if specified triggering events occur. With guarantees, such as commercial or financial contracts, non-performance by the guaranteed party triggers the obligation of the Company to make payments to the beneficiary of the guarantee. The majority of the Company’s guarantees relate to debt of nonconsolidated affiliates, which have expiration dates ranging from less than one year to 16 years. The Company’s current expectation is that future payment or performance related to the non-performance of others is considered remote. TDCC has entered into guarantee agreements related to Sadara, a nonconsolidated affiliate. Sadara reached an agreement with its lenders to re-profile its outstanding project financing debt in the first quarter of 2021. In conjunction with the debt re-profiling, TDCC entered into a guarantee of up to approximately $1.3 billion of Sadara’s debt, proportionate to the Company's 35 percent ownership interest. The debt re-profiling includes a grace period until June 2026, during which Sadara is obligated to make interest-only payments which are guaranteed by TDCC in proportion to the Company's 35 percent ownership interest. As part of the debt re-profiling, Sadara established a $500 million revolving credit facility guaranteed by Dow, which would be used to fund Dow’s pro-rata share of any potential shortfall during the grace period. Based on Sadara's forecasted cash flows and no significant scheduled debt repayments until 2026, the Company does not expect Sadara to draw on the facility. See Note 11 for additional information. Asset Retirement Obligations The Company has 104 manufacturing sites in 31 countries. Most of these sites contain numerous individual manufacturing operations, particularly at the Company’s larger sites. Asset retirement obligations are recorded as incurred and reasonably estimable, including obligations for which the timing and/or method of settlement are conditional on a future event that may or may not be within the control of the Company. The retirement of assets may involve such efforts as remediation and treatment of asbestos, contractually required demolition, and other related activities, depending on the nature and location of the assets; and retirement obligations are typically realized only upon demolition of those facilities. In identifying asset retirement obligations, the Company considers identification of legally enforceable obligations, changes in existing law, estimates of potential settlement dates and the calculation of an appropriate discount rate to be used in calculating the fair value of the obligations. The Company has a well-established global process to identify, approve and track the demolition of retired or to-be-retired facilities; and no assets are retired from service until this process has been followed. The Company typically forecasts demolition projects based on the usefulness of the assets; environmental, health and safety concerns; and other similar considerations. Under this process, as demolition projects are identified and approved, reasonable estimates are determined for the time frames during which any related asset retirement obligations are expected to be settled. For those assets where a range of potential settlement dates may be reasonably estimated, obligations are recorded. The Company routinely reviews all changes to items under

LEASES (Notes)

LEASES (Notes)	12 Months Ended
	Dec. 31, 2022
Leases [Abstract]
Lessee, Operating And Finance Leases	LEASES Operating lease ROU assets are included in "Operating lease right-of-use assets" while finance lease ROU assets are included in "Net property" in the consolidated balance sheets. With respect to lease liabilities, operating lease liabilities are included in "Operating lease liabilities - current" and "Operating lease liabilities - noncurrent," and finance lease liabilities are included in "Long-term debt due within one year" and "Long-Term Debt" in the consolidated balance sheets. Dow routinely leases sales and administrative offices, power plants, production facilities, warehouses and tanks for product storage, aircraft, motor vehicles, railcars, computers, office machines and equipment. Some leases contain renewal provisions, purchase options and escalation clauses and the terms for these leased assets vary depending on the lease agreement. These leased assets have remaining lease terms of up to 53 years. See Note 1 for additional information on leases. The components of lease cost for operating and finance leases for the years ended December 31, 2022, 2021 and 2020 were as follows: Lease Cost 2022 2021 2020 In millions Operating lease cost $ 397 $ 494 $ 484 Finance lease cost Amortization of right-of-use assets - finance 105 76 58 Interest on lease liabilities - finance 32 27 25 Total finance lease cost 137 103 83 Short-term lease cost 255 238 213 Variable lease cost 611 381 199 Sublease income (10) (6) (5) Total lease cost $ 1,390 $ 1,210 $ 974 The following table provides supplemental cash flow and other information related to leases: Other Lease Information 2022 2021 2020 In millions Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows for operating leases $ 393 $ 497 $ 482 Operating cash flows for finance leases $ 32 $ 27 $ 25 Financing cash flows for finance leases $ 114 $ 74 $ 58 Right-of-use assets obtained in exchange for lease obligations: Operating leases 1 $ 151 $ (25) $ 185 Finance leases 1 $ 62 $ 512 $ 178 1. In 2021, $193 million of leased assets were reclassified from Operating leases to Finance leases due to an amendment that extended the term of the agreement. The following table summarizes the lease-related assets and liabilities recorded in the consolidated balance sheets at December 31, 2022 and 2021. Lease Position Balance Sheet Classification Dec 31, 2022 Dec 31, 2021 In millions Assets Operating lease assets Operating lease right-of-use assets $ 1,227 $ 1,412 Finance lease assets Property 1,167 1,158 Finance lease amortization Accumulated depreciation (441) (368) Total lease assets $ 1,953 $ 2,202 Liabilities Current Operating Operating lease liabilities - current $ 287 $ 314 Finance Long-term debt due within one year 109 106 Noncurrent Operating Operating lease liabilities - noncurrent 997 1,149 Finance Long-Term Debt 681 763 Total lease liabilities $ 2,074 $ 2,332 In 2021, the Company executed buy-outs of certain leased assets for $687 million. The lease buyouts reduced “Operating lease right-of-use assets” by $166 million and reduced “Operating lease liabilities - current” and “Operating lease liabilities - noncurrent” by $44 million and $158 million, respectively. The Company recognized a pretax loss related to the lease buy-outs of $37 million included in “Sundry income (expense) - net” in the consolidated statements of income. The lease buy-outs are included in “Purchases of previously leased assets” in the consolidated statements of cash flows. Additionally, in 2021, the Company amended an agreement to extend leases of certain assets. The amendment and related remeasurement resulted in a reclassification of $73 million from “Operating lease liabilities – noncurrent” to “Long-Term Debt” and $34 million from “Operating lease liabilities - current” to “Long-term debt due within one year." In addition to the reclassifications, the amendment increased “Long-Term Debt” by $152 million and decreased “Long-term debt due within one year" by $2 million. The weighted-average remaining lease term and discount rate for leases recorded in the consolidated balance sheets at December 31, 2022 and 2021 are provided below: Lease Term and Discount Rate Dec 31, 2022 Dec 31, 2021 Weighted-average remaining lease term Operating leases 7.6 years 7.9 years Finance leases 11.0 years 11.8 years Weighted-average discount rate Operating leases 4.49 % 3.72 % Finance leases 4.29 % 4.17 % The following table provides the maturities of lease liabilities at December 31, 2022: Maturities of Lease Liabilities Operating Leases Finance Leases In millions 2023 $ 333 $ 138 2024 253 153 2025 199 78 2026 160 70 2027 129 64 2028 and thereafter 470 487 Total future undiscounted lease payments $ 1,544 $ 990 Less: Imputed interest 260 200 Total present value of lease liabilities $ 1,284 $ 790 At December 31, 2022, Dow had additional leases of approximately $142 million, primarily for equipment, which had not yet commenced. These leases are expected to commence in 2023 and 2025, with lease terms of up to 16 years. Dow provides guarantees related to certain leased assets, specifying the residual value that will be available to the lessor at lease termination through the sale of the assets to the lessee or third parties. The following table provides a summary of the final expiration, maximum future payments and recorded liability reflected in the consolidated balance sheets for residual value guarantees at December 31, 2022 and 2021. The lease agreements do not contain any material restrictive covenants. Lease Guarantees Dec 31, 2022 Dec 31, 2021 In millions Final Expiration Maximum Future Payments Recorded Liability Final Expiration Maximum Future Payments Recorded Liability Residual value guarantees 2031 $ 258 $ — 2031 $ 280 $ —

STOCKHOLDERS' EQUITY (Notes)

STOCKHOLDERS' EQUITY (Notes)	12 Months Ended
	Dec. 31, 2022
Stockholders' Equity Note [Abstract]
STOCKHOLDERS' EQUITY	STOCKHOLDERS’ EQUITY Common Stock On April 1, 2019, Dow Inc. became an independent, publicly traded company. The principal market for Dow Inc.'s common stock is the New York Stock Exchange, traded under the symbol “DOW.” Dow Inc. is the direct parent company of The Dow Chemical Company and its consolidated subsidiaries, ("TDCC" and together with Dow Inc., "Dow" or the "Company"), owning all of the outstanding common shares of TDCC. The Company may issue shares of Dow Inc. common stock out of treasury stock or as new shares of common stock for options exercised and for the release of restricted stock units ("RSUs"), performance stock units ("PSUs"), the Employee Stock Purchase Plan ("ESPP") and the Employees' Savings Plan (the "Savings Plan"). Common stock shares issued to employees and non-employee directors was approximately 7.5 million in 2022 (8.2 million in 2021 and 4.8 million in 2020). See Note 20 for additional information on the Company's equity awards. Retained Earnings Dow Inc. There are no significant restrictions limiting Dow Inc.’s ability to pay dividends. Dow Inc. declared dividends of $2.80 per share in 2022, 2021 and 2020. Undistributed earnings of nonconsolidated affiliates included in retained earnings were $669 million at December 31, 2022 and $1,155 million at December 31, 2021. TDCC TDCC's Board determines whether or not there will be a dividend distribution to Dow Inc. TDCC declared and paid dividends to Dow Inc. of $4,375 million in 2022, $3,264 million in 2021 and $2,233 million in 2020. Employee Stock Ownership Plan The Dow Employee Stock Ownership Plan (the “ESOP”) allocated the remaining shares in 2022 and no shares remain unallocated at December 31, 2022. Unallocated shares at December 31, 2021 and 2020 were excluded from the Company's earnings per share calculation. Compensation expense for allocated shares is recorded at the fair value of the shares on the date of allocation. Compensation expense reflected in income before income taxes for ESOP shares allocated was $31 million in 2022, $77 million in 2021 and $72 million in 2020. At December 31, 2022, all remaining unallocated ESOP shares were allocated to plan participants. Treasury Stock On April 1, 2019, the Dow Inc. Board ratified the share repurchase program originally approved on March 15, 2019, authorizing up to $3.0 billion for the repurchase of the Company's common stock, with no expiration date. The Company completed the April 1, 2019 share repurchase program in the second quarter of 2022. On April 13, 2022, the Dow Inc. Board approved a new share repurchase program authorizing up to $3.0 billion for the repurchase of the Company's common stock, with no expiration date. In 2022, the Company repurchased $2,325 million of its common stock ($1,000 million in 2021 and $125 million in 2020). At December 31, 2022, $2.0 billion of the share repurchase program authorization remained available for repurchases. The Company began issuing treasury shares to satisfy its obligations to make matching contributions to plan participants under The Dow Employees' Savings Plan in the first quarter of 2022. The Company issued 1.5 million treasury shares under its compensation and benefit plans in 2022. Compensation expense for issued shares is recorded at the fair value of the shares on the date of issuance. Compensation expense reflected in income before income taxes for treasury shares issued was $94 million in 2022. The following table provides a reconciliation of Dow Inc. common stock activity for the years ended December 31, 2022, 2021 and 2020: Shares of Dow Inc. Common Stock Issued Held in Treasury Balance at Jan 1, 2020 751,228,644 9,729,834 Issued 1 4,764,554 — Repurchased — 3,073,469 Balance at Jan 1, 2021 755,993,198 12,803,303 Issued 1 8,233,684 — Repurchased — 16,208,270 Balance at Jan 1, 2022 764,226,882 29,011,573 Issued 1 7,451,643 (1,499,610) Repurchased — 39,286,642 Balance at Dec 31, 2022 771,678,525 66,798,605 1. Shares issued to employees and non-employee directors under the Company's equity compensation plans. Accumulated Other Comprehensive Loss The changes in each component of AOCL for the years ended December 31, 2022, 2021 and 2020 were as follows: Accumulated Other Comprehensive Loss 2022 2021 2020 In millions Unrealized Gains (Losses) on Investments Beginning balance $ 59 $ 104 $ 64 Unrealized gains (losses) on investments (326) (21) 104 Tax (expense) benefit 13 5 (23) Net unrealized gains (losses) on investments (313) (16) 81 (Gains) losses reclassified from AOCL to net income 1 2 (38) (54) Tax expense (benefit) 2 (1) 9 13 Net (gains) losses reclassified from AOCL to net income 1 (29) (41) Other comprehensive income (loss), net of tax (312) (45) 40 Ending balance $ (253) $ 59 $ 104 Cumulative Translation Adjustment Beginning balance $ (1,355) $ (930) $ (1,135) Gains (losses) on foreign currency translation (557) (375) 227 Tax (expense) benefit 24 (40) 25 Net gains (losses) on foreign currency translation (533) (415) 252 (Gains) losses reclassified from AOCL to net income 3 (46) (10) (47) Other comprehensive income (loss), net of tax (579) (425) 205 Ending balance $ (1,934) $ (1,355) $ (930) Pension and Other Postretirement Benefits Beginning balance $ (7,334) $ (9,559) $ (8,781) Gains (losses) arising during the period 2,611 2,094 (1,769) Tax (expense) benefit (630) (464) 411 Net gains (losses) arising during the period 1,981 1,630 (1,358) Amortization of net loss and prior service credits reclassified from AOCL to net income 4 622 776 753 Tax expense (benefit) 2 (146) (181) (173) Net loss and prior service credits reclassified from AOCL to net income 476 595 580 Other comprehensive income (loss), net of tax 2,457 2,225 (778) Ending balance $ (4,877) $ (7,334) $ (9,559) Derivative Instruments Beginning balance $ (347) $ (470) $ (394) Gains (losses) on derivative instruments 638 155 (96) Tax (expense) benefit (87) 3 (1) Net gains (losses) on derivative instruments 551 158 (97) (Gains) losses reclassified from AOCL to net income 5 (313) (38) 30 Tax expense (benefit) 2 34 3 (9) Net (gains) losses reclassified from AOCL to net income (279) (35) 21 Other comprehensive income (loss), net of tax 272 123 (76) Ending balance $ (75) $ (347) $ (470) Total AOCL ending balance $ (7,139) $ (8,977) $ (10,855) 1. Reclassified to "Net sales" and "Sundry income (expense) - net." 2. Reclassified to "Provision for income taxes." 3. Reclassified to "Sundry income (expense) - net." 4. These AOCL components are included in the computation of net periodic benefit cost of the Company's defined benefit pension and other postretirement benefit plans. See Note 19 for additional information. 5. Reclassified to "Cost of sales," "Sundry income (expense) - net" and "Interest expense and amortization of debt discount."

NONCONTROLLING INTERESTS (Notes

NONCONTROLLING INTERESTS (Notes)	12 Months Ended
	Dec. 31, 2022
Noncontrolling Interest [Abstract]
NONCONTROLLING INTERESTS	NONCONTROLLING INTERESTS Ownership interests in the Company's subsidiaries held by parties other than the Company are presented separately from the Company's equity in the consolidated balance sheets as "Noncontrolling interests." The amount of consolidated net income attributable to the Company and the noncontrolling interests are both presented on the face of the consolidated statements of income. The following table summarizes the activity for equity attributable to noncontrolling interests for the years ended December 31, 2022, 2021 and 2020: Noncontrolling Interests In millions 2022 2021 2020 Balance at Jan 1 $ 574 $ 570 $ 553 Net income attributable to noncontrolling interests 1 58 94 69 Distributions to noncontrolling interests 2 (76) (66) (55) Deconsolidation of noncontrolling interests 3 — — (7) Cumulative translation adjustments (28) (25) 9 Other 1 1 1 Balance at Dec 31 $ 529 $ 574 $ 570 1. 2022 includes the portion of asset related charges attributable to noncontrolling interests related to a joint venture in Russia. See Note 4 for additional information. 2. Distributions to noncontrolling interests are net of $7 million in 2022, 2021 and 2020 in dividends paid to a joint venture, which were reclassified to "Equity in earnings (losses) of nonconsolidated affiliates" in the consolidated statements of income. 3. Related to the divestiture of the Company's interest in a cogeneration facility in Brazil in the third quarter of 2020.

PENSION PLANS AND OTHER POSTRET

PENSION PLANS AND OTHER POSTRETIREMENT BENEFITS (Notes)	12 Months Ended
	Dec. 31, 2022
Retirement Benefits [Abstract]
PENSION PLANS AND OTHER POSTRETIREMENT BENEFITS	PENSION PLANS AND OTHER POSTRETIREMENT BENEFITS Defined Benefit Pension Plans The Company has both funded and unfunded defined benefit pension plans that cover employees in the United States and a number of other countries. The U.S. tax-qualified plan covering the parent company is the largest plan. Benefits for employees hired before January 1, 2008, are based on length of service and the employee’s three highest consecutive years of compensation. Employees hired after January 1, 2008, earn benefits that are based on a set percentage of annual pay, plus interest. On March 4, 2021, the Company announced changes to its U.S. tax-qualified and non-qualified pension plans. Effective December 31, 2023 ("Effective Date"), the Company will freeze the pensionable compensation and credited service amounts used to calculate pension benefits for employees who participate in its U.S. tax-qualified and non-qualified retirement programs (collectively, the "U.S. Plans"). As a result, at the Effective Date and subject to any bargaining obligations required by law, active participants of the U.S. Plans will not accrue additional benefits for future service and compensation. In connection with these plan amendments, the Company remeasured its U.S. Plans effective February 28, 2021, which resulted in a pretax actuarial gain of $1,268 million, included in other comprehensive income and inclusive of a $345 million reduction in the projected benefit obligation resulting from the plan amendments, and a pretax curtailment gain of $19 million, recognized in the first quarter of 2021. The Company's funding policy is to contribute to the plans when pension laws and/or economics either require or encourage funding. Total global pension contributions were $235 million in 2022, which includes contributions necessary to fund benefit payments for the Company's unfunded pension plans. The Company expects to contribute approximately $150 million to its pension plans in 2023. The weighted-average assumptions used to determine pension plan obligations and net periodic benefit costs for all plans are summarized in the table below: Weighted-Average Assumptions for All Pension Plans Benefit Obligations Net Periodic Benefit Costs 2022 2021 2022 2021 2020 Discount rate 5.18 % 2.57 % 2.57 % 2.40 % 2.81 % Interest crediting rate for applicable benefits 4.19 % 3.57 % 3.57 % 3.55 % 3.51 % Rate of compensation increase 4.05 % 3.94 % 3.94 % 3.91 % 3.92 % Expected return on plan assets 6.68 % 6.86 % 7.00 % The weighted-average assumptions used to determine pension plan obligations and net periodic benefit costs for U.S. plans are summarized in the table below: Weighted-Average Assumptions for U.S. Pension Plans Benefit Obligations Net Periodic Benefit Costs 2022 2021 2022 2021 2020 Discount rate 5.64 % 3.04 % 3.04 % 3.03 % 3.41 % Interest crediting rate for applicable benefits 4.50 % 4.50 % 4.50 % 4.50 % 4.50 % Rate of compensation increase 4.25 % 4.25 % 4.25 % 4.25 % 4.25 % Expected return on plan assets 7.95 % 7.96 % 7.95 % Other Postretirement Benefit Plans The Company provides certain health care and life insurance benefits to retired employees and survivors. The Company’s plans outside of the United States are not significant; therefore, this discussion relates to the U.S. plans only. The plans provide health care benefits, including hospital, physicians’ services, drug and major medical expense coverage, and life insurance benefits. In general, for employees hired before January 1, 1993, the plans provide benefits supplemental to Medicare when retirees are eligible for these benefits. The Company and the retiree share the cost of these benefits, with the Company portion increasing as the retiree has increased years of credited service, although there is a cap on the Company portion. The Company has the ability to change these benefits at any time. Employees hired after January 1, 2008, are not covered under the plans. The Company funds most of the cost of these health care and life insurance benefits as incurred. In 2022, the Company did not make any contributions to its other postretirement benefit plan trusts. The trusts did not hold assets at December 31, 2022. The Company does not expect to contribute assets to its other postretirement benefit plan trusts in 2023. The weighted-average assumptions used to determine other postretirement benefit plan obligations and net periodic benefit costs for the U.S. plans are provided below: Weighted-Average Assumptions for U.S. Other Postretirement Benefits Plans Benefit Obligations Net Periodic Benefit Costs 2022 2021 2022 2021 2020 Discount rate 5.57 % 2.85 % 2.85 % 2.38 % 3.19 % Health care cost trend rate assumed for next year 6.79 % 6.50 % 6.50 % 6.75 % 6.25 % Rate to which the cost trend rate is assumed to decline (the ultimate health care cost trend rate) 5.00 % 5.00 % 5.00 % 5.00 % 5.00 % Year that the rate reaches the ultimate health care cost trend rate 2033 2028 2028 2028 2025 Assumptions The Company determines the expected long-term rate of return on plan assets by performing a detailed analysis of key economic and market factors driving historical returns for each asset class and formulating a projected return based on factors in the current environment. Factors considered include, but are not limited to, inflation, real economic growth, interest rate yield, interest rate spreads and other valuation measures and market metrics. The expected long-term rate of return for each asset class is then weighted based on the strategic asset allocation approved by the governing body for each plan. The Company’s historical experience with the pension fund asset performance is also considered. The Company uses the spot rate approach to determine the discount rate utilized to measure the service cost and interest cost components of net periodic pension and other postretirement benefit costs for the U.S. and other selected countries. Under the spot rate approach, the Company calculates service cost and interest cost by applying individual spot rates from the Willis Towers Watson RATE:Link yield curve (based on high-quality corporate bond yields) for each selected country to the separate expected cash flow components of service cost and interest cost. Service cost and interest cost for all other plans are determined on the basis of the single equivalent discount rates derived in determining those plan obligations. The discount rates utilized to measure the pension and other postretirement obligations of the U.S. plans are based on the yield on high-quality corporate fixed income investments at the measurement date. Future expected actuarially determined cash flows for the Company’s U.S. plans are individually discounted at the spot rates under the Willis Towers Watson U.S. RATE:Link 60-90 corporate yield curve (based on 60th to 90th percentile high-quality corporate bond yields) to arrive at the plan’s obligations as of the measurement date. The Company’s mortality assumption used for the US plans is a benefit-weighted version of the Society of Actuaries’ RP-2014 base table with future rates of mortality improvement based on a modified version of the assumptions used in the Social Security Administration’s 2021 trustees report. Summarized information on the Company's pension and other postretirement benefit plans is as follows: Change in Projected Benefit Obligations, Plan Assets and Funded Status of All Significant Plans Defined Benefit Pension Plans Other Postretirement Benefit Plans In millions 2022 2021 2022 2021 Change in projected benefit obligations: Benefit obligations at beginning of year $ 32,977 $ 35,309 $ 1,251 $ 1,464 Service cost 392 387 6 7 Interest cost 680 594 26 23 Plan participants' contributions 12 10 — — Actuarial changes in assumptions and experience (8,433) (820) (318) (98) Benefits paid (1,539) (1,582) (67) (141) Plan amendments (25) 2 — — Acquisitions/divestitures/other 1 (602) 8 — — Effect of foreign exchange rates (600) (545) (5) (4) Termination benefits/curtailments/settlements 2 (1) (386) — — Benefit obligations at end of year $ 22,861 $ 32,977 $ 893 $ 1,251 Change in plan assets: Fair value of plan assets at beginning of year $ 28,167 $ 26,406 $ — $ — Actual return on plan assets (4,556) 2,501 — — Employer contributions 235 1,219 — — Plan participants' contributions 12 10 — — Benefits paid (1,539) (1,582) — — Other 3 (592) 10 — — Effect of foreign exchange rates (496) (397) — — Fair value of plan assets at end of year $ 21,231 $ 28,167 $ — $ — Funded status: U.S. plans with plan assets $ (545) $ (2,585) $ — $ — Non-U.S. plans with plan assets (473) (1,467) — — All other plans (612) (758) (893) (1,251) Funded status at end of year $ (1,630) $ (4,810) $ (893) $ (1,251) Amounts recognized in the consolidated balance sheets at Dec 31: Deferred charges and other assets $ 1,035 $ 1,173 $ — $ — Accrued and other current liabilities (66) (58) (88) (99) Pension and other postretirement benefits - noncurrent (2,599) (5,925) (805) (1,152) Net amount recognized $ (1,630) $ (4,810) $ (893) $ (1,251) Pretax amounts recognized in accumulated other comprehensive loss at Dec 31: Net loss (gain) $ 7,045 $ 9,934 $ (523) $ (221) Prior service credit (116) (112) — — Pretax balance in accumulated other comprehensive loss at end of year $ 6,929 $ 9,822 $ (523) $ (221) 1. The 2022 impact primarily relates to the transfer of benefit obligations in the U.S. through the purchase of annuity contracts from an insurance company. 2. The 2021 impact primarily relates to the freeze of pensionable compensation and credited service amounts for employees that participate in the U.S. Plans. 3. The 2022 impact relates to the purchase of an annuity contract associated with the transfer of benefit obligations to an insurance company. A significant component of the overall decrease in the Company's benefit obligation for the year ended December 31, 2022 was due to the change in weighted-average discount rates, which increased from 2.57 percent at December 31, 2021 to 5.18 percent at December 31, 2022. A significant component of the overall decrease in the Company's benefit obligation for the year ended December 31, 2021 was due to the change in weighted-average discount rates, which increased from 2.20 percent at December 31, 2020 to 2.57 percent at December 31, 2021. The accumulated benefit obligation for all significant pension plans was $22.6 billion and $32.5 billion at December 31, 2022 and 2021, respectively. Pension Plans with Accumulated Benefit Obligations in Excess of Plan Assets at Dec 31 2022 2021 In millions Accumulated benefit obligations $ 18,300 $ 27,052 Fair value of plan assets $ 15,723 $ 21,385 Pension Plans with Projected Benefit Obligations in Excess of Plan Assets at Dec 31 2022 2021 In millions Projected benefit obligations $ 18,388 $ 27,367 Fair value of plan assets $ 15,723 $ 21,385 Net Periodic Benefit Costs for All Significant Plans for the Year Ended Dec 31 Defined Benefit Pension Plans Other Postretirement Benefit Plans In millions 2022 2021 2020 2022 2021 2020 Net Periodic Benefit Costs: Service cost $ 392 $ 387 $ 399 $ 6 $ 7 $ 7 Interest cost 680 594 767 26 23 40 Expected return on plan assets (1,686) (1,724) (1,658) — — — Amortization of prior service credit (21) (22) (19) — — — Amortization of unrecognized (gain) loss 658 822 773 (15) (6) (10) Curtailment/settlement/other 1 — (18) 9 — — — Net periodic benefit costs $ 23 $ 39 $ 271 $ 17 $ 24 $ 37 Changes in plan assets and benefit obligations recognized in other comprehensive (income) loss: Net (gain) loss $ (2,231) $ (1,980) $ 1,753 $ (317) $ (98) $ 8 Prior service cost (credit) (25) 2 8 — — — Amortization of prior service credit 21 22 19 — — — Amortization of unrecognized gain (loss) (658) (822) (773) 15 6 10 Curtailment and settlement gain (loss) 1 — 18 (9) — — — Total recognized in other comprehensive (income) loss $ (2,893) $ (2,760) $ 998 $ (302) $ (92) $ 18 Total recognized in net periodic benefit cost and other comprehensive (income) loss $ (2,870) $ (2,721) $ 1,269 $ (285) $ (68) $ 55 1. The 2021 impact primarily relates to the freeze of pensionable compensation and credited service amounts for employees that participate in the U.S. Plans. The 2020 impact relates to pension plan curtailments of a European plan resulting from the 2020 Restructuring Program and the settlement of certain plan obligations of a U.S. non-qualified pension plan resulting from lump-sum payments. Except for plan curtailment costs related to the 2020 Restructuring Program, which are included in "Restructuring and asset related charges - net" in the consolidated statements of income, non-service cost components of net periodic benefit cost are included in "Sundry income (expense) - net" in the consolidated statements of income. See Notes 5 and 6 for additional information. Estimated Future Benefit Payments The estimated future benefit payments, reflecting expected future service, as appropriate, are presented in the following table: Estimated Future Benefit Payments at Dec 31, 2022 Defined Benefit Pension Plans Other Postretirement Benefit Plans In millions 2023 $ 1,597 $ 90 2024 1,474 85 2025 1,496 82 2026 1,515 82 2027 1,531 80 2028-2032 7,783 350 Total $ 15,396 $ 769 Plan Assets Plan assets consist primarily of equity and fixed income securities of U.S. and foreign issuers, and include alternative investments, such as real estate, private equity and absolute return strategies. Plan assets totaled $21.2 billion at December 31, 2022 and $28.2 billion at December 31, 2021 and included no directly held common stock of Dow Inc. The Company's investment strategy for plan assets is to manage the assets in relation to the liability in order to pay retirement benefits to plan participants over the life of the plans. This is accomplished by identifying and managing the exposure to various market risks, diversifying investments across various asset classes and earning an acceptable long-term rate of return consistent with an acceptable amount of risk, while considering the liquidity needs of the plans. The plans are permitted to use derivative instruments for investment purposes, as well as for hedging the underlying asset and liability exposure and rebalancing the asset allocation. The plans use value-at-risk, stress testing, scenario analysis and Monte Carlo simulations to monitor and manage both the risk within the portfolios and the surplus risk of the plans. Equity securities primarily include investments in large- and small-cap companies located in both developed and emerging markets around the world. Fixed income securities include investment and non-investment grade corporate bonds of companies diversified across industries, U.S. treasuries, non-U.S. developed market securities, U.S. agency mortgage-backed securities, emerging market securities and fixed income related funds. Alternative investments primarily include investments in real estate, private equity and absolute return strategies. Other significant investment types include various insurance contracts and interest rate, equity, commodity and foreign exchange derivative investments and hedges. The Company mitigates the credit risk of investments by establishing guidelines with investment managers that limit investment in any single issue or issuer to an amount that is not material to the portfolio being managed. These guidelines are monitored for compliance both by the Company and external managers. Credit risk related to derivative activity is mitigated by utilizing multiple counterparties, collateral support agreements and centralized clearing, where appropriate. A short-term investment money market fund is utilized as the sweep vehicle for the U.S. plans, which from time to time can represent a significant investment. The weighted-average target allocation for plan assets of the Company's pension plans is summarized as follows: Target Allocation for Plan Assets at Dec 31, 2022 Target Allocation Asset Category Equity securities 25 % Fixed income securities 43 Alternative investments 29 Other investments 3 Total 100 % Fair value calculations may not be indicative of net realizable value or reflective of future fair values. Furthermore, although the Company believes its valuation methods are appropriate and consistent with other market participants, the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different fair value measurement at the reporting date. For pension plan assets classified as Level 1 measurements (measured using quoted prices in active markets), total fair value is either the price of the most recent trade at the time of the market close or the official close price, as defined by the exchange on which the asset is most actively traded on the last trading day of the period, multiplied by the number of units held without consideration of transaction costs. For pension plan assets classified as Level 2 measurements, where the security is frequently traded in less active markets, fair value is based on the closing price at the end of the period; where the security is less frequently traded, fair value is based on the price a dealer would pay for the security or similar securities, adjusted for any terms specific to that asset or liability. Market inputs are obtained from well-established and recognized vendors of market data and subjected to tolerance and quality checks. For derivative assets and liabilities, standard industry models are used to calculate the fair value of the various financial instruments based on significant observable market inputs, such as foreign exchange rates, commodity prices, swap rates, interest rates and implied volatilities obtained from various market sources. For other pension plan assets for which observable inputs are used, fair value is derived through the use of fair value models, such as a discounted cash flow model or other standard pricing models. For pension plan assets classified as Level 3 measurements, total fair value is based on significant unobservable inputs including assumptions where there is little, if any, market activity for the investment. Certain pension plan assets are held in funds where fair value is based on an estimated net asset value per share (or its equivalent) as of the most recently available fund financial statements which are received on a monthly or quarterly basis. These valuations are reviewed for reasonableness based on applicable sector, benchmark and company performance. Adjustments to valuations are made where appropriate to arrive at an estimated net asset value per share at the measurement date. These funds are not classified within the fair value hierarchy. The following table summarizes the bases used to measure the Company’s pension plan assets at fair value for the years ended December 31, 2022 and 2021: Basis of Fair Value Measurements Dec 31, 2022 Dec 31, 2021 In millions Total Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Cash and cash equivalents $ 1,240 $ 989 $ 251 $ — $ 1,463 $ 1,353 $ 110 $ — Equity securities: U.S. equity securities $ 1,855 $ 1,845 $ 7 $ 3 $ 4,117 $ 4,097 $ 18 $ 2 Non - U.S. equity securities 2,120 1,924 193 3 4,559 3,935 620 4 Total equity securities $ 3,975 $ 3,769 $ 200 $ 6 $ 8,676 $ 8,032 $ 638 $ 6 Fixed income securities: Debt - government-issued $ 3,885 $ 57 $ 3,827 $ 1 $ 4,838 $ 242 $ 4,596 $ — Debt - corporate-issued 4,231 441 3,790 — 4,949 1,095 3,854 — Debt - asset-backed 128 44 84 — 117 — 116 1 Total fixed income securities $ 8,244 $ 542 $ 7,701 $ 1 $ 9,904 $ 1,337 $ 8,566 $ 1 Alternative investments: Private markets $ 5 $ — $ — $ 5 $ 5 $ — $ — $ 5 Real estate 48 48 — — 67 67 — — Derivatives - asset position 348 5 343 — 399 2 397 — Derivatives - liability position (479) (6) (473) — (324) (2) (322) — Total alternative investments $ (78) $ 47 $ (130) $ 5 $ 147 $ 67 $ 75 $ 5 Other investments $ 1,103 $ 16 $ 1,087 $ — $ 1,068 $ 7 $ 1,061 $ — Subtotal $ 14,484 $ 5,363 $ 9,109 $ 12 $ 21,258 $ 10,796 $ 10,450 $ 12 Investments measured at net asset value: Hedge funds $ 964 $ 1,312 Private markets 3,873 3,857 Real estate 1,956 1,793 Total investments measured at net asset value $ 6,793 $ 6,962 Items to reconcile to fair value of plan assets: Pension trust receivables 1 $ 31 $ 62 Pension trust payables 2 (77) (115) Total $ 21,231 $ 28,167 1. Primarily receivables for investment securities sold. 2. Primarily payables for investment securities purchased. The following table summarizes the changes in the fair value of Level 3 pension plan assets for the years ended December 31, 2022 and 2021: Fair Value Measurement of Level 3 Pension Plan Assets Equity Securities Fixed Income Securities Alternative Investments Other Investments Total In millions Balance at Jan 1, 2021 $ 10 $ 2 $ 13 $ 2 $ 27 Actual return on assets: Relating to assets held at Dec 31, 2021 1 — (11) — (10) Purchases, sales and settlements, net (5) (1) 3 (2) (5) Balance at Dec 31, 2021 $ 6 $ 1 $ 5 $ — $ 12 Actual return on assets: Relating to assets held at Dec 31, 2022 (6) — (6) — (12) Purchases, sales and settlements, net — — 6 — 6 Transfers into Level 3, net 6 — — — 6 Balance at Dec 31, 2022 $ 6 $ 1 $ 5 $ — $ 12 Defined Contribution Plans U.S. employees may participate in defined contribution plans by contributing a portion of their compensation, which is partially matched by the Company. Defined contribution plans also cover employees in some subsidiaries in other countries, including Brazil, The Netherlands, Canada, Korea, Spain and the United Kingdom. Expense recognized for all defined contribution plans was $150 million in 2022, $165 million in 2021 and $156 million in 2020.

STOCK-BASED COMPENSATION (Notes

STOCK-BASED COMPENSATION (Notes)	12 Months Ended
	Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]
STOCK-BASED COMPENSATION	STOCK-BASED COMPENSATION The Company provides stock-based compensation in the form of the Employee Stock Purchase Plan, which grants eligible employees the right to purchase shares of the Company's common stock at a discounted price. The Company also grants stock-based compensation to employees and non-employee directors under stock incentive plans, in the form of stock options, stock appreciation rights, PSUs and RSUs. The total stock-based compensation expense included in the consolidated statements of income was $211 million, $276 million and $171 million in 2022, 2021 and 2020, respectively. The income tax benefits related to stock-based compensation arrangements were $47 million, $62 million and $39 million in 2022, 2021 and 2020, respectively. Accounting for Stock-Based Compensation The Company grants stock-based compensation awards that vest over a specified period or upon employees meeting certain performance and/or retirement eligibility criteria. The fair value of equity instruments issued to employees is measured on the grant date. The fair value of liability instruments (granted to executive employees subject to stock ownership requirements, that provide the recipient the option to elect to receive a cash payment equal to the value of the stock award on the date of delivery) is measured at the end of each quarter. The fair value of equity and liability instruments is expensed over the vesting period or, in the case of retirement, from the grant date to the date on which retirement eligibility provisions have been met and additional service is no longer required. The Company estimates expected forfeitures based on historical activity. The Company uses the Black-Scholes option valuation model to estimate the fair value of stock options. The weighted-average assumptions used to calculate total stock-based compensation are included in the following table: Weighted-Average Assumptions 2022 2021 2020 Dividend yield 4.59 % 4.86 % 5.80 % Expected volatility 30.20 % 33.40 % 26.70 % Risk-free interest rate 2.00 % 0.68 % 1.49 % Expected life of stock options granted during period (years) 6.25 6.25 6.10 The dividend yield assumption was equal to the dividend yield on the grant date, which reflected the Company's quarterly dividend payments of $0.70 per share in 2022, 2021 and 2020 on Dow Inc. common stock. The expected volatility assumptions for the 2022, 2021 and 2020 stock options were based on an equal weighting of the historical daily volatility for the expected term of the awards and current implied volatility from exchange-traded options. The expected volatility assumption for the market portion of the 2022, 2021 and 2020 PSU awards were based on historical daily volatility for the term of the award. The risk-free interest rate was based on the U.S. Treasury strip rates over the expected life of the 2022, 2021 and 2020 options. The expected life of stock options granted was based on an analysis of historical exercise patterns. Stock Incentive Plan The Company has historically granted equity awards under various plans (the "Prior Plans"). On February 9, 2012, the TDCC Board authorized The Dow Chemical Company 2012 Stock Incentive Plan (the "2012 Plan"), which was approved by stockholders at TDCC's annual meeting on May 10, 2012 ("2012 Plan Effective Date") and became effective on that date. On February 13, 2014, the TDCC Board adopted The Dow Chemical Company Amended and Restated 2012 Stock Incentive Plan (the "2012 Restated Plan"). The 2012 Restated Plan was approved by stockholders at TDCC's annual meeting on May 15, 2014, and became effective on that date. The Prior Plans were superseded by the 2012 Plan and the 2012 Restated Plan (collectively, the "2012 Plan"). Under the 2012 Plan, the Company granted options, RSUs, PSUs, restricted stock, stock appreciation rights and stock units to employees and non-employee directors, subject to an aggregate limit and annual individual limits. The terms of the grants were fixed at the grant date. TDCC's stock based compensation programs were assumed by DowDuPont and continued in place with the ability to grant and issue DowDuPont common stock until separation. On April 1, 2019 ("Original Effective Date"), in connection with the separation, the Company adopted the 2019 Stock Incentive Plan (the "2019 Plan"). Under the 2019 Plan, the Company may grant stock options, RSUs, PSUs, stock appreciation rights and stock units to employees and non-employee directors until the tenth anniversary of the Original Effective Date, subject to an aggregate limit and annual individual limits. The terms of the grants are fixed at the grant date. At December 31, 2022, there were approximately 53 million shares of common stock available for grant under the 2019 Plan. Stock Options The Company grants stock options to certain employees, subject to certain annual and individual limits, with terms of the grants fixed at the grant date. The exercise price of each stock option equals the market price of the common stock on the grant date. Options vest from one year to three years and have a maximum term of ten years. The following table summarizes stock option activity for 2022: Stock Options 2022 Shares in thousands Shares Exercise Price 1 Outstanding at Jan 1, 2022 16,280 $ 50.56 Granted 1,199 $ 60.95 Exercised (2,968) $ 38.50 Forfeited/Expired (86) $ 61.20 Outstanding at Dec 31, 2022 14,425 $ 53.84 Remaining contractual life in years 4.65 Aggregate intrinsic value in millions $ 38 Exercisable at Dec 31, 2022 11,727 $ 53.19 Remaining contractual life in years 3.81 Aggregate intrinsic value in millions $ 36 1. Weighted-average per share. Additional Information about Stock Options In millions, except per share amounts 2022 2021 2020 Weighted-average fair value per share of options granted $ 11.08 $ 10.37 $ 5.89 Total compensation expense for stock option plans $ 13 $ 14 $ 22 Related tax benefit $ 3 $ 3 $ 5 Total amount of cash received from the exercise of options $ 109 $ 217 $ 108 Total intrinsic value of options exercised 1 $ 73 $ 121 $ 41 Related tax benefit $ 16 $ 27 $ 9 1. Difference between the market price at exercise and the price paid by the employee to exercise the options. Total unrecognized compensation cost related to unvested stock option awards of $4 million at December 31, 2022, is expected to be recognized over a weighted-average period of 1.47 years. Restricted Stock Units The Company grants RSUs to certain employees and non-employee directors. The grants vest after a designated period of time, generally three years for employees and two years for non-employee directors. The following table shows changes in nonvested RSUs: RSU Awards 2022 Shares in thousands Shares Grant Date Fair Value 1 Nonvested at Jan 1, 2022 3,543 $ 53.67 Granted 2,080 $ 58.60 Vested (1,676) $ 56.30 Canceled (122) $ 55.80 Nonvested at Dec 31, 2022 3,825 $ 55.13 1. Weighted-average per share. Additional Information about RSUs In millions, except per share amounts 2022 2021 2020 Weighted-average fair value per share of RSUs granted $ 58.60 $ 57.96 $ 47.66 Total fair value of RSUs vested 1 $ 102 $ 33 $ 106 Related tax benefit $ 23 $ 7 $ 24 Total compensation expense for RSU awards $ 99 $ 95 $ 93 Related tax benefit $ 22 $ 21 $ 21 1. Includes the fair value of shares vested in prior years and delivered in the reporting year. In 2022, the Company did not settle any RSUs in cash (zero RSUs settled in cash in 2021 and 85,000 RSUs settled in cash for $4 million in 2020). Total unrecognized compensation cost related to RSU awards of $86 million at December 31, 2022 is expected to be recognized over a weighted-average period of 2.09 years. At December 31, 2022, approximately 1.8 million RSUs with a grant date weighted-average fair value per share of $54.32 had previously vested, but were not issued. These shares are scheduled to be issued to employees within six months to three years or to non-employee directors upon retirement. Performance Stock Units The Company grants PSUs to certain employees. The grants vest when the Company attains specified performance targets, such as return on capital, cumulative cash from operations, environmental, social and governance metrics, and relative total shareholder return, over a predetermined period, generally one year to three years. Performance and payouts are determined independently for each metric. Compensation expense related to PSU awards is recognized over the lesser of the service or performance period. Changes in the fair value of liability instruments are recognized as compensation expense each quarter. The following table shows the PSU awards granted: PSU Awards Target Shares Granted 1 Grant Date Fair Value 2 Shares in thousands Year Performance Period 2022 Jan 1, 2022 – Dec 31, 2024 1,157 $ 65.83 2021 Jan 1, 2021 – Dec 31, 2023 1,223 $ 61.48 2020 Jan 1, 2020 – Dec 31, 2022 1,426 $ 48.35 1. At the end of the performance period, the actual number of shares issued can range from zero to 200 percent of target shares granted for the 2022 and 2021 awards and can range from zero to 100 percent of the target shares granted for the 2020 award. 2. Weighted-average per share. The following table shows changes in nonvested PSUs: PSUs 2022 Shares in thousands Shares Grant Date Fair Value 1 Nonvested at Jan 1, 2022 3,639 $ 55.36 Granted 1,157 $ 65.83 Vested 2 (1,079) $ 57.58 Canceled (77) $ 59.73 Nonvested at Dec 31, 2022 3,640 $ 57.93 1. Weighted-average per share. 2. Includes 226,240 shares that were not delivered at vesting due to the final performance of program. Additional Information about PSUs In millions, except share amounts 2022 2021 2020 Total fair value of PSUs vested and delivered 1 $ 51 $ — $ — Related tax benefit $ 11 $ — $ — Total compensation expense for PSU awards $ 70 $ 138 $ 56 Related tax benefit $ 16 $ 31 $ 13 Shares of PSUs settled in cash (in thousands) 2 162 — — Total cash paid to settle PSUs 3 $ 10 $ — $ — 1. Includes the fair value of shares vested in prior years and delivered in the reporting year. 2. PSU awards vested in prior years and delivered in the reporting year. 3. Cash paid to certain executive employees for PSU awards vested in prior periods and delivered in the reporting year, equal to the value of the stock award on the date of delivery. Total unrecognized compensation cost related to PSU awards of $37 million at December 31, 2022, is expected to be recognized over a weighted-average period of 1.45 years. Employee Stock Purchase Plan The Dow Inc. Board unanimously approved the Dow Inc. 2021 Employee Stock Purchase Plan (the "2021 ESPP"), which was approved by the Company's stockholders at the 2021 Annual Meeting of Stockholders held on April 15, 2021. Under the 2022 ESPP offering, most employees were eligible to purchase shares of common stock of Dow Inc. valued at up to 10 percent of their annual total base salary or wages. The number of shares purchased was determined using the amount contributed by the employee divided by the plan price. The plan price of the stock was equal to 85 percent of the fair market value (closing price) of the common stock at April 1, 2022 (beginning) or October 7, 2022 (ending) of the offering period, whichever was lower. In 2022, employees subscribed to the right to purchase approximately 2.7 million shares at a weighted-average price of $37.75 per share. The plan price was fixed upon the close of the offering period. The shares were delivered to employees in the fourth quarter of 2022. In 2021, employees subscribed to the right to purchase approximately 2.3 million shares at a weighted-average price of $45.11 per share. The plan price was fixed upon the close of the offering period. The shares were delivered to employees in the fourth quarter of 2021. Additional Information about Employee Stock Purchase Plan In millions, except per share amounts 2022 2021 Weighted-average fair value per share of purchase rights granted $ 14.28 $ 16.26 Total compensation expense for ESPP $ 29 $ 30 Related tax benefit $ 7 $ 7 Total amount of cash received from the exercise of purchase rights $ 103 $ 103 Total intrinsic value of purchase rights exercised 1 $ 18 $ 18 Related tax benefit $ 4 $ 4 1. Difference between the market price at exercise and the price paid by the employee to exercise the purchase rights.

FINANCIAL INSTRUMENTS (Notes)

FINANCIAL INSTRUMENTS (Notes)	12 Months Ended
	Dec. 31, 2022
Investments, All Other Investments [Abstract]
FINANCIAL INSTRUMENTS	FINANCIAL INSTRUMENTS The following table summarizes the fair value of financial instruments at December 31, 2022 and 2021: Fair Value of Financial Instruments at Dec 31 2022 2021 In millions Cost Gain Loss Fair Value Cost Gain Loss Fair Value Cash equivalents: Held-to-maturity securities 1 $ 872 $ — $ — $ 872 $ 317 $ — $ — $ 317 Money market funds 355 — — 355 489 — — 489 Total cash equivalents $ 1,227 $ — $ — $ 1,227 $ 806 $ — $ — $ 806 Marketable securities 2 $ 927 $ 12 $ — $ 939 $ 237 $ 8 $ — $ 245 Other investments: Debt securities: Government debt 3 $ 754 $ 1 $ (133) $ 622 $ 746 $ 17 $ (28) $ 735 Corporate bonds 1,274 10 (159) 1,125 1,251 93 (20) 1,324 Total debt securities $ 2,028 $ 11 $ (292) $ 1,747 $ 1,997 $ 110 $ (48) $ 2,059 Equity securities 4 5 5 — 10 7 13 — 20 Total other investments $ 2,033 $ 16 $ (292) $ 1,757 $ 2,004 $ 123 $ (48) $ 2,079 Total cash equivalents, marketable securities and other investments $ 4,187 $ 28 $ (292) $ 3,923 $ 3,047 $ 131 $ (48) $ 3,130 Long-term debt including debt due within one year 5 $ (15,060) $ 1,683 $ (498) $ (13,875) $ (14,511) $ 27 $ (2,641) $ (17,125) Derivatives relating to: Interest rates 6 $ — $ 105 $ — $ 105 $ — $ 1 $ (140) $ (139) Foreign currency — 115 (30) 85 — 46 (18) 28 Commodities 6 — 72 (61) 11 — 142 (92) 50 Total derivatives $ — $ 292 $ (91) $ 201 $ — $ 189 $ (250) $ (61) 1. The Company's held-to-maturity securities primarily included treasury bills and time deposits. 2. The Company's investments in marketable securities are included in "Other current assets" in the consolidated balance sheets. 3. U.S. Treasury obligations, U.S. agency obligations, U.S. agency mortgage-backed securities and other municipalities’ obligations. 4. Equity securities with a readily determinable fair value. 5. Cost includes fair value hedge adjustment gains of $46 million at December 31, 2022 and $47 million at December 31, 2021 on $2,279 million of debt at December 31, 2022 and December 31, 2021. 6. Presented net of cash collateral where master netting arrangements allow. Cost approximates fair value for all other financial instruments. Debt Securities The Company’s investments in debt securities are primarily classified as available-for-sale. The following table provides the investing results from available-for-sale securities for the years ended December 31, 2022, 2021 and 2020. Investing Results In millions 2022 2021 2020 Proceeds from sales of available-for-sale securities $ 543 $ 424 $ 837 Gross realized gains $ 43 $ 50 $ 94 Gross realized losses $ 45 $ 12 $ 40 The following table summarizes the contractual maturities of the Company’s investments in debt securities: Contractual Maturities of Debt Securities at Dec 31, 2022 1 Cost Fair In millions Within one year $ 71 $ 68 One to five years 855 773 Six to ten years 594 503 After ten years 508 403 Total $ 2,028 $ 1,747 1. Includes marketable securities with maturities of less than one year. Portfolio managers regularly review the Company’s holdings to determine if any investments in debt securities are other-than-temporarily impaired. The analysis includes reviewing the amount of the impairment, as well as the length of time it has been impaired. The credit rating of the issuer, current credit rating trends, the trends of the issuer’s overall sector, the ability of the issuer to pay expected cash flows and the length of time the security has been in a loss position are considered in determining whether unrealized losses represent an other-than-temporary impairment. The Company did not have any credit-related losses in 2022, 2021 or 2020. The following table provides the fair value and gross unrealized losses of the Company’s investments in debt securities that were deemed to be temporarily impaired at December 31, 2022 and 2021, aggregated by investment category: Temporarily Impaired Debt Securities at Less than 12 months 12 months or more Total Fair Unrealized Fair Unrealized Fair Value Unrealized Losses In millions 2022 Government debt 1 $ 273 $ (37) $ 333 $ (96) $ 606 $ (133) Corporate bonds 818 (110) 158 (49) 976 (159) Total temporarily impaired debt securities $ 1,091 $ (147) $ 491 $ (145) $ 1,582 $ (292) 2021 Government debt 1 $ 295 $ (13) $ 151 $ (15) $ 446 $ (28) Corporate bonds 355 (17) 16 (3) 371 (20) Total temporarily impaired debt securities $ 650 $ (30) $ 167 $ (18) $ 817 $ (48) 1. U.S. Treasury obligations, U.S. agency obligations, U.S. agency mortgage-backed securities and other municipalities' obligations. Equity Securities There were no material adjustments to the carrying value of the not readily determinable investments for impairment or observable price changes for the year ended December 31, 2022. The net unrealized loss recognized in earnings on equity securities totaled $8 million for the year ended December 31, 2022 ($13 million net unrealized loss for the year ended December 31, 2021). Investments in Equity Securities Dec 31, 2022 Dec 31, 2021 In millions Readily determinable fair value $ 10 $ 20 Not readily determinable fair value $ 186 $ 209 Risk Management The Company’s business operations give rise to market risk exposure due to changes in foreign exchange rates, interest rates, commodity prices and other market factors such as equity prices. To manage such risks effectively, the Company enters into hedging transactions, pursuant to established guidelines and policies that enable it to mitigate the adverse effects of financial market risk. Derivatives used for this purpose are designated as hedges per the accounting guidance related to derivatives and hedging activities, where appropriate. A secondary objective is to add value by creating additional non-specific exposure within established limits and policies; derivatives used for this purpose are not designated as hedges. The potential impact of creating such additional exposure is not material to the Company’s results. Accounting guidance requires companies to recognize all derivative instruments as either assets or liabilities at fair value. The Company’s risk management program for interest rate, foreign currency and commodity risks is based on fundamental, mathematical and technical models that take into account the implicit cost of hedging. Risks created by derivative instruments and the mark-to-market valuations of positions are strictly monitored at all times, using value-at-risk and stress tests. Counterparty credit risk arising from these contracts is not significant because the Company minimizes counterparty concentration, deals primarily with major financial institutions of solid credit quality, and the majority of its hedging transactions mature in less than three months. In addition, the Company minimizes concentrations of credit risk through its global orientation by transacting with large, internationally diversified financial counterparties. It is the Company’s policy to not have credit risk-related contingent features in its derivative instruments. No significant concentration of counterparty credit risk existed at December 31, 2022. The Company does not anticipate losses from credit risk, and the net cash requirements arising from counterparty risk associated with risk management activities are not expected to be material in 2023. The Company revises its strategies as market conditions dictate and management reviews its overall financial strategies and the impacts from using derivatives in its risk management program with the Company’s senior leadership who also reviews these strategies with the Dow Inc. Board and/or relevant committees thereof. Derivative Instruments The notional amounts of the Company's derivative instruments at December 31, 2022 and 2021, were as follows: Notional Amounts 1 Dec 31, 2022 Dec 31, 2021 In millions Derivatives designated as hedging instruments Interest rate contracts $ 1,500 $ 3,000 Foreign currency contracts $ 2,408 $ 5,300 Derivatives not designated as hedging instruments Interest rate contracts $ 3 $ 36 Foreign currency contracts $ 8,837 $ 8,234 1. Notional amounts represent the absolute value of open derivative positions at the end of the period. Multi-leg option positions are reflected at the maximum notional position at expiration. The notional amounts of the Company's commodity derivatives at December 31, 2022 and 2021, were as follows: Commodity Notionals 1 Dec 31, 2022 Dec 31, 2021 Notional Volume Unit Derivatives designated as hedging instruments Hydrocarbon derivatives 19.2 9.7 million barrels of oil equivalent Derivatives not designated as hedging instruments Hydrocarbon derivatives — 0.1 million barrels of oil equivalent Power derivatives — 3.3 thousands of megawatt hours 1. Notional amounts represent the net volume of open derivative positions outstanding at the end of the period. Maturity Dates of Derivatives Designated as Hedging Instruments Year Interest rate contracts 2023 Foreign currency contracts 2023 Commodity contracts 2026 Interest Rate Risk Management The main objective of interest rate risk management is to reduce the total funding cost to the Company and to alter the interest rate exposure to the desired risk profile. To achieve this objective, the Company hedges using interest rate swaps, “swaptions,” and exchange-traded instruments. Foreign Currency Risk Management The global nature of the Company's business requires active participation in the foreign exchange markets. The Company has assets, liabilities and cash flows in currencies other than the U.S. dollar. The primary objective of the Company's foreign currency risk management is to optimize the U.S. dollar value of net assets and cash flows. To achieve this objective, the Company hedges on a net exposure basis using foreign currency forward contracts, over-the-counter option contracts, cross-currency swaps and nonderivative instruments in foreign currencies. Exposures primarily relate to assets, liabilities and bonds denominated in foreign currencies, as well as economic exposure, which is derived from the risk that currency fluctuations could affect the dollar value of future cash flows related to operating activities. Commodity Risk Management The Company has exposure to the prices of commodities in its procurement of certain raw materials. The primary purpose of commodity hedging activities is to manage the price volatility associated with these forecasted inventory purchases. Derivatives Not Designated in Hedging Relationships Foreign Currency Contracts The Company also uses foreign exchange forward contracts, options and cross-currency swaps that are not designated as hedging instruments primarily to manage foreign currency exposure. Commodity Contracts The Company utilizes futures, options and swap instruments that are effective as economic hedges of commodity price exposures, but do not meet hedge accounting criteria for derivatives and hedging, to reduce exposure to commodity price fluctuations on purchases of raw materials and inventory. Interest Rate Contracts The Company uses swap instruments that are not designated as hedging instruments to manage interest rate exposures. The Company uses interest rate swaps, "swaptions," and exchange-traded instruments to accomplish this objective. Accounting for Derivative Instruments and Hedging Activities Cash Flow Hedges For derivatives that are designated and qualify as cash flow hedging instruments, the gain or loss on the derivative is recorded in AOCL; it is reclassified to income in the same period or periods that the hedged transaction affects income. The unrealized amounts in AOCL fluctuate based on changes in the fair value of open contracts at the end of each reporting period. The Company anticipates volatility in AOCL and net income from its cash flow hedges. The amount of volatility varies with the level of derivative activities and market conditions during any period. The portion of the mark-to-market effects of the foreign currency contracts is recorded in AOCL; it is reclassified to income in the same period or periods that the underlying item affects income. Commodity swaps, futures and option contracts with maturities of not more than 60 months are utilized and designated as cash flow hedges of forecasted commodity purchases. The designated portion of the mark-to-market effect of the cash flow hedge instrument is recorded in AOCL; it is reclassified to income in the same period or periods that the underlying commodity purchase affects income. Fair Value Hedges For interest rate instruments that are designated and qualify as fair value hedges, the gain or loss on the derivative as well as the offsetting loss or gain on the hedge item attributable to the hedged risk are recognized in current period income and reflected as “Interest expense and amortization of debt discount” in the consolidated statements of income, except for amounts excluded from the assessment of effectiveness that are recognized in earnings through an amortization approach. Net Foreign Investment Hedges The Company designates derivatives that qualify as effective net foreign investment hedges, the results of which are presented in the effect of derivative instruments table. The Company also utilizes non-derivative instruments as net foreign investment hedges. The Company had outstanding foreign-currency denominated debt designated as a hedge of net foreign investment of $152 million at December 31, 2022 ($174 million at December 31, 2021). The following tables provide the fair value and balance sheet classification of derivative instruments at December 31, 2022 and 2021: Fair Value of Derivative Instruments Dec 31, 2022 In millions Balance Sheet Classification Gross Counterparty and Cash Collateral Netting 1 Net Amounts Included in Consolidated Balance Sheets Asset derivatives Derivatives designated as hedging instruments Interest rate contracts Other current assets $ 351 $ (246) $ 105 Foreign currency contracts Other current assets 58 (39) 19 Commodity contracts Other current assets 199 (148) 51 Total $ 608 $ (433) $ 175 Derivatives not designated as hedging instruments Foreign currency contracts Other current assets $ 146 $ (50) $ 96 Commodity contracts Other current assets 22 (1) 21 Total $ 168 $ (51) $ 117 Total asset derivatives $ 776 $ (484) $ 292 Liability derivatives Derivatives designated as hedging instruments Interest rate contracts Accrued and other current liabilities $ 246 $ (246) $ — Foreign currency contracts Accrued and other current liabilities 58 (39) 19 Commodity contracts Accrued and other current liabilities 258 (198) 60 Total $ 562 $ (483) $ 79 Derivatives not designated as hedging instruments Foreign currency contracts Accrued and other current liabilities $ 61 $ (50) $ 11 Commodity contracts Accrued and other current liabilities 12 (11) 1 Total $ 73 $ (61) $ 12 Total liability derivatives $ 635 $ (544) $ 91 1. Counterparty and cash collateral amounts represent the estimated net settlement amount when applying netting and set-off rights included in master netting arrangements between the Company and its counterparties and the payable or receivable for cash collateral held or placed with the same counterparty. Fair Value of Derivative Instruments Dec 31, 2021 In millions Balance Sheet Classification Gross Counterparty and Cash Collateral Netting 1 Net Amounts Included in Consolidated Balance Sheets Asset derivatives Derivatives designated as hedging instruments Interest rate contracts Other current assets $ 14 $ (14) $ — Interest rate contracts Deferred charges and other assets 130 (130) — Foreign currency contracts Other current assets 24 (13) 11 Foreign currency contracts Deferred charges and other assets 117 (89) 28 Commodity contracts Other current assets 305 (173) 132 Commodity contracts Deferred charges and other assets 9 (2) 7 Total $ 599 $ (421) $ 178 Derivatives not designated as hedging instruments Interest rate contracts Other current assets $ 1 $ — $ 1 Foreign currency contracts Other current assets 23 (16) 7 Foreign currency contracts Deferred charges and other assets 1 (1) — Commodity contracts Other current assets 8 (5) 3 Total $ 33 $ (22) $ 11 Total asset derivatives $ 632 $ (443) $ 189 Liability derivatives Derivatives designated as hedging instruments Interest rate contracts Accrued and other current liabilities $ 33 $ (14) $ 19 Interest rate contracts Other noncurrent obligations 192 (130) 62 Foreign currency contracts Accrued and other current liabilities 15 (13) 2 Foreign currency contracts Other noncurrent obligations 90 (89) 1 Commodity contracts Accrued and other current liabilities 267 (192) 75 Commodity contracts Other noncurrent obligations 2 (2) — Total $ 599 $ (440) $ 159 Derivatives not designated as hedging instruments Interest rate contracts Accrued and other current liabilities $ 59 $ — $ 59 Foreign currency contracts Accrued and other current liabilities 31 (16) 15 Foreign currency contracts Other noncurrent obligations 1 (1) — Commodity contracts Accrued and other current liabilities 25 (8) 17 Total $ 116 $ (25) $ 91 Total liability derivatives $ 715 $ (465) $ 250 1. Counterparty and cash collateral amounts represent the estimated net settlement amount when applying netting and set-off rights included in master netting arrangements between the Company and its counterparties and the payable or receivable for cash collateral held or placed with the same counterparty. Assets and liabilities related to forward contracts, interest rate swaps, currency swaps, options and other conditional or exchange contracts executed with the same counterparty under a master netting arrangement are netted. Collateral accounts are netted with corresponding assets or liabilities, when applicable. The Company posted cash collateral of $80 million at December 31, 2022 ($71 million at December 31, 2021). Cash collateral of $2 million was posted by counterparties with the Company at December 31, 2022 (zero at December 31, 2021). The following table summarizes the gain (loss) of derivative instruments in the consolidated statements of income and comprehensive income for the years ended December 31, 2022, 2021 and 2020: Effect of Derivative Instruments Amount of gain (loss) recognized in OCI 1 Amount of gain (loss) recognized in income 2 Income Statement Classification In millions 2022 2021 2020 2022 2021 2020 Derivatives designated as hedging instruments: Fair value hedges: Interest rate contracts $ — $ — $ — $ — $ (25) $ 69 Interest expense and amortization of debt discount 3 Excluded components 4 — 2 7 — — — Interest expense and amortization of debt discount Cash flow hedges: Interest rate contracts 239 (62) — (10) (9) (2) Interest expense and amortization of debt discount Foreign currency contracts 5 13 (20) 13 (15) 3 Cost of sales Commodity contracts 166 133 (8) 310 62 (31) Cost of sales Net foreign investment hedges: Foreign currency contracts 34 31 (38) — — — Excluded components 4 59 54 27 44 11 20 Sundry income (expense) - net Total derivatives designated as hedging instruments $ 503 $ 171 $ (32) $ 357 $ 24 $ 59 Derivatives not designated as hedging instruments: Interest rate contracts $ — $ — $ — $ (1) $ (8) $ (16) Interest expense and amortization of debt discount Foreign currency contracts — — — (249) (253) 28 Sundry income (expense) - net Commodity contracts — — — 48 (46) 11 Cost of sales Total derivatives not designated as hedging instruments $ — $ — $ — $ (202) $ (307) $ 23 Total derivatives $ 503 $ 171 $ (32) $ 155 $ (283) $ 82 1. OCI is defined as other comprehensive income (loss). 2. Pretax amounts. 3. Gain (loss) recognized in income of derivatives is offset by gain (loss) recognized in income of the hedged item. 4. The excluded components are related to the time value of the derivatives designated as hedges. The following table provides the net after-tax gain (loss) expected to be reclassified from AOCL to income within the next 12 months: Expected Reclassifications from AOCL within the next 12 months Dec 31, Cash flow hedges: Interest rate contracts $ (7) Commodity contracts $ (48) Foreign currency contracts $ 2 Net foreign investment hedges: Excluded components $ —

FAIR VALUE MEASUREMENTS (Notes)

FAIR VALUE MEASUREMENTS (Notes)	12 Months Ended
	Dec. 31, 2022
Fair Value Disclosures [Abstract]
FAIR VALUE MEASUREMENTS	FAIR VALUE MEASUREMENTS Fair Value Measurements on a Recurring Basis The following table summarizes the bases used to measure certain assets and liabilities at fair value on a recurring basis: Basis of Fair Value Measurements on a Recurring Basis Dec 31, 2022 Dec 31, 2021 In millions Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Total Assets at fair value: Cash equivalents: Held-to-maturity securities 1 $ — $ 872 $ — $ 872 $ — $ 317 $ — $ 317 Money market funds — 355 — 355 — 489 — 489 Marketable securities 2 — 939 — 939 — 245 — 245 Equity securities 3 10 — — 10 20 — — 20 Nonconsolidated affiliates 4 — — 7 7 — — — — Debt securities: 3 Government debt 5 — 622 — 622 — 735 — 735 Corporate bonds 35 1,090 — 1,125 44 1,280 — 1,324 Derivatives relating to: 6 Interest rates — 351 — 351 — 145 — 145 Foreign currency — 204 — 204 — 165 — 165 Commodities 63 158 — 221 15 307 — 322 Total assets at fair value $ 108 $ 4,591 $ 7 $ 4,706 $ 79 $ 3,683 $ — $ 3,762 Liabilities at fair value: Long-term debt including debt due within one year 7 $ — $ 13,875 $ — $ 13,875 $ — $ 17,125 $ — $ 17,125 Guarantee liability 8 — — 199 199 — — 220 220 Derivatives relating to: 6 Interest rates — 246 — 246 — 284 — 284 Foreign currency — 119 — 119 — 137 — 137 Commodities 103 167 — 270 37 257 — 294 Total liabilities at fair value $ 103 $ 14,407 $ 199 $ 14,709 $ 37 $ 17,803 $ 220 $ 18,060 1. The Company's held-to-maturity securities primarily included treasury bills and time deposits. 2. The Company's investments in marketable securities are included in "Other current assets" in the consolidated balance sheets. 3. The Company's investments in debt securities, which are primarily available-for-sale, and equity securities are included in "Other investments" in the consolidated balance sheets. 4. Estimated asset for an investment in a limited liability company included in "Investment in nonconsolidated affiliates" in the consolidated balance sheets. 5. U.S. Treasury obligations, U.S. agency obligations, U.S. agency mortgage-backed securities and other municipalities' obligations. 6. See Note 21 for the classification of derivatives in the consolidated balance sheets. 7. See Note 21 for information on fair value measurements of long-term debt. 8. Estimated liability for TDCC's guarantee of Sadara's debt which is included in "Other noncurrent obligations" in the consolidated balance sheets. See Note 15 for additional information. For assets and liabilities classified as Level 1 measurements (measured using quoted prices in active markets), total fair value is either the price of the most recent trade at the time of the market close or the official close price, as defined by the exchange on which the asset is most actively traded on the last trading day of the period, multiplied by the number of units held without consideration of transaction costs. For assets and liabilities classified as Level 2 measurements, where the security is frequently traded in less active markets, fair value is based on the closing price at the end of the period; where the security is less frequently traded, fair value is based on the price a dealer would pay for the security or similar securities, adjusted for any terms specific to that asset or liability, or by using observable market data points of similar, more liquid securities to imply the price. Market inputs are obtained from well-established and recognized vendors of market data and subjected to tolerance and quality checks. For derivative assets and liabilities, standard industry models are used to calculate the fair value of the various financial instruments based on significant observable market inputs, such as foreign exchange rates, commodity prices, swap rates, interest rates and implied volatilities obtained from various market sources. Market inputs are obtained from well-established and recognized vendors of market data and subjected to tolerance/quality checks. For all other assets and liabilities for which observable inputs are used, fair value is derived through the use of fair value models, such as a discounted cash flow model or other standard pricing models. See Note 21 for further information on the types of instruments used by the Company for risk management. There were no transfers between Levels 1 and 2 in the years ended December 31, 2022 and 2021. For assets classified as Level 3 measurements, fair value is based on significant unobservable inputs including assumptions where there is little, if any, market activity. The level 3 asset value represents the fair value of an investment in a limited liability company, accounted for as an investment in nonconsolidated affiliates. There was no unfunded commitment on the investment at December 31, 2022. For liabilities classified as Level 3 measurements, the fair value is based on significant unobservable inputs including assumptions where there is little, if any, market activity. The fair value of the Company’s accrued liability related to the guarantee of Sadara's debt is in proportion to the Company's 35 percent ownership interest in Sadara. The estimated fair value of the guarantee was calculated using a "with" and "without" method. The fair value of the debt was calculated "with" the guarantee less the fair value of the debt "without" the guarantee. The "with" and "without" values were calculated using a discounted cash flow method based on contractual cash flows as well as projected prepayments made on the debt by Sadara. See Note 15 for further information on guarantees classified as Level 3 measurements. The following table summarizes the changes in fair value measurements using Level 3 inputs for the years ended December 31, 2022 and 2021: Fair Value Measurements Using Level 3 Inputs for Accrued Liability of Sadara Guarantee at Dec 31, 2022 2021 In millions Balance at Jan 1 $ (220) $ — Recognition of liability 1 — (235) Gain included in earnings 2 21 15 Balance at Dec 31 $ (199) $ (220) 1. Included in "Other noncurrent obligations" in the consolidated balance sheets. 2. Included in "Equity in earnings (losses) of nonconsolidated affiliates" in the consolidated income statements. For equity securities calculated at net asset value per share (or its equivalent), the Company had $92 million in private equity and $20 million in real estate at December 31, 2022 ($106 million in private equity and $22 million in real estate at December 31, 2021). There are no redemption restrictions and the unfunded commitments on these investments were $54 million at December 31, 2022 ($59 million at December 31, 2021). Fair Value Measurements on a Nonrecurring Basis The following table summarizes the bases used to measure certain assets at fair value on a nonrecurring basis in the consolidated balance sheets: Basis of Fair Value Measurements on a Nonrecurring Basis at Dec 31 (Level 3) Total Losses In millions 2020 Assets at fair value: Long-lived assets and other assets $ 121 $ (245) 2022 Fair Value Measurements on a Nonrecurring Basis The Company's fair value measurements on a nonrecurring basis were insignificant in 2022. 2021 Fair Value Measurements on a Nonrecurring Basis The Company's fair value measurements on a nonrecurring basis were insignificant in 2021. 2020 Fair Value Measurements on a Nonrecurring Basis As part of the 2020 Restructuring Program, the Company has or will shut down and write off several small manufacturing facilities and miscellaneous assets around the world. The assets associated with this plan were written down to zero. In addition, impairments of leased, non-manufacturing facilities, which were classified as Level 3 measurements, resulted in a write-down of right-of-use assets to a fair value of $110 million using unobservable inputs. The impairment charges related to the 2020 Restructuring Program, totaling $196 million, were included in "Restructuring and asset related charges - net" in the consolidated statements of income and related to Packaging & Specialty Plastics ($11 million), Industrial Intermediates & Infrastructure ($22 million), Performance Materials & Coatings ($116 million) and Corporate ($47 million). In 2020, the Company recognized impairment charges of $30 million related to the write-down of a non-manufacturing asset and certain corporate leased equipment and the write-off of a capital project. The assets, classified as Level 3 measurements, were valued at $11 million using unobservable inputs. The impairment charges were included in "Restructuring and asset related charges - net" in the consolidated statements of income and related to Performance Materials & Coatings ($15 million) and Corporate ($15 million). In 2020, the Company recognized an additional pretax impairment charge of $19 million related to capital additions made to a bio-ethanol manufacturing facility in Santa Vitoria, Minas Gerais, Brazil, which was impaired in 2017. The assets were written down to zero in 2020. The impairment charge was included in “Restructuring and asset related charges - net” in the consolidated statements of income and related to Packaging & Specialty Plastics. On September 29, 2020, the Company divested the bio-ethanol manufacturing facility. See Note 5 for additional information on the Company's restructuring activities.

VARIABLE INTEREST ENTITIES (Not

VARIABLE INTEREST ENTITIES (Notes)	12 Months Ended
	Dec. 31, 2022
VARIABLE INTEREST ENTITIES [Abstract]
VARIABLE INTEREST ENTITIES	VARIABLE INTEREST ENTITIES Consolidated Variable Interest Entities ("VIEs") The Company holds a variable interest in the following joint ventures or entities for which it is the primary beneficiary: Asia Pacific Joint Ventures The Company has variable interests in two joint ventures that own and operate manufacturing and logistics facilities, which produce chemicals and provide services in Asia Pacific. The Company's variable interests in these joint ventures relate to arrangements between the joint ventures and the Company, involving the majority of the output on take-or-pay terms with pricing ensuring a guaranteed return to the joint ventures. Ethylene Storage Joint Venture The Company has variable interests in a joint venture that provides ethylene storage in Alberta, Canada. The Company's variable interests relate to arrangements involving a majority of the joint venture's storage capacity on take-or-pay terms with pricing ensuring a guaranteed return to the joint venture; and favorably priced leases provided to the joint venture. The Company provides the joint venture with operation and maintenance services and utilities. Assets and Liabilities of Consolidated VIEs The Company's consolidated financial statements include the assets, liabilities and results of operations of VIEs for which the Company is the primary beneficiary. The other equity holders’ interests are reflected in "Net income attributable to noncontrolling interests" in the consolidated statements of income and "Noncontrolling interests" in the consolidated balance sheets. The following table summarizes the carrying amounts of these entities’ assets and liabilities included in the Company’s consolidated balance sheets at December 31, 2022 and 2021: Assets and Liabilities of Consolidated VIEs at Dec 31 In millions 2022 2021 Cash and cash equivalents $ 17 $ 40 Other current assets 36 40 Net property 157 184 Other noncurrent assets 17 15 Total assets 1 $ 227 $ 279 Current liabilities $ 30 $ 37 Long-term debt — 3 Other noncurrent obligations 12 13 Total liabilities 2 $ 42 $ 53 1. All assets were restricted at December 31, 2022 and 2021. 2. All liabilities were nonrecourse at December 31, 2022 and 2021. Amounts presented in the consolidated balance sheets and the table above as restricted assets or nonrecourse obligations relating to consolidated VIEs at December 31, 2022 and 2021 are adjusted for intercompany eliminations. Nonconsolidated VIEs The Company holds a variable interest in the following entities for which the Company is not the primary beneficiary: Silicon Joint Ventures The Company holds minority voting interests in certain joint ventures that produce silicon inputs for the Company. These joint ventures operate under supply agreements that sell inventory to the equity owners using pricing mechanisms that guarantee a return, therefore shielding the joint ventures from the obligation to absorb expected losses. As a result of the pricing mechanisms of these agreements, these entities are determined to be VIEs. The Company is not the primary beneficiary, as it does not hold the power to direct the activities that most significantly impact the economic performance of these entities; therefore, the entities are accounted for under the equity method of accounting. The Company's maximum exposure to loss as a result of its involvement with these variable interest entities is determined to be the carrying value of the investment in these entities. At December 31, 2022, the Company's investment in these joint ventures was $113 million ($110 million at December 31, 2021), classified as "Investment in nonconsolidated affiliates" in the consolidated balance sheets, representing the Company's maximum exposure to loss.

RELATED PARTY TRANSACTIONS (Not

RELATED PARTY TRANSACTIONS (Notes)	12 Months Ended
	Dec. 31, 2022
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	RELATED PARTY TRANSACTIONS TDCC has committed to fund Dow Inc.'s dividends paid to common stockholders and share repurchases, as approved by the Dow Inc. Board from time to time, as well as certain governance expenses. Funding is accomplished through intercompany loans. TDCC's Board reviews and determines a dividend distribution to Dow Inc. to settle the intercompany loans. The following table summarizes cash dividends TDCC declared and paid to Dow Inc. for the years ended 2022, 2021 and 2020. TDCC Cash Dividends Declared and Paid 2022 2021 2020 In millions Cash dividends declared and paid $ 4,375 $ 3,264 $ 2,233 At December 31, 2022 and 2021, TDCC's intercompany loan balance with Dow Inc. was insignificant.

SEGMENTS AND GEOGRAPHIC REGIONS

SEGMENTS AND GEOGRAPHIC REGIONS (Notes)	12 Months Ended
	Dec. 31, 2022
Segment Reporting [Abstract]
Segments and Geographic Regions [Text Block]	SEGMENTS AND GEOGRAPHIC REGIONS Sales are attributed to geographic region based on customer location; long-lived assets are attributed to geographic region based on asset location. Geographic Region Information United EMEAI Rest of Total In millions 2022 Sales to external customers $ 19,336 $ 19,631 $ 17,935 $ 56,902 Long-lived assets $ 14,638 $ 2,578 $ 3,226 $ 20,442 2021 Sales to external customers $ 18,083 $ 19,746 $ 17,139 $ 54,968 Long-lived assets $ 14,425 $ 2,703 $ 3,427 $ 20,555 2020 Sales to external customers $ 12,547 $ 12,969 $ 13,026 $ 38,542 Long-lived assets $ 13,833 $ 2,813 $ 3,593 $ 20,239 See Part I, Item 1. Business for further discussion of the Company's segments. Dow’s measure of profit/loss for segment reporting purposes is Operating EBIT as this is the manner in which the Company's chief operating decision maker ("CODM") assesses performance and allocates resources. The Company defines Operating EBIT as earnings (i.e., "Income before income taxes") before interest, excluding the impact of significant items. Operating EBIT by segment includes all operating items relating to the businesses; items that principally apply to Dow as a whole are assigned to Corporate. Segment Information Pack. & Spec. Plastics Ind. Interm. & Infrast. Perf. Materials & Coatings Corp. Total In millions 2022 Net sales $ 29,260 $ 16,606 $ 10,764 $ 272 $ 56,902 Restructuring and asset related charges - net 1 8 73 6 31 118 Equity in earnings (losses) of nonconsolidated affiliates 359 (91) 10 (10) 268 Operating EBIT 2 4,110 1,418 1,328 (266) 6,590 Depreciation and amortization 1,396 550 789 23 2,758 Total assets 30,017 12,883 13,028 4,675 60,603 Investments in nonconsolidated affiliates 846 454 115 174 1,589 Capital expenditures 1,069 385 369 — 1,823 2021 Net sales $ 28,128 $ 16,851 $ 9,672 $ 317 $ 54,968 Restructuring and asset related charges (credits) - net 1 8 1 10 (13) 6 Equity in earnings of nonconsolidated affiliates 490 471 7 7 975 Operating EBIT 2 6,638 2,282 866 (253) 9,533 Depreciation and amortization 1,358 612 842 30 2,842 Total assets 30,556 13,750 13,810 4,874 62,990 Investments in nonconsolidated affiliates 1,230 670 111 34 2,045 Capital expenditures 808 359 334 — 1,501 2020 Net sales $ 18,301 $ 12,021 $ 7,951 $ 269 $ 38,542 Restructuring and asset related charges - net 1 30 22 192 464 708 Equity in earnings (losses) of nonconsolidated affiliates 173 (166) 6 (31) (18) Operating EBIT 2 2,325 355 314 (279) 2,715 Depreciation and amortization 1,372 605 870 27 2,874 Total assets 30,069 12,220 13,915 5,266 61,470 Investments in nonconsolidated affiliates 661 531 108 27 1,327 Capital expenditures 678 268 306 — 1,252 1. See Note 5 for information regarding the Company's restructuring programs and other asset related charges. 2. Operating EBIT for TDCC in 2022, 2021 and 2020 is substantially the same as that of Dow Inc. and therefore is not disclosed separately in the table above. A reconciliation of "Net income" to Operating EBIT is provided in the following table. Reconciliation of "Net income" to Operating EBIT 2022 2021 2020 In millions Net income $ 4,640 $ 6,405 $ 1,294 + Provision for income taxes 1,450 1,740 777 Income before income taxes $ 6,090 $ 8,145 $ 2,071 - Interest income 173 55 38 + Interest expense and amortization of debt discount 662 731 827 - Significant items (11) (712) 145 Operating EBIT $ 6,590 $ 9,533 $ 2,715 The following tables summarize the pretax impact of significant items by segment that are excluded from Operating EBIT: Significant Items by Segment for 2022 Pack. & Spec. Plastics Ind. Interm. & Infrast. Perf. Materials & Coatings Corp. Total In millions Digitalization program costs 1 $ — $ — $ — $ (230) $ (230) Restructuring, implementation costs and asset related charges - net 2 — — — (40) (40) Russia / Ukraine conflict charges 3 (8) (73) (6) (31) (118) Loss on early extinguishment of debt 4 — — — (8) (8) Litigation related charges, awards and adjustments 5 321 — — 60 381 Indemnification and other transaction related costs 6 — — — 4 4 Total $ 313 $ (73) $ (6) $ (245) $ (11) 1. Includes costs associated with implementing the Company's Digital Acceleration program. 2. Includes costs associated with implementing the Company's 2020 Restructuring Program. 3. Asset related charges due to the Russia and Ukraine conflict. See Note 5 for additional information. 4. The Company redeemed outstanding long-term debt resulting in a loss on early extinguishment. See Note 14 for additional information. 5. Includes a gain associated with a legal matter with Nova Chemicals Corporation and a gain related to an adjustment of the Dow Silicones breast implant liability. See Note 15 for additional information. 6. Primarily related to charges associated with agreements entered into with DuPont and Corteva as part of the separation and distribution which, among other matters, provides for cross-indemnities and allocations of obligations and liabilities for periods prior to, at and after the completion of the separation. Significant Items by Segment for 2021 Pack. & Spec. Plastics Ind. Interm. & Infrast. Perf. Materials & Coatings Corp. Total In millions Digitalization program costs 1 $ — $ — $ — $ (169) $ (169) Restructuring, implementation costs and asset related charges - net 2 (8) (1) (10) (50) (69) Loss on early extinguishment of debt 3 — — — (574) (574) Net gain on divestitures and asset sale 4 16 — — — 16 Litigation related charges, awards and adjustments 5 — 54 — — 54 Indemnification and other transaction related costs 6 — — — 30 30 Total $ 8 $ 53 $ (10) $ (763) $ (712) 1. Includes costs associated with implementing the Company's Digital Acceleration program. 2. Includes costs associated with implementing the Company's 2020 Restructuring Program, and asset-related charges, which include other asset impairments. See Note 5 for additional information. 3. The Company redeemed outstanding long-term debt resulting in a loss on early extinguishment. See Note 14 for additional information. 4. Includes post-closing adjustments on a previous divestiture. 5. Related to an arbitration award received from Luxi Chemical Group Co., Ltd. See Note 15 for additional information. 6. Primarily related to charges associated with agreements entered into with DuPont and Corteva as part of the separation and distribution which, among other matters, provides for cross-indemnities and allocations of obligations and liabilities for periods prior to, at and after the completion of the separation. Significant Items by Segment for 2020 Pack. & Spec. Plastics Ind. Interm. & Infrast. Perf. Materials & Coatings Corp. Total In millions Integration and separation costs 1 $ — $ — $ — $ (239) $ (239) Restructuring, implementation costs and asset related charges - net 2 (30) (22) (192) (474) (718) Warranty accrual adjustment of exited business 3 — — — 11 11 Net gain on divestitures and asset sale 4 52 61 — 604 717 Litigation related charges, awards and adjustments 5 544 — — — 544 Loss on early extinguishment of debt 6 — — — (149) (149) Indemnification and other transaction related costs 7 — — — (21) (21) Total $ 566 $ 39 $ (192) $ (268) $ 145 1. Costs related to business separation activities. 2. Includes costs associated with implementing the Company's 2020 Restructuring Program, and asset-related charges, which include other asset impairments. See Note 5 for additional information. 3. Includes an adjustment to the warranty accrual of an exited business. 4. Primarily related to a gain on the sale of rail infrastructure in the U.S. and Canada and a gain on the sale of marine and terminal operations and assets in the U.S. See Notes 4 and 6 for additional information. 5. Includes recognition of gains associated with a legal matter with Nova. See Note 15 for additional information. 6. The Company redeemed outstanding long-term debt resulting in a loss on early extinguishment. See Note 14 for additional information. 7. Primarily related to charges associated with agreements entered into with DuPont and Corteva as part of the separation and distribution which, among other matters, provides for cross-indemnities and allocations of obligations and liabilities for periods prior to, at and after the completion of the separation.

VALUATION AND QUALIFYING ACCOUN

VALUATION AND QUALIFYING ACCOUNTS (Notes)	12 Months Ended
	Dec. 31, 2022
SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]
VALUATION AND QUALIFYING ACCOUNTINGS	(In millions) For the years ended Dec 31, 2022 2021 2020 Accounts Receivable - Allowance for Doubtful Receivables Balance at beginning of year $ 54 $ 51 $ 45 Additions charged to expenses 61 16 22 Deductions from reserves 1 (5) (13) (16) Balance at end of year $ 110 $ 54 $ 51 Inventory - Obsolescence Reserve Balance at beginning of year $ 14 $ 23 $ 35 Additions charged to expenses 50 3 2 Deductions from reserves 2 (7) (12) (14) Balance at end of year $ 57 $ 14 $ 23 Reserves for Other Investments and Noncurrent Receivables Balance at beginning of year $ 2,033 $ 2,093 $ 2,215 Additions charged to expenses 17 19 7 Deductions from reserves 3 (100) (79) (129) Balance at end of year $ 1,950 $ 2,033 $ 2,093 Deferred Tax Assets - Valuation Allowance Balance at beginning of year $ 1,391 $ 1,302 $ 1,262 Additions charged to expenses 120 201 313 Deductions from reserves (242) (112) (273) Balance at end of year $ 1,269 $ 1,391 $ 1,302 1. Deductions included write-offs, recoveries, currency translation adjustments and other miscellaneous items. 2. Deductions included disposals and currency translation adjustments. 3. Deductions from reserves for "Reserves for Other Investments and Noncurrent Receivables" included $77 million in 2022, 2021 and 2020 related to the Company's investment in Sadara. See Note 11 to the Consolidated Financial Statements for additional information.

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	12 Months Ended
	Dec. 31, 2022
Accounting Policies [Abstract]
Principles of Consolidation and Basis of Presentation	Principles of Consolidation and Basis of Presentation The accompanying consolidated financial statements of Dow Inc. and TDCC were prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and include the assets, liabilities, revenues and expenses of all majority-owned subsidiaries over which Dow exercises control and, when applicable, entities for which Dow has a controlling financial interest or is the primary beneficiary. Intercompany transactions and balances are eliminated in consolidation. Investments in nonconsolidated affiliates (20-50 percent owned companies or less than 20 percent owned companies over which significant influence is exercised) are primarily accounted for using the equity method. Dow Inc. owns all of the outstanding common shares of TDCC. As a result of the parent/subsidiary relationship between Dow Inc. and TDCC, and considering that the financial statements and disclosures of each company are substantially similar, the companies are filing a combined report for this Annual Report on Form 10-K. The information reflected in the report is equally applicable to both Dow Inc. and TDCC, except where otherwise noted. Transactions between TDCC and Dow Inc. are treated as related party transactions for TDCC. See Note 24 for additional information. The Company conducts its worldwide operations through six global businesses which are organized into the following operating segments: Packaging & Specialty Plastics, Industrial Intermediates & Infrastructure and Performance Materials & Coatings. Corporate contains the reconciliation between the totals for the operating segments and the Company's totals. See Note 25 for additional information.
Use of Estimates in Financial Statement Preparation	Use of Estimates in Financial Statement Preparation The preparation of financial statements in accordance with U.S. GAAP requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. The Company’s consolidated financial statements include amounts that are based on management’s best estimates and judgments. Actual results could differ from those estimates.
Asbestos-Related Matters	Asbestos-Related Matters Accruals for asbestos-related matters, including defense and processing costs, are recorded based on an analysis of claim and resolution activity, defense spending, and pending and future claims. These accruals are assessed at each balance sheet date to determine if the asbestos-related liability remains appropriate. Accruals for asbestos-related matters are included in the consolidated balance sheets in “Accrued and other current liabilities” and “Asbestos-related liabilities - noncurrent.” See Note 15 for additional information.
Legal Costs	Legal Costs
Foreign Currency Translation	Foreign Currency TranslationThe local currency has been primarily used as the functional currency throughout the world. Translation gains and losses of those operations that use local currency as the functional currency are included in the consolidated balance sheets in "Accumulated other comprehensive loss" ("AOCL"). For certain subsidiaries, the U.S. dollar is used as the functional currency. This occurs when the subsidiary operates in an economic environment where the products produced and sold are tied to U.S. dollar-denominated markets, or when the foreign subsidiary operates in a hyper-inflationary environment. Where the U.S. dollar is used as the functional currency, foreign currency translation gains and losses are reflected in income.
Environmental Matters	Environmental Matters Accruals for environmental matters are recorded when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated based on current law and existing technologies. These accruals are adjusted periodically as assessment and remediation efforts progress or as additional technical or legal information becomes available. Accruals for environmental liabilities are included in the consolidated balance sheets in “Accrued and other current liabilities” and “Other noncurrent obligations” at undiscounted amounts. Accruals for related insurance or other third-party recoveries for environmental liabilities are recorded when it is probable that a recovery will be realized and are included in the consolidated balance sheets in “Accounts and notes receivable - Other” or "Noncurrent receivables." Environmental costs are capitalized if the costs extend the life of the property, increase its capacity and/or mitigate or prevent contamination from future operations. Environmental costs are also capitalized in recognition of legal asset retirement obligations resulting from the acquisition, construction and/or normal operation of a long-lived asset. Costs related to environmental contamination treatment and cleanup are charged to expense. Estimated future incremental operations, maintenance and management costs directly related to remediation are accrued when such costs are probable and reasonably estimable.
Cash and Cash Equivalents	Cash and Cash Equivalents Cash and cash equivalents include time deposits and investments with maturities of three months or less at the time of purchase.
Financial Instruments Accounting, Policy	Financial Instruments The Company calculates the fair value of financial instruments using quoted market prices when available. When quoted market prices are not available for financial instruments, the Company uses standard pricing models with market-based inputs that take into account the present value of estimated future cash flows. The Company utilizes derivatives to manage exposures to foreign currency exchange rates, commodity prices and interest rate risk. The fair values of all derivatives are recognized as assets or liabilities at the balance sheet date. Changes in the fair values of these instruments are reported in income or AOCL, depending on the use of the derivative and whether the Company has elected hedge accounting treatment. Gains and losses on derivatives that are designated and qualify as cash flow hedging instruments are recorded in AOCL until the underlying transactions are recognized in income. Gains and losses on derivative and non-derivative instruments used as hedges of the Company’s net investment in foreign operations are recorded in AOCL as part of the cumulative translation adjustment. Gains and losses on derivatives designated and qualifying as fair value hedging instruments, as well as the offsetting losses and gains on the hedged items, are reported in income in the same accounting period. Derivatives not designated as hedging instruments are marked-to-market at the end of each accounting period with the results included in income.
Inventories	Inventories Inventories are stated at the lower of cost or net realizable value. The method of determining cost for each subsidiary varies among last-in, first-out (“LIFO”); first-in, first-out (“FIFO”); and average cost, and is used consistently from year to year. At December 31, 2022, approximately 27 percent, 64 percent and 9 percent of the Company's inventories were accounted for under the LIFO, FIFO and average cost methods, respectively. At December 31, 2021, approximately 27 percent, 65 percent and 8 percent of the Company's inventories were accounted for under the LIFO, FIFO and average cost methods, respectively. The Company routinely exchanges and swaps raw materials and finished goods with other companies to reduce delivery time, freight and other transportation costs. These transactions are treated as non-monetary exchanges and are valued at cost.
Property	PropertyLand, buildings and equipment are carried at cost less accumulated depreciation or amortization. Property under finance lease agreements is carried at the present value of lease payments over the lease term less accumulated amortization. Depreciation is based on the estimated service lives of depreciable assets and is calculated using the straight-line method. Fully depreciated assets are retained in property and accumulated depreciation accounts until they are removed from service. In the case of disposals, assets and related accumulated depreciation are removed from the accounts, and the net amounts, less proceeds from disposal, are included in income.
Impairment and Disposal of Long-Lived Assets	Impairment and Disposal of Long-Lived Assets The Company evaluates long-lived assets (property, finite-lived intangible assets and right-of-use assets) for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. When undiscounted future cash flows are not expected to be sufficient to recover an asset’s carrying amount, the asset is written down to its fair value based on bids received from third parties or a discounted cash flow analysis based on market participant assumptions. Long-lived assets to be disposed of by sale, if material, are classified as held for sale and reported at the lower of carrying amount or fair value less cost to sell, and depreciation/amortization is ceased. Long-lived assets to be disposed of other than by sale are classified as held and used until they are disposed of and reported at the lower of carrying amount or fair value, and depreciation/amortization is recognized over the remaining useful life of the assets.
Goodwill and Other Intangible Assets	Goodwill and Other Intangible Assets The Company records goodwill when the purchase price of a business combination exceeds the estimated fair value of net identified tangible and intangible assets acquired. Goodwill is tested for impairment at the reporting unit level annually in the fourth quarter, or more frequently when events or changes in circumstances indicate that the fair value of a reporting unit has more likely than not declined below its carrying value. When testing goodwill for impairment, the Company may first assess qualitative factors. If an initial qualitative assessment identifies that it is more likely than not that the fair value of a reporting unit is less than its carrying value, additional quantitative testing is performed. The Company may also elect to skip the qualitative testing and proceed directly to the quantitative testing. If the quantitative testing indicates that goodwill is impaired, an impairment charge is recognized based on the difference between the reporting unit's carrying value and its fair value. The Company primarily utilizes a discounted cash flow methodology to calculate the fair value of its reporting units.
Asset Retirement Obligations	Asset Retirement ObligationsThe Company records asset retirement obligations as incurred and reasonably estimable, including obligations for which the timing and/or method of settlement are conditional on a future event that may or may not be within the control of the Company. The fair values of obligations are recorded as liabilities on a discounted basis and are accreted over time for the change in present value. Costs associated with the liabilities are capitalized and amortized over the estimated remaining useful life of the asset, generally for periods of 10 years or less.
Investments	Investments Investments in debt securities, primarily held by the Company's insurance operations, are classified as trading, available-for-sale or held-to-maturity. Investments classified as trading are reported at fair value with unrealized gains and losses related to mark-to-market adjustments included in income. Those classified as available-for-sale are reported at fair value with unrealized gains and losses recorded in AOCL. Those classified as held-to-maturity are recorded at amortized cost. The cost of investments sold is determined by FIFO or specific identification. Investments in equity securities with a readily determinable fair value are reported at fair value with unrealized gains and losses related to mark-to-market adjustments included in income. Equity securities without a readily determinable fair value are accounted for at cost, adjusted for impairments and observable price changes in orderly transactions. The Company routinely reviews its investments for declines in fair value below the cost basis. When events or changes in circumstances indicate the carrying value of an asset may not be recoverable, the security is written down, establishing a new cost basis.
Lessee, Leases [Policy Text Block]	Leases The Company determines whether a contract contains a lease at contract inception. A contract contains a lease if there is an identified asset and the Company has the right to control the asset. Operating lease right-of-use (“ROU”) assets represent the Company's right to use an underlying asset for the lease term, and lease liabilities represent the Company's obligation to make lease payments arising from the lease. Operating lease ROU assets and lease liabilities are recognized at commencement date based on the present value of lease payments over the lease term. The Company uses the incremental borrowing rate in determining the present value of lease payments, unless the implicit rate is readily determinable. If lease terms include options to extend or terminate the lease, the ROU asset and lease liability are measured based on the reasonably certain decision. Leases with a term of 12 months or less at the commencement date are not recognized on the balance sheet and are expensed as incurred. The Company has lease agreements with lease and non-lease components, which are accounted for as a single lease component for nearly all classes of leased assets for which the Company is the lessee. Additionally, for certain equipment leases, the portfolio approach is applied to account for the operating lease ROU assets and lease liabilities. In the consolidated statements of income, lease expense for operating lease payments is recognized on a straight-line basis over the lease term. For finance leases, interest expense is recognized on the lease liability and the ROU asset is amortized over the lease term. Some leasing arrangements require variable payments that are dependent upon usage or output, or may vary for other reasons, such as insurance or tax payments. Variable lease payments are recognized as incurred and are not presented as part of the ROU asset or lease liability. See Note 16 for additional information.
Revenue	Revenue The Company recognizes revenue when its customer obtains control of promised goods or services in an amount that reflects the consideration which the Company expects to receive in exchange for those goods or services. To determine revenue recognition, the Company performs the following five steps: (1) identify the contract(s) with a customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract and (5) recognize revenue when (or as) the entity satisfies a performance obligation. See Note 3 for additional information.
Severance Costs	Severance Costs The Company routinely reviews its operations around the world in an effort to ensure competitiveness across its businesses and geographic regions. When the reviews result in a workforce reduction related to the shutdown of facilities or other optimization activities, severance benefits are provided to employees primarily under the Company’s ongoing benefit arrangements. These severance costs are accrued once management commits to a plan of termination and it becomes probable that employees will be entitled to benefits at amounts that can be reasonably estimated.
Income Taxes	Income Taxes The Company accounts for income taxes using the asset and liability method. Under this method, deferred tax assets and liabilities are recognized for the future tax consequences of temporary differences between the carrying amounts and tax bases of assets and liabilities using enacted tax rates. The effect of a change in tax rates on deferred tax assets or liabilities is recognized in income in the period that includes the enactment date. The Company uses the portfolio approach for releasing income tax effects from AOCL. The Company recognizes the financial statement effects of an uncertain income tax position when it is more likely than not, based on the technical merits, that the position will be sustained upon examination. The Company accrues for other tax contingencies when it is probable that a liability to a taxing authority has been incurred and the amount of the contingency can be reasonably estimated. The current portion of uncertain income tax positions is included in “Income taxes payable” and the long-term portion is included in “Other noncurrent obligations” in the consolidated balance sheets. Provision is made for taxes on undistributed earnings of foreign subsidiaries and related companies to the extent that such earnings are not deemed to be permanently invested.
Earnings per common share	Earnings per Common Share The calculation of earnings per common share is based on the weighted-average number of the Company's common shares outstanding for the applicable period. The calculation of diluted earnings per common share reflects the effect of all potential common shares that were outstanding during the respective periods, unless the effect of doing so is antidilutive.

REVENUE (Tables)

REVENUE (Tables)	12 Months Ended
	Dec. 31, 2022
Revenue from Contract with Customer [Abstract]
Disaggregation of Revenue [Table Text Block]	Disaggregation of Revenue Dow disaggregates its revenue from contracts with customers by operating segment and business, as the Company believes it best depicts the nature, amount, timing and uncertainty of its revenue and cash flows. See details in the tables below: Net Trade Sales by Segment and Business 2022 2021 2020 In millions Hydrocarbons & Energy $ 9,414 $ 8,149 $ 4,271 Packaging and Specialty Plastics 19,846 19,979 14,030 Packaging & Specialty Plastics $ 29,260 $ 28,128 $ 18,301 Industrial Solutions $ 5,682 $ 5,139 $ 3,929 Polyurethanes & Construction Chemicals 10,907 11,700 8,080 Others 17 12 12 Industrial Intermediates & Infrastructure $ 16,606 $ 16,851 $ 12,021 Coatings & Performance Monomers $ 4,051 $ 4,050 $ 3,258 Consumer Solutions 6,713 5,622 4,693 Performance Materials & Coatings $ 10,764 $ 9,672 $ 7,951 Corporate $ 272 $ 317 $ 269 Total $ 56,902 $ 54,968 $ 38,542 Net Trade Sales by Geographic Region 2022 2021 2020 In millions U.S. & Canada $ 20,945 $ 19,613 $ 13,582 EMEAI 1 19,631 19,746 12,969 Asia Pacific 10,344 10,043 8,165 Latin America 5,982 5,566 3,826 Total $ 56,902 $ 54,968 $ 38,542 1. Europe, Middle East, Africa and India.
Contract with Customer, Asset and Liability	The following table summarizes the contract assets and liabilities at December 31, 2022 and 2021: Contract Assets and Liabilities at Dec 31 Balance Sheet Classification 2022 2021 In millions Accounts and notes receivable - trade Accounts and notes receivable - trade $ 5,611 $ 6,841 Contract assets - current Other current assets $ 48 $ 34 Contract assets - noncurrent Deferred charges and other assets $ 16 $ 26 Contract liabilities - current 1 Accrued and other current liabilities $ 275 $ 209 Contract liabilities - noncurrent 2 Other noncurrent obligations $ 1,725 $ 1,925 1. The increase from December 31, 2021 to December 31, 2022 was due to the reclassification of deferred royalty payments from noncurrent to current. 2. The decrease from December 31, 2021 to December 31, 2022 was due to the recognition of revenue on long-term product supply agreements and the reclassification of deferred royalty payments from noncurrent to current.

RESTRUCTURING, GOODWILL IMPAI_2

RESTRUCTURING, GOODWILL IMPAIRMENT AND ASSET RELATED CHARGES - NET (Tables)	12 Months Ended
	Dec. 31, 2022
2020 Restructuring Program [Member]
Restructuring Cost and Reserve [Line Items]
Schedule of Restructuring Reserve by Type of Cost [Table Text Block]	The following table summarizes the activities related to the 2020 Restructuring Program: 2020 Restructuring Program Severance and Related Benefit Costs Asset Write-downs and Write-offs Costs Associated with Exit and Disposal Activities Total In millions Packaging & Specialty Plastics $ — $ 11 $ — $ 11 Industrial Intermediates & Infrastructure — 22 — 22 Performance Materials & Coatings — 116 61 177 Corporate 297 47 19 363 Total restructuring charges $ 297 $ 196 $ 80 $ 573 Charges against the reserve — (196) (5) (201) Cash payments (8) — — (8) Reserve balance at Dec 31, 2020 $ 289 $ — $ 75 $ 364 Packaging & Specialty Plastics $ — $ — $ 8 $ 8 Industrial Intermediates & Infrastructure — 1 — 1 Performance Materials & Coatings — 8 2 10 Corporate (10) 3 — (7) Total restructuring charges $ (10) $ 12 $ 10 $ 12 Charges against the reserve — (12) — (12) Cash payments (175) — (21) (196) Reserve balance at Dec 31, 2021 $ 104 $ — $ 64 $ 168 Cash payments (88) — (11) (99) Reserve balance at Dec 31, 2022 $ 16 $ — $ 53 $ 69

SUPPLEMENTARY INFORMATION (Tabl

SUPPLEMENTARY INFORMATION (Tables)	12 Months Ended
	Dec. 31, 2022
Supplementary Information [Abstract]
Sundry Income, Net	Sundry Income (Expense) – Net Dow Inc. TDCC In millions 2022 2021 2020 2022 2021 2020 Non-operating pension and other postretirement benefit plan net credits 1 $ 358 $ 332 $ 103 $ 358 $ 332 $ 103 Foreign exchange losses 2 (117) (8) (62) (126) (13) (65) Loss on early extinguishment of debt 3 (8) (574) (149) (8) (574) (149) Gain on sales of other assets and investments 78 105 48 78 105 48 Indemnification and other transaction related costs 4 4 30 (21) — (2) (11) Luxi arbitration award 5 — 54 — — 54 — Gain (loss) on divestitures and asset sale 6 — 16 (15) — 16 (15) Gain on divestiture of rail infrastructure operations and assets 7 — — 233 — — 233 Gain on divestiture of marine and terminal operations and assets 7 — — 499 — — 499 Gain related to Nova legal matter 5 321 — 544 321 — 544 Dow Silicones breast implant liability adjustment 5 60 — 5 60 — 5 Other - net 31 10 84 31 3 82 Total sundry income (expense) – net $ 727 $ (35) $ 1,269 $ 714 $ (79) $ 1,274 1. See Note 19 for additional information. 2. Foreign exchange losses in 2022 relate primarily to exposures in the Argentinian peso. 3. See Note 14 for additional information. 4. Primarily related to charges associated with agreements entered into with DuPont and Corteva as part of the separation and distribution. 5. See Note 15 for additional information. 6. The year ended December 31, 2021 includes post-closing adjustments on a previous divestiture, related to Packaging & Specialty Plastics. The year ended December 31, 2020 primarily relates to a loss on the divestiture of a bio-ethanol manufacturing facility in Brazil, related to Packaging & Specialty Plastics. 7. See Note 4 for additional information.
Schedule of Cash Flow, Supplemental Disclosures	The following table shows cash paid for interest and income taxes for the years ended December 31, 2022, 2021 and 2020: Supplemental Cash Flow Information 2022 2021 2020 In millions Cash paid during year for: Interest $ 675 $ 801 $ 842 Income taxes $ 793 $ 731 $ 518

INCOME TAXES (Tables)

INCOME TAXES (Tables)	12 Months Ended
	Dec. 31, 2022
Income Tax Disclosure [Abstract]
Schedule of Income before Income Tax, Domestic and Foreign	Geographic Allocation of Income and Provision for Income Taxes In millions 2022 2021 2020 Income (loss) before income taxes Domestic $ 2,383 $ 1,523 $ (681) Foreign 3,707 6,622 2,752 Income before income taxes $ 6,090 $ 8,145 $ 2,071 Current tax expense (benefit) Federal $ 434 $ (46) $ (176) State and local 82 48 4 Foreign 855 1,460 691 Total current tax expense $ 1,371 $ 1,462 $ 519 Deferred tax expense Federal $ 63 $ 130 $ 184 State and local 1 26 19 Foreign 15 122 55 Total deferred tax expense $ 79 $ 278 $ 258 Provision for income taxes $ 1,450 $ 1,740 $ 777 Net income $ 4,640 $ 6,405 $ 1,294
Schedule of Effective Income Tax Rate Reconciliation	Reconciliation to U.S. Statutory Rate 2022 2021 2020 Statutory U.S. federal income tax rate 21.0 % 21.0 % 21.0 % Equity earnings effect (1.2) (2.2) 0.2 Foreign income taxed at rates other than the statutory U.S. federal income tax rate (1.4) (1.3) (2.3) U.S. tax effect of foreign earnings and dividends 1.2 1.7 3.9 Unrecognized tax benefits 1.3 4.7 7.3 Divestitures 1 — — (5.1) Changes in valuation allowances (2.8) 2.6 12.6 Federal tax accrual adjustment 2 0.6 (5.3) 0.3 State and local income taxes 2.8 0.2 0.3 Other - net 2.3 — (0.7) Effective tax rate 23.8 % 21.4 % 37.5 % 1. The 2020 impact relates to the divestiture of a bio-ethanol manufacturing facility in Brazil. See Note 5 for additional information.
Schedule of Deferred Tax Assets and Liabilities	Deferred Tax Balances at Dec 31 2022 2021 In millions Assets Liabilities Assets Liabilities Property $ 505 $ 3,001 $ 484 $ 3,150 Tax loss and credit carryforwards 1,472 — 1,784 — Postretirement benefit obligations 749 239 1,753 303 Other accruals and reserves 1,497 279 1,487 191 Intangibles 36 415 108 556 Inventory 129 278 33 203 Investments 116 41 31 26 Other – net 999 131 1,093 101 Subtotal $ 5,503 $ 4,384 $ 6,773 $ 4,530 Valuation allowances (1,269) — (1,391) — Total $ 4,234 $ 4,384 $ 5,382 $ 4,530
Summary of Operating Loss Carryforwards	Operating Loss and Tax Credit Carryforwards at Dec 31 2022 2021 In millions Assets Assets Operating loss carryforwards Expire within 5 years $ 158 $ 240 Expire after 5 years or indefinite expiration 752 817 Total operating loss carryforwards $ 910 $ 1,057 Tax credit carryforwards Expire within 5 years $ 77 $ 227 Expire after 5 years or indefinite expiration 96 103 Total tax credit carryforwards $ 173 $ 330 Capital loss carryforwards Expire within 5 years $ 389 $ 397 Total tax loss and tax credit carryforwards $ 1,472 $ 1,784
Schedule of Total Gross Unrecognized Tax Benefits	The following table provides a reconciliation of the Company's unrecognized tax benefits: Total Gross Unrecognized Tax Benefits In millions 2022 2021 2020 Total unrecognized tax benefits at Jan 1 $ 580 $ 373 $ 319 Decreases related to positions taken on items from prior years (47) (3) (1) Increases related to positions taken on items from prior years 53 187 52 Increases related to positions taken in the current year 46 44 18 Settlement of uncertain tax positions with tax authorities (111) (18) (14) Decreases due to expiration of statutes of limitations — (1) (1) Foreign exchange gain (1) (2) — Total unrecognized tax benefits at Dec 31 $ 520 $ 580 $ 373 Total unrecognized tax benefits that, if recognized, would impact the effective tax rate $ 520 $ 501 $ 285 Total amount of interest and penalties expense (benefit) recognized in "Provision for income taxes" $ (27) $ 359 $ 84 Total accrual for interest and penalties recognized in the consolidated balance sheets $ 498 $ 502 $ 144

EARNINGS PER SHARE (Tables)

EARNINGS PER SHARE (Tables)	12 Months Ended
	Dec. 31, 2022
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	The following tables provide earnings per share calculations of Dow Inc. for the years ended December 31, 2022, 2021 and 2020. In accordance with the accounting guidance for earnings per share, earnings per share of TDCC is not presented as this information is not required in financial statements of wholly owned subsidiaries. Net Income for Earnings Per Share Calculations 2022 2021 2020 In millions Net income $ 4,640 $ 6,405 $ 1,294 Net income attributable to noncontrolling interests 58 94 69 Net income attributable to participating securities 1 24 32 9 Net income attributable to common stockholders $ 4,558 $ 6,279 $ 1,216 1. Restricted stock units are considered participating securities due to the Company's practice of paying dividend equivalents on unvested shares. Earnings Per Share - Basic and Diluted 2022 2021 2020 Dollars per share Earnings per common share - basic $ 6.32 $ 8.44 $ 1.64 Earnings per common share - diluted $ 6.28 $ 8.38 $ 1.64 Share Count Information 2022 2021 2020 Shares in millions Weighted-average common shares outstanding - basic 721.0 743.6 740.5 Plus dilutive effect of equity compensation plans 4.6 5.4 1.8 Weighted-average common shares outstanding - diluted 725.6 749.0 742.3 Stock options and restricted stock units excluded from EPS calculations 1 7.6 5.8 14.2 1. These outstanding options to purchase shares of common stock and restricted stock units were excluded from the calculation of diluted earnings per share because the effect of including them would have been antidilutive.

INVENTORIES (Tables)

INVENTORIES (Tables)	12 Months Ended
	Dec. 31, 2022
Inventory Disclosure [Abstract]
Schedule of Inventory	The following table provides a breakdown of inventories: Inventories at Dec 31 In millions 2022 2021 Finished goods $ 4,150 $ 4,554 Work in process 1,476 1,615 Raw materials 954 822 Supplies 892 866 Total $ 7,472 $ 7,857 Adjustment of inventories to the LIFO basis (484) (485) Total inventories $ 6,988 $ 7,372

PROPERTY (Tables)

PROPERTY (Tables)	12 Months Ended
	Dec. 31, 2022
Property, Plant and Equipment [Abstract]
Schedule of property	The following table provides a breakdown of property: Property at Dec 31 Estimated Useful 2022 2021 In millions Land and land improvements 0-25 $ 2,129 $ 2,045 Buildings 5-50 5,045 5,108 Machinery and equipment 3-25 42,131 42,627 Other property 3-50 6,622 6,286 Construction in progress — 2,128 1,538 Total property $ 58,055 $ 57,604 In millions 2022 2021 2020 Depreciation expense $ 1,958 $ 2,063 $ 2,092 Capitalized interest $ 63 $ 59 $ 64

NONCONSOLIDATED AFFILIATES (Tab

NONCONSOLIDATED AFFILIATES (Tables)	12 Months Ended
	Dec. 31, 2022
Equity Method Investments and Joint Ventures [Abstract]
Nonconsolidated Affiliates - Investments and Dividends	The Company’s investments in companies accounted for using the equity method (“nonconsolidated affiliates”), by classification in the consolidated balance sheets, and dividends received from nonconsolidated affiliates are shown in the following tables: Investments in Nonconsolidated Affiliates at Dec 31 2022 1 2021 1 In millions Investment in nonconsolidated affiliates $ 1,589 $ 2,045 Other noncurrent obligations (144) — Net investment in nonconsolidated affiliates $ 1,445 $ 2,045 1. The carrying amount of the Company’s investments in nonconsolidated affiliates at December 31, 2022 and 2021 was $55 million less than its share of the investees’ net assets, exclusive of additional differences relating to Sadara, EQUATE Petrochemical Company K.S.C.C. ("EQUATE") and AgroFresh Solutions Inc. ("AFSI"), which are discussed separately in the disclosures that follow. Dividends Received from Nonconsolidated Affiliates 2022 2021 2020 In millions Dividends from nonconsolidated affiliates 1 $ 964 $ 324 $ 425 1. Included in "Earnings of nonconsolidated affiliates less than (in excess of) dividends received" in the consolidated statements of cash flows.
Balances Due To or Due From Nonconsolidated Affiliates	Balances due to or due from nonconsolidated affiliates at December 31, 2022 and 2021 were as follows: Balances Due To or Due From Nonconsolidated Affiliates at Dec 31 2022 2021 In millions Accounts and notes receivable - Other $ 307 $ 357 Accounts payable - Other $ 1,083 $ 1,611
Equity Method Investment	The Company's principal nonconsolidated affiliates and its ownership interest (direct and indirect) for each at December 31, 2022, 2021 and 2020 are as follows: Principal Nonconsolidated Affiliates at Dec 31 Country Ownership Interest 2022 2021 2020 EQUATE Petrochemical Company K.S.C.C. Kuwait 42.5 % 42.5 % 42.5 % The Kuwait Olefins Company K.S.C.C. Kuwait 42.5 % 42.5 % 42.5 % The Kuwait Styrene Company K.S.C.C. Kuwait 42.5 % 42.5 % 42.5 % Map Ta Phut Olefins Company Limited 1 Thailand 32.77 % 32.77 % 32.77 % Sadara Chemical Company Saudi Arabia 35 % 35 % 35 % The SCG-Dow Group: Siam Polyethylene Company Limited Thailand 50 % 50 % 50 % Siam Polystyrene Company Limited Thailand 50 % 50 % 50 % Siam Styrene Monomer Company Limited Thailand 50 % 50 % 50 % Siam Synthetic Latex Company Limited Thailand 50 % 50 % 50 % 1. The Company's effective ownership of Map Ta Phut Olefins Company Limited ("Map Ta Phut") is 32.77 percent, of which the Company directly owns 20.27 percent and indirectly owns 12.5 percent through its equity interest in Siam Polyethylene Company Limited. The Company’s investment in and equity earnings from its principal nonconsolidated affiliates are as follows: Investment in Principal Nonconsolidated Affiliates at Dec 31 2022 2021 In millions Investment in nonconsolidated affiliates $ 1,116 $ 1,621 Other noncurrent obligations (144) — Net investment in principal nonconsolidated affiliates $ 972 $ 1,621 Equity in Earnings (Losses) of Principal Nonconsolidated Affiliates 2022 2021 2020 In millions Equity in earnings (losses) of principal nonconsolidated affiliates $ 192 $ 918 $ (16)
Equity Method Investment Summarized Balance Sheet Information	The summarized financial information that follows represents the combined accounts (at 100 percent) of the principal nonconsolidated affiliates. Summarized Balance Sheet Information at Dec 31 2022 2021 In millions Current assets $ 6,241 $ 8,158 Noncurrent assets 22,526 23,681 Total assets $ 28,767 $ 31,839 Current liabilities $ 3,754 $ 3,990 Noncurrent liabilities 18,999 20,039 Total liabilities $ 22,753 $ 24,029 Noncontrolling interests $ 223 $ 174
Equity Method Investment Summarized Income Statement Information	Summarized Income Statement Information 1 2022 2021 2020 In millions Sales $ 14,026 $ 14,969 $ 9,470 Gross profit $ 1,246 $ 3,219 $ 619 Income (loss), net of tax $ (91) $ 2,013 $ (461) 1. The results in this table include purchase and sale activity between certain principal nonconsolidated affiliates and the Company, as previously discussed in the "Transactions with Nonconsolidated Affiliates" section.

GOODWILL AND OTHER INTANGIBLE_2

GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)	12 Months Ended
	Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of goodwill	The following table shows changes in the carrying amounts of goodwill by reportable segment for the years ended December 31, 2022 and 2021: Goodwill Packaging & Specialty Plastics Industrial Intermediates & Infrastructure Performance Materials & Coatings Total In millions Balance at Jan 1, 2021 $ 5,115 $ 1,100 $ 2,693 $ 8,908 Foreign currency impact (10) (4) (130) (144) Balance at Dec 31, 2021 $ 5,105 $ 1,096 $ 2,563 $ 8,764 Foreign currency impact (5) (3) (112) (120) Balance at Dec 31, 2022 $ 5,100 $ 1,093 $ 2,451 $ 8,644
Schedule of Intangible Assets and Goodwill	The following table provides information regarding the Company’s other intangible assets: Other Intangible Assets at Dec 31 2022 2021 In millions Gross Accum Amort Net Gross Accum Amort Net Intangible assets: Developed technology 1 $ 2,651 $ (2,025) $ 626 $ 2,654 $ (1,871) $ 783 Software 1,358 (962) 396 1,396 (945) 451 Trademarks/tradenames 352 (345) 7 352 (344) 8 Customer-related 3,103 (1,690) 1,413 3,204 (1,565) 1,639 Total other intangible assets $ 7,464 $ (5,022) $ 2,442 $ 7,606 $ (4,725) $ 2,881 1. Includes $17 million gross carrying amount in 2022 and 2021 for in-process research and development that has not yet commercialized.
Finite-lived Intangible Assets Amortization Expense	The following table provides information regarding amortization expense related to intangible assets: Amortization Expense 2022 2021 2020 In millions Other intangible assets, excluding software $ 336 $ 388 $ 401 Software, included in "Cost of sales" $ 80 $ 90 $ 96
Schedule of estimated future amortization expense	Total estimated amortization expense for the next five fiscal years, including amounts expected to be capitalized, is as follows: Estimated Amortization Expense for Next Five Years In millions 2023 $ 387 2024 $ 368 2025 $ 278 2026 $ 203 2027 $ 170

NOTES PAYABLE, LONG-TERM DEBT_2

NOTES PAYABLE, LONG-TERM DEBT AND AVAILABLE CREDIT FACILITIES (Tables)	12 Months Ended
	Dec. 31, 2022
Debt Disclosure [Abstract]
Schedule of notes payable	Notes Payable at Dec 31 In millions 2022 2021 Commercial paper $ 299 $ — Notes payable to banks and other lenders 63 161 Total notes payable $ 362 $ 161 Year-end average interest rates 6.55 % 5.78 %
Schedule of long-term debt	Long-Term Debt at Dec 31 2022 Average Rate 2022 2021 2021 In millions Promissory notes and debentures: Final maturity 2022 — % $ — 8.64 % $ 121 Final maturity 2023 7.63 % 250 7.63 % 250 Final maturity 2025 5.63 % 333 5.63 % 333 Final maturity 2026 — % — 3.63 % 750 Final maturity 2028 and thereafter 1 5.36 % 10,864 5.15 % 9,363 Other facilities: Foreign currency notes and loans, various rates and maturities 1.16 % 2,562 1.17 % 2,730 InterNotes®, varying maturities through 2052 3.87 % 543 3.37 % 392 Finance lease obligations 2 790 869 Unamortized debt discount and issuance costs (282) (297) Long-term debt due within one year 3 (362) (231) Long-term debt $ 14,698 $ 14,280 1. Cost includes net fair value hedge adjustment gains of $46 million at December 31, 2022 ($47 million at December 31, 2021). See Note 21 for additional information. 2. See Note 16 for additional information. 3. Presented net of current portion of unamortized debt issuance costs.
Schedule of maturities of long-term debt	Maturities of Long-Term Debt for Next Five Years at Dec 31, 2022 In millions 2023 $ 362 2024 $ 127 2025 $ 388 2026 $ 78 2027 $ 1,209 2022 Activity In the second quarter of 2022, the Company redeemed $750 million aggregate principal amount of 3.625 percent notes due May 2026. As a result of the redemption, the Company recognized a pretax loss on the early extinguishment of debt of $8 million, included in "Sundry income (expense) - net" in the consolidated statements of income and related to Corporate. In the fourth quarter of 2022, the Company issued $1.5 billion of senior unsecured notes. The offering included $600 million aggregate principal amount of 6.30 percent notes due 2033 and $900 million aggregate principal amount of 6.90 percent notes due 2053.
Schedule of committed and available credit facilities	The following table summarizes the Company's credit facilities: Committed and Available Credit Facilities at Dec 31, 2022 In millions Committed Credit Credit Available Maturity Date Interest Five Year Competitive Advance and Revolving Credit Facility $ 5,000 $ 5,000 November 2027 Floating rate Bilateral Revolving Credit Facility 300 300 September 2023 Floating rate Bilateral Revolving Credit Facility 1 500 500 November 2024 Floating rate Bilateral Revolving Credit Facility 100 100 March 2025 Floating rate Bilateral Revolving Credit Facility 100 100 March 2025 Floating rate Bilateral Revolving Credit Facility 100 100 March 2025 Floating rate Bilateral Revolving Credit Facility 200 200 September 2025 Floating rate Bilateral Revolving Credit Facility 250 250 September 2025 Floating rate Bilateral Revolving Credit Facility 300 300 November 2025 Floating rate Bilateral Revolving Credit Facility 100 100 March 2026 Floating rate Bilateral Revolving Credit Facility 150 150 November 2026 Floating rate Bilateral Revolving Credit Facility 200 200 November 2026 Floating rate Bilateral Revolving Credit Facility 250 250 March 2027 Floating rate Bilateral Revolving Credit Facility 100 100 May 2027 Floating rate Bilateral Revolving Credit Facility 350 350 June 2027 Floating rate Bilateral Revolving Credit Facility 200 200 September 2027 Floating rate Bilateral Revolving Credit Facility 100 100 October 2027 Floating rate Bilateral Revolving Credit Facility 100 100 November 2027 Floating rate Total Committed and Available Credit Facilities $ 8,400 $ 8,400

COMMITMENTS AND CONTINGENCIES_2

COMMITMENTS AND CONTINGENCIES (Tables)	12 Months Ended
	Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Environmental Loss Contingency	The following table summarizes the activity in the Company's accrued obligations for environmental matters for the years ended December 31, 2022 and 2021: Accrued Obligations for Environmental Matters 2022 2021 In millions Balance at Jan 1 $ 1,220 $ 1,244 Accrual adjustment 184 159 Payments against reserve (204) (162) Foreign currency impact (8) (21) Balance at Dec 31 $ 1,192 $ 1,220
Schedule of Guarantor Obligations	The following table provides a summary of the final expiration, maximum future payments and recorded liability reflected in the consolidated balance sheets for guarantees: Guarantees Dec 31, 2022 Dec 31, 2021 In millions Final Maximum Future Payments 1 Recorded Liability Final Maximum Future Payments Recorded Liability Guarantees 2038 $ 1,236 $ 200 2038 $ 1,273 $ 220 1. In addition, TDCC has provided guarantees, in proportion to the Company's 35 percent ownership interest, of all future interest payments that will become due on Sadara’s project financing debt during the grace period, which Dow's share is estimated to be $393 million at December 31, 2022 ($446 million at December 31, 2021). Based on Sadara's current forecasted cash flows, the Company does not expect to be required to perform under the guarantees.
Schedule of Change in Asset Retirement Obligation	The following table shows changes in the aggregate carrying amount of the Company’s asset retirement obligations for the years ended December 31, 2022 and 2021: Asset Retirement Obligations 2022 2021 In millions Balance at Jan 1 $ 118 $ 112 Additional accruals 14 13 Liabilities settled (8) (7) Accretion expense 2 1 Revisions in estimated cash flows (9) (1) Other 2 — Balance at Dec 31 $ 119 $ 118

LEASES (Tables)

LEASES (Tables)	12 Months Ended
	Dec. 31, 2022
Lease, Cost [Table Text Block]	The components of lease cost for operating and finance leases for the years ended December 31, 2022, 2021 and 2020 were as follows: Lease Cost 2022 2021 2020 In millions Operating lease cost $ 397 $ 494 $ 484 Finance lease cost Amortization of right-of-use assets - finance 105 76 58 Interest on lease liabilities - finance 32 27 25 Total finance lease cost 137 103 83 Short-term lease cost 255 238 213 Variable lease cost 611 381 199 Sublease income (10) (6) (5) Total lease cost $ 1,390 $ 1,210 $ 974
Schedule of Supplemental Cash Flow Information Related to Leases [Table Text Block]	The following table provides supplemental cash flow and other information related to leases: Other Lease Information 2022 2021 2020 In millions Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows for operating leases $ 393 $ 497 $ 482 Operating cash flows for finance leases $ 32 $ 27 $ 25 Financing cash flows for finance leases $ 114 $ 74 $ 58 Right-of-use assets obtained in exchange for lease obligations: Operating leases 1 $ 151 $ (25) $ 185 Finance leases 1 $ 62 $ 512 $ 178
Schedule of Lease Assets and Liabilities [Table Text Block]	The following table summarizes the lease-related assets and liabilities recorded in the consolidated balance sheets at December 31, 2022 and 2021. Lease Position Balance Sheet Classification Dec 31, 2022 Dec 31, 2021 In millions Assets Operating lease assets Operating lease right-of-use assets $ 1,227 $ 1,412 Finance lease assets Property 1,167 1,158 Finance lease amortization Accumulated depreciation (441) (368) Total lease assets $ 1,953 $ 2,202 Liabilities Current Operating Operating lease liabilities - current $ 287 $ 314 Finance Long-term debt due within one year 109 106 Noncurrent Operating Operating lease liabilities - noncurrent 997 1,149 Finance Long-Term Debt 681 763 Total lease liabilities $ 2,074 $ 2,332 In 2021, the Company executed buy-outs of certain leased assets for $687 million. The lease buyouts reduced “Operating lease right-of-use assets” by $166 million and reduced “Operating lease liabilities - current” and “Operating lease liabilities - noncurrent” by $44 million and $158 million, respectively. The Company recognized a pretax loss related to the lease buy-outs of $37 million included in “Sundry income (expense) - net” in the consolidated statements of income. The lease buy-outs are included in “Purchases of previously leased assets” in the consolidated statements of cash flows. Additionally, in 2021, the Company amended an agreement to extend leases of certain assets. The amendment and related remeasurement resulted in a reclassification of $73 million from “Operating lease liabilities – noncurrent” to “Long-Term Debt” and $34 million from “Operating lease liabilities - current” to “Long-term debt due within one year." In addition to the reclassifications, the amendment increased “Long-Term Debt” by $152 million and decreased “Long-term debt due within one year" by $2 million.
Lease Terms and Discount Rates [Table Text Block]	The weighted-average remaining lease term and discount rate for leases recorded in the consolidated balance sheets at December 31, 2022 and 2021 are provided below: Lease Term and Discount Rate Dec 31, 2022 Dec 31, 2021 Weighted-average remaining lease term Operating leases 7.6 years 7.9 years Finance leases 11.0 years 11.8 years Weighted-average discount rate Operating leases 4.49 % 3.72 % Finance leases 4.29 % 4.17 %
Maturities of Lease Liabilities [Table Text Block]	The following table provides the maturities of lease liabilities at December 31, 2022: Maturities of Lease Liabilities Operating Leases Finance Leases In millions 2023 $ 333 $ 138 2024 253 153 2025 199 78 2026 160 70 2027 129 64 2028 and thereafter 470 487 Total future undiscounted lease payments $ 1,544 $ 990 Less: Imputed interest 260 200 Total present value of lease liabilities $ 1,284 $ 790
Schedule of Guarantor Obligations	The following table provides a summary of the final expiration, maximum future payments and recorded liability reflected in the consolidated balance sheets for guarantees: Guarantees Dec 31, 2022 Dec 31, 2021 In millions Final Maximum Future Payments 1 Recorded Liability Final Maximum Future Payments Recorded Liability Guarantees 2038 $ 1,236 $ 200 2038 $ 1,273 $ 220 1. In addition, TDCC has provided guarantees, in proportion to the Company's 35 percent ownership interest, of all future interest payments that will become due on Sadara’s project financing debt during the grace period, which Dow's share is estimated to be $393 million at December 31, 2022 ($446 million at December 31, 2021). Based on Sadara's current forecasted cash flows, the Company does not expect to be required to perform under the guarantees.
Residual Value Guarantees
Schedule of Guarantor Obligations	Lease Guarantees Dec 31, 2022 Dec 31, 2021 In millions Final Expiration Maximum Future Payments Recorded Liability Final Expiration Maximum Future Payments Recorded Liability Residual value guarantees 2031 $ 258 $ — 2031 $ 280 $ —

STOCKHOLDERS' EQUITY (Tables)

STOCKHOLDERS' EQUITY (Tables)	12 Months Ended
	Dec. 31, 2022
Stockholders' Equity Note [Abstract]
Schedule of Common Stock and Treasury Stock Outstanding Roll Forward	The following table provides a reconciliation of Dow Inc. common stock activity for the years ended December 31, 2022, 2021 and 2020: Shares of Dow Inc. Common Stock Issued Held in Treasury Balance at Jan 1, 2020 751,228,644 9,729,834 Issued 1 4,764,554 — Repurchased — 3,073,469 Balance at Jan 1, 2021 755,993,198 12,803,303 Issued 1 8,233,684 — Repurchased — 16,208,270 Balance at Jan 1, 2022 764,226,882 29,011,573 Issued 1 7,451,643 (1,499,610) Repurchased — 39,286,642 Balance at Dec 31, 2022 771,678,525 66,798,605 1. Shares issued to employees and non-employee directors under the Company's equity compensation plans.
Comprehensive Income (Loss)	The changes in each component of AOCL for the years ended December 31, 2022, 2021 and 2020 were as follows: Accumulated Other Comprehensive Loss 2022 2021 2020 In millions Unrealized Gains (Losses) on Investments Beginning balance $ 59 $ 104 $ 64 Unrealized gains (losses) on investments (326) (21) 104 Tax (expense) benefit 13 5 (23) Net unrealized gains (losses) on investments (313) (16) 81 (Gains) losses reclassified from AOCL to net income 1 2 (38) (54) Tax expense (benefit) 2 (1) 9 13 Net (gains) losses reclassified from AOCL to net income 1 (29) (41) Other comprehensive income (loss), net of tax (312) (45) 40 Ending balance $ (253) $ 59 $ 104 Cumulative Translation Adjustment Beginning balance $ (1,355) $ (930) $ (1,135) Gains (losses) on foreign currency translation (557) (375) 227 Tax (expense) benefit 24 (40) 25 Net gains (losses) on foreign currency translation (533) (415) 252 (Gains) losses reclassified from AOCL to net income 3 (46) (10) (47) Other comprehensive income (loss), net of tax (579) (425) 205 Ending balance $ (1,934) $ (1,355) $ (930) Pension and Other Postretirement Benefits Beginning balance $ (7,334) $ (9,559) $ (8,781) Gains (losses) arising during the period 2,611 2,094 (1,769) Tax (expense) benefit (630) (464) 411 Net gains (losses) arising during the period 1,981 1,630 (1,358) Amortization of net loss and prior service credits reclassified from AOCL to net income 4 622 776 753 Tax expense (benefit) 2 (146) (181) (173) Net loss and prior service credits reclassified from AOCL to net income 476 595 580 Other comprehensive income (loss), net of tax 2,457 2,225 (778) Ending balance $ (4,877) $ (7,334) $ (9,559) Derivative Instruments Beginning balance $ (347) $ (470) $ (394) Gains (losses) on derivative instruments 638 155 (96) Tax (expense) benefit (87) 3 (1) Net gains (losses) on derivative instruments 551 158 (97) (Gains) losses reclassified from AOCL to net income 5 (313) (38) 30 Tax expense (benefit) 2 34 3 (9) Net (gains) losses reclassified from AOCL to net income (279) (35) 21 Other comprehensive income (loss), net of tax 272 123 (76) Ending balance $ (75) $ (347) $ (470) Total AOCL ending balance $ (7,139) $ (8,977) $ (10,855) 1. Reclassified to "Net sales" and "Sundry income (expense) - net." 2. Reclassified to "Provision for income taxes." 3. Reclassified to "Sundry income (expense) - net." 4. These AOCL components are included in the computation of net periodic benefit cost of the Company's defined benefit pension and other postretirement benefit plans. See Note 19 for additional information. 5. Reclassified to "Cost of sales," "Sundry income (expense) - net" and "Interest expense and amortization of debt discount."

NONCONTROLLING INTERESTS Noncon

NONCONTROLLING INTERESTS Noncontrolling Interests (Tables)	12 Months Ended
	Dec. 31, 2022
Noncontrolling Interest [Abstract]
Noncontrolling Interests	The following table summarizes the activity for equity attributable to noncontrolling interests for the years ended December 31, 2022, 2021 and 2020: Noncontrolling Interests In millions 2022 2021 2020 Balance at Jan 1 $ 574 $ 570 $ 553 Net income attributable to noncontrolling interests 1 58 94 69 Distributions to noncontrolling interests 2 (76) (66) (55) Deconsolidation of noncontrolling interests 3 — — (7) Cumulative translation adjustments (28) (25) 9 Other 1 1 1 Balance at Dec 31 $ 529 $ 574 $ 570 1. 2022 includes the portion of asset related charges attributable to noncontrolling interests related to a joint venture in Russia. See Note 4 for additional information. 2. Distributions to noncontrolling interests are net of $7 million in 2022, 2021 and 2020 in dividends paid to a joint venture, which were reclassified to "Equity in earnings (losses) of nonconsolidated affiliates" in the consolidated statements of income. 3. Related to the divestiture of the Company's interest in a cogeneration facility in Brazil in the third quarter of 2020.

PENSION PLANS AND OTHER POSTR_2

PENSION PLANS AND OTHER POSTRETIREMENT BENEFITS (Tables)	12 Months Ended
	Dec. 31, 2022
Defined Benefit Plan Disclosure [Line Items]
Schedule of Change in Projected Benefit Obligations, Plan Assets and Funded Status of All Significant Plans	Summarized information on the Company's pension and other postretirement benefit plans is as follows: Change in Projected Benefit Obligations, Plan Assets and Funded Status of All Significant Plans Defined Benefit Pension Plans Other Postretirement Benefit Plans In millions 2022 2021 2022 2021 Change in projected benefit obligations: Benefit obligations at beginning of year $ 32,977 $ 35,309 $ 1,251 $ 1,464 Service cost 392 387 6 7 Interest cost 680 594 26 23 Plan participants' contributions 12 10 — — Actuarial changes in assumptions and experience (8,433) (820) (318) (98) Benefits paid (1,539) (1,582) (67) (141) Plan amendments (25) 2 — — Acquisitions/divestitures/other 1 (602) 8 — — Effect of foreign exchange rates (600) (545) (5) (4) Termination benefits/curtailments/settlements 2 (1) (386) — — Benefit obligations at end of year $ 22,861 $ 32,977 $ 893 $ 1,251 Change in plan assets: Fair value of plan assets at beginning of year $ 28,167 $ 26,406 $ — $ — Actual return on plan assets (4,556) 2,501 — — Employer contributions 235 1,219 — — Plan participants' contributions 12 10 — — Benefits paid (1,539) (1,582) — — Other 3 (592) 10 — — Effect of foreign exchange rates (496) (397) — — Fair value of plan assets at end of year $ 21,231 $ 28,167 $ — $ — Funded status: U.S. plans with plan assets $ (545) $ (2,585) $ — $ — Non-U.S. plans with plan assets (473) (1,467) — — All other plans (612) (758) (893) (1,251) Funded status at end of year $ (1,630) $ (4,810) $ (893) $ (1,251) Amounts recognized in the consolidated balance sheets at Dec 31: Deferred charges and other assets $ 1,035 $ 1,173 $ — $ — Accrued and other current liabilities (66) (58) (88) (99) Pension and other postretirement benefits - noncurrent (2,599) (5,925) (805) (1,152) Net amount recognized $ (1,630) $ (4,810) $ (893) $ (1,251) Pretax amounts recognized in accumulated other comprehensive loss at Dec 31: Net loss (gain) $ 7,045 $ 9,934 $ (523) $ (221) Prior service credit (116) (112) — — Pretax balance in accumulated other comprehensive loss at end of year $ 6,929 $ 9,822 $ (523) $ (221) 1. The 2022 impact primarily relates to the transfer of benefit obligations in the U.S. through the purchase of annuity contracts from an insurance company. 2. The 2021 impact primarily relates to the freeze of pensionable compensation and credited service amounts for employees that participate in the U.S. Plans. 3. The 2022 impact relates to the purchase of an annuity contract associated with the transfer of benefit obligations to an insurance company.
Schedule of Accumulated Benefit Obligations in Excess of Fair Value of Plan Assets	Pension Plans with Accumulated Benefit Obligations in Excess of Plan Assets at Dec 31 2022 2021 In millions Accumulated benefit obligations $ 18,300 $ 27,052 Fair value of plan assets $ 15,723 $ 21,385
Schedule of Projected Benefit Obligations in Excess of Fair Value of Plan Assets	Pension Plans with Projected Benefit Obligations in Excess of Plan Assets at Dec 31 2022 2021 In millions Projected benefit obligations $ 18,388 $ 27,367 Fair value of plan assets $ 15,723 $ 21,385
Schedule of Net Benefit Costs	Net Periodic Benefit Costs for All Significant Plans for the Year Ended Dec 31 Defined Benefit Pension Plans Other Postretirement Benefit Plans In millions 2022 2021 2020 2022 2021 2020 Net Periodic Benefit Costs: Service cost $ 392 $ 387 $ 399 $ 6 $ 7 $ 7 Interest cost 680 594 767 26 23 40 Expected return on plan assets (1,686) (1,724) (1,658) — — — Amortization of prior service credit (21) (22) (19) — — — Amortization of unrecognized (gain) loss 658 822 773 (15) (6) (10) Curtailment/settlement/other 1 — (18) 9 — — — Net periodic benefit costs $ 23 $ 39 $ 271 $ 17 $ 24 $ 37 Changes in plan assets and benefit obligations recognized in other comprehensive (income) loss: Net (gain) loss $ (2,231) $ (1,980) $ 1,753 $ (317) $ (98) $ 8 Prior service cost (credit) (25) 2 8 — — — Amortization of prior service credit 21 22 19 — — — Amortization of unrecognized gain (loss) (658) (822) (773) 15 6 10 Curtailment and settlement gain (loss) 1 — 18 (9) — — — Total recognized in other comprehensive (income) loss $ (2,893) $ (2,760) $ 998 $ (302) $ (92) $ 18 Total recognized in net periodic benefit cost and other comprehensive (income) loss $ (2,870) $ (2,721) $ 1,269 $ (285) $ (68) $ 55 1. The 2021 impact primarily relates to the freeze of pensionable compensation and credited service amounts for employees that participate in the U.S. Plans. The 2020 impact relates to pension plan curtailments of a European plan resulting from the 2020 Restructuring Program and the settlement of certain plan obligations of a U.S. non-qualified pension plan resulting from lump-sum payments.
Schedule of Expected Benefit Payments	The estimated future benefit payments, reflecting expected future service, as appropriate, are presented in the following table: Estimated Future Benefit Payments at Dec 31, 2022 Defined Benefit Pension Plans Other Postretirement Benefit Plans In millions 2023 $ 1,597 $ 90 2024 1,474 85 2025 1,496 82 2026 1,515 82 2027 1,531 80 2028-2032 7,783 350 Total $ 15,396 $ 769
Schedule of Allocation of Plan Assets	The weighted-average target allocation for plan assets of the Company's pension plans is summarized as follows: Target Allocation for Plan Assets at Dec 31, 2022 Target Allocation Asset Category Equity securities 25 % Fixed income securities 43 Alternative investments 29 Other investments 3 Total 100 %
Schedule of Defined Benefit Plans Disclosures	The following table summarizes the bases used to measure the Company’s pension plan assets at fair value for the years ended December 31, 2022 and 2021: Basis of Fair Value Measurements Dec 31, 2022 Dec 31, 2021 In millions Total Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Cash and cash equivalents $ 1,240 $ 989 $ 251 $ — $ 1,463 $ 1,353 $ 110 $ — Equity securities: U.S. equity securities $ 1,855 $ 1,845 $ 7 $ 3 $ 4,117 $ 4,097 $ 18 $ 2 Non - U.S. equity securities 2,120 1,924 193 3 4,559 3,935 620 4 Total equity securities $ 3,975 $ 3,769 $ 200 $ 6 $ 8,676 $ 8,032 $ 638 $ 6 Fixed income securities: Debt - government-issued $ 3,885 $ 57 $ 3,827 $ 1 $ 4,838 $ 242 $ 4,596 $ — Debt - corporate-issued 4,231 441 3,790 — 4,949 1,095 3,854 — Debt - asset-backed 128 44 84 — 117 — 116 1 Total fixed income securities $ 8,244 $ 542 $ 7,701 $ 1 $ 9,904 $ 1,337 $ 8,566 $ 1 Alternative investments: Private markets $ 5 $ — $ — $ 5 $ 5 $ — $ — $ 5 Real estate 48 48 — — 67 67 — — Derivatives - asset position 348 5 343 — 399 2 397 — Derivatives - liability position (479) (6) (473) — (324) (2) (322) — Total alternative investments $ (78) $ 47 $ (130) $ 5 $ 147 $ 67 $ 75 $ 5 Other investments $ 1,103 $ 16 $ 1,087 $ — $ 1,068 $ 7 $ 1,061 $ — Subtotal $ 14,484 $ 5,363 $ 9,109 $ 12 $ 21,258 $ 10,796 $ 10,450 $ 12 Investments measured at net asset value: Hedge funds $ 964 $ 1,312 Private markets 3,873 3,857 Real estate 1,956 1,793 Total investments measured at net asset value $ 6,793 $ 6,962 Items to reconcile to fair value of plan assets: Pension trust receivables 1 $ 31 $ 62 Pension trust payables 2 (77) (115) Total $ 21,231 $ 28,167 1. Primarily receivables for investment securities sold. 2. Primarily payables for investment securities purchased.
Schedule of Effect of Significant Unobservable Inputs, Changes in Plan Assets	The following table summarizes the changes in the fair value of Level 3 pension plan assets for the years ended December 31, 2022 and 2021: Fair Value Measurement of Level 3 Pension Plan Assets Equity Securities Fixed Income Securities Alternative Investments Other Investments Total In millions Balance at Jan 1, 2021 $ 10 $ 2 $ 13 $ 2 $ 27 Actual return on assets: Relating to assets held at Dec 31, 2021 1 — (11) — (10) Purchases, sales and settlements, net (5) (1) 3 (2) (5) Balance at Dec 31, 2021 $ 6 $ 1 $ 5 $ — $ 12 Actual return on assets: Relating to assets held at Dec 31, 2022 (6) — (6) — (12) Purchases, sales and settlements, net — — 6 — 6 Transfers into Level 3, net 6 — — — 6 Balance at Dec 31, 2022 $ 6 $ 1 $ 5 $ — $ 12
Defined Benefit Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Schedule of Assumptions Used	The weighted-average assumptions used to determine pension plan obligations and net periodic benefit costs for all plans are summarized in the table below: Weighted-Average Assumptions for All Pension Plans Benefit Obligations Net Periodic Benefit Costs 2022 2021 2022 2021 2020 Discount rate 5.18 % 2.57 % 2.57 % 2.40 % 2.81 % Interest crediting rate for applicable benefits 4.19 % 3.57 % 3.57 % 3.55 % 3.51 % Rate of compensation increase 4.05 % 3.94 % 3.94 % 3.91 % 3.92 % Expected return on plan assets 6.68 % 6.86 % 7.00 % The weighted-average assumptions used to determine pension plan obligations and net periodic benefit costs for U.S. plans are summarized in the table below: Weighted-Average Assumptions for U.S. Pension Plans Benefit Obligations Net Periodic Benefit Costs 2022 2021 2022 2021 2020 Discount rate 5.64 % 3.04 % 3.04 % 3.03 % 3.41 % Interest crediting rate for applicable benefits 4.50 % 4.50 % 4.50 % 4.50 % 4.50 % Rate of compensation increase 4.25 % 4.25 % 4.25 % 4.25 % 4.25 % Expected return on plan assets 7.95 % 7.96 % 7.95 %
Other Postretirement Benefit Plans
Defined Benefit Plan Disclosure [Line Items]
Schedule of Assumptions Used	The weighted-average assumptions used to determine other postretirement benefit plan obligations and net periodic benefit costs for the U.S. plans are provided below: Weighted-Average Assumptions for U.S. Other Postretirement Benefits Plans Benefit Obligations Net Periodic Benefit Costs 2022 2021 2022 2021 2020 Discount rate 5.57 % 2.85 % 2.85 % 2.38 % 3.19 % Health care cost trend rate assumed for next year 6.79 % 6.50 % 6.50 % 6.75 % 6.25 % Rate to which the cost trend rate is assumed to decline (the ultimate health care cost trend rate) 5.00 % 5.00 % 5.00 % 5.00 % 5.00 % Year that the rate reaches the ultimate health care cost trend rate 2033 2028 2028 2028 2025

STOCK-BASED COMPENSATION (Table

STOCK-BASED COMPENSATION (Tables)	12 Months Ended
	Dec. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions	The weighted-average assumptions used to calculate total stock-based compensation are included in the following table: Weighted-Average Assumptions 2022 2021 2020 Dividend yield 4.59 % 4.86 % 5.80 % Expected volatility 30.20 % 33.40 % 26.70 % Risk-free interest rate 2.00 % 0.68 % 1.49 % Expected life of stock options granted during period (years) 6.25 6.25 6.10
Employee Stock Option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation, Stock Options, Activity	The following table summarizes stock option activity for 2022: Stock Options 2022 Shares in thousands Shares Exercise Price 1 Outstanding at Jan 1, 2022 16,280 $ 50.56 Granted 1,199 $ 60.95 Exercised (2,968) $ 38.50 Forfeited/Expired (86) $ 61.20 Outstanding at Dec 31, 2022 14,425 $ 53.84 Remaining contractual life in years 4.65 Aggregate intrinsic value in millions $ 38 Exercisable at Dec 31, 2022 11,727 $ 53.19 Remaining contractual life in years 3.81 Aggregate intrinsic value in millions $ 36 1. Weighted-average per share. Additional Information about Stock Options In millions, except per share amounts 2022 2021 2020 Weighted-average fair value per share of options granted $ 11.08 $ 10.37 $ 5.89 Total compensation expense for stock option plans $ 13 $ 14 $ 22 Related tax benefit $ 3 $ 3 $ 5 Total amount of cash received from the exercise of options $ 109 $ 217 $ 108 Total intrinsic value of options exercised 1 $ 73 $ 121 $ 41 Related tax benefit $ 16 $ 27 $ 9 1. Difference between the market price at exercise and the price paid by the employee to exercise the options.
Restricted Stock Units (RSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Schedule of Nonvested Restricted Stock Units Activity	The Company grants RSUs to certain employees and non-employee directors. The grants vest after a designated period of time, generally three years for employees and two years for non-employee directors. The following table shows changes in nonvested RSUs: RSU Awards 2022 Shares in thousands Shares Grant Date Fair Value 1 Nonvested at Jan 1, 2022 3,543 $ 53.67 Granted 2,080 $ 58.60 Vested (1,676) $ 56.30 Canceled (122) $ 55.80 Nonvested at Dec 31, 2022 3,825 $ 55.13 1. Weighted-average per share.
Schedule of Additional Information About Deferred Restricted Stock Units	Additional Information about RSUs In millions, except per share amounts 2022 2021 2020 Weighted-average fair value per share of RSUs granted $ 58.60 $ 57.96 $ 47.66 Total fair value of RSUs vested 1 $ 102 $ 33 $ 106 Related tax benefit $ 23 $ 7 $ 24 Total compensation expense for RSU awards $ 99 $ 95 $ 93 Related tax benefit $ 22 $ 21 $ 21 1. Includes the fair value of shares vested in prior years and delivered in the reporting year.
Performance Stock Units (PSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value	The following table shows the PSU awards granted: PSU Awards Target Shares Granted 1 Grant Date Fair Value 2 Shares in thousands Year Performance Period 2022 Jan 1, 2022 – Dec 31, 2024 1,157 $ 65.83 2021 Jan 1, 2021 – Dec 31, 2023 1,223 $ 61.48 2020 Jan 1, 2020 – Dec 31, 2022 1,426 $ 48.35 1. At the end of the performance period, the actual number of shares issued can range from zero to 200 percent of target shares granted for the 2022 and 2021 awards and can range from zero to 100 percent of the target shares granted for the 2020 award.
Share-based Payment Arrangement, Performance Shares, Activity	The following table shows changes in nonvested PSUs: PSUs 2022 Shares in thousands Shares Grant Date Fair Value 1 Nonvested at Jan 1, 2022 3,639 $ 55.36 Granted 1,157 $ 65.83 Vested 2 (1,079) $ 57.58 Canceled (77) $ 59.73 Nonvested at Dec 31, 2022 3,640 $ 57.93 1. Weighted-average per share. 2. Includes 226,240 shares that were not delivered at vesting due to the final performance of program.
Schedule of Additional Information About Performance Deferred Stock	Additional Information about PSUs In millions, except share amounts 2022 2021 2020 Total fair value of PSUs vested and delivered 1 $ 51 $ — $ — Related tax benefit $ 11 $ — $ — Total compensation expense for PSU awards $ 70 $ 138 $ 56 Related tax benefit $ 16 $ 31 $ 13 Shares of PSUs settled in cash (in thousands) 2 162 — — Total cash paid to settle PSUs 3 $ 10 $ — $ — 1. Includes the fair value of shares vested in prior years and delivered in the reporting year. 2. PSU awards vested in prior years and delivered in the reporting year.
Employee Stock Purchase Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Schedule of Share-based Compensation, Employee Stock Purchase Plan, Activity	Additional Information about Employee Stock Purchase Plan In millions, except per share amounts 2022 2021 Weighted-average fair value per share of purchase rights granted $ 14.28 $ 16.26 Total compensation expense for ESPP $ 29 $ 30 Related tax benefit $ 7 $ 7 Total amount of cash received from the exercise of purchase rights $ 103 $ 103 Total intrinsic value of purchase rights exercised 1 $ 18 $ 18 Related tax benefit $ 4 $ 4

FINANCIAL INSTRUMENTS (Tables)

FINANCIAL INSTRUMENTS (Tables)	12 Months Ended
	Dec. 31, 2022
Investments, All Other Investments [Abstract]
Fair Value of Financial Instruments	The following table summarizes the fair value of financial instruments at December 31, 2022 and 2021: Fair Value of Financial Instruments at Dec 31 2022 2021 In millions Cost Gain Loss Fair Value Cost Gain Loss Fair Value Cash equivalents: Held-to-maturity securities 1 $ 872 $ — $ — $ 872 $ 317 $ — $ — $ 317 Money market funds 355 — — 355 489 — — 489 Total cash equivalents $ 1,227 $ — $ — $ 1,227 $ 806 $ — $ — $ 806 Marketable securities 2 $ 927 $ 12 $ — $ 939 $ 237 $ 8 $ — $ 245 Other investments: Debt securities: Government debt 3 $ 754 $ 1 $ (133) $ 622 $ 746 $ 17 $ (28) $ 735 Corporate bonds 1,274 10 (159) 1,125 1,251 93 (20) 1,324 Total debt securities $ 2,028 $ 11 $ (292) $ 1,747 $ 1,997 $ 110 $ (48) $ 2,059 Equity securities 4 5 5 — 10 7 13 — 20 Total other investments $ 2,033 $ 16 $ (292) $ 1,757 $ 2,004 $ 123 $ (48) $ 2,079 Total cash equivalents, marketable securities and other investments $ 4,187 $ 28 $ (292) $ 3,923 $ 3,047 $ 131 $ (48) $ 3,130 Long-term debt including debt due within one year 5 $ (15,060) $ 1,683 $ (498) $ (13,875) $ (14,511) $ 27 $ (2,641) $ (17,125) Derivatives relating to: Interest rates 6 $ — $ 105 $ — $ 105 $ — $ 1 $ (140) $ (139) Foreign currency — 115 (30) 85 — 46 (18) 28 Commodities 6 — 72 (61) 11 — 142 (92) 50 Total derivatives $ — $ 292 $ (91) $ 201 $ — $ 189 $ (250) $ (61) 1. The Company's held-to-maturity securities primarily included treasury bills and time deposits. 2. The Company's investments in marketable securities are included in "Other current assets" in the consolidated balance sheets. 3. U.S. Treasury obligations, U.S. agency obligations, U.S. agency mortgage-backed securities and other municipalities’ obligations. 4. Equity securities with a readily determinable fair value. 5. Cost includes fair value hedge adjustment gains of $46 million at December 31, 2022 and $47 million at December 31, 2021 on $2,279 million of debt at December 31, 2022 and December 31, 2021.
Investing Results	The following table provides the investing results from available-for-sale securities for the years ended December 31, 2022, 2021 and 2020. Investing Results In millions 2022 2021 2020 Proceeds from sales of available-for-sale securities $ 543 $ 424 $ 837 Gross realized gains $ 43 $ 50 $ 94 Gross realized losses $ 45 $ 12 $ 40
Contractual Maturities of Debt Securities	The following table summarizes the contractual maturities of the Company’s investments in debt securities: Contractual Maturities of Debt Securities at Dec 31, 2022 1 Cost Fair In millions Within one year $ 71 $ 68 One to five years 855 773 Six to ten years 594 503 After ten years 508 403 Total $ 2,028 $ 1,747 1. Includes marketable securities with maturities of less than one year.
Schedule of Temporary Impairment Losses, Investments	The following table provides the fair value and gross unrealized losses of the Company’s investments in debt securities that were deemed to be temporarily impaired at December 31, 2022 and 2021, aggregated by investment category: Temporarily Impaired Debt Securities at Less than 12 months 12 months or more Total Fair Unrealized Fair Unrealized Fair Value Unrealized Losses In millions 2022 Government debt 1 $ 273 $ (37) $ 333 $ (96) $ 606 $ (133) Corporate bonds 818 (110) 158 (49) 976 (159) Total temporarily impaired debt securities $ 1,091 $ (147) $ 491 $ (145) $ 1,582 $ (292) 2021 Government debt 1 $ 295 $ (13) $ 151 $ (15) $ 446 $ (28) Corporate bonds 355 (17) 16 (3) 371 (20) Total temporarily impaired debt securities $ 650 $ (30) $ 167 $ (18) $ 817 $ (48) 1. U.S. Treasury obligations, U.S. agency obligations, U.S. agency mortgage-backed securities and other municipalities' obligations.
Equity Securities with and without Readily Determinable Fair Value	Investments in Equity Securities Dec 31, 2022 Dec 31, 2021 In millions Readily determinable fair value $ 10 $ 20 Not readily determinable fair value $ 186 $ 209
Schedule of Notional Amounts of Outstanding Derivative Positions	The notional amounts of the Company's derivative instruments at December 31, 2022 and 2021, were as follows: Notional Amounts 1 Dec 31, 2022 Dec 31, 2021 In millions Derivatives designated as hedging instruments Interest rate contracts $ 1,500 $ 3,000 Foreign currency contracts $ 2,408 $ 5,300 Derivatives not designated as hedging instruments Interest rate contracts $ 3 $ 36 Foreign currency contracts $ 8,837 $ 8,234 1. Notional amounts represent the absolute value of open derivative positions at the end of the period. Multi-leg option positions are reflected at the maximum notional position at expiration. The notional amounts of the Company's commodity derivatives at December 31, 2022 and 2021, were as follows: Commodity Notionals 1 Dec 31, 2022 Dec 31, 2021 Notional Volume Unit Derivatives designated as hedging instruments Hydrocarbon derivatives 19.2 9.7 million barrels of oil equivalent Derivatives not designated as hedging instruments Hydrocarbon derivatives — 0.1 million barrels of oil equivalent Power derivatives — 3.3 thousands of megawatt hours 1. Notional amounts represent the net volume of open derivative positions outstanding at the end of the period.
Schedule of Derivative Instruments	Maturity Dates of Derivatives Designated as Hedging Instruments Year Interest rate contracts 2023 Foreign currency contracts 2023 Commodity contracts 2026
Schedule Fair Values of Derivative Instruments	The following tables provide the fair value and balance sheet classification of derivative instruments at December 31, 2022 and 2021: Fair Value of Derivative Instruments Dec 31, 2022 In millions Balance Sheet Classification Gross Counterparty and Cash Collateral Netting 1 Net Amounts Included in Consolidated Balance Sheets Asset derivatives Derivatives designated as hedging instruments Interest rate contracts Other current assets $ 351 $ (246) $ 105 Foreign currency contracts Other current assets 58 (39) 19 Commodity contracts Other current assets 199 (148) 51 Total $ 608 $ (433) $ 175 Derivatives not designated as hedging instruments Foreign currency contracts Other current assets $ 146 $ (50) $ 96 Commodity contracts Other current assets 22 (1) 21 Total $ 168 $ (51) $ 117 Total asset derivatives $ 776 $ (484) $ 292 Liability derivatives Derivatives designated as hedging instruments Interest rate contracts Accrued and other current liabilities $ 246 $ (246) $ — Foreign currency contracts Accrued and other current liabilities 58 (39) 19 Commodity contracts Accrued and other current liabilities 258 (198) 60 Total $ 562 $ (483) $ 79 Derivatives not designated as hedging instruments Foreign currency contracts Accrued and other current liabilities $ 61 $ (50) $ 11 Commodity contracts Accrued and other current liabilities 12 (11) 1 Total $ 73 $ (61) $ 12 Total liability derivatives $ 635 $ (544) $ 91 1. Counterparty and cash collateral amounts represent the estimated net settlement amount when applying netting and set-off rights included in master netting arrangements between the Company and its counterparties and the payable or receivable for cash collateral held or placed with the same counterparty. Fair Value of Derivative Instruments Dec 31, 2021 In millions Balance Sheet Classification Gross Counterparty and Cash Collateral Netting 1 Net Amounts Included in Consolidated Balance Sheets Asset derivatives Derivatives designated as hedging instruments Interest rate contracts Other current assets $ 14 $ (14) $ — Interest rate contracts Deferred charges and other assets 130 (130) — Foreign currency contracts Other current assets 24 (13) 11 Foreign currency contracts Deferred charges and other assets 117 (89) 28 Commodity contracts Other current assets 305 (173) 132 Commodity contracts Deferred charges and other assets 9 (2) 7 Total $ 599 $ (421) $ 178 Derivatives not designated as hedging instruments Interest rate contracts Other current assets $ 1 $ — $ 1 Foreign currency contracts Other current assets 23 (16) 7 Foreign currency contracts Deferred charges and other assets 1 (1) — Commodity contracts Other current assets 8 (5) 3 Total $ 33 $ (22) $ 11 Total asset derivatives $ 632 $ (443) $ 189 Liability derivatives Derivatives designated as hedging instruments Interest rate contracts Accrued and other current liabilities $ 33 $ (14) $ 19 Interest rate contracts Other noncurrent obligations 192 (130) 62 Foreign currency contracts Accrued and other current liabilities 15 (13) 2 Foreign currency contracts Other noncurrent obligations 90 (89) 1 Commodity contracts Accrued and other current liabilities 267 (192) 75 Commodity contracts Other noncurrent obligations 2 (2) — Total $ 599 $ (440) $ 159 Derivatives not designated as hedging instruments Interest rate contracts Accrued and other current liabilities $ 59 $ — $ 59 Foreign currency contracts Accrued and other current liabilities 31 (16) 15 Foreign currency contracts Other noncurrent obligations 1 (1) — Commodity contracts Accrued and other current liabilities 25 (8) 17 Total $ 116 $ (25) $ 91 Total liability derivatives $ 715 $ (465) $ 250
Derivative Instruments, Gain (Loss)	The following table summarizes the gain (loss) of derivative instruments in the consolidated statements of income and comprehensive income for the years ended December 31, 2022, 2021 and 2020: Effect of Derivative Instruments Amount of gain (loss) recognized in OCI 1 Amount of gain (loss) recognized in income 2 Income Statement Classification In millions 2022 2021 2020 2022 2021 2020 Derivatives designated as hedging instruments: Fair value hedges: Interest rate contracts $ — $ — $ — $ — $ (25) $ 69 Interest expense and amortization of debt discount 3 Excluded components 4 — 2 7 — — — Interest expense and amortization of debt discount Cash flow hedges: Interest rate contracts 239 (62) — (10) (9) (2) Interest expense and amortization of debt discount Foreign currency contracts 5 13 (20) 13 (15) 3 Cost of sales Commodity contracts 166 133 (8) 310 62 (31) Cost of sales Net foreign investment hedges: Foreign currency contracts 34 31 (38) — — — Excluded components 4 59 54 27 44 11 20 Sundry income (expense) - net Total derivatives designated as hedging instruments $ 503 $ 171 $ (32) $ 357 $ 24 $ 59 Derivatives not designated as hedging instruments: Interest rate contracts $ — $ — $ — $ (1) $ (8) $ (16) Interest expense and amortization of debt discount Foreign currency contracts — — — (249) (253) 28 Sundry income (expense) - net Commodity contracts — — — 48 (46) 11 Cost of sales Total derivatives not designated as hedging instruments $ — $ — $ — $ (202) $ (307) $ 23 Total derivatives $ 503 $ 171 $ (32) $ 155 $ (283) $ 82 1. OCI is defined as other comprehensive income (loss). 2. Pretax amounts. 3. Gain (loss) recognized in income of derivatives is offset by gain (loss) recognized in income of the hedged item. 4. The excluded components are related to the time value of the derivatives designated as hedges.
Schedule of Hedging Amounts in Accumulated Other Comprehensive Income (Loss) to be Recognized Over Next Fiscal Year [Table Text Block]	The following table provides the net after-tax gain (loss) expected to be reclassified from AOCL to income within the next 12 months: Expected Reclassifications from AOCL within the next 12 months Dec 31, Cash flow hedges: Interest rate contracts $ (7) Commodity contracts $ (48) Foreign currency contracts $ 2 Net foreign investment hedges: Excluded components $ —

FAIR VALUE MEASUREMENTS (Tables

FAIR VALUE MEASUREMENTS (Tables)	12 Months Ended
	Dec. 31, 2022
Fair Value Disclosures [Abstract]
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis	The following table summarizes the bases used to measure certain assets and liabilities at fair value on a recurring basis: Basis of Fair Value Measurements on a Recurring Basis Dec 31, 2022 Dec 31, 2021 In millions Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Total Assets at fair value: Cash equivalents: Held-to-maturity securities 1 $ — $ 872 $ — $ 872 $ — $ 317 $ — $ 317 Money market funds — 355 — 355 — 489 — 489 Marketable securities 2 — 939 — 939 — 245 — 245 Equity securities 3 10 — — 10 20 — — 20 Nonconsolidated affiliates 4 — — 7 7 — — — — Debt securities: 3 Government debt 5 — 622 — 622 — 735 — 735 Corporate bonds 35 1,090 — 1,125 44 1,280 — 1,324 Derivatives relating to: 6 Interest rates — 351 — 351 — 145 — 145 Foreign currency — 204 — 204 — 165 — 165 Commodities 63 158 — 221 15 307 — 322 Total assets at fair value $ 108 $ 4,591 $ 7 $ 4,706 $ 79 $ 3,683 $ — $ 3,762 Liabilities at fair value: Long-term debt including debt due within one year 7 $ — $ 13,875 $ — $ 13,875 $ — $ 17,125 $ — $ 17,125 Guarantee liability 8 — — 199 199 — — 220 220 Derivatives relating to: 6 Interest rates — 246 — 246 — 284 — 284 Foreign currency — 119 — 119 — 137 — 137 Commodities 103 167 — 270 37 257 — 294 Total liabilities at fair value $ 103 $ 14,407 $ 199 $ 14,709 $ 37 $ 17,803 $ 220 $ 18,060 1. The Company's held-to-maturity securities primarily included treasury bills and time deposits. 2. The Company's investments in marketable securities are included in "Other current assets" in the consolidated balance sheets. 3. The Company's investments in debt securities, which are primarily available-for-sale, and equity securities are included in "Other investments" in the consolidated balance sheets. 4. Estimated asset for an investment in a limited liability company included in "Investment in nonconsolidated affiliates" in the consolidated balance sheets. 5. U.S. Treasury obligations, U.S. agency obligations, U.S. agency mortgage-backed securities and other municipalities' obligations. 6. See Note 21 for the classification of derivatives in the consolidated balance sheets. 7. See Note 21 for information on fair value measurements of long-term debt. 8. Estimated liability for TDCC's guarantee of Sadara's debt which is included in "Other noncurrent obligations" in the consolidated balance sheets. See Note 15 for additional information.
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation	The following table summarizes the changes in fair value measurements using Level 3 inputs for the years ended December 31, 2022 and 2021: Fair Value Measurements Using Level 3 Inputs for Accrued Liability of Sadara Guarantee at Dec 31, 2022 2021 In millions Balance at Jan 1 $ (220) $ — Recognition of liability 1 — (235) Gain included in earnings 2 21 15 Balance at Dec 31 $ (199) $ (220) 1. Included in "Other noncurrent obligations" in the consolidated balance sheets.
Fair Value, Assets and Liabilities Measured on Nonrecurring Basis	The following table summarizes the bases used to measure certain assets at fair value on a nonrecurring basis in the consolidated balance sheets: Basis of Fair Value Measurements on a Nonrecurring Basis at Dec 31 (Level 3) Total Losses In millions 2020 Assets at fair value: Long-lived assets and other assets $ 121 $ (245)

VARIABLE INTEREST ENTITIES (Tab

VARIABLE INTEREST ENTITIES (Tables)	12 Months Ended
	Dec. 31, 2022
Variable Interest Entity, Primary Beneficiary
Variable Interest Entity [Line Items]
Schedule of Variable Interest Entities	The following table summarizes the carrying amounts of these entities’ assets and liabilities included in the Company’s consolidated balance sheets at December 31, 2022 and 2021: Assets and Liabilities of Consolidated VIEs at Dec 31 In millions 2022 2021 Cash and cash equivalents $ 17 $ 40 Other current assets 36 40 Net property 157 184 Other noncurrent assets 17 15 Total assets 1 $ 227 $ 279 Current liabilities $ 30 $ 37 Long-term debt — 3 Other noncurrent obligations 12 13 Total liabilities 2 $ 42 $ 53 1. All assets were restricted at December 31, 2022 and 2021. 2. All liabilities were nonrecourse at December 31, 2022 and 2021.

RELATED PARTY TRANSACTIONS (Tab

RELATED PARTY TRANSACTIONS (Tables)	12 Months Ended
	Dec. 31, 2022
Related Party Transactions [Abstract]
Dividends Declared	The following table summarizes cash dividends TDCC declared and paid to Dow Inc. for the years ended 2022, 2021 and 2020. TDCC Cash Dividends Declared and Paid 2022 2021 2020 In millions Cash dividends declared and paid $ 4,375 $ 3,264 $ 2,233

SEGMENTS AND GEOGRAPHIC REGIO_2

SEGMENTS AND GEOGRAPHIC REGIONS (Tables)	12 Months Ended
	Dec. 31, 2022
Segment Reporting [Abstract]
Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]	Sales are attributed to geographic region based on customer location; long-lived assets are attributed to geographic region based on asset location. Geographic Region Information United EMEAI Rest of Total In millions 2022 Sales to external customers $ 19,336 $ 19,631 $ 17,935 $ 56,902 Long-lived assets $ 14,638 $ 2,578 $ 3,226 $ 20,442 2021 Sales to external customers $ 18,083 $ 19,746 $ 17,139 $ 54,968 Long-lived assets $ 14,425 $ 2,703 $ 3,427 $ 20,555 2020 Sales to external customers $ 12,547 $ 12,969 $ 13,026 $ 38,542 Long-lived assets $ 13,833 $ 2,813 $ 3,593 $ 20,239 See Part I, Item 1. Business for further discussion of the Company's segments. Dow’s measure of profit/loss for segment reporting purposes is Operating EBIT as this is the manner in which the Company's chief operating decision maker ("CODM") assesses performance and allocates resources. The Company defines Operating EBIT as earnings (i.e., "Income before income taxes") before interest, excluding the impact of significant items. Operating EBIT by segment includes all operating items relating to the businesses; items that principally apply to Dow as a whole are assigned to Corporate.
Schedule of Segment Reporting Information, by Segment [Table Text Block]	Segment Information Pack. & Spec. Plastics Ind. Interm. & Infrast. Perf. Materials & Coatings Corp. Total In millions 2022 Net sales $ 29,260 $ 16,606 $ 10,764 $ 272 $ 56,902 Restructuring and asset related charges - net 1 8 73 6 31 118 Equity in earnings (losses) of nonconsolidated affiliates 359 (91) 10 (10) 268 Operating EBIT 2 4,110 1,418 1,328 (266) 6,590 Depreciation and amortization 1,396 550 789 23 2,758 Total assets 30,017 12,883 13,028 4,675 60,603 Investments in nonconsolidated affiliates 846 454 115 174 1,589 Capital expenditures 1,069 385 369 — 1,823 2021 Net sales $ 28,128 $ 16,851 $ 9,672 $ 317 $ 54,968 Restructuring and asset related charges (credits) - net 1 8 1 10 (13) 6 Equity in earnings of nonconsolidated affiliates 490 471 7 7 975 Operating EBIT 2 6,638 2,282 866 (253) 9,533 Depreciation and amortization 1,358 612 842 30 2,842 Total assets 30,556 13,750 13,810 4,874 62,990 Investments in nonconsolidated affiliates 1,230 670 111 34 2,045 Capital expenditures 808 359 334 — 1,501 2020 Net sales $ 18,301 $ 12,021 $ 7,951 $ 269 $ 38,542 Restructuring and asset related charges - net 1 30 22 192 464 708 Equity in earnings (losses) of nonconsolidated affiliates 173 (166) 6 (31) (18) Operating EBIT 2 2,325 355 314 (279) 2,715 Depreciation and amortization 1,372 605 870 27 2,874 Total assets 30,069 12,220 13,915 5,266 61,470 Investments in nonconsolidated affiliates 661 531 108 27 1,327 Capital expenditures 678 268 306 — 1,252 1. See Note 5 for information regarding the Company's restructuring programs and other asset related charges. 2. Operating EBIT for TDCC in 2022, 2021 and 2020 is substantially the same as that of Dow Inc. and therefore is not disclosed separately in the table above. A reconciliation of "Net income" to Operating EBIT is provided in the following table.
Reconciliation of income from continuing operations, net of tax to Operating EBIT [Table Text Block]	Reconciliation of "Net income" to Operating EBIT 2022 2021 2020 In millions Net income $ 4,640 $ 6,405 $ 1,294 + Provision for income taxes 1,450 1,740 777 Income before income taxes $ 6,090 $ 8,145 $ 2,071 - Interest income 173 55 38 + Interest expense and amortization of debt discount 662 731 827 - Significant items (11) (712) 145 Operating EBIT $ 6,590 $ 9,533 $ 2,715
Schedule of significant items [Table Text Block]	The following tables summarize the pretax impact of significant items by segment that are excluded from Operating EBIT: Significant Items by Segment for 2022 Pack. & Spec. Plastics Ind. Interm. & Infrast. Perf. Materials & Coatings Corp. Total In millions Digitalization program costs 1 $ — $ — $ — $ (230) $ (230) Restructuring, implementation costs and asset related charges - net 2 — — — (40) (40) Russia / Ukraine conflict charges 3 (8) (73) (6) (31) (118) Loss on early extinguishment of debt 4 — — — (8) (8) Litigation related charges, awards and adjustments 5 321 — — 60 381 Indemnification and other transaction related costs 6 — — — 4 4 Total $ 313 $ (73) $ (6) $ (245) $ (11) 1. Includes costs associated with implementing the Company's Digital Acceleration program. 2. Includes costs associated with implementing the Company's 2020 Restructuring Program. 3. Asset related charges due to the Russia and Ukraine conflict. See Note 5 for additional information. 4. The Company redeemed outstanding long-term debt resulting in a loss on early extinguishment. See Note 14 for additional information. 5. Includes a gain associated with a legal matter with Nova Chemicals Corporation and a gain related to an adjustment of the Dow Silicones breast implant liability. See Note 15 for additional information. 6. Primarily related to charges associated with agreements entered into with DuPont and Corteva as part of the separation and distribution which, among other matters, provides for cross-indemnities and allocations of obligations and liabilities for periods prior to, at and after the completion of the separation. Significant Items by Segment for 2021 Pack. & Spec. Plastics Ind. Interm. & Infrast. Perf. Materials & Coatings Corp. Total In millions Digitalization program costs 1 $ — $ — $ — $ (169) $ (169) Restructuring, implementation costs and asset related charges - net 2 (8) (1) (10) (50) (69) Loss on early extinguishment of debt 3 — — — (574) (574) Net gain on divestitures and asset sale 4 16 — — — 16 Litigation related charges, awards and adjustments 5 — 54 — — 54 Indemnification and other transaction related costs 6 — — — 30 30 Total $ 8 $ 53 $ (10) $ (763) $ (712) 1. Includes costs associated with implementing the Company's Digital Acceleration program. 2. Includes costs associated with implementing the Company's 2020 Restructuring Program, and asset-related charges, which include other asset impairments. See Note 5 for additional information. 3. The Company redeemed outstanding long-term debt resulting in a loss on early extinguishment. See Note 14 for additional information. 4. Includes post-closing adjustments on a previous divestiture. 5. Related to an arbitration award received from Luxi Chemical Group Co., Ltd. See Note 15 for additional information. 6. Primarily related to charges associated with agreements entered into with DuPont and Corteva as part of the separation and distribution which, among other matters, provides for cross-indemnities and allocations of obligations and liabilities for periods prior to, at and after the completion of the separation. Significant Items by Segment for 2020 Pack. & Spec. Plastics Ind. Interm. & Infrast. Perf. Materials & Coatings Corp. Total In millions Integration and separation costs 1 $ — $ — $ — $ (239) $ (239) Restructuring, implementation costs and asset related charges - net 2 (30) (22) (192) (474) (718) Warranty accrual adjustment of exited business 3 — — — 11 11 Net gain on divestitures and asset sale 4 52 61 — 604 717 Litigation related charges, awards and adjustments 5 544 — — — 544 Loss on early extinguishment of debt 6 — — — (149) (149) Indemnification and other transaction related costs 7 — — — (21) (21) Total $ 566 $ 39 $ (192) $ (268) $ 145 1. Costs related to business separation activities. 2. Includes costs associated with implementing the Company's 2020 Restructuring Program, and asset-related charges, which include other asset impairments. See Note 5 for additional information. 3. Includes an adjustment to the warranty accrual of an exited business. 4. Primarily related to a gain on the sale of rail infrastructure in the U.S. and Canada and a gain on the sale of marine and terminal operations and assets in the U.S. See Notes 4 and 6 for additional information. 5. Includes recognition of gains associated with a legal matter with Nova. See Note 15 for additional information. 6. The Company redeemed outstanding long-term debt resulting in a loss on early extinguishment. See Note 14 for additional information. 7. Primarily related to charges associated with agreements entered into with DuPont and Corteva as part of the separation and distribution which, among other matters, provides for cross-indemnities and allocations of obligations and liabilities for periods prior to, at and after the completion of the separation.

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Percentage of LIFO Inventory	27%	27%
Percentage of FIFO Inventory	64%	65%
Percentage of Weighted Average Cost Inventory	9%	8%
Minimum
Useful life	3 years
Maximum
Useful life	20 years
Asset retirement obligations, estimated remaining useful life	10 years

REVENUE (Details)

REVENUE (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Revenue from External Customer [Line Items]
Contract with Customer, Liability, Revenue Recognized	$ 250	$ 295	$ 145
Contract with Customer, Asset, Reclassified to Receivable	15	35
Trade (net of allowance for doubtful receivables - 2022: $110; 2021: $54)	5,611	6,841
Contract assets - current	48	34
Contract assets - noncurrent	16	26
Contract liabilities - current	275	209
Contract liabilities - noncurrent	1,725	1,925
The Dow Chemical Company
Revenue from External Customer [Line Items]
Trade (net of allowance for doubtful receivables - 2022: $110; 2021: $54)	5,611	6,841
U.S.& Canada [Member]
Revenue from External Customer [Line Items]
Revenues	20,945	19,613	13,582
Europe, Middle East, Africa and India
Revenue from External Customer [Line Items]
Revenues	19,631	19,746	12,969
Asia Pacific [Member]
Revenue from External Customer [Line Items]
Revenues	10,344	10,043	8,165
Latin America [Member]
Revenue from External Customer [Line Items]
Revenues	5,982	5,566	3,826
Corporate Segment [Member]
Revenue from External Customer [Line Items]
Revenues	272	317	269
Hydrocarbons & Energy [Member] | Packaging & Specialty Plastics [Member] [Domain]
Revenue from External Customer [Line Items]
Revenues	9,414	8,149	4,271
Packaging and Specialty Plastics [Member] | Packaging & Specialty Plastics [Member] [Domain]
Revenue from External Customer [Line Items]
Revenues	19,846	19,979	14,030
Industrial Solutions [Member] | Industrial Intermediates & Infrastructure [Member]
Revenue from External Customer [Line Items]
Revenues	5,682	5,139	3,929
Polyurethanes & Construction Chemicals | Industrial Intermediates & Infrastructure [Member]
Revenue from External Customer [Line Items]
Revenues	10,907	11,700	8,080
Other [Member] | Industrial Intermediates & Infrastructure [Member]
Revenue from External Customer [Line Items]
Revenues	17	12	12
Coatings and Performance Monomers [Member] | Performance Materials & Coatings [Member]
Revenue from External Customer [Line Items]
Revenues	4,051	4,050	3,258
Consumer Solutions [Member] | Performance Materials & Coatings [Member]
Revenue from External Customer [Line Items]
Revenues	$ 6,713	$ 5,622	$ 4,693
Maximum
Revenue from External Customer [Line Items]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period	18 years
Product
Revenue from External Customer [Line Items]
Revenue, Percentage from Products and Service Transferred to Customers	99%	99%	99%
Licensing of Technology
Revenue from External Customer [Line Items]
Revenue, Remaining Performance Obligation, Amount	$ 840	$ 829

DIVESTITURES (Details)

DIVESTITURES (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Proceeds from sales of property and businesses, net of cash divested	$ 32	$ 68	$ 929
Gain on disposal		16	717
Rail Infrastructure Operations and Assets [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Proceeds from sales of property and businesses, net of cash divested			303
Disposal Group, Including Discontinued Operation, Assets, Noncurrent			68
Disposal Group, Including Discontinued Operation, Goodwill			2
Gain on disposal			233
Marine and Terminal Operations and Assets
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Proceeds from sales of property and businesses, net of cash divested			600
Disposal Group, Including Discontinued Operation, Assets, Noncurrent			93
Disposal Group, Including Discontinued Operation, Goodwill			8
Gain on disposal			499
Packaging & Specialty Plastics [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Gain on disposal		16	52
Packaging & Specialty Plastics [Member] | Rail Infrastructure Operations and Assets [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Disposal Group, Including Discontinued Operation, Assets			16
Gain on disposal			48
Packaging & Specialty Plastics [Member] | Marine and Terminal Operations and Assets
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Disposal Group, Including Discontinued Operation, Assets			7
Gain on disposal			17
Industrial Intermediates & Infrastructure [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Gain on disposal		0	61
Industrial Intermediates & Infrastructure [Member] | Marine and Terminal Operations and Assets
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Disposal Group, Including Discontinued Operation, Assets			17
Gain on disposal			61
Corporate Segment [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Gain on disposal		$ 0	604
Corporate Segment [Member] | Rail Infrastructure Operations and Assets [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Disposal Group, Including Discontinued Operation, Assets			54
Gain on disposal			185
Corporate Segment [Member] | Marine and Terminal Operations and Assets
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Disposal Group, Including Discontinued Operation, Assets			77
Gain on disposal			$ 421

RESTRUCTURING, GOODWILL IMPAI_3

RESTRUCTURING, GOODWILL IMPAIRMENT AND ASSET RELATED CHARGES - NET (2020 Restructuring Program) (Details) - USD ($) $ in Millions	3 Months Ended				6 Months Ended	12 Months Ended			27 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2020	Sep. 30, 2020	Dec. 31, 2020	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2022	Sep. 29, 2020
Restructuring Cost and Reserve [Line Items]
Restructuring and asset related charges - net						$ 118	$ 6	$ 708
Restructuring Charges						40	69	718
Packaging & Specialty Plastics [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and asset related charges - net						8	8	30
Restructuring Charges						0	8	30
Industrial Intermediates & Infrastructure [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and asset related charges - net						73	1	22
Restructuring Charges						0	1	22
Performance Materials & Coatings [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and asset related charges - net						6	10	192
Restructuring Charges						0	10	192
Corporate Segment [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and asset related charges - net						31	13	464
Restructuring Charges						40	50	474
2020 Restructuring Program [Member]
Restructuring Cost and Reserve [Line Items]
restructuring and related cost, percentage										6%
Restructuring and asset related charges - net			$ 573	$ 575
Restructuring Reserve, Accrual Adjustment							12
Restructuring Reserve, Settled without Cash			(201)				(12)
Payments for Restructuring			(8)			(99)	(196)
Restructuring Reserve	$ 168	$ 364	364		$ 364	69	168	364	$ 69
Restructuring Charges									585
2020 Restructuring Program [Member] | Accrued and Other Current Liabilities [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Reserve	112					22	112		22
2020 Restructuring Program [Member] | Other Noncurrent Obligations
Restructuring Cost and Reserve [Line Items]
Restructuring Reserve	56					47	56		47
2020 Restructuring Program [Member] | Packaging & Specialty Plastics [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and asset related charges - net			11
Restructuring Reserve, Accrual Adjustment						8
2020 Restructuring Program [Member] | Industrial Intermediates & Infrastructure [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and asset related charges - net			22
Restructuring Reserve, Accrual Adjustment						1
2020 Restructuring Program [Member] | Performance Materials & Coatings [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and asset related charges - net			177
Restructuring Reserve, Accrual Adjustment						10
2020 Restructuring Program [Member] | Corporate Segment [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and asset related charges - net			363
Restructuring Reserve, Accrual Adjustment						(7)
2020 Restructuring Program [Member] | Asset Write-downs and Write-offs
Restructuring Cost and Reserve [Line Items]
Restructuring and asset related charges - net			196	197				196
Restructuring Reserve, Accrual Adjustment		(1)					12
Restructuring Reserve, Settled without Cash					(196)		(12)
Payments for Restructuring					0	0	0
Restructuring Reserve	0	0	0		0	0	0	0	0
Restructuring Charges									208
2020 Restructuring Program [Member] | Asset Write-downs and Write-offs | Packaging & Specialty Plastics [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and asset related charges - net			11					11
Restructuring Reserve, Accrual Adjustment						0
2020 Restructuring Program [Member] | Asset Write-downs and Write-offs | Industrial Intermediates & Infrastructure [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and asset related charges - net			22					22
Restructuring Reserve, Accrual Adjustment							1
2020 Restructuring Program [Member] | Asset Write-downs and Write-offs | Performance Materials & Coatings [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and asset related charges - net			116					116
Restructuring Reserve, Accrual Adjustment							8
2020 Restructuring Program [Member] | Asset Write-downs and Write-offs | Corporate Segment [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and asset related charges - net			47					47
Restructuring Reserve, Accrual Adjustment							3
2020 Restructuring Program [Member] | Costs Associated with Exit and Disposal Activities [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and asset related charges - net			80	81
Restructuring Reserve, Accrual Adjustment		(1)					10
Restructuring Reserve, Settled without Cash					(5)		0
Payments for Restructuring			0			(11)	(21)
Restructuring Reserve	64	75	75		75	53	64	75	53
Restructuring Charges									90
2020 Restructuring Program [Member] | Costs Associated with Exit and Disposal Activities [Member] | Contract Termination [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and asset related charges - net			19
2020 Restructuring Program [Member] | Costs Associated with Exit and Disposal Activities [Member] | Environmental Remediation [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and asset related charges - net			56
2020 Restructuring Program [Member] | Costs Associated with Exit and Disposal Activities [Member] | Packaging & Specialty Plastics [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and asset related charges - net			0
Restructuring Reserve, Accrual Adjustment							8
2020 Restructuring Program [Member] | Costs Associated with Exit and Disposal Activities [Member] | Industrial Intermediates & Infrastructure [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and asset related charges - net			0
Restructuring Reserve, Accrual Adjustment						0
2020 Restructuring Program [Member] | Costs Associated with Exit and Disposal Activities [Member] | Performance Materials & Coatings [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and asset related charges - net			61
Restructuring Reserve, Accrual Adjustment							2
2020 Restructuring Program [Member] | Costs Associated with Exit and Disposal Activities [Member] | Performance Materials & Coatings [Member] | Contract Termination [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and asset related charges - net			9
2020 Restructuring Program [Member] | Costs Associated with Exit and Disposal Activities [Member] | Performance Materials & Coatings [Member] | Environmental Remediation [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and asset related charges - net			52
2020 Restructuring Program [Member] | Costs Associated with Exit and Disposal Activities [Member] | Corporate Segment [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and asset related charges - net			19
Restructuring Reserve, Accrual Adjustment						0
2020 Restructuring Program [Member] | Costs Associated with Exit and Disposal Activities [Member] | Corporate Segment [Member] | Contract Termination [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and asset related charges - net			10
2020 Restructuring Program [Member] | Costs Associated with Exit and Disposal Activities [Member] | Corporate Segment [Member] | Environmental Remediation [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and asset related charges - net			4
2020 Restructuring Program [Member] | Costs Associated with Exit and Disposal Activities [Member] | Corporate Segment [Member] | Pension Costs [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and asset related charges - net					5
2020 Restructuring Program [Member] | Severance and Related Benefit Costs
Restructuring Cost and Reserve [Line Items]
Restructuring and asset related charges - net			297	$ 297
Restructuring Reserve, Accrual Adjustment	(10)						(10)
Restructuring Reserve, Settled without Cash					0		0
Payments for Restructuring					(8)	(88)	(175)
Restructuring Reserve	$ 104	$ 289	289		$ 289	$ 16	104	$ 289	16
Restructuring Charges									$ 287
2020 Restructuring Program [Member] | Severance and Related Benefit Costs | Packaging & Specialty Plastics [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and asset related charges - net			0
Restructuring Reserve, Accrual Adjustment							0
2020 Restructuring Program [Member] | Severance and Related Benefit Costs | Industrial Intermediates & Infrastructure [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and asset related charges - net			0
Restructuring Reserve, Accrual Adjustment							0
2020 Restructuring Program [Member] | Severance and Related Benefit Costs | Performance Materials & Coatings [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and asset related charges - net			0
Restructuring Reserve, Accrual Adjustment							0
2020 Restructuring Program [Member] | Severance and Related Benefit Costs | Corporate Segment [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and asset related charges - net			$ 297
Restructuring Reserve, Accrual Adjustment							$ (10)

RESTRUCTURING, GOODWILL IMPAI_4

RESTRUCTURING, GOODWILL IMPAIRMENT AND ASSET RELATED CHARGES - NET (DowDuPont Cost Synergy Program) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Restructuring Cost and Reserve [Line Items]
Restructuring Charges	$ 40	$ 69	$ 718
Industrial Intermediates & Infrastructure [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Charges	0	1	22
Performance Materials & Coatings [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Charges	0	10	192
Corporate Segment [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Charges	$ 40	$ 50	$ 474

RESTRUCTURING, GOODWILL IMPAI_5

RESTRUCTURING, GOODWILL IMPAIRMENT AND ASSET RELATED CHARGES - NET (Goodwill Impairment and Asset Related Charges) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Restructuring Cost and Reserve [Line Items]
Asset Impairment Charges	$ 118		$ 49
Restructuring and asset related charges - net	118	$ 6	708
Performance Materials & Coatings [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and asset related charges - net	6	10	192
Packaging & Specialty Plastics [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and asset related charges - net	8	8	30
Corporate Segment [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and asset related charges - net	31	13	464
Industrial Intermediates & Infrastructure [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and asset related charges - net	73	$ 1	22
Fair Value, Measurements, Nonrecurring | Performance Materials & Coatings [Member]
Restructuring Cost and Reserve [Line Items]
Asset Impairment Charges	6		15
Fair Value, Measurements, Nonrecurring | Packaging & Specialty Plastics [Member]
Restructuring Cost and Reserve [Line Items]
Asset Impairment Charges	8		19
Fair Value, Measurements, Nonrecurring | Corporate Segment [Member]
Restructuring Cost and Reserve [Line Items]
Asset Impairment Charges	31		$ 15
Fair Value, Measurements, Nonrecurring | Industrial Intermediates & Infrastructure [Member]
Restructuring Cost and Reserve [Line Items]
Asset Impairment Charges	$ 73

RESTRUCTURING, GOODWILL IMPAI_6

RESTRUCTURING, GOODWILL IMPAIRMENT AND ASSET RELATED CHARGES - NET (2023 Restructuring Program) (Details)	3 Months Ended	12 Months Ended
	Mar. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)	Dec. 31, 2020 USD ($)
Restructuring Cost and Reserve [Line Items]
Restructuring and asset related charges - net		$ 118,000,000	$ 6,000,000	$ 708,000,000
2023 Restructuring Program | Subsequent Event [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and related workforce reduction	2,000
2023 Restructuring Program | Subsequent Event [Member] | Minimum
Restructuring Cost and Reserve [Line Items]
Restructuring and asset related charges - net	$ 550,000,000
Payments for Restructuring	450,000,000
2023 Restructuring Program | Subsequent Event [Member] | Maximum
Restructuring Cost and Reserve [Line Items]
Restructuring and asset related charges - net	725,000,000
Payments for Restructuring	550,000,000
Severance and Related Benefit Costs | 2023 Restructuring Program | Subsequent Event [Member] | Minimum
Restructuring Cost and Reserve [Line Items]
Restructuring and asset related charges - net	330,000,000
Severance and Related Benefit Costs | 2023 Restructuring Program | Subsequent Event [Member] | Maximum
Restructuring Cost and Reserve [Line Items]
Restructuring and asset related charges - net	425,000,000
Costs Associated with Exit and Disposal Activities [Member] | 2023 Restructuring Program | Subsequent Event [Member] | Minimum
Restructuring Cost and Reserve [Line Items]
Restructuring and asset related charges - net	20,000,000
Costs Associated with Exit and Disposal Activities [Member] | 2023 Restructuring Program | Subsequent Event [Member] | Maximum
Restructuring Cost and Reserve [Line Items]
Restructuring and asset related charges - net	50,000,000
Asset Write-downs and Write-offs | 2023 Restructuring Program | Subsequent Event [Member] | Minimum
Restructuring Cost and Reserve [Line Items]
Restructuring and asset related charges - net	200,000,000
Asset Write-downs and Write-offs | 2023 Restructuring Program | Subsequent Event [Member] | Maximum
Restructuring Cost and Reserve [Line Items]
Restructuring and asset related charges - net	$ 250,000,000

SUPPLEMENTARY INFORMATION (Sund

SUPPLEMENTARY INFORMATION (Sundry Income, Net) (Details) - USD ($) $ in Millions	3 Months Ended				12 Months Ended
	Dec. 31, 2022	Dec. 31, 2020	Jun. 30, 2020	Sep. 30, 2019	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Supplementary Information [Line Items]
Non-operating pension and other postretirement benefit plan net credit					$ 358	$ 332	$ 103
Foreign exchange losses 2					(117)	(8)	(62)
Loss on early extinguishment of debt					(8)	(574)	(149)
Gain (loss) related to litigation settlement					381	54	544
Gain (Loss) on Disposition of Other Assets					78	105	48
Charges related to separation, distribution and tax matters agreements					(4)	(30)	21
Other - net					31	10	84
Sundry income (expense) - net					$ 727	$ (35)	$ 1,269
Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal, Statement of Income or Comprehensive Income [Extensible Enumeration]					Sundry income (expense) - net	Sundry income (expense) - net	Sundry income (expense) - net
Dow V. Nova Chemicals Corporation Ethylene Asset Matter [Member] [Member]
Supplementary Information [Line Items]
Gain (loss) related to litigation settlement		$ 552	$ 18	$ 186
Dow V. Nova Chemicals Corporation Patent Infringement Matter
Supplementary Information [Line Items]
Gain (loss) related to litigation settlement	$ 341
Marine and Terminal Operations and Assets
Supplementary Information [Line Items]
Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal, Statement of Income or Comprehensive Income [Extensible Enumeration]					Sundry income (expense) - net	Sundry income (expense) - net	Sundry income (expense) - net
Rail Infrastructure Operations and Assets [Member]
Supplementary Information [Line Items]
Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal, Statement of Income or Comprehensive Income [Extensible Enumeration]					Sundry income (expense) - net	Sundry income (expense) - net	Sundry income (expense) - net
Nonoperating Income (Expense)
Supplementary Information [Line Items]
Charges related to separation, distribution and tax matters agreements					$ 4	$ 30	$ (21)
Nonoperating Income (Expense) | Breast Implant and Other Products Liability Claims
Supplementary Information [Line Items]
Loss Contingency Accrual, Period Increase (Decrease)					60	0	5
Nonoperating Income (Expense) | Luxi Chemical Group Breach of Contract Matter
Supplementary Information [Line Items]
Gain (loss) related to litigation settlement					0	54	0
Nonoperating Income (Expense) | Dow V. Nova Chemicals Corporation Patent Infringement Matter
Supplementary Information [Line Items]
Gain (loss) related to litigation settlement					321	0	544
The Dow Chemical Company
Supplementary Information [Line Items]
Non-operating pension and other postretirement benefit plan net credit					358	332	103
Foreign exchange losses 2					(126)	(13)	(65)
Loss on early extinguishment of debt					(8)	(574)	(149)
Gain (Loss) on Disposition of Other Assets					78	105	48
Other - net					31	3	82
Sundry income (expense) - net					$ 714	$ (79)	$ 1,274
Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal, Statement of Income or Comprehensive Income [Extensible Enumeration]					Sundry income (expense) - net	Sundry income (expense) - net	Sundry income (expense) - net
The Dow Chemical Company | Marine and Terminal Operations and Assets
Supplementary Information [Line Items]
Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal, Statement of Income or Comprehensive Income [Extensible Enumeration]					Sundry income (expense) - net	Sundry income (expense) - net	Sundry income (expense) - net
The Dow Chemical Company | Rail Infrastructure Operations and Assets [Member]
Supplementary Information [Line Items]
Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal, Statement of Income or Comprehensive Income [Extensible Enumeration]					Sundry income (expense) - net	Sundry income (expense) - net	Sundry income (expense) - net
The Dow Chemical Company | Nonoperating Income (Expense)
Supplementary Information [Line Items]
Charges related to separation, distribution and tax matters agreements					$ 0	$ (2)	$ (11)
The Dow Chemical Company | Nonoperating Income (Expense) | Breast Implant and Other Products Liability Claims
Supplementary Information [Line Items]
Loss Contingency Accrual, Period Increase (Decrease)					60	0	5
The Dow Chemical Company | Nonoperating Income (Expense) | Dow V. Nova Chemicals Corporation Ethylene Asset Matter [Member] [Member]
Supplementary Information [Line Items]
Gain (loss) related to litigation settlement					321	0	544
The Dow Chemical Company | Nonoperating Income (Expense) | Luxi Chemical Group Breach of Contract Matter
Supplementary Information [Line Items]
Gain (loss) related to litigation settlement					$ 0	$ 54	$ 0

SUPPLEMENTARY INFORMATION (Accr

SUPPLEMENTARY INFORMATION (Accrued and other current liabilities) (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Accrued and other current liabilities	$ 2,770	$ 3,481
Employee-related Liabilities, Current	650	1,030
The Dow Chemical Company
Accrued and other current liabilities	$ 2,613	$ 3,299

SUPPLEMENTARY INFORMATION (Supp

SUPPLEMENTARY INFORMATION (Supplemental Cash Flow Information) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Supplementary Information [Abstract]
Interest , net of amounts capitalized	$ 675	$ 801	$ 842
Income taxes	$ 793	$ 731	$ 518

INCOME TAXES (Geographic Alloca

INCOME TAXES (Geographic Allocation of Income and Provision for Income Taxes) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Income (loss) before income taxes
Domestic	$ 2,383	$ 1,523	$ (681)
Foreign	3,707	6,622	2,752
Income before income taxes	6,090	8,145	2,071
Current tax expense (benefit)
Federal	434	(46)	(176)
State and local	82	48	4
Foreign	855	1,460	691
Total current tax expense	1,371	1,462	519
Deferred tax expense
Federal	63	130	184
State and local	1	26	19
Foreign	15	122	55
Provision (Credit) for deferred income tax	79	278	258
Provision for income taxes	1,450	1,740	777
Income from continuing operations, net of tax	$ 4,640	$ 6,405	$ 1,294

INCOME TAXES (Reconciliation to

INCOME TAXES (Reconciliation to U.S. Statutory Rate) (Details)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Income Tax Disclosure [Abstract]
Statutory U.S. federal income tax rate	21%	21%	21%
Equity earnings effect	(1.20%)	(2.20%)	0.20%
Foreign income taxed at rates other than the statutory U.S. federal income tax rate	(1.40%)	(1.30%)	(2.30%)
U.S. tax effect of foreign earnings and dividends	1.20%	1.70%	3.90%
Unrecognized tax benefits	1.30%	4.70%	7.30%
Acquisitions, divestitures and ownership restructuring activities	0%	0%	(5.10%)
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent	(2.80%)	2.60%	12.60%
Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Percent	0.60%	(5.30%)	0.30%
State and local income taxes	2.80%	0.20%	0.30%
Other - net	2.30%	0%	(0.70%)
Effective tax rate	23.80%	21.40%	37.50%

INCOME TAXES (Deferred Tax Bala

INCOME TAXES (Deferred Tax Balances) (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Income Tax Disclosure [Abstract]
Deferred Tax Assets, Property, Plant and Equipment	$ 505	$ 484
Deferred Tax Liabilities, Property, Plant and Equipment	3,001	3,150
Deferred Tax Assets, Loss and Credit Carryforwards	1,472	1,784
Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Postretirement Benefits	749	1,753
Deferred Tax Liabilities, Tax Deferred Expense, Compensation and Benefits, Postretirement Benefits	239	303
Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Other	1,497	1,487
Deferred Tax Liabilities, Deferred Expense, Reserves and Accruals, Other	279	191
Deferred Tax Assets, Goodwill and Intangible Assets	36	108
Deferred Tax Liabilities, Goodwill and Intangible Assets	415	556
Deferred Tax Assets, Inventory	129	33
Deferred Tax Liabilities, Inventory	278	203
Deferred Tax Assets, Investments	116	31
Deferred Tax Liabilities, Investments	41	26
Deferred Tax Assets, Other	999	1,093
Deferred Tax Liabilities, Other	131	101
Deferred Tax Assets, Gross	5,503	6,773
Deferred Tax Liabilities, Gross	4,384	4,530
Deferred Tax Assets, Valuation Allowance	(1,269)	(1,391)
Deferred Tax Assets, Net of Valuation Allowance	$ 4,234	$ 5,382

INCOME TAXES (Operating Loss an

INCOME TAXES (Operating Loss and Tax Credit Carryforwards) (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Operating Loss Carryforwards [Line Items]
Operating loss carryforwards	$ 910	$ 1,057
Tax credit carryforwards	173	330
Total tax loss and tax credit carryforwards	1,472	1,784
Undistributed earnings of foreign subsidiaries	6,013	7,769
Expiring Within Five Years [Member]
Operating Loss Carryforwards [Line Items]
Operating loss carryforwards	158	240
Tax credit carryforwards	77	227
Deferred Tax Assets, Capital Loss Carryforwards	389	397
Expiring After Five Years or Having Indefinite Expiration [Member]
Operating Loss Carryforwards [Line Items]
Operating loss carryforwards	752	817
Tax credit carryforwards	$ 96	$ 103

INCOME TAXES (Total Gross Unrec

INCOME TAXES (Total Gross Unrecognized Tax Benefits) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]
Unrecognized Tax Benefits	$ 580	$ 373	$ 319
Decreases related to positions taken on items from prior years	(47)	(3)	(1)
Increases related to positions taken on items from prior years	53	187	52
Increases related to positions taken in the current year	46	44	18
Settlement of uncertain tax positions with tax authorities	(111)	(18)	(14)
Decreases due to expiration of statutes of limitations	0	(1)	(1)
Foreign exchange gain	(1)	(2)	0
Unrecognized Tax Benefits	520	580	373
Total unrecognized tax benefits that, if recognized, would impact the effective tax rate	520	501	285
Total amount of interest and penalties expense (benefit) recognized in "Provision for income taxes"	(27)	359	84
Total accrual for interest and penalties recognized in the consolidated balance sheets	$ 498	$ 502	$ 144

INCOME TAXES (Additional Inform

INCOME TAXES (Additional Information) (Details)	12 Months Ended
	Dec. 31, 2022
State and Local Jurisdiction
Income Tax Contingency [Line Items]
Income Tax Examination, Year under Examination	2004
Internal Revenue Service (IRS)
Income Tax Contingency [Line Items]
Income Tax Examination, Year under Examination	2007
Foreign Tax Authority
Income Tax Contingency [Line Items]
Income Tax Examination, Year under Examination	2011

EARNINGS PER SHARE Earnings Per

EARNINGS PER SHARE Earnings Per Share (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Income (loss) from continuing operations, net of tax	$ 4,640	$ 6,405	$ 1,294
Net income attributable to participating securities 1	24	32	9
Net income attributable to common stockholders	$ 4,558	$ 6,279	$ 1,216
Earnings (loss) per common share - basic	$ 6.32	$ 8.44	$ 1.64
Earnings (loss) per common share - diluted	$ 6.28	$ 8.38	$ 1.64
Weighted-average common shares outstanding - basic	721	743.6	740.5
Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements	4.6	5.4	1.8
Weighted-average common shares outstanding - diluted	725.6	749	742.3
Stock options and restricted stock units excluded from EPS calculations 1	7.6	5.8	14.2
Noncontrolling Interests
Net income attributable to noncontrolling interests - continuing operations	$ 58	$ 94	$ 69

INVENTORIES (Details)

INVENTORIES (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Inventory Disclosure [Abstract]
Finished goods	$ 4,150	$ 4,554
Work in process	1,476	1,615
Raw materials	954	822
Supplies	892	866
Total	7,472	7,857
Adjustment of inventories to the LIFO basis	(484)	(485)
Total inventories	$ 6,988	$ 7,372
Percentage of LIFO Inventory	27%	27%

PROPERTY (Schedule of Property)

PROPERTY (Schedule of Property) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Property, Plant and Equipment [Line Items]
Total property	$ 58,055	$ 57,604
Depreciation expense	1,958	2,063	$ 2,092
Capitalized interest	63	59	$ 64
Land and land improvements
Property, Plant and Equipment [Line Items]
Total property	$ 2,129	2,045
Land and land improvements | Minimum
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Estimated Useful Lives	0 years
Land and land improvements | Maximum
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Estimated Useful Lives	25 years
Buildings
Property, Plant and Equipment [Line Items]
Total property	$ 5,045	5,108
Buildings | Minimum
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Estimated Useful Lives	5 years
Buildings | Maximum
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Estimated Useful Lives	50 years
Machinery and equipment
Property, Plant and Equipment [Line Items]
Total property	$ 42,131	42,627
Machinery and equipment | Minimum
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Estimated Useful Lives	3 years
Machinery and equipment | Maximum
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Estimated Useful Lives	25 years
Other property
Property, Plant and Equipment [Line Items]
Total property	$ 6,622	6,286
Other property | Minimum
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Estimated Useful Lives	3 years
Other property | Maximum
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Estimated Useful Lives	50 years
Construction in progress
Property, Plant and Equipment [Line Items]
Total property	$ 2,128	$ 1,538

NONCONSOLIDATED AFFILIATES (Nar

NONCONSOLIDATED AFFILIATES (Narrative) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Schedule of Equity Method Investments [Line Items]
Investment in nonconsolidated affiliates	$ 1,589	$ 2,045	$ 1,327
Other noncurrent obligations	(144)	0
Net investment in nonconsolidated affiliates	1,445	2,045
Dividends from nonconsolidated affiliates	964	324	425
Packaging & Specialty Plastics [Member]
Schedule of Equity Method Investments [Line Items]
Investment in nonconsolidated affiliates	846	1,230	661
Industrial Intermediates & Infrastructure [Member]
Schedule of Equity Method Investments [Line Items]
Investment in nonconsolidated affiliates	454	670	$ 531
Exclusive of additional differences for EQUATE, Sadara and AFSI [Member]
Schedule of Equity Method Investments [Line Items]
Equity Method Investment, Difference Between Carrying Amount and Underlying Equity	55	55
Sadara Chemical Company
Schedule of Equity Method Investments [Line Items]
Investment in nonconsolidated affiliates	322
Other noncurrent obligations		416
Equity Method Investment, Difference Between Carrying Amount and Underlying Equity	$ 1,464	$ 1,541
Ownership percentage	35%	35%	35%
Related Party Transaction, Due from (to) Related Party			$ 333
Sadara Chemical Company | Equity Method Investee
Schedule of Equity Method Investments [Line Items]
Noncurrent receivables, Balance Due From Nonconsolidated Affiliates	$ 0	$ 0
EQUATE Petrochemical Company K.S.C.
Schedule of Equity Method Investments [Line Items]
Investment in nonconsolidated affiliates	144
Other noncurrent obligations		115
Equity Method Investment, Difference Between Carrying Amount and Underlying Equity	$ 447	$ 458
Ownership percentage	42.50%	42.50%	42.50%
Equity Method Investment, Difference Between Carrying Amount and Underlying Equity, Portion Amortized Over Remaining Useful Life	$ 126	$ 140
AgroFresh
Schedule of Equity Method Investments [Line Items]
Investment in nonconsolidated affiliates	0	0
Equity Method Investment, Difference Between Carrying Amount and Underlying Equity	$ 72	$ 96
Ownership percentage	40%	40%

NONCONSOLIDATED AFFILIATES (Imp

NONCONSOLIDATED AFFILIATES (Impact of Sales to Nonconsolidated Affiliates) (Details) - Equity Method Investee	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
MEGlobal | Customer Concentration Risk | Revenue Benchmark
Schedule of Equity Method Investments [Line Items]
Concentration Risk, Percentage	1%	1%	1%
MEGlobal | Customer Concentration Risk | Packaging & Specialty Plastics [Member] | Revenue, Segment Benchmark
Schedule of Equity Method Investments [Line Items]
Concentration Risk, Percentage	2%	2%	2%
MEGlobal | Customer Concentration Risk | Industrial Intermediates & Infrastructure [Member] | Revenue, Segment Benchmark
Schedule of Equity Method Investments [Line Items]
Concentration Risk, Percentage	1%	1%	1%
Sadara Chemical Company | Supplier Concentration Risk | Cost of Goods and Service Benchmark
Schedule of Equity Method Investments [Line Items]
Concentration Risk, Percentage	7%	9%	8%
SCG-Dow Group | Supplier Concentration Risk | Cost of Goods and Service Benchmark
Schedule of Equity Method Investments [Line Items]
Concentration Risk, Percentage	3%	3%	3%

NONCONSOLIDATED AFFILIATES (Bal

NONCONSOLIDATED AFFILIATES (Balances Due To or Due From Nonconsolidated Affiliates) (Details) - Equity Method Investee - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Schedule of Equity Method Investments [Line Items]
Accounts and notes receivable - Other	$ 307	$ 357
Accounts payable - Other	$ 1,083	$ 1,611

NONCONSOLIDATED AFFILIATES (Sch

NONCONSOLIDATED AFFILIATES (Schedule of the Company's Direct or Indirect Ownership Interest in Principal Nonconsolidated Affiliates) (Details) $ in Millions	12 Months Ended
	Dec. 31, 2022 USD ($) jointventures	Dec. 31, 2021 USD ($) jointventures	Dec. 31, 2020 USD ($)
Schedule of Equity Method Investments [Line Items]
Equity Method Investment, Ownership Interest, Number of Affiliates | jointventures	37	37
Investment in nonconsolidated affiliates	$ 1,589	$ 2,045	$ 1,327
Other noncurrent obligations	(144)	0
Net investment in nonconsolidated affiliates	1,445	2,045
Equity in earnings (losses) of nonconsolidated affiliates	268	975	$ (18)
Principal Nonconsolidated Affiliates Noncurrent Obligations
Schedule of Equity Method Investments [Line Items]
Other noncurrent obligations	(144)	0
Net Investment of Principal Nonconsolidated Affiliates
Schedule of Equity Method Investments [Line Items]
Net investment in nonconsolidated affiliates	$ 972	$ 1,621
EQUATE Petrochemical Company K.S.C.
Schedule of Equity Method Investments [Line Items]
Ownership percentage	42.50%	42.50%	42.50%
Investment in nonconsolidated affiliates	$ 144
Other noncurrent obligations		$ 115
The Kuwait Olefins Company K.S.C.
Schedule of Equity Method Investments [Line Items]
Ownership percentage	42.50%	42.50%	42.50%
The Kuwait Styrene Company KSC
Schedule of Equity Method Investments [Line Items]
Ownership percentage	42.50%	42.50%	42.50%
Map Ta Phut Olefins Company
Schedule of Equity Method Investments [Line Items]
Ownership percentage	32.77%	32.77%	32.77%
Equity Method Investment, Ownership Percentage, Direct	20.27%
Equity Method Investment, Ownership Percentage, Indirect	12.50%
Sadara Chemical Company
Schedule of Equity Method Investments [Line Items]
Ownership percentage	35%	35%	35%
Investment in nonconsolidated affiliates	$ 322
Other noncurrent obligations		$ 416
Siam Polyethylene Company Limited
Schedule of Equity Method Investments [Line Items]
Ownership percentage	50%	50%	50%
Siam Polystyrene Company Limited
Schedule of Equity Method Investments [Line Items]
Ownership percentage	50%	50%	50%
Siam Styrene Monomer Company Limited
Schedule of Equity Method Investments [Line Items]
Ownership percentage	50%	50%	50%
Siam Synthetic Latex Company Limited
Schedule of Equity Method Investments [Line Items]
Ownership percentage	50%	50%	50%
Principal Nonconsolidated Affiliates
Schedule of Equity Method Investments [Line Items]
Investment in nonconsolidated affiliates	$ 1,116	$ 1,621
Equity in earnings (losses) of nonconsolidated affiliates	$ 192	$ 918	$ (16)

NONCONSOLIDATED AFFILIATES (Sum

NONCONSOLIDATED AFFILIATES (Summarized Financial Information) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Schedule of Equity Method Investments [Line Items]
Percent of principal nonconsolidated entities financial information which is presented	100%
Total current assets	$ 20,477	$ 20,848
Total Assets	60,603	62,990	$ 61,470
Total current liabilities	11,331	13,226
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	4,640	6,405	1,294
Principal Nonconsolidated Affiliates
Schedule of Equity Method Investments [Line Items]
Total current assets	6,241	8,158
Assets, Noncurrent	22,526	23,681
Total Assets	28,767	31,839
Total current liabilities	3,754	3,990
Liabilities, Noncurrent	18,999	20,039
Liabilities	22,753	24,029
Noncontrolling interests	223	174
Revenues	14,026	14,969	9,470
Gross margin	1,246	3,219	619
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$ (91)	$ 2,013	$ (461)

GOODWILL AND OTHER INTANGIBLE_3

GOODWILL AND OTHER INTANGIBLE ASSETS (Schedule of Goodwill) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Goodwill [Roll Forward]
Net goodwill, beginning balance	$ 8,764	$ 8,908
Foreign currency impact	(120)	(144)
Net goodwill, ending balance	8,644	8,764
Packaging & Specialty Plastics [Member]
Goodwill [Roll Forward]
Net goodwill, beginning balance	5,105	5,115
Foreign currency impact	(5)	(10)
Net goodwill, ending balance	5,100	5,105
Industrial Intermediates & Infrastructure [Member]
Goodwill [Roll Forward]
Net goodwill, beginning balance	1,096	1,100
Foreign currency impact	(3)	(4)
Net goodwill, ending balance	1,093	1,096
Performance Materials & Coatings [Member]
Goodwill [Roll Forward]
Net goodwill, beginning balance	2,563	2,693
Foreign currency impact	(112)	(130)
Net goodwill, ending balance	$ 2,451	$ 2,563

GOODWILL AND OTHER INTANGIBLE_4

GOODWILL AND OTHER INTANGIBLE ASSETS (Annual Goodwill Impairment Test) (Details) $ in Millions	12 Months Ended
	Dec. 31, 2022 USD ($) ReportingUnits	Dec. 31, 2021 USD ($) ReportingUnits	Dec. 31, 2020 USD ($) ReportingUnits
Goodwill [Line Items]
Number of Reporting Units, Quantitative Testing | ReportingUnits	0	0	1
Goodwill	$ 8,644	$ 8,764	$ 8,908
Industrial Intermediates & Infrastructure [Member]
Goodwill [Line Items]
Goodwill, Impaired, Accumulated Impairment Loss	309	309
Goodwill	1,093	1,096	1,100
Performance Materials & Coatings [Member]
Goodwill [Line Items]
Goodwill, Impaired, Accumulated Impairment Loss	2,530	2,530
Goodwill	$ 2,451	$ 2,563	$ 2,693

GOODWILL AND OTHER INTANGIBLE_5

GOODWILL AND OTHER INTANGIBLE ASSETS (Other Intangible Assets) (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Other Intangible Assets [Line Items]
Other Intangible Assets, Accumulated Amortization	$ (5,022)	$ (4,725)
Intangible Assets, Gross (Excluding Goodwill)	7,464	7,606
Other intangible assets	2,442	2,881
In Process Research and Development [Member]
Other Intangible Assets [Line Items]
Indefinite-lived Intangible Assets (Excluding Goodwill)	17	17
Developed technology 1
Other Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross	2,651	2,654
Other Intangible Assets, Accumulated Amortization	(2,025)	(1,871)
Finite-Lived Intangible Assets, Net	626	783
Software
Other Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross	1,358	1,396
Other Intangible Assets, Accumulated Amortization	(962)	(945)
Finite-Lived Intangible Assets, Net	396	451
Trademarks/tradenames
Other Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross	352	352
Other Intangible Assets, Accumulated Amortization	(345)	(344)
Finite-Lived Intangible Assets, Net	7	8
Customer-related
Other Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross	3,103	3,204
Other Intangible Assets, Accumulated Amortization	(1,690)	(1,565)
Finite-Lived Intangible Assets, Net	$ 1,413	$ 1,639

GOODWILL AND OTHER INTANGIBLE_6

GOODWILL AND OTHER INTANGIBLE ASSETS (Schedule of Amortization Expense of Intangible Assets) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Finite-Lived Intangible Assets [Line Items]
Amortization of intangibles	$ 336	$ 388	$ 401
Other intangible assets, excluding software
Finite-Lived Intangible Assets [Line Items]
Amortization of intangibles	336	388	401
Software
Finite-Lived Intangible Assets [Line Items]
Amortization of intangibles	$ 80	$ 90	$ 96

(Schedule of Future Amortizatio

(Schedule of Future Amortization Expense of Intangible Assets) (Details) $ in Millions	Dec. 31, 2022 USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
2020	$ 387
2021	368
2022	278
2023	203
2024	$ 170

TRANSFERS OF FINANCIAL ASSETS_2

TRANSFERS OF FINANCIAL ASSETS (Sale of Trade Accounts Receivable in North America and Europe) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Accounts Receivable Facility, U.S. [Member]
Trade Accounts Receivable Eligible for Sale	$ 900
Cash Flows Between Transferor and Transferee, Proceeds from New Transfers	391	$ 0
Accounts Receivable Facility, Europe [Member]
Trade Accounts Receivable Eligible for Sale	500
Cash Flows Between Transferor and Transferee, Proceeds from New Transfers	$ 391	$ 0

NOTES PAYABLE, LONG-TERM DEBT_3

NOTES PAYABLE, LONG-TERM DEBT AND AVAILABLE CREDIT FACILITIES (Schedule of Notes Payable) (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Short-term Debt [Line Items]
Total notes payable	$ 362	$ 161
Year-end average interest rates	6.55%	5.78%
Commercial paper
Short-term Debt [Line Items]
Total notes payable	$ 299	$ 0
Notes payable to banks and other lenders
Short-term Debt [Line Items]
Total notes payable	$ 63	$ 161

NOTES PAYABLE, LONG-TERM DEBT_4

NOTES PAYABLE, LONG-TERM DEBT AND AVAILABLE CREDIT FACILITIES (Schedule of Long-Term Debt) (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Debt Instrument [Line Items]
Long-term debt	$ 14,698	$ 14,280
Unamortized debt discount and issuance costs	(282)	(297)
Long-term debt due within one year	(362)	(231)
Long Term Debt, Accumulated Fair Value Adjustment	46	$ 47
Maturities of Long-term Debt [Abstract]
2022	362
2023	127
2024	388
2025	78
2026	$ 1,209
Promissory notes and debentures | Final maturity 2022
Debt Instrument [Line Items]
Weighted average rate	0%	8.64%
Long-term debt, gross	$ 0	$ 121
Promissory notes and debentures | Final maturity 2023
Debt Instrument [Line Items]
Weighted average rate	7.63%	7.63%
Long-term debt, gross	$ 250	$ 250
Promissory notes and debentures | Final maturity 2025
Debt Instrument [Line Items]
Weighted average rate	5.63%	5.63%
Long-term debt, gross	$ 333	$ 333
Promissory notes and debentures | Final maturity 2026
Debt Instrument [Line Items]
Weighted average rate	0%	3.63%
Long-term debt, gross	$ 0	$ 750
Promissory notes and debentures | Final maturity 2028 and thereafter 1
Debt Instrument [Line Items]
Weighted average rate	5.36%	5.15%
Long-term debt, gross	$ 10,864	$ 9,363
Promissory notes and debentures | Foreign currency notes and loans, various rates and maturities
Debt Instrument [Line Items]
Weighted average rate	1.16%	1.17%
Long-term debt, gross	$ 2,562	$ 2,730
Medium-term notes, varying maturities through 2049
Debt Instrument [Line Items]
Weighted average rate	3.87%	3.37%
Long-term debt, gross	$ 543	$ 392
Finance Lease Obligations
Debt Instrument [Line Items]
Long-term debt	$ 790	$ 869

NOTES PAYABLE, LONG-TERM DEBT_5

NOTES PAYABLE, LONG-TERM DEBT AND AVAILABLE CREDIT FACILITIES (Narrative) (Details) € in Millions, $ in Millions

1 Months Ended

3 Months Ended

12 Months Ended

Sep. 30, 2020 USD ($)

Aug. 31, 2020 USD ($)

Jun. 30, 2022 USD ($)

Sep. 30, 2021 USD ($)

Jun. 30, 2021 USD ($)

Sep. 30, 2020 USD ($)

Mar. 31, 2020 USD ($)

Dec. 31, 2022 USD ($)

Dec. 31, 2021 USD ($)

Dec. 31, 2020 USD ($)

Aug. 31, 2020 EUR (€)

Feb. 28, 2020 EUR (€)

Debt Instrument [Line Items]

Loss on early extinguishment of debt

$ (8)

$ (574)

$ (149)

Repayments of Long-term Debt

$ 81

121

259

134

Total notes payable

362

161

Notes payable to banks and other lenders

Debt Instrument [Line Items]

Total notes payable

63

161

Uncommitted Credit Facility [Member] | Notes payable to banks and other lenders

Debt Instrument [Line Items]

Total notes payable

$ 800

3.625 Percent Notes Due May 2026

Debt Instrument [Line Items]

Repayments of Debt

$ 750

Stated interest rate

3.625%

3.625 Percent Notes Due May 2026 | Sundry Income (Expense), Net

Debt Instrument [Line Items]

Loss on early extinguishment of debt

$ 8

Senior Unsecured Notes

Debt Instrument [Line Items]

Debt Instrument, Face Amount on Issuance

$ 1,500

Senior Unsecured Notes, 6 Point 30 Percent, Due 2033

Debt Instrument [Line Items]

Stated interest rate

6.30%

Debt Instrument, Face Amount on Issuance

$ 600

Senior Unsecured Notes, 6 Point 90 Percent, Due 2053

Debt Instrument [Line Items]

Stated interest rate

6.90%

Debt Instrument, Face Amount on Issuance

$ 900

InterNotes [Member]

Debt Instrument [Line Items]

Notes Issued

167

109

190

InterNotes redeemed

Debt Instrument [Line Items]

Repayments of Notes Payable

31

180

InterNotes redeemed, Various maturities [Member]

Debt Instrument [Line Items]

Repayments of Notes Payable

213

400

InterNotes redeemed, Various maturities [Member] | Sundry Income (Expense), Net

Debt Instrument [Line Items]

Loss on early extinguishment of debt

1

2

Long Term Debt Repayment - Variable Interest Entity

Debt Instrument [Line Items]

Repayments of Debt

$ 3

$ 25

$ 29

Three Point One Five Percent Notes Due 2024

Debt Instrument [Line Items]

Repayments of Debt

$ 208

Stated interest rate

3.15%

Three Point Five Percent Notes Due 2024

Debt Instrument [Line Items]

Repayments of Debt

$ 811

Stated interest rate

3.50%

3.15 Percent Notes Due 2024 and 3.50 Percent Notes Due 2024 | Sundry Income (Expense), Net

Debt Instrument [Line Items]

Loss on early extinguishment of debt

$ 101

Debt Securities [Member]

Debt Instrument [Line Items]

Repayments of Debt

1,042

Repayments of Long-term Debt

$ 493

Debt Securities [Member] | Sundry Income (Expense), Net

Debt Instrument [Line Items]

Loss on early extinguishment of debt

$ 472

$ 62

Euros Notes [Member]

Debt Instrument [Line Items]

Stated interest rate

1%

Debt Instrument, Face Amount on Issuance | €

€ 2,250

0.50 Percent Notes Due 2027 [Member]

Debt Instrument [Line Items]

Stated interest rate

0.50%

Debt Instrument, Face Amount on Issuance | €

€ 1,000

1.125 Percent Notes Due 2032 [Member]

Debt Instrument [Line Items]

Stated interest rate

1.125%

Debt Instrument, Face Amount on Issuance | €

€ 750

1.875 Percent Notes Due 2040 [Member]

Debt Instrument [Line Items]

Stated interest rate

1.875%

Debt Instrument, Face Amount on Issuance | €

€ 500

Term Loan Facility, Due September 2023 [Member] | Revolving Credit Facility

Debt Instrument [Line Items]

Repayments of Debt

$ 1,250

$ 750

3.0 Percent Notes Due 2022 [Member]

Debt Instrument [Line Items]

Stated interest rate

3%

Repayments of Notes Payable

$ 1,250

3.0 Percent Notes Due 2022 [Member] | Sundry Income (Expense), Net

Debt Instrument [Line Items]

Loss on early extinguishment of debt

$ 85

U.S. Dollar Notes [Member]

Debt Instrument [Line Items]

Debt Instrument, Face Amount on Issuance | €

€ 2,000

Proceeds from Issuance of Long-term Debt

$ 556

2.1 Percent Notes Due 2030 [Member]

Debt Instrument [Line Items]

Stated interest rate

2.10%

Debt Instrument, Face Amount on Issuance | €

€ 850

3.6 Percent Notes Due 2050 [Member]

Debt Instrument [Line Items]

Stated interest rate

3.60%

Debt Instrument, Face Amount on Issuance | €

€ 1,150

NOTES PAYABLE, LONG-TERM DEBT_6

NOTES PAYABLE, LONG-TERM DEBT AND AVAILABLE CREDIT FACILITIES (Schedule of Committed and Available Credit Facilities) (Details) $ in Millions	Dec. 31, 2022 USD ($)
Line of Credit Facility [Line Items]
Committed Credit	$ 8,400
Credit Available	8,400
Letters of Credit Outstanding, Amount	600
Revolving Credit Facility | Five Year Competitive Advance and Revolving Credit Facility
Line of Credit Facility [Line Items]
Committed Credit	5,000
Credit Available	5,000
Revolving Credit Facility | Bilateral Revolving Credit Facility, Due September 2023, Facility One
Line of Credit Facility [Line Items]
Committed Credit	300
Credit Available	300
Revolving Credit Facility | Bilateral Revolving Credit Facility, Due March 2025, Facility One
Line of Credit Facility [Line Items]
Committed Credit	100
Credit Available	100
Revolving Credit Facility | Bilateral Revolving Credit Facility, Due March 2025, Facility Two
Line of Credit Facility [Line Items]
Committed Credit	100
Credit Available	100
Revolving Credit Facility | Bilateral Revolving Credit Facility, Due March 2025, Facility Three
Line of Credit Facility [Line Items]
Committed Credit	100
Credit Available	100
Revolving Credit Facility | Bilateral Revolving Credit Facility, Due March 2026
Line of Credit Facility [Line Items]
Committed Credit	100
Credit Available	100
Revolving Credit Facility | Bilateral Revolving Credit Facility, Due May 2027
Line of Credit Facility [Line Items]
Committed Credit	100
Credit Available	100
Revolving Credit Facility | Bilateral Revolving Credit Facility, Due June 2027
Line of Credit Facility [Line Items]
Committed Credit	350
Credit Available	350
Revolving Credit Facility | Bilateral Revolving Credit Facility, Due September 2027
Line of Credit Facility [Line Items]
Committed Credit	200
Credit Available	200
Revolving Credit Facility | Bilateral Revolving Credit Facility, Due November 2023
Line of Credit Facility [Line Items]
Committed Credit	500
Credit Available	500
Revolving Credit Facility | Bilateral Revolving Credit Facility, Due September 2025, Facility One
Line of Credit Facility [Line Items]
Committed Credit	200
Credit Available	200
Revolving Credit Facility | Bilateral Revolving Credit Facility, Due September 2025, Facility Two
Line of Credit Facility [Line Items]
Committed Credit	250
Credit Available	250
Revolving Credit Facility | Bilateral Revolving Credit Facility, Due November 2025
Line of Credit Facility [Line Items]
Committed Credit	300
Credit Available	300
Revolving Credit Facility | Bilateral Revolving Credit Facility, Due November 2026, Facility One
Line of Credit Facility [Line Items]
Committed Credit	150
Credit Available	150
Revolving Credit Facility | Bilateral Revolving Credit Facility, Due November 2026, Facility Two
Line of Credit Facility [Line Items]
Committed Credit	200
Credit Available	200
Revolving Credit Facility | Bilateral Revolving Credit Facility, Due March 2027
Line of Credit Facility [Line Items]
Committed Credit	250
Credit Available	250
Revolving Credit Facility | Bilateral Revolving Credit Facility, Due October 2027
Line of Credit Facility [Line Items]
Committed Credit	100
Credit Available	100
Revolving Credit Facility | Bilateral Revolving Credit Facility, Due November 2027
Line of Credit Facility [Line Items]
Committed Credit	100
Credit Available	$ 100

NOTES PAYABLE, LONG-TERM DEBT_7

NOTES PAYABLE, LONG-TERM DEBT AND AVAILABLE CREDIT FACILITIES (Debt Covenants) (Details) $ in Millions	12 Months Ended
	Dec. 31, 2022 USD ($)
The Dow Chemical Company
Debt Instrument [Line Items]
Amount at which a failure to pay results in repayment acceleration	$ 100
Amount of principal to be accelerated upon default	400
Amount of judgment which will cause a default	$ 400
The Dow Chemical Company | Revolving Credit Facility | Five Year Competitive Advance and Revolving Credit Facility
Debt Instrument [Line Items]
Ratio of total indebtedness to total capitalization	0.70
Aggregate amount outstanding to trigger indebtedness to total capitalization covenant	$ 500
Dow Inc. [Member]
Debt Instrument [Line Items]
Debt Instrument, Debt Default, Default Trigger, Amount Guaranteed for Third Party Indebtedness for Borrowed Money	$ 250

COMMITMENTS AND CONTINGENCIES_3

COMMITMENTS AND CONTINGENCIES (Environmental Matters) (Details) - USD ($) $ in Millions	3 Months Ended			12 Months Ended
	Dec. 31, 2020	Dec. 31, 2020	Sep. 30, 2020	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Accrual for Environmental Loss Contingencies [Roll Forward]
Accrual adjustment				$ 184	$ 159
Payments against reserve				(204)	(162)
Foreign currency impact				(8)	(21)
Capital expenditures for environmental protection				137	65	$ 80
Restructuring and asset related charges - net				$ 118	$ 6	$ 708
Environmental Remediation Expense, Statement of Income or Comprehensive Income [Extensible Enumeration]				Cost of sales	Cost of sales	Cost of sales
Performance Materials & Coatings [Member]
Accrual for Environmental Loss Contingencies [Roll Forward]
Restructuring and asset related charges - net				$ 6	$ 10	$ 192
Corporate Segment [Member]
Accrual for Environmental Loss Contingencies [Roll Forward]
Restructuring and asset related charges - net				31	13	464
2020 Restructuring Program [Member]
Accrual for Environmental Loss Contingencies [Roll Forward]
Restructuring and asset related charges - net		$ 573	$ 575
2020 Restructuring Program [Member] | Performance Materials & Coatings [Member]
Accrual for Environmental Loss Contingencies [Roll Forward]
Restructuring and asset related charges - net		177
2020 Restructuring Program [Member] | Corporate Segment [Member]
Accrual for Environmental Loss Contingencies [Roll Forward]
Restructuring and asset related charges - net		363
Costs Associated with Exit and Disposal Activities [Member] | 2020 Restructuring Program [Member]
Accrual for Environmental Loss Contingencies [Roll Forward]
Restructuring and asset related charges - net		80	81
Costs Associated with Exit and Disposal Activities [Member] | 2020 Restructuring Program [Member] | Performance Materials & Coatings [Member]
Accrual for Environmental Loss Contingencies [Roll Forward]
Restructuring and asset related charges - net		61
Costs Associated with Exit and Disposal Activities [Member] | 2020 Restructuring Program [Member] | Corporate Segment [Member]
Accrual for Environmental Loss Contingencies [Roll Forward]
Restructuring and asset related charges - net		19
Environmental Remediation [Member] | Costs Associated with Exit and Disposal Activities [Member] | 2020 Restructuring Program [Member]
Accrual for Environmental Loss Contingencies [Roll Forward]
Restructuring and asset related charges - net		56
Environmental Remediation [Member] | Costs Associated with Exit and Disposal Activities [Member] | 2020 Restructuring Program [Member] | Performance Materials & Coatings [Member]
Accrual for Environmental Loss Contingencies [Roll Forward]
Restructuring and asset related charges - net		52
Environmental Remediation [Member] | Costs Associated with Exit and Disposal Activities [Member] | 2020 Restructuring Program [Member] | Corporate Segment [Member]
Accrual for Environmental Loss Contingencies [Roll Forward]
Restructuring and asset related charges - net		4
Tittabawassee and Saginaw Rivers, Saginaw Bay [Member]
Site Contingency [Line Items]
Accrued obligations for environmental matters					77
Accrual for Environmental Loss Contingencies [Roll Forward]
Balance at Jan 1				77
Balance at Dec 31					77
Payments for Legal Settlements	$ 15
Tittabawassee and Saginaw Rivers, Saginaw Bay - Local Projects [Member]
Accrual for Environmental Loss Contingencies [Roll Forward]
Payments for Legal Settlements	7
Other Environmental Matters
Site Contingency [Line Items]
Accrued obligations for environmental matters				1,192	1,220
Accrual for Environmental Loss Contingencies [Roll Forward]
Balance at Jan 1				1,220
Balance at Dec 31				1,192	1,220
Environmental Loss Contingency Statement Of Financial Position Extensible Enumeration Not Disclosed Flag	$ 1,244	$ 1,244		1,192	1,220	$ 1,244
Other Environmental Matters | Superfund Sites
Site Contingency [Line Items]
Accrued obligations for environmental matters				244	237
Accrual for Environmental Loss Contingencies [Roll Forward]
Balance at Jan 1				237
Balance at Dec 31				244	237
Other Environmental Matters, Off-Site Matters
Site Contingency [Line Items]
Accrued obligations for environmental matters				92	104
Accrual for Environmental Loss Contingencies [Roll Forward]
Balance at Jan 1				104
Balance at Dec 31				92	104
Dow Silicones Corporation
Site Contingency [Line Items]
Indemnification asset				$ 98	$ 95
Dow Silicones Corporation | Environmental Issue [Member]
Site Contingency [Line Items]
Indemnification asset			$ 50

COMMITMENTS AND CONTINGENCIES_4

COMMITMENTS AND CONTINGENCIES (Asbestos-Related Matters of Union Carbide Corporation) (Details) - Union Carbide Corporation - Asbestos Related Matters - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Loss Contingencies [Line Items]
Liability for asbestos-related pending and future claims	$ 947	$ 1,016
Percentage of recorded asbestos liability related to pending claims	23%	25%
Percentage of recorded asbestos liability related to future claims	77%	75%

COMMITMENTS AND CONTINGENCIES_5

COMMITMENTS AND CONTINGENCIES (Dow Silicones Chapter 11 Related Matters) (Details) - Dow Silicones Corporation - USD ($) $ in Millions	Jun. 01, 2016	Dec. 31, 2022	Dec. 31, 2021
Loss Contingencies [Line Items]
Indemnification asset		$ 98	$ 95
Indemnification percentage	50%
Between May 31, 2018 and May 31, 2023
Loss Contingencies [Line Items]
Indemnification loss cap	$ 1,000
After May 31, 2023
Loss Contingencies [Line Items]
Indemnification loss cap	$ 0
Breast Implant and Other Products Liability Claims
Loss Contingencies [Line Items]
Payments for product liabilities		1,846
Product liability		$ 16	$ 130

COMMITMENTS AND CONTINGENCIES_6

COMMITMENTS AND CONTINGENCIES (Dow v Nova & Luxi) (Details) $ in Millions, $ in Millions

3 Months Ended

12 Months Ended

Mar. 31, 2020 USD ($)

Jul. 06, 2017 USD ($)

Jun. 29, 2017 USD ($)

Jun. 29, 2017 CAD ($)

Dec. 31, 2022 USD ($)

Sep. 30, 2022 USD ($)

Dec. 31, 2020 USD ($)

Jun. 30, 2020 USD ($)

Dec. 31, 2019 USD ($)

Dec. 31, 2019 CAD ($)

Sep. 30, 2019 USD ($)

Sep. 30, 2019 CAD ($)

Jun. 30, 2017 USD ($)

Dec. 31, 2022 USD ($)

Dec. 31, 2021 USD ($)

Dec. 31, 2020 USD ($)

Loss Contingencies [Line Items]

Gain (loss) related to litigation settlement

$ 381

$ 54

$ 544

Packaging & Specialty Plastics [Member]

Loss Contingencies [Line Items]

Gain (loss) related to litigation settlement

321

0

$ 544

Dow V. Nova Chemicals Corporation Patent Infringement Matter

Loss Contingencies [Line Items]

Settlement amount

$ 495

$ 645

Proceeds from settlements

$ 501

Gain (loss) related to litigation settlement

$ 341

Dow V. Nova Chemicals Corporation Patent Infringement Matter | Accrued and Other Current Liabilities [Member]

Loss Contingencies [Line Items]

Estimated Litigation Liability, Current

0

0

341

Dow V. Nova Chemicals Corporation Patent Infringement Matter | Sundry Income (Expense), Net

Loss Contingencies [Line Items]

Gain (loss) related to litigation settlement

321

Dow V. Nova Chemicals Corporation Patent Infringement Matter | Selling, General and Administrative Expenses

Loss Contingencies [Line Items]

Gain (loss) related to litigation settlement

20

Dow V. Nova Chemicals Corporation Patent Infringement Matter | Packaging & Specialty Plastics [Member]

Loss Contingencies [Line Items]

Gain (loss) related to litigation settlement

$ 160

Dow V. Nova Chemicals Corporation Ethylene Asset Matter [Member] [Member]

Loss Contingencies [Line Items]

Settlement amount

$ 1,080

$ 1,430

Proceeds from settlements

$ 259

$ 800

$ 1,080

Gain (loss) related to litigation settlement

$ 552

$ 18

$ 186

Litigation settlement, Amount Awarded from Other Party - Withholding Tax

$ 347

Estimated liability

$ 323

$ 323

$ 323

Dow V. Nova Chemicals Corporation Ethylene Asset Matter [Member] [Member] | Sundry Income (Expense), Net

Loss Contingencies [Line Items]

Gain (loss) related to litigation settlement

538

6

Dow V. Nova Chemicals Corporation Ethylene Asset Matter [Member] [Member] | Selling, General and Administrative Expenses

Loss Contingencies [Line Items]

Gain (loss) related to litigation settlement

$ 14

$ 12

Luxi Chemical Group Breach of Contract Matter | Sundry Income (Expense), Net

Loss Contingencies [Line Items]

Gain (loss) related to litigation settlement

$ 54

Commitment and Contingencies (B

Commitment and Contingencies (Brazil Tax Credits) (Details) - Dow V. Brazil - Excess PIS/COFINS Taxes - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Gain Contingencies [Line Items]
Gain on Indirect Tax Contingencies Realized	$ 112	$ 67
Other Assets	$ 126	$ 52

COMMITMENTS AND CONTINGENCIES_7

COMMITMENTS AND CONTINGENCIES (Guarantees) (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Sadara Chemical Company
Guarantees [Abstract]
Ownership interest	35%	35%	35%
Sadara Chemical Company | Total Project Financing
Guarantees [Abstract]
Maximum future payments	$ 393	$ 446
Guarantees
Guarantees [Abstract]
Maximum future payments	1,236	1,273
Recorded liability	$ 200	220
Guarantees | Sadara Chemical Company | Sadara Chemical Company
Guarantees [Abstract]
Maximum future payments		500
Guarantees | Sadara Chemical Company | Sadara Chemical Company
Guarantees [Abstract]
Maximum future payments		$ 1,300

COMMITMENTS AND CONTINGENCIES_8

COMMITMENTS AND CONTINGENCIES (Asset Retirement Obligations) (Details) $ in Millions	12 Months Ended
	Dec. 31, 2022 USD ($) wells brinesandwells manufacturingsites countries	Dec. 31, 2021 USD ($)
Commitments and Contingencies Disclosure [Abstract]
Number of Manufacturing Sites | manufacturingsites	104
Number of Countries With Manufacturing Sites | countries	31
Conditional Asset Retirement Obligations Carrying Value	$ 11	$ 13
Asset Retirement Obligation, Roll Forward Analysis [Roll Forward]
Balance at Jan 1	118	112
Additional accruals	14	13
Liabilities settled	(8)	(7)
Accretion expense	2	1
Revisions in estimated cash flows	(9)	(1)
Asset Retirement Obligation Other Activity	2	0
Balance at Dec 31	$ 119	$ 118
Asset retirement obligation discount rate	5.53%	1.13%
Number of underground storage wells without conditional asset retirement obligation | wells	35
Number of underground brine, mining and other wells without conditional asset retirement obligation | brinesandwells	129

LEASES (Details)

LEASES (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Operating Lease, Cost	$ 397	$ 494	$ 484
Amortization of right-of-use assets - finance	105	76	58
Interest on lease liabilities - finance	32	27	25
Total finance lease cost	137	103	83
Short-term lease cost	255	238	213
Variable lease cost	611	381	199
Sublease income	(10)	(6)	(5)
Total lease cost	1,390	1,210	974
Operating cash flows for operating leases	393	497	482
Operating cash flows for finance leases	32	27	25
Financing cash flows for finance leases	114	74	58
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability	(151)	(25)	(185)
Right-of-Use Asset Obtained in Exchange for Finance Lease Liability	62	512	178
Operating lease right-of-use assets	1,227	1,412
Total Lease Assets	1,953	2,202
Operating lease liabilities - current	287	314
Operating lease liabilities - noncurrent	997	1,149
Total Lease Liabilities	2,074	2,332
Payments to Acquire Equipment on Lease	$ 7	$ 694	$ 5
Weighted-average remaining lease term - Operating leases	7 years 7 months 6 days	7 years 10 months 24 days
Weighted-average remaining lease term - Finance leases	11 years	11 years 9 months 18 days
Weighted-average discount rate - Operating leases	4.49%	3.72%
Weighted-average discount rate - Finance leases	4.29%	4.17%
Lessee, Operating Lease, Liability, to be Paid, Year One	$ 333
Finance Lease, Liability, to be Paid, Year One	138
Lessee, Operating Lease, Liability, to be Paid, Year Two	253
Finance Lease, Liability, Payments, Due Year Two	153
Lessee, Operating Lease, Liability, Payments, Due Year Three	199
Finance Lease, Liability, Payments, Due Year Three	78
Lessee, Operating Lease, Liability, Payments, Due Year Four	160
Finance Lease, Liability, Payments, Due Year Four	70
Lessee, Operating Lease, Liability, Payments, Due Year Five	129
Finance Lease, Liability, Payments, Due Year Five	64
Lessee, Operating Lease, Liability, Payments, Due after Year Five	470
Finance Lease, Liability, Payments, Due after Year Five	487
Lessee, Operating Lease, Liability, Payments, Due	1,544
Finance Lease, Liability, Payment, Due	990
Lessee, Operating Lease, Liability, Undiscounted Excess Amount	260
Finance Lease, Liability, Undiscounted Excess Amount	200
Lease liability	1,284
Finance Lease, Liability	790
Lessee, Additional Leases Not yet Commenced, Assumptions and Judgment, Amount	$ 142
Lessee, Additional Leases Not yet Commenced, Term of Contract	16 years
Lease Buy-Outs
Payments to Acquire Equipment on Lease		$ 687
Increase (Decrease) Operating Lease, Right-of-Use Asset		(166)
Increase (Decrease) Operating Lease, Liability, Current		(44)
Increase (Decrease) Operating Lease, Liability, Noncurrent		(158)
Gain (Loss) on Termination of Lease		(37)
Lease Contract Amendments
Increase (Decrease) Right-of-Use Asset Obtained in Exchange for Operating Lease Liability		(193)
Increase (Decrease) Operating Lease, Liability, Current		(34)
Increase (Decrease) Operating Lease, Liability, Noncurrent		(73)
Increase (Decrease) Finance Lease, Liability, Noncurrent		152
Increase (Decrease) Finance Lease, Liability, Current		(2)
Property, Plant and Equipment
Finance Lease, Right-of-Use Asset, before Accumulated Amortization	$ 1,167	1,158
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment
Finance Lease, Right-of-Use Asset, Accumulated Amortization	441	368
Long-term Debt Due Within One Year
Finance Lease, Liability	109	106
Long-Term Debt and Lease Obligations
Finance Lease, Liability	681	763
Residual Value Guarantees
Recorded liability	0	0
Maximum future payments	$ 258	$ 280
Maximum
Lessee, Operating and Finance Leases, Remaining Lease Term	53 years

STOCKHOLDERS' EQUITY (Common St

STOCKHOLDERS' EQUITY (Common Stock) (Details) - shares shares in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Non-Employee Directors | Common Stock
Class of Stock [Line Items]
Stock Issued During Period, Shares, Employee Stock Purchase Plans	7,500	8,200	4,800

STOCKHOLDERS' EQUITY (Retained

STOCKHOLDERS' EQUITY (Retained Earnings) (Details) - USD ($) $ / shares in Units, $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Dividends declared (in dollars per share)	$ 2.80	$ 2.80	$ 2.80
Undistributed Earnings of Nonconsolidated Affiliates	$ 669	$ 1,155
The Dow Chemical Company | Dow Inc. [Member]
Dividends declared and paid	$ 4,375	$ 3,264	$ 2,233

STOCKHOLDERS' EQUITY (Employee

STOCKHOLDERS' EQUITY (Employee Stock Ownership Plan) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Dow ESOP
Employee Stock Ownership Plan (ESOP) Disclosures [Line Items]
ESOP, compensation expense	$ 31	$ 77	$ 72

STOCKHOLDERS' EQUITY (Treasury

STOCKHOLDERS' EQUITY (Treasury Stock) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Apr. 13, 2022	Apr. 01, 2019
Equity, Class of Treasury Stock [Line Items]
Treasury Stock Reissued	1,499,610	0	0
Share buy-back program authorized amount				$ 3,000	$ 3,000
Stock Repurchase Program, Remaining Authorized Repurchase Amount	$ 2,000
Treasury Stock, Common
Equity, Class of Treasury Stock [Line Items]
Treasury Stock, Value, Acquired, Cost Method	2,325	$ 1,000	$ 125
Compensation Expense, Excluding Cost of Good and Service Sold	$ 94
Stock Issued During Period, Shares, Treasury Stock Reissued - compensation and benefit plans	1,500,000
Treasury Stock, Value, Acquired, Cost Method	$ 2,325	$ 1,000	$ 125
Compensation Expense, Excluding Cost of Good and Service Sold	$ 94
Stock Issued During Period, Shares, Treasury Stock Reissued - compensation and benefit plans	1,500,000

STOCKHOLDERS' EQUITY (Shares of

STOCKHOLDERS' EQUITY (Shares of Dow Common Stock) (Details) - shares	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Schedule of Common Stock and Treasury Stock Outstanding Roll Forward [Line Items]
Issued (in shares)	7,451,643	8,233,684	4,764,554
Treasury Stock Reissued	(1,499,610)	0	0
Treasury Stock, Common, Shares	66,798,605	29,011,573
Issued
Schedule of Common Stock and Treasury Stock Outstanding Roll Forward [Line Items]
Shares, Outstanding	771,678,525	764,226,882	755,993,198	751,228,644
Treasury Stock, Common
Schedule of Common Stock and Treasury Stock Outstanding Roll Forward [Line Items]
Repurchased	39,286,642	16,208,270	3,073,469
Treasury Stock, Common, Shares	66,798,605	29,011,573	12,803,303	9,729,834

STOCKHOLDERS' EQUITY (Accumulat

STOCKHOLDERS' EQUITY (Accumulated Other Comprehensive Loss) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning Balance	$ (8,977)	$ (10,855)
Total other comprehensive income (loss)	1,838	1,878	$ (609)
Ending Balance	(7,139)	(8,977)	(10,855)
Unrealized Gains (Losses) on Investments
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning Balance	59	104	64
Other Comprehensive Income (Loss), before Reclassifications, before Tax	(326)	(21)	104
Other Comprehensive Income (Loss) before Reclassifications, Tax	13	5	(23)
Other comprehensive income (loss) before reclassifications	(313)	(16)	81
Total other comprehensive income (loss)	(312)	(45)	40
Ending Balance	(253)	59	104
Cumulative Translation Adj
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning Balance	(1,355)	(930)	(1,135)
Other Comprehensive Income (Loss), before Reclassifications, before Tax	(557)	(375)	227
Other Comprehensive Income (Loss) before Reclassifications, Tax	24	(40)	25
Other comprehensive income (loss) before reclassifications	(533)	(415)	252
Total other comprehensive income (loss)	(579)	(425)	205
Ending Balance	(1,934)	(1,355)	(930)
Pension and Other Postretire Benefits
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning Balance	(7,334)	(9,559)	(8,781)
Other Comprehensive Income (Loss), before Reclassifications, before Tax	2,611	2,094	(1,769)
Other Comprehensive Income (Loss) before Reclassifications, Tax	(630)	(464)	411
Other comprehensive income (loss) before reclassifications	1,981	1,630	(1,358)
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax	622	776	753
Reclassification from AOCI, Current Period, Tax	(146)	(181)	(173)
Amounts reclassified from accumulated other comprehensive income (loss)	476	595	580
Total other comprehensive income (loss)	2,457	2,225	(778)
Ending Balance	(4,877)	(7,334)	(9,559)
Derivative Instruments
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning Balance	(347)	(470)	(394)
Other Comprehensive Income (Loss), before Reclassifications, before Tax	638	155	(96)
Other Comprehensive Income (Loss) before Reclassifications, Tax	(87)	3	(1)
Other comprehensive income (loss) before reclassifications	551	158	(97)
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax	(313)	(38)	30
Reclassification from AOCI, Current Period, Tax	34	3	(9)
Amounts reclassified from accumulated other comprehensive income (loss)	(279)	(35)	21
Total other comprehensive income (loss)	272	123	(76)
Ending Balance	(75)	(347)	(470)
Reclassification out of Accumulated Other Comprehensive Income [Member] | Unrealized Gains (Losses) on Investments
Accumulated Other Comprehensive Income (Loss) [Line Items]
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax	2	(38)	(54)
Reclassification from AOCI, Current Period, Tax	(1)	9	13
Amounts reclassified from accumulated other comprehensive income (loss)	1	(29)	(41)
Reclassification out of Accumulated Other Comprehensive Income [Member] | Cumulative Translation Adj
Accumulated Other Comprehensive Income (Loss) [Line Items]
Amounts reclassified from accumulated other comprehensive income (loss)	$ (46)	$ (10)	$ (47)

NONCONTROLLING INTERESTS Nonc_2

NONCONTROLLING INTERESTS Noncontrolling Interests (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]
Balance at Jan 1	$ 574	$ 570
Balance at Dec 31	529	574	$ 570
Noncontrolling Interests
Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]
Balance at Jan 1	574	570	553
Net income attributable to noncontrolling interests - continuing operations	58	94	69
Distributions to noncontrolling interests	(76)	(66)	(55)
Deconsolidation of noncontrolling interests	0	0	(7)
Cumulative translation adjustments	(28)	(25)	9
Noncontrolling Interest, Increase (Decrease) From Other Activity	1	1	1
Balance at Dec 31	529	574	570
Dividends Paid to a Joint Venture Not Included in Distributions to NCI	$ 7	$ 7	$ 7

PENSION PLANS AND OTHER POSTR_3

PENSION PLANS AND OTHER POSTRETIREMENT BENEFITS (Defined Benefit Pension Plans) (Details) - USD ($) $ in Millions	3 Months Ended	12 Months Ended
	Mar. 31, 2021	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)	$ 1,268
Increase (Decrease) in Obligation, Pension Benefits	345
Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement and Curtailment	$ 19
Pension Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)		$ 8,433	$ 820
Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement and Curtailment		0	18	$ (9)
Employer contributions		235	$ 1,219
Expected pension contributions		$ 150
Defined Benefit Plan, Assumptions Used in Calculations [Abstract]
Discount rate - benefit obligations		5.18%	2.57%	2.20%
Discount rate - net periodic costs		2.57%	2.40%	2.81%
Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Weighted-Average Interest Crediting Rate		4.19%	3.57%
Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Weighted-Average Interest Crediting Rate		3.57%	3.55%	3.51%
Rate of compensation increase - benefit obligations		4.05%	3.94%
Rate of compensation increase - net periodic costs		3.94%	3.91%	3.92%
Expected return on plan assets - net periodic costs		6.68%	6.86%	7%
UNITED STATES
Defined Benefit Plan, Assumptions Used in Calculations [Abstract]
Discount rate - benefit obligations		5.64%	3.04%
Discount rate - net periodic costs		3.04%	3.03%	3.41%
Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Weighted-Average Interest Crediting Rate		4.50%	4.50%
Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Weighted-Average Interest Crediting Rate		4.50%	4.50%	4.50%
Rate of compensation increase - benefit obligations		4.25%	4.25%
Rate of compensation increase - net periodic costs		4.25%	4.25%	4.25%
Expected return on plan assets - net periodic costs		7.95%	7.96%	7.95%

PENSION PLANS AND OTHER POSTR_4

PENSION PLANS AND OTHER POSTRETIREMENT BENEFITS (Other Postretirement Benefits) (Details) - Other Postretirement Benefit Plans	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Defined Benefit Plan Disclosure [Line Items]
Discount rate - benefit obligations	5.57%	2.85%
Discount rate - net periodic costs	2.85%	2.38%	3.19%
Health Care Cost Trend Rate Assumed for Next Year - benefit obligations	6.79%	6.50%
Health Care Cost Trend Rate Assumed for Next Year - net periodic costs	6.50%	6.75%	6.25%
Rate to which the cost trend rate is assumed to decline (the ultimate health care cost trend rate) - benefit obligations	5%	5%
Rate to which the cost trend rate is assumed to decline (the ultimate health care cost trend rate) - net periodic costs	5%	5%	5%
Defined Benefit Plan, Ultimate Health Care Cost Trend Rate to Calculate PBO, End of Year	2033	2028
Year that the Rate Reaches the Ultimate Health Care Cost Trend Rate	2028	2028	2025

PENSION PLANS AND OTHER POSTR_5

PENSION PLANS AND OTHER POSTRETIREMENT BENEFITS (Change in Projected Benefit Obligations, Plan Assets and Funded Status of All Significant Plans) (Details) - USD ($) $ in Millions	3 Months Ended	12 Months Ended
	Mar. 31, 2021	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Defined Benefit Plan, Change in Benefit Obligations [Roll Forward]
Actuarial changes in assumptions and experience	$ (1,268)
Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]
Fair value of plan assets at beginning of year		$ 28,200
Fair value of plan assets at end of year		21,200	$ 28,200
Defined Benefit Pension Plans
Defined Benefit Plan, Change in Benefit Obligations [Roll Forward]
Benefit obligations at beginning of year	35,309	32,977	35,309
Service cost		392	387	$ 399
Interest cost		680	594	767
Plan participants' contributions		12	10
Actuarial changes in assumptions and experience		(8,433)	(820)
Benefits paid		(1,539)	(1,582)
Plan amendments		(25)	2
Defined Benefit Plan Business Combinations And Acquisitions Divestiture Other Benefit Obligation		(602)	8
Effect of foreign exchange rates		(600)	(545)
Termination Benefits/curtailment cost/settlements		(1)	(386)
Benefit obligations at end of year		22,861	32,977	35,309
Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]
Fair value of plan assets at beginning of year	26,406	28,167	26,406
Actual return on plan assets		(4,556)	2,501
Employer contributions		235	1,219
Plan participants' contributions		12	10
Benefits paid		(1,539)	(1,582)
Defined Benefit Plan, Plan Assets, Increase (Decrease) for Assets Transferred to (from) Plan		(592)	10
Effect of foreign exchange rates		(496)	(397)
Fair value of plan assets at end of year		21,231	28,167	26,406
Defined Benefit Plan, Funded Status [Abstract]
Defined Benefit Plan, Funded (Unfunded) Status of Plan		(1,630)	(4,810)
Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position [Abstract]
Assets for Plan Benefits, Defined Benefit Plan		1,035	1,173
Accrued and other current liabilities		(66)	(58)
Pension and other postretirement benefits - noncurrent		(2,599)	(5,925)
Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position		(1,630)	(4,810)
Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, before Tax [Abstract]
Net loss (gain)		7,045	9,934
Prior service credit		(116)	(112)
Pretax balance in AOCL at end of year		6,929	9,822
Other Postretirement Benefit Plans
Defined Benefit Plan, Change in Benefit Obligations [Roll Forward]
Benefit obligations at beginning of year	1,464	1,251	1,464
Service cost		6	7	7
Interest cost		26	23	40
Plan participants' contributions		0	0
Actuarial changes in assumptions and experience		(318)	(98)
Benefits paid		(67)	(141)
Plan amendments		0	0
Defined Benefit Plan Business Combinations And Acquisitions Divestiture Other Benefit Obligation		0	0
Effect of foreign exchange rates		(5)	(4)
Termination Benefits/curtailment cost/settlements		0	0
Benefit obligations at end of year		893	1,251	1,464
Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]
Fair value of plan assets at beginning of year	$ 0	0	0
Actual return on plan assets		0	0
Employer contributions		0	0
Plan participants' contributions		0	0
Benefits paid		0	0
Defined Benefit Plan, Plan Assets, Increase (Decrease) for Assets Transferred to (from) Plan		0	0
Effect of foreign exchange rates		0	0
Fair value of plan assets at end of year		0	0	$ 0
Defined Benefit Plan, Funded Status [Abstract]
Defined Benefit Plan, Funded (Unfunded) Status of Plan		(893)	(1,251)
Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position [Abstract]
Assets for Plan Benefits, Defined Benefit Plan		0	0
Accrued and other current liabilities		(88)	(99)
Pension and other postretirement benefits - noncurrent		(805)	(1,152)
Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position		(893)	(1,251)
Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, before Tax [Abstract]
Net loss (gain)		(523)	(221)
Prior service credit		0	0
Pretax balance in AOCL at end of year		(523)	(221)
UNITED STATES
Defined Benefit Plan, Funded Status [Abstract]
Defined Benefit Plan, Funded (Unfunded) Status of Plan		(545)	(2,585)
Non-US [Member]
Defined Benefit Plan, Funded Status [Abstract]
Defined Benefit Plan, Funded (Unfunded) Status of Plan		(473)	(1,467)
Pension Plan, Excluding Plans with Plan Assets
Defined Benefit Plan, Funded Status [Abstract]
Defined Benefit Plan, Funded (Unfunded) Status of Plan		(612)	(758)
Other Postretirement Benefit Plans, Excluding Plans with Plan Assets
Defined Benefit Plan, Funded Status [Abstract]
Defined Benefit Plan, Funded (Unfunded) Status of Plan		$ (893)	$ (1,251)

PENSION PLANS AND OTHER POSTR_6

PENSION PLANS AND OTHER POSTRETIREMENT BENEFITS (Accum Benefit Obligations in Excess) (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Retirement Benefits [Abstract]
Defined Benefit Plan, Accumulated Benefit Obligation	$ 22,600	$ 32,500
Accumulated benefit obligations	18,300	27,052
Fair value of plan assets	$ 15,723	$ 21,385

PENSION PLANS AND OTHER POSTR_7

PENSION PLANS AND OTHER POSTRETIREMENT BENEFITS (Projected Benefit Obligations in Excess) (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Retirement Benefits [Abstract]
Projected benefit obligations	$ 18,388	$ 27,367
Defined Benefit Plan, Pension Plan with Projected Benefit Obligation in Excess of Plan Assets, Plan Assets	$ 15,723	$ 21,385

PENSION PLANS AND OTHER POSTR_8

PENSION PLANS AND OTHER POSTRETIREMENT BENEFITS (Net Periodic Benefit Cost and Other Changes in Plan Assets and Benefit Obligations Recognized in Other Comprehensive Income for All Significant Plans) (Details) - USD ($) $ in Millions	3 Months Ended	12 Months Ended
	Mar. 31, 2021	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement and Curtailment	$ 19
Net periodic benefit cost		$ (358)	$ (332)	$ (103)
Defined Benefit Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Service cost		392	387	399
Interest cost		680	594	767
Expected return on plan assets		(1,686)	(1,724)	(1,658)
Amortization of prior service credit		(21)	(22)	(19)
Amortization of unrecognized (gain) loss		658	822	773
Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement and Curtailment		0	18	(9)
Net periodic benefit cost		23	39	271
Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, before Tax		2,231	1,980	(1,753)
Prior service cost (credit)		(25)	2	8
Amortization of prior service credit		21	22	19
Amortization of unrecognized gain (loss)		(658)	(822)	(773)
Curtailment/Settlement gain (loss)		0	18	(9)
Total recognized in other comprehensive (income) loss		(2,893)	(2,760)	998
Total recognized in net periodic benefit cost and other comprehensive (income) loss		(2,870)	(2,721)	1,269
Other Postretirement Benefit Plans
Defined Benefit Plan Disclosure [Line Items]
Service cost		6	7	7
Interest cost		26	23	40
Expected return on plan assets		0	0	0
Amortization of prior service credit		0	0	0
Amortization of unrecognized (gain) loss		(15)	(6)	(10)
Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement and Curtailment		0	0	0
Net periodic benefit cost		17	24	37
Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, before Tax		317	98	(8)
Prior service cost (credit)		0	0	0
Amortization of prior service credit		0	0	0
Amortization of unrecognized gain (loss)		15	6	10
Curtailment/Settlement gain (loss)		0	0	0
Total recognized in other comprehensive (income) loss		(302)	(92)	18
Total recognized in net periodic benefit cost and other comprehensive (income) loss		$ (285)	$ (68)	$ 55

PENSION PLANS AND OTHER POSTR_9

PENSION PLANS AND OTHER POSTRETIREMENT BENEFITS (Estimated Future Benefit Payments) (Details) $ in Millions	Dec. 31, 2022 USD ($)
Defined Benefit Pension Plans
Defined Benefit Plan, Expected Future Benefit Payment [Abstract]
Defined Benefit Plan, Expected Future Benefit Payment, Year One	$ 1,597
Defined Benefit Plan, Expected Future Benefit Payment, Year Two	1,474
Defined Benefit Plan, Expected Future Benefit Payment, Year Three	1,496
Defined Benefit Plan, Expected Future Benefit Payment, Year Four	1,515
Defined Benefit Plan, Expected Future Benefit Payment, Year Five	1,531
Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years	7,783
Total	15,396
Other Postretirement Benefit Plans
Defined Benefit Plan, Expected Future Benefit Payment [Abstract]
Defined Benefit Plan, Expected Future Benefit Payment, Year One	90
Defined Benefit Plan, Expected Future Benefit Payment, Year Two	85
Defined Benefit Plan, Expected Future Benefit Payment, Year Three	82
Defined Benefit Plan, Expected Future Benefit Payment, Year Four	82
Defined Benefit Plan, Expected Future Benefit Payment, Year Five	80
Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years	350
Total	$ 769

PENSION PLANS AND OTHER POST_10

PENSION PLANS AND OTHER POSTRETIREMENT BENEFITS (Target Allocation for Plan Investment Strategy and Risk Management for Plan Assets) (Details) - Defined Benefit Pension Plans	Dec. 31, 2022
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Plan Assets, Target Allocation, Percentage	100%
Equity securities
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Plan Assets, Target Allocation, Percentage	25%
Fixed Income securities
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Plan Assets, Target Allocation, Percentage	43%
Alternative Investments
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Plan Assets, Target Allocation, Percentage	29%
Other Investments
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Plan Assets, Target Allocation, Percentage	3%

PENSION PLANS AND OTHER POST_11

PENSION PLANS AND OTHER POSTRETIREMENT BENEFITS (Basis of Fair Value Measurements of Pension Plan Assets) (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	$ 21,200	$ 28,200
Defined Benefit Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	21,231	28,167	$ 26,406
Subtotal	14,484	21,258
Defined Benefit Pension Plans | Quoted Prices in Active Markets for Identical Items (Level 1)
Defined Benefit Plan Disclosure [Line Items]
Subtotal	5,363	10,796
Defined Benefit Pension Plans | Significant Other Observable Inputs (Level 2)
Defined Benefit Plan Disclosure [Line Items]
Subtotal	9,109	10,450
Defined Benefit Pension Plans | Significant Unobservable Inputs (Level 3)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	12	12	27
Subtotal	12	12
Cash and Cash Equivalents | Defined Benefit Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	1,240	1,463
Cash and Cash Equivalents | Defined Benefit Pension Plans | Quoted Prices in Active Markets for Identical Items (Level 1)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	989	1,353
Cash and Cash Equivalents | Defined Benefit Pension Plans | Significant Other Observable Inputs (Level 2)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	251	110
Cash and Cash Equivalents | Defined Benefit Pension Plans | Significant Unobservable Inputs (Level 3)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0	0
U.S. Equity [Member] | Defined Benefit Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Plan Assets, Investment within Plan Asset Category, Amount	1,855	4,117
U.S. Equity [Member] | Defined Benefit Pension Plans | Quoted Prices in Active Markets for Identical Items (Level 1)
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Plan Assets, Investment within Plan Asset Category, Amount	1,845	4,097
U.S. Equity [Member] | Defined Benefit Pension Plans | Significant Other Observable Inputs (Level 2)
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Plan Assets, Investment within Plan Asset Category, Amount	7	18
U.S. Equity [Member] | Defined Benefit Pension Plans | Significant Unobservable Inputs (Level 3)
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Plan Assets, Investment within Plan Asset Category, Amount	3	2
Non-U.S. Equity [Member] | Defined Benefit Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Plan Assets, Investment within Plan Asset Category, Amount	2,120	4,559
Non-U.S. Equity [Member] | Defined Benefit Pension Plans | Quoted Prices in Active Markets for Identical Items (Level 1)
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Plan Assets, Investment within Plan Asset Category, Amount	1,924	3,935
Non-U.S. Equity [Member] | Defined Benefit Pension Plans | Significant Other Observable Inputs (Level 2)
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Plan Assets, Investment within Plan Asset Category, Amount	193	620
Non-U.S. Equity [Member] | Defined Benefit Pension Plans | Significant Unobservable Inputs (Level 3)
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Plan Assets, Investment within Plan Asset Category, Amount	3	4
Equity securities | Defined Benefit Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	3,975	8,676
Equity securities | Defined Benefit Pension Plans | Quoted Prices in Active Markets for Identical Items (Level 1)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	3,769	8,032
Equity securities | Defined Benefit Pension Plans | Significant Other Observable Inputs (Level 2)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	200	638
Equity securities | Defined Benefit Pension Plans | Significant Unobservable Inputs (Level 3)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	6	6	10
Government debt | Defined Benefit Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Plan Assets, Investment within Plan Asset Category, Amount	3,885	4,838
Government debt | Defined Benefit Pension Plans | Quoted Prices in Active Markets for Identical Items (Level 1)
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Plan Assets, Investment within Plan Asset Category, Amount	57	242
Government debt | Defined Benefit Pension Plans | Significant Other Observable Inputs (Level 2)
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Plan Assets, Investment within Plan Asset Category, Amount	3,827	4,596
Government debt | Defined Benefit Pension Plans | Significant Unobservable Inputs (Level 3)
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Plan Assets, Investment within Plan Asset Category, Amount	1	0
Corporate bonds | Defined Benefit Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Plan Assets, Investment within Plan Asset Category, Amount	4,231	4,949
Corporate bonds | Defined Benefit Pension Plans | Quoted Prices in Active Markets for Identical Items (Level 1)
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Plan Assets, Investment within Plan Asset Category, Amount	441	1,095
Corporate bonds | Defined Benefit Pension Plans | Significant Other Observable Inputs (Level 2)
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Plan Assets, Investment within Plan Asset Category, Amount	3,790	3,854
Corporate bonds | Defined Benefit Pension Plans | Significant Unobservable Inputs (Level 3)
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Plan Assets, Investment within Plan Asset Category, Amount	0	0
Debt - asset-backed | Defined Benefit Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Plan Assets, Investment within Plan Asset Category, Amount	128	117
Debt - asset-backed | Defined Benefit Pension Plans | Quoted Prices in Active Markets for Identical Items (Level 1)
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Plan Assets, Investment within Plan Asset Category, Amount	44	0
Debt - asset-backed | Defined Benefit Pension Plans | Significant Other Observable Inputs (Level 2)
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Plan Assets, Investment within Plan Asset Category, Amount	84	116
Debt - asset-backed | Defined Benefit Pension Plans | Significant Unobservable Inputs (Level 3)
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Plan Assets, Investment within Plan Asset Category, Amount	0	1
Total fixed income securities | Defined Benefit Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	8,244	9,904
Total fixed income securities | Defined Benefit Pension Plans | Quoted Prices in Active Markets for Identical Items (Level 1)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	542	1,337
Total fixed income securities | Defined Benefit Pension Plans | Significant Other Observable Inputs (Level 2)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	7,701	8,566
Total fixed income securities | Defined Benefit Pension Plans | Significant Unobservable Inputs (Level 3)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	1	1	2
Private Equity Funds | Defined Benefit Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Plan Assets, Investment within Plan Asset Category, Amount	5	5
Investments measured at NAV	3,873	3,857
Private Equity Funds | Defined Benefit Pension Plans | Quoted Prices in Active Markets for Identical Items (Level 1)
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Plan Assets, Investment within Plan Asset Category, Amount	0	0
Private Equity Funds | Defined Benefit Pension Plans | Significant Other Observable Inputs (Level 2)
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Plan Assets, Investment within Plan Asset Category, Amount	0	0
Private Equity Funds | Defined Benefit Pension Plans | Significant Unobservable Inputs (Level 3)
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Plan Assets, Investment within Plan Asset Category, Amount	5	5
Real Estate | Defined Benefit Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Plan Assets, Investment within Plan Asset Category, Amount	48	67
Investments measured at NAV	1,956	1,793
Real Estate | Defined Benefit Pension Plans | Quoted Prices in Active Markets for Identical Items (Level 1)
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Plan Assets, Investment within Plan Asset Category, Amount	48	67
Real Estate | Defined Benefit Pension Plans | Significant Other Observable Inputs (Level 2)
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Plan Assets, Investment within Plan Asset Category, Amount	0	0
Real Estate | Defined Benefit Pension Plans | Significant Unobservable Inputs (Level 3)
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Plan Assets, Investment within Plan Asset Category, Amount	0	0
Derivatives - asset position | Defined Benefit Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Plan Assets, Investment within Plan Asset Category, Amount	348	399
Derivatives - asset position | Defined Benefit Pension Plans | Quoted Prices in Active Markets for Identical Items (Level 1)
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Plan Assets, Investment within Plan Asset Category, Amount	5	2
Derivatives - asset position | Defined Benefit Pension Plans | Significant Other Observable Inputs (Level 2)
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Plan Assets, Investment within Plan Asset Category, Amount	343	397
Derivatives - asset position | Defined Benefit Pension Plans | Significant Unobservable Inputs (Level 3)
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Plan Assets, Investment within Plan Asset Category, Amount	0	0
Derivatives - liability position | Defined Benefit Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Plan Assets, Investment within Plan Asset Category, Amount	479	324
Derivatives - liability position | Defined Benefit Pension Plans | Quoted Prices in Active Markets for Identical Items (Level 1)
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Plan Assets, Investment within Plan Asset Category, Amount	6	2
Derivatives - liability position | Defined Benefit Pension Plans | Significant Other Observable Inputs (Level 2)
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Plan Assets, Investment within Plan Asset Category, Amount	473	322
Derivatives - liability position | Defined Benefit Pension Plans | Significant Unobservable Inputs (Level 3)
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Plan Assets, Investment within Plan Asset Category, Amount	0	0
Alternative Investments | Defined Benefit Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	(78)	147
Alternative Investments | Defined Benefit Pension Plans | Quoted Prices in Active Markets for Identical Items (Level 1)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	47	67
Alternative Investments | Defined Benefit Pension Plans | Significant Other Observable Inputs (Level 2)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	(130)	75
Alternative Investments | Defined Benefit Pension Plans | Significant Unobservable Inputs (Level 3)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	5	5	13
Other Investments | Defined Benefit Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	1,103	1,068
Other Investments | Defined Benefit Pension Plans | Quoted Prices in Active Markets for Identical Items (Level 1)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	16	7
Other Investments | Defined Benefit Pension Plans | Significant Other Observable Inputs (Level 2)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	1,087	1,061
Other Investments | Defined Benefit Pension Plans | Significant Unobservable Inputs (Level 3)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0	0	$ 2
Hedge Funds | Defined Benefit Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Investments measured at NAV	964	1,312
Plan Assets, Retirement Plan, Total investments measured at NAV [Member] | Defined Benefit Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	6,793	6,962
Pension Trust Receivables [Member] | Defined Benefit Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	31	62
Pension Trust Payables [Member] | Defined Benefit Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	$ (77)	$ (115)

PENSION PLANS AND OTHER POST_12

PENSION PLANS AND OTHER POSTRETIREMENT BENEFITS (Fair Value Measurement of Level 3 Pension Plan Assets) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	$ 21,200	$ 28,200
Defined Benefit Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	21,231	28,167	$ 26,406
Defined Benefit Pension Plans | Significant Unobservable Inputs (Level 3)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	12	12	27
Plan Assets Still Held	(12)	(10)
Purchases, sales and settlements, net	6	(5)
Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Increase (Decrease) for Assets Transferred into (out of) Level 3	6
Equity securities | Defined Benefit Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	3,975	8,676
Equity securities | Defined Benefit Pension Plans | Significant Unobservable Inputs (Level 3)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	6	6	10
Plan Assets Still Held	(6)	1
Purchases, sales and settlements, net	0	(5)
Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Increase (Decrease) for Assets Transferred into (out of) Level 3	6
Fixed Income Securities | Defined Benefit Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	8,244	9,904
Fixed Income Securities | Defined Benefit Pension Plans | Significant Unobservable Inputs (Level 3)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	1	1	2
Plan Assets Still Held	0	0
Purchases, sales and settlements, net	0	(1)
Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Increase (Decrease) for Assets Transferred into (out of) Level 3	0
Alternative Investments | Defined Benefit Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	(78)	147
Alternative Investments | Defined Benefit Pension Plans | Significant Unobservable Inputs (Level 3)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	5	5	13
Plan Assets Still Held	(6)	(11)
Purchases, sales and settlements, net	6	3
Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Increase (Decrease) for Assets Transferred into (out of) Level 3	0
Other Investments | Defined Benefit Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	1,103	1,068
Other Investments | Defined Benefit Pension Plans | Significant Unobservable Inputs (Level 3)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0	0	$ 2
Plan Assets Still Held	0	0
Purchases, sales and settlements, net	0	$ (2)
Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Increase (Decrease) for Assets Transferred into (out of) Level 3	$ 0

PENSION PLANS AND OTHER POST_13

PENSION PLANS AND OTHER POSTRETIREMENT BENEFITS (Defined Contribution Plans) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Retirement Benefits [Abstract]
Defined Contribution Plan, Cost	$ 150	$ 165	$ 156
Defined Contribution Plan Disclosure [Line Items]
Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay	5%
Automatic Non-Elective Contribution
Defined Contribution Plan Disclosure [Line Items]
Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay	4%

STOCK-BASED COMPENSATION (Accou

STOCK-BASED COMPENSATION (Accounting for Stock-Based Compensation) (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Payment Arrangement, Expense	$ 211	$ 276	$ 171
Share-based Payment Arrangement, Expense, Tax Benefit	$ 47	$ 62	$ 39
Dividend yield	4.59%	4.86%	5.80%
Expected volatility	30.20%	33.40%	26.70%
Risk-free interest rate	2%	0.68%	1.49%
Common Stock, Dividends, Per Share, Cash Paid	$ 0.70	$ 0.70	$ 0.70
Employee Stock Option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Payment Arrangement, Expense	$ 13	$ 14	$ 22
Share-based Payment Arrangement, Expense, Tax Benefit	$ 3	$ 3	$ 5
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term	6 years 3 months	6 years 3 months	6 years 1 month 6 days
Employee Stock Option | 2019 Stock Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant	53

STOCK-BASED COMPENSATION (Stock

STOCK-BASED COMPENSATION (Stock Options) (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Payment Arrangement, Expense	$ 211	$ 276	$ 171
Share-based Payment Arrangement, Expense, Tax Benefit	$ 47	$ 62	$ 39
Employee Stock Option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Maximum term by share based compensation after vesting	10 years
Weighted-average fair value per share of options granted	$ 11.08	$ 10.37	$ 5.89
Share-based Payment Arrangement, Expense	$ 13	$ 14	$ 22
Share-based Payment Arrangement, Expense, Tax Benefit	3	3	5
Total amount of cash received from the exercise of options	109	217	108
Total intrinsic value of options exercised	73	121	41
Share-based Payment Arrangement, Exercise of Option, Tax Benefit	16	$ 27	$ 9
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount	$ 4
Employee Service Share-based Compensation, Nonvested, Total Compensation Cost not yet recognized and period for recognition in years	1 year 5 months 19 days
Employee Stock Option | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period	1 year
Employee Stock Option | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period	3 years
2019 Stock Incentive Plan [Member] | Employee Stock Option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number	14,425	16,280
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted-Average Exercise Price	$ 53.84	$ 50.56
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures	1,199
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted-Average Exercise Price	$ 60.95
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period	(2,968)
Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price	$ 38.50
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period	(86)
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price	$ 61.20
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term	4 years 7 months 24 days
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value	$ 38
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number	11,727
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price	$ 53.19
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term	3 years 9 months 21 days
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value	$ 36

STOCK-BASED COMPENSATION (Restr

STOCK-BASED COMPENSATION (Restricted Stock Units) (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Payment Arrangement, Expense	$ 211	$ 276	$ 171
Share-based Payment Arrangement, Expense, Tax Benefit	$ 47	$ 62	$ 39
Restricted Stock Units (RSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number	3,825	3,543
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value	$ 55.13	$ 53.67
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period	2,080
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value	$ 58.60	$ 57.96	$ 47.66
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period	(1,676)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value	$ 56.30
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period	(122)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value	$ 55.80
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value	$ 102	$ 33	$ 106
Employee Service Share-based Compensation, Tax Benefit Realized from Vesting of Deferred Stock Awards	23	7	24
Share-based Payment Arrangement, Expense	99	95	93
Share-based Payment Arrangement, Expense, Tax Benefit	22	$ 21	21
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount	$ 86
Employee Service Share-based Compensation, Nonvested, Total Compensation Cost not yet recognized and period for recognition in years	2 years 1 month 2 days
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested But Not Issued	1,800
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested But Not Issued, Weighted Average Grant Date Fair Value	$ 54.32
Restricted Stock Units (RSUs) [Member] | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period	3 years
Restricted Stock Units (RSUs) [Member] | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period	2 years
Executive Officer [Member] | Restricted Stock Units (RSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock Redeemed or Called During Period, Value	$ 0		$ 4
Stock Redeemed or Called During Period, Shares		0	85

STOCK-BASED COMPENSATION (Perfo

STOCK-BASED COMPENSATION (Performance Stock Units) (Details) - USD ($) $ / shares in Units, $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Payment Arrangement, Expense	$ 211	$ 276	$ 171
Share-based Payment Arrangement, Expense, Tax Benefit	$ 47	$ 62	$ 39
Performance Stock Units (PSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period	1,157,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value	$ 65.83
Actual number of shares granted above target minimum range	0%	0%	0%
Actual number of shares granted above target maximum range	200%	200%	100%
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number	3,640,000	3,639,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value	$ 57.93	$ 55.36
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period	(1,079,000)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value	$ 57.58
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period	(77,000)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value	$ 59.73
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value	$ 51	$ 0	$ 0
Employee Service Share-based Compensation, Tax Benefit Realized from Vesting of Performance Deferred Stock Awards	11	0	0
Share-based Payment Arrangement, Expense	70	138	56
Share-based Payment Arrangement, Expense, Tax Benefit	$ 16	$ 31	$ 13
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period	162,000	0	0
Total cash paid to settle PSUs	$ 10	$ 0	$ 0
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount	$ 37
Employee Service Share-based Compensation, Nonvested, Total Compensation Cost not yet recognized and period for recognition in years	1 year 5 months 12 days
Performance Stock Units (PSUs) [Member] | Vested PSUs Undelivered Due to Performance [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period	(226,240)
Performance Stock Units (PSUs) [Member] | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period	1 year
Performance Stock Units (PSUs) [Member] | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period	3 years
January 1, 2020 - December 31, 2020 | Performance Stock Units (PSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period	1,157,000	1,223,000	1,426,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value	$ 65.83	$ 61.48	$ 48.35

STOCK-BASED COMPENSATION (ESPP)

STOCK-BASED COMPENSATION (ESPP) (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Payment Arrangement, Expense	$ 211	$ 276	$ 171
Share-based Payment Arrangement, Expense, Tax Benefit	$ 47	$ 62	$ 39
Employee Stock Purchase Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Rate	10%
Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent	85%
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted-Average Exercise Price	$ 37,750,000	$ 45,110,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value	$ 14.28	$ 16.26
Share-Based Payment Arrangement, Noncash Expense	$ 29	$ 30
Share-Based Payment Arrangement, Expense, after Tax	7	7
Total amount of cash received from the exercise of purchase rights	103	103
Share based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Intrinsic Value Monetary	18	18
Employee Service Share-based Compensation, Tax Benefit Realized from Exercise of Employee Stock Puchase Plan Purchase Rights Exercised	$ 4	$ 4
Employee Stock Purchase Plan | Employee
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Right to Purchase Shares Subscribed by Employee	2,700	2,300

FINANCIAL INSTRUMENTS (Summary

FINANCIAL INSTRUMENTS (Summary of Fair Value of Financial Instruments) (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Debt Securities, Available-for-sale [Line Items]
Cash Equivalents, at Carrying Value	$ 1,227	$ 806
Cash Equivalents, Accumulated Gross Unrealized Loss, Before Tax	0	0
Cash Equivalents, Accumulated Gross Unrealized Loss, Before Tax	0	0
Cash Equivalents, Fair Value	1,227	806
Total, Amortized Cost	2,028	1,997
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax	11	110
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax	(292)	(48)
Debt Securities, Available-for-sale	1,747	2,059
Equity securities	10	20
Other Investments and Securities, at Cost	2,033	2,004
Other Investments and Securities, Accumulated Gross Unrealized Gain, Before Tax	16	123
Other Investments and Securities, Accumulated Gross Unrealized Loss, Before Tax	(292)	(48)
Cash Equivalents, Marketable Securities and Other Investments, Amortized Cost Basis	4,187	3,047
Cash Equivalents, Marketable Securities and Other Investments, Accumulated Gross Unrealized Gain, Before Tax	28	131
Cash Equivalents, Marketable Securities and Other Investments, Accumulated Gross Unrealized Loss, Before Tax	(292)	(48)
Cash Equivalents, Marketable Securities and Other Investments, Fair Value	3,923	3,130
Long-term Debt	(15,060)	(14,511)
Long Term Debt, Accumulated Gross Unrealized Gain, Before Tax	1,683	27
Long Term Debt, Accumulated Gross Unrealized Loss, Before Tax	(498)	(2,641)
Long-term debt	(13,875)	(17,125)
Derivative Assets (Liabilities), Accumulated Gross Unrealized Gain, Before Tax	292	189
Derivative Assets (Liabilities), Accumulated Gross Unrealized Loss, Before Tax	(91)	(250)
Derivative Assets (Liabilities), at Fair Value, Net	201	(61)
Long Term Debt, Accumulated Fair Value Adjustment	46	47
Derivative, Amount of Hedged Item	2,279	2,279
Investments carried at fair value	1,757	2,079
Interest rates 6
Debt Securities, Available-for-sale [Line Items]
Derivative Assets (Liabilities), Accumulated Gross Unrealized Gain, Before Tax	105	1
Derivative Assets (Liabilities), Accumulated Gross Unrealized Loss, Before Tax	0	(140)
Derivative Assets (Liabilities), at Fair Value, Net	105	(139)
Foreign currency
Debt Securities, Available-for-sale [Line Items]
Derivative Assets (Liabilities), Accumulated Gross Unrealized Gain, Before Tax	115	46
Derivative Assets (Liabilities), Accumulated Gross Unrealized Loss, Before Tax	(30)	(18)
Derivative Assets (Liabilities), at Fair Value, Net	85	28
Commodities
Debt Securities, Available-for-sale [Line Items]
Derivative Assets (Liabilities), Accumulated Gross Unrealized Gain, Before Tax	72	142
Derivative Assets (Liabilities), Accumulated Gross Unrealized Loss, Before Tax	(61)	(92)
Derivative Assets (Liabilities), at Fair Value, Net	11	50
Government debt
Debt Securities, Available-for-sale [Line Items]
Total, Amortized Cost	754	746
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax	1	17
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax	(133)	(28)
Debt Securities, Available-for-sale	622	735
Corporate bonds
Debt Securities, Available-for-sale [Line Items]
Total, Amortized Cost	1,274	1,251
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax	10	93
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax	(159)	(20)
Debt Securities, Available-for-sale	1,125	1,324
Equity securities
Debt Securities, Available-for-sale [Line Items]
Equity Securities, Accumulated Gross Unrealized Gain, Before Tax	5	13
Equity Securities, Accumulated Gross Unrealized Loss, Before Tax	0	0
Available-for-sale Equity Securities, Amortized Cost Basis	5	7
Equity securities	10	20
Marketable securities 2
Debt Securities, Available-for-sale [Line Items]
Debt Securities, Available-for-sale, Current	939	245
Held-to-maturity Securities [Member]
Debt Securities, Available-for-sale [Line Items]
Cash Equivalents, at Carrying Value	872	317
Cash Equivalents, Accumulated Gross Unrealized Loss, Before Tax	0	0
Cash Equivalents, Accumulated Gross Unrealized Loss, Before Tax	0	0
Cash Equivalents, Fair Value	872	317
Money Market Funds [Member]
Debt Securities, Available-for-sale [Line Items]
Cash Equivalents, at Carrying Value	355	489
Cash Equivalents, Accumulated Gross Unrealized Loss, Before Tax	0	0
Cash Equivalents, Accumulated Gross Unrealized Loss, Before Tax	0	0
Cash Equivalents, Fair Value	355	489
Marketable securities 2
Debt Securities, Available-for-sale [Line Items]
Available-for-sale Debt Securities, Amortized Cost Basis, Current	927	237
Available-for-sale Debt Securities, Accumulated Gross Unrealized Gain, Current, before Tax	12	8
Available-for-sale Debt Securities, Accumulated Gross Unrealized Loss, Current, before Tax	$ 0	$ 0

FINANCIAL INSTRUMENTS (Investme

FINANCIAL INSTRUMENTS (Investments) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Cash and Cash Equivalents [Line Items]
Gross realized gains	$ 43	$ 50	$ 94
Gross realized losses	45	12	40
Within one year, Amortized Cost	71
One to five years, Amortized Cost	855
Six to ten years, Amortized Cost	594
After ten years, Amortized Cost	508
Total, Amortized Cost	2,028	1,997
Within one year, Fair Value	68
One to five years, Fair Value	773
Six to ten years, Fair Value	503
After ten years, Fair Value	403
Total, Fair Value	1,747	2,059
Equity securities	10	20
Proceeds from Sale of Debt Securities, Available-for-sale	$ 543	$ 424	$ 837

FINANCIAL INSTRUMENTS (Temporar

FINANCIAL INSTRUMENTS (Temporarily Impaired Securities) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Debt Securities, Available-for-sale [Line Items]
Temporarily Impaired Securities, Less than 12 Months, Fair Value	$ 1,091	$ 650
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	(147)	(30)
Debt Securities, Held-to-maturity, Continuous Unrealized Loss Position, 12 Months or Longer, Fair Value	491	167
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer	(145)	(18)
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value	1,582	817
Available-for-sale Securities, Continuous Unrealized Position	(292)	(48)
Cost method investments, aggregate cost	186	209
Net unrealized gain recognized in equity securities	8	13
Government debt
Debt Securities, Available-for-sale [Line Items]
Temporarily Impaired Securities, Less than 12 Months, Fair Value	273	295
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	(37)	(13)
Debt Securities, Held-to-maturity, Continuous Unrealized Loss Position, 12 Months or Longer, Fair Value	333	151
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer	(96)	(15)
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value	606	446
Available-for-sale Securities, Continuous Unrealized Position	(133)	(28)
Corporate bonds
Debt Securities, Available-for-sale [Line Items]
Temporarily Impaired Securities, Less than 12 Months, Fair Value	818	355
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	(110)	(17)
Debt Securities, Held-to-maturity, Continuous Unrealized Loss Position, 12 Months or Longer, Fair Value	158	16
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer	(49)	(3)
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value	976	371
Available-for-sale Securities, Continuous Unrealized Position	$ (159)	$ (20)

FINANCIAL INSTRUMENTS (Notional

FINANCIAL INSTRUMENTS (Notional Amounts) (Details) bbl in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2022 USD ($) MWh bbl	Dec. 31, 2021 USD ($) MWh bbl
Derivatives designated as hedging instruments: | Interest rates
Derivative [Line Items]
Derivative, Notional Amount	$ 1,500	$ 3,000
Derivatives designated as hedging instruments: | Foreign currency
Derivative [Line Items]
Derivative, Notional Amount	$ 2,408	$ 5,300
Derivatives designated as hedging instruments: | Hydrocarbon derivatives
Derivative [Line Items]
Derivative, Nonmonetary Notional Amount, Volume | bbl	19.2	9.7
Derivatives not designated as hedging instruments: | Interest rates
Derivative [Line Items]
Derivative, Notional Amount	$ 3	$ 36
Derivatives not designated as hedging instruments: | Foreign currency
Derivative [Line Items]
Derivative, Notional Amount	$ 8,837	$ 8,234
Derivatives not designated as hedging instruments: | Hydrocarbon derivatives
Derivative [Line Items]
Derivative, Nonmonetary Notional Amount, Volume | bbl	0	0.1
Derivatives not designated as hedging instruments: | Power derivatives
Derivative [Line Items]
Derivative, Nonmonetary Notional Amount, Energy Measure | MWh	0	3.3

FINANCIAL INSTRUMENTS (Accounti

FINANCIAL INSTRUMENTS (Accounting for Derivative Instruments and Hedging Activities) (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Foreign Currency Denominated Debt [Member]
Derivative [Line Items]
Nonderivative Instruments Notional	$ 152	$ 174

FINANCIAL INSTRUMENTS (Schedule

FINANCIAL INSTRUMENTS (Schedule of Fair Values of Derivative Instruments) (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Derivatives, Fair Value [Line Items]
Derivative Asset, Fair Value, Gross Asset	$ 776
Counterparty and Cash Collateral Netting	(484)
Derivative Asset	(292)
Derivative Asset Statement Of Financial Position Extensible Enumeration, Not Disclosed Flag		$ 189
Derivative Liability, Fair Value, Gross Liability	635
Counterparty and Cash Collateral Netting	(544)
Derivative Liability	(91)
Derivative Liability, Collateral, Right to Reclaim Cash, Offset	80	71
Derivative Asset, Collateral, Obligation to Return Cash, Offset	2	0
Derivatives designated as hedging instruments:
Derivatives, Fair Value [Line Items]
Derivative Asset, Fair Value, Gross Asset	608
Counterparty and Cash Collateral Netting	(433)
Derivative Asset	(175)
Derivative Liability, Fair Value, Gross Liability	562
Counterparty and Cash Collateral Netting	(483)
Derivative Liability	(79)
Derivatives designated as hedging instruments: | Foreign currency
Derivatives, Fair Value [Line Items]
Derivative Liability, Current	19
Derivative Asset, Current	19
Derivatives designated as hedging instruments: | Foreign currency | Other current assets
Derivatives, Fair Value [Line Items]
Derivative Asset, Fair Value, Gross Asset	58
Counterparty and Cash Collateral Netting	(39)
Derivatives designated as hedging instruments: | Foreign currency | Accrued and Other Current Liabilities [Member]
Derivatives, Fair Value [Line Items]
Derivative Liability, Fair Value, Gross Liability	58
Counterparty and Cash Collateral Netting	(39)
Derivatives designated as hedging instruments: | Commodities
Derivatives, Fair Value [Line Items]
Derivative Liability, Current	60
Derivative Asset, Current	51
Derivatives designated as hedging instruments: | Commodities | Other current assets
Derivatives, Fair Value [Line Items]
Derivative Asset, Fair Value, Gross Asset	199
Counterparty and Cash Collateral Netting	(148)
Derivatives designated as hedging instruments: | Commodities | Accrued and Other Current Liabilities [Member]
Derivatives, Fair Value [Line Items]
Derivative Liability, Fair Value, Gross Liability	258
Counterparty and Cash Collateral Netting	(198)
Derivatives not designated as hedging instruments:
Derivatives, Fair Value [Line Items]
Derivative Asset, Fair Value, Gross Asset	168
Counterparty and Cash Collateral Netting	(51)
Derivative Asset	117
Derivative Liability, Fair Value, Gross Liability	73
Counterparty and Cash Collateral Netting	(61)
Derivative Liability	12
Derivatives not designated as hedging instruments: | Foreign currency
Derivatives, Fair Value [Line Items]
Derivative Liability, Current	11
Derivative Asset, Current	96
Derivatives not designated as hedging instruments: | Foreign currency | Other current assets
Derivatives, Fair Value [Line Items]
Derivative Asset, Fair Value, Gross Asset	146
Counterparty and Cash Collateral Netting	(50)
Derivatives not designated as hedging instruments: | Foreign currency | Accrued and Other Current Liabilities [Member]
Derivatives, Fair Value [Line Items]
Derivative Liability, Fair Value, Gross Liability	61
Counterparty and Cash Collateral Netting	(50)
Derivatives not designated as hedging instruments: | Commodities
Derivatives, Fair Value [Line Items]
Derivative Liability, Current	1
Derivative Asset, Current	21
Derivatives not designated as hedging instruments: | Commodities | Other current assets
Derivatives, Fair Value [Line Items]
Derivative Asset, Fair Value, Gross Asset	22
Counterparty and Cash Collateral Netting	(1)
Derivatives not designated as hedging instruments: | Commodities | Accrued and Other Current Liabilities [Member]
Derivatives, Fair Value [Line Items]
Derivative Liability, Fair Value, Gross Liability	12
Counterparty and Cash Collateral Netting	(11)
Fair Value, Inputs, Level 2 [Member]
Derivatives, Fair Value [Line Items]
Derivative Asset, Fair Value, Gross Asset		632
Counterparty and Cash Collateral Netting		(443)
Derivative Liability, Fair Value, Gross Liability		715
Counterparty and Cash Collateral Netting		(465)
Derivative Liability Statement Of Financial Position Extensible Enumeration, Not Disclosed Flag		250
Fair Value, Inputs, Level 2 [Member] | Derivatives designated as hedging instruments:
Derivatives, Fair Value [Line Items]
Derivative Asset, Fair Value, Gross Asset		599
Counterparty and Cash Collateral Netting		(421)
Derivative Asset		178
Derivative Liability, Fair Value, Gross Liability		599
Counterparty and Cash Collateral Netting		(440)
Derivative Liability		159
Fair Value, Inputs, Level 2 [Member] | Derivatives designated as hedging instruments: | Interest rates 6
Derivatives, Fair Value [Line Items]
Derivative Liability, Current	0	19
Derivative Liability, Noncurrent		62
Derivative Asset, Current	105	0
Derivative Asset, Noncurrent		0
Fair Value, Inputs, Level 2 [Member] | Derivatives designated as hedging instruments: | Interest rates 6 | Deferred charges and other assets [Member]
Derivatives, Fair Value [Line Items]
Derivative Asset, Fair Value, Gross Asset		130
Counterparty and Cash Collateral Netting		(130)
Fair Value, Inputs, Level 2 [Member] | Derivatives designated as hedging instruments: | Interest rates 6 | Other current assets
Derivatives, Fair Value [Line Items]
Derivative Asset, Fair Value, Gross Asset	351	14
Counterparty and Cash Collateral Netting	(246)	(14)
Fair Value, Inputs, Level 2 [Member] | Derivatives designated as hedging instruments: | Interest rates 6 | Accrued and Other Current Liabilities [Member]
Derivatives, Fair Value [Line Items]
Derivative Liability, Fair Value, Gross Liability	246	33
Counterparty and Cash Collateral Netting	$ (246)	(14)
Fair Value, Inputs, Level 2 [Member] | Derivatives designated as hedging instruments: | Interest rates 6 | Other noncurrent obligations
Derivatives, Fair Value [Line Items]
Derivative Liability, Fair Value, Gross Liability		192
Counterparty and Cash Collateral Netting		(130)
Fair Value, Inputs, Level 2 [Member] | Derivatives designated as hedging instruments: | Foreign currency
Derivatives, Fair Value [Line Items]
Derivative Liability, Current		2
Derivative Liability, Noncurrent		1
Derivative Asset, Current		11
Derivative Asset, Noncurrent		28
Fair Value, Inputs, Level 2 [Member] | Derivatives designated as hedging instruments: | Foreign currency | Deferred charges and other assets [Member]
Derivatives, Fair Value [Line Items]
Derivative Asset, Fair Value, Gross Asset		117
Counterparty and Cash Collateral Netting		(89)
Fair Value, Inputs, Level 2 [Member] | Derivatives designated as hedging instruments: | Foreign currency | Other current assets
Derivatives, Fair Value [Line Items]
Derivative Asset, Fair Value, Gross Asset		24
Counterparty and Cash Collateral Netting		(13)
Fair Value, Inputs, Level 2 [Member] | Derivatives designated as hedging instruments: | Foreign currency | Accrued and Other Current Liabilities [Member]
Derivatives, Fair Value [Line Items]
Derivative Liability, Fair Value, Gross Liability		15
Counterparty and Cash Collateral Netting		(13)
Fair Value, Inputs, Level 2 [Member] | Derivatives designated as hedging instruments: | Foreign currency | Other noncurrent obligations
Derivatives, Fair Value [Line Items]
Derivative Liability, Fair Value, Gross Liability		90
Counterparty and Cash Collateral Netting		(89)
Fair Value, Inputs, Level 2 [Member] | Derivatives designated as hedging instruments: | Commodities
Derivatives, Fair Value [Line Items]
Derivative Liability, Current		75
Derivative Liability, Noncurrent		0
Derivative Asset, Current		132
Derivative Asset, Noncurrent		7
Fair Value, Inputs, Level 2 [Member] | Derivatives designated as hedging instruments: | Commodities | Deferred charges and other assets [Member]
Derivatives, Fair Value [Line Items]
Derivative Asset, Fair Value, Gross Asset		9
Counterparty and Cash Collateral Netting		(2)
Fair Value, Inputs, Level 2 [Member] | Derivatives designated as hedging instruments: | Commodities | Other current assets
Derivatives, Fair Value [Line Items]
Derivative Asset, Fair Value, Gross Asset		305
Counterparty and Cash Collateral Netting		(173)
Fair Value, Inputs, Level 2 [Member] | Derivatives designated as hedging instruments: | Commodities | Accrued and Other Current Liabilities [Member]
Derivatives, Fair Value [Line Items]
Derivative Liability, Fair Value, Gross Liability		267
Counterparty and Cash Collateral Netting		(192)
Fair Value, Inputs, Level 2 [Member] | Derivatives designated as hedging instruments: | Commodities | Other noncurrent obligations
Derivatives, Fair Value [Line Items]
Derivative Liability, Fair Value, Gross Liability		2
Counterparty and Cash Collateral Netting		(2)
Fair Value, Inputs, Level 2 [Member] | Derivatives not designated as hedging instruments:
Derivatives, Fair Value [Line Items]
Derivative Asset, Fair Value, Gross Asset		33
Counterparty and Cash Collateral Netting		(22)
Derivative Asset		11
Derivative Liability, Fair Value, Gross Liability		116
Counterparty and Cash Collateral Netting		(25)
Derivative Liability		91
Fair Value, Inputs, Level 2 [Member] | Derivatives not designated as hedging instruments: | Interest rates 6
Derivatives, Fair Value [Line Items]
Derivative Liability, Current		59
Derivative Asset, Current		1
Fair Value, Inputs, Level 2 [Member] | Derivatives not designated as hedging instruments: | Interest rates 6 | Other current assets
Derivatives, Fair Value [Line Items]
Derivative Asset, Fair Value, Gross Asset		1
Counterparty and Cash Collateral Netting		0
Fair Value, Inputs, Level 2 [Member] | Derivatives not designated as hedging instruments: | Interest rates 6 | Accrued and Other Current Liabilities [Member]
Derivatives, Fair Value [Line Items]
Derivative Liability, Fair Value, Gross Liability		59
Counterparty and Cash Collateral Netting		0
Fair Value, Inputs, Level 2 [Member] | Derivatives not designated as hedging instruments: | Foreign currency
Derivatives, Fair Value [Line Items]
Derivative Liability, Current		15
Derivative Liability, Noncurrent		0
Derivative Asset, Current		7
Derivative Asset, Noncurrent		0
Fair Value, Inputs, Level 2 [Member] | Derivatives not designated as hedging instruments: | Foreign currency | Deferred charges and other assets [Member]
Derivatives, Fair Value [Line Items]
Derivative Asset, Fair Value, Gross Asset		1
Counterparty and Cash Collateral Netting		(1)
Fair Value, Inputs, Level 2 [Member] | Derivatives not designated as hedging instruments: | Foreign currency | Other current assets
Derivatives, Fair Value [Line Items]
Derivative Asset, Fair Value, Gross Asset		23
Counterparty and Cash Collateral Netting		(16)
Fair Value, Inputs, Level 2 [Member] | Derivatives not designated as hedging instruments: | Foreign currency | Accrued and Other Current Liabilities [Member]
Derivatives, Fair Value [Line Items]
Derivative Liability, Fair Value, Gross Liability		31
Counterparty and Cash Collateral Netting		(16)
Fair Value, Inputs, Level 2 [Member] | Derivatives not designated as hedging instruments: | Foreign currency | Other noncurrent obligations
Derivatives, Fair Value [Line Items]
Counterparty and Cash Collateral Netting		(1)
Derivative Liability, Fair Value, Gross Liability Including Not Subject to Master Netting Arrangement		1
Fair Value, Inputs, Level 2 [Member] | Derivatives not designated as hedging instruments: | Commodities
Derivatives, Fair Value [Line Items]
Derivative Liability, Current		17
Derivative Asset, Current		3
Fair Value, Inputs, Level 2 [Member] | Derivatives not designated as hedging instruments: | Commodities | Other current assets
Derivatives, Fair Value [Line Items]
Derivative Asset, Fair Value, Gross Asset		8
Counterparty and Cash Collateral Netting		(5)
Fair Value, Inputs, Level 2 [Member] | Derivatives not designated as hedging instruments: | Commodities | Accrued and Other Current Liabilities [Member]
Derivatives, Fair Value [Line Items]
Counterparty and Cash Collateral Netting		(8)
Derivative Liability, Fair Value, Gross Liability Including Not Subject to Master Netting Arrangement		$ 25

FINANCIAL INSTRUMENTS (Effect o

FINANCIAL INSTRUMENTS (Effect of Derivative Instruments) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Derivative Instruments, Gain (Loss) [Line Items]
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax	$ 272	$ 123	$ (76)
Total derivatives	155	(283)	82
Derivative
Derivative Instruments, Gain (Loss) [Line Items]
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax	503	171	(32)
Derivatives designated as hedging instruments:
Derivative Instruments, Gain (Loss) [Line Items]
Amount of gain (loss) recognized in income	357	24	59
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax	503	171	(32)
Derivatives designated as hedging instruments: | Fair value hedges: | Interest rates
Derivative Instruments, Gain (Loss) [Line Items]
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax	0	0	0
Derivatives designated as hedging instruments: | Fair value hedges: | Excluded Components [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivatives used in Net Investment Hedge, Gain (Loss), Reclassified to Earnings, Net of Tax	0	0	0
Derivatives designated as hedging instruments: | Fair value hedges: | Interest expense and amortization of debt discount 3 | Interest rates
Derivative Instruments, Gain (Loss) [Line Items]
Amount of gain (loss) recognized in income	0	(25)	69
Derivatives designated as hedging instruments: | Cash flow hedges: | Interest rates
Derivative Instruments, Gain (Loss) [Line Items]
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax	239	(62)	0
Derivatives designated as hedging instruments: | Cash flow hedges: | Commodities
Derivative Instruments, Gain (Loss) [Line Items]
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax	166	133	(8)
Derivatives designated as hedging instruments: | Cash flow hedges: | Interest expense and amortization of debt discount 3 | Interest rates
Derivative Instruments, Gain (Loss) [Line Items]
Amount of gain (loss) recognized in income	(10)	(9)	(2)
Derivatives designated as hedging instruments: | Cash flow hedges: | Cost of sales | Foreign currency
Derivative Instruments, Gain (Loss) [Line Items]
Amount of gain (loss) recognized in income	13	(15)	3
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax	5	13	(20)
Derivatives designated as hedging instruments: | Cash flow hedges: | Cost of sales | Commodities
Derivative Instruments, Gain (Loss) [Line Items]
Amount of gain (loss) recognized in income	310	62	(31)
Derivatives designated as hedging instruments: | Net foreign investment hedges: | Foreign currency
Derivative Instruments, Gain (Loss) [Line Items]
Amount of gain (loss) recognized in income	0	0	0
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax	34	31	(38)
Derivatives designated as hedging instruments: | Net foreign investment hedges: | Sundry income (expense) - net | Excluded Components [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivatives used in Net Investment Hedge, Gain (Loss), Reclassified to Earnings, Net of Tax	44	11	20
Derivatives not designated as hedging instruments:
Derivative Instruments, Gain (Loss) [Line Items]
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax	0	0	0
Amount of gain (loss) recognized in income	(202)	(307)	23
Derivatives not designated as hedging instruments: | Interest rates 6
Derivative Instruments, Gain (Loss) [Line Items]
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax	0	0	0
Derivatives not designated as hedging instruments: | Foreign currency
Derivative Instruments, Gain (Loss) [Line Items]
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax	0	0	0
Derivatives not designated as hedging instruments: | Commodities
Derivative Instruments, Gain (Loss) [Line Items]
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax	0	0	0
Derivatives not designated as hedging instruments: | Interest expense and amortization of debt discount 3 | Interest rates 6
Derivative Instruments, Gain (Loss) [Line Items]
Amount of gain (loss) recognized in income	(1)	(8)	(16)
Derivatives not designated as hedging instruments: | Cost of sales | Commodities
Derivative Instruments, Gain (Loss) [Line Items]
Amount of gain (loss) recognized in income	48	(46)	11
Derivatives not designated as hedging instruments: | Sundry income (expense) - net | Foreign currency
Derivative Instruments, Gain (Loss) [Line Items]
Amount of gain (loss) recognized in income	(249)	(253)	28
Cumulative Translation Adjustments [Member] | Derivatives designated as hedging instruments: | Fair value hedges: | Excluded Components [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax	0	2	7
Cumulative Translation Adjustments [Member] | Derivatives designated as hedging instruments: | Net foreign investment hedges: | Excluded Components [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax	$ 59	$ 54	$ 27

FINANCIAL INSTRUMENTS (Expected

FINANCIAL INSTRUMENTS (Expected Reclassification) (Details) $ in Millions	Dec. 31, 2022 USD ($)
Interest rates 6
Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net	$ (7)
Commodities
Price Risk Cash Flow Hedge Unrealized Gain (Loss) to be Reclassified During Next 12 Months	(48)
Foreign currency
Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months	2
Excluded Components [Member]
Hedge Gain (Loss) to be Reclassified During Next 12 Months, Excluded Components, Net	$ 0

FAIR VALUE MEASUREMENTS (Basis

FAIR VALUE MEASUREMENTS (Basis of Fair Value Measurements on a Recurring Basis) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment in nonconsolidated affiliates	$ 1,589	$ 2,045	$ 1,327
Debt securities	1,747	2,059
Derivative Asset, Fair Value, Gross Asset	776
Long-term debt including debt due within one year	13,875	17,125
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value	(199)	(220)	$ 0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances	0	(235)
Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]	21
Gain included in earnings		15
Sadara Chemical Company
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment in nonconsolidated affiliates	322
Government debt
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities	622	735
Corporate bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities	1,125	1,324
Significant Other Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Asset, Fair Value, Gross Asset		632
Fair Value, Measurements, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities 2	939	245
Equity securities	10	20
Total assets at fair value	4,706	3,762
Long-term debt including debt due within one year	13,875	17,125
Total liabilities at fair value	14,709	18,060
Fair Value, Measurements, Recurring | Equity Method Investments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment in nonconsolidated affiliates	7	0
Fair Value, Measurements, Recurring | Sadara Chemical Company
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Guarantees, Fair Value Disclosure	199	220
Fair Value, Measurements, Recurring | Interest rates 6
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Asset, Fair Value, Gross Asset	351	145
Fair Value, Measurements, Recurring | Foreign currency
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Asset, Fair Value, Gross Asset	204	165
Derivative Liability, Fair Value, Gross Liability	119	137
Fair Value, Measurements, Recurring | Commodities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Asset, Fair Value, Gross Asset	221	322
Derivative Liability, Fair Value, Gross Liability	270	294
Fair Value, Measurements, Recurring | Interest rates
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability, Fair Value, Gross Liability	246	284
Fair Value, Measurements, Recurring | Government debt
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities	622	735
Fair Value, Measurements, Recurring | Corporate bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities	1,125	1,324
Fair Value, Measurements, Recurring | Quoted Prices in Active Markets for Identical Items (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities 2	0	0
Equity securities	10	20
Total assets at fair value	108	79
Long-term debt including debt due within one year	0	0
Total liabilities at fair value	103	37
Fair Value, Measurements, Recurring | Quoted Prices in Active Markets for Identical Items (Level 1) | Equity Method Investments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment in nonconsolidated affiliates	0	0
Fair Value, Measurements, Recurring | Quoted Prices in Active Markets for Identical Items (Level 1) | Sadara Chemical Company
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Guarantees, Fair Value Disclosure	0	0
Fair Value, Measurements, Recurring | Quoted Prices in Active Markets for Identical Items (Level 1) | Interest rates 6
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Asset, Fair Value, Gross Asset	0	0
Fair Value, Measurements, Recurring | Quoted Prices in Active Markets for Identical Items (Level 1) | Foreign currency
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Asset, Fair Value, Gross Asset	0	0
Derivative Liability, Fair Value, Gross Liability	0	0
Fair Value, Measurements, Recurring | Quoted Prices in Active Markets for Identical Items (Level 1) | Commodities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Asset, Fair Value, Gross Asset	63	15
Derivative Liability, Fair Value, Gross Liability	103	37
Fair Value, Measurements, Recurring | Quoted Prices in Active Markets for Identical Items (Level 1) | Interest rates
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability, Fair Value, Gross Liability	0	0
Fair Value, Measurements, Recurring | Quoted Prices in Active Markets for Identical Items (Level 1) | Government debt
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities	0	0
Fair Value, Measurements, Recurring | Quoted Prices in Active Markets for Identical Items (Level 1) | Corporate bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities	35	44
Fair Value, Measurements, Recurring | Significant Other Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities 2	939	245
Equity securities	0	0
Total assets at fair value	4,591	3,683
Long-term debt including debt due within one year	13,875	17,125
Total liabilities at fair value	14,407	17,803
Fair Value, Measurements, Recurring | Significant Other Observable Inputs (Level 2) | Equity Method Investments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment in nonconsolidated affiliates	0	0
Fair Value, Measurements, Recurring | Significant Other Observable Inputs (Level 2) | Sadara Chemical Company
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Guarantees, Fair Value Disclosure	0	0
Fair Value, Measurements, Recurring | Significant Other Observable Inputs (Level 2) | Interest rates 6
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Asset, Fair Value, Gross Asset	351	145
Fair Value, Measurements, Recurring | Significant Other Observable Inputs (Level 2) | Foreign currency
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Asset, Fair Value, Gross Asset	204	165
Derivative Liability, Fair Value, Gross Liability	119	137
Fair Value, Measurements, Recurring | Significant Other Observable Inputs (Level 2) | Commodities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Asset, Fair Value, Gross Asset	158	307
Derivative Liability, Fair Value, Gross Liability	167	257
Fair Value, Measurements, Recurring | Significant Other Observable Inputs (Level 2) | Interest rates
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability, Fair Value, Gross Liability	246	284
Fair Value, Measurements, Recurring | Significant Other Observable Inputs (Level 2) | Government debt
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities	622	735
Fair Value, Measurements, Recurring | Significant Other Observable Inputs (Level 2) | Corporate bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities	1,090	1,280
Fair Value, Measurements, Recurring | Significant Unobservable Inputs (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities 2	0	0
Equity securities	0	0
Total assets at fair value	7	0
Long-term debt including debt due within one year	0	0
Total liabilities at fair value	199	220
Fair Value, Measurements, Recurring | Significant Unobservable Inputs (Level 3) | Equity Method Investments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment in nonconsolidated affiliates	7	0
Fair Value, Measurements, Recurring | Significant Unobservable Inputs (Level 3) | Sadara Chemical Company
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Guarantees, Fair Value Disclosure	199	220
Fair Value, Measurements, Recurring | Significant Unobservable Inputs (Level 3) | Interest rates 6
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Asset, Fair Value, Gross Asset	0	0
Fair Value, Measurements, Recurring | Significant Unobservable Inputs (Level 3) | Foreign currency
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Asset, Fair Value, Gross Asset	0	0
Derivative Liability, Fair Value, Gross Liability	0	0
Fair Value, Measurements, Recurring | Significant Unobservable Inputs (Level 3) | Commodities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Asset, Fair Value, Gross Asset	0	0
Derivative Liability, Fair Value, Gross Liability	0	0
Fair Value, Measurements, Recurring | Significant Unobservable Inputs (Level 3) | Interest rates
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability, Fair Value, Gross Liability	0	0
Fair Value, Measurements, Recurring | Significant Unobservable Inputs (Level 3) | Government debt
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities	0	0
Fair Value, Measurements, Recurring | Significant Unobservable Inputs (Level 3) | Corporate bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt securities	0	0
Held-to-maturity Securities [Member] | Fair Value, Measurements, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	872	317
Held-to-maturity Securities [Member] | Fair Value, Measurements, Recurring | Quoted Prices in Active Markets for Identical Items (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	0	0
Held-to-maturity Securities [Member] | Fair Value, Measurements, Recurring | Significant Other Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	872	317
Held-to-maturity Securities [Member] | Fair Value, Measurements, Recurring | Significant Unobservable Inputs (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	0	0
Money Market Funds [Member] | Fair Value, Measurements, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	355	489
Money Market Funds [Member] | Fair Value, Measurements, Recurring | Quoted Prices in Active Markets for Identical Items (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	0	0
Money Market Funds [Member] | Fair Value, Measurements, Recurring | Significant Other Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	355	489
Money Market Funds [Member] | Fair Value, Measurements, Recurring | Significant Unobservable Inputs (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	$ 0	$ 0

FAIR VALUE MEASUREMENTS (Additi

FAIR VALUE MEASUREMENTS (Additional Information) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value	$ (220)	$ 0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances	0	(235)
Gain included in earnings		15
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value	(199)	(220)
Fair Value, Measurements, Nonrecurring | Fair Value Measured at Net Asset Value Per Share | Private Market Securities and Real Estate
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Unfunded commitments on investments	54	59
Fair Value, Measurements, Nonrecurring | Fair Value Measured at Net Asset Value Per Share | Private Market Securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets at fair value:	92	106
Fair Value, Measurements, Nonrecurring | Fair Value Measured at Net Asset Value Per Share | Real Estate
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets at fair value:	$ 20	$ 22

FAIR VALUE MEASUREMENTS (Basi_2

FAIR VALUE MEASUREMENTS (Basis of Fair Value Measurements on a Nonrecurring Basis) (Details) - USD ($) $ in Millions	3 Months Ended		12 Months Ended
	Dec. 31, 2020	Sep. 30, 2020	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Restructuring, Settlement and Impairment Provisions			$ 118	$ 6	$ 708
Asset Impairment Charges			118		49
2020 Restructuring Program [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Restructuring, Settlement and Impairment Provisions	$ 573	$ 575
Performance Materials & Coatings [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Restructuring, Settlement and Impairment Provisions			6	10	192
Performance Materials & Coatings [Member] | 2020 Restructuring Program [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Restructuring, Settlement and Impairment Provisions	177
Corporate Segment [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Restructuring, Settlement and Impairment Provisions			31	13	464
Corporate Segment [Member] | 2020 Restructuring Program [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Restructuring, Settlement and Impairment Provisions	363
Packaging & Specialty Plastics [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Restructuring, Settlement and Impairment Provisions			8	8	30
Packaging & Specialty Plastics [Member] | 2020 Restructuring Program [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Restructuring, Settlement and Impairment Provisions	11
Industrial Intermediates & Infrastructure [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Restructuring, Settlement and Impairment Provisions			73	$ 1	22
Industrial Intermediates & Infrastructure [Member] | 2020 Restructuring Program [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Restructuring, Settlement and Impairment Provisions	22
Fair Value, Measurements, Nonrecurring | Changes Measurement [Member] | Manufacturing Assets, Equity Method Investments, and Other Assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets at fair value	(245)				(245)
Fair Value, Measurements, Nonrecurring | Performance Materials & Coatings [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Asset Impairment Charges			6		15
Fair Value, Measurements, Nonrecurring | Corporate Segment [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Asset Impairment Charges			31		15
Fair Value, Measurements, Nonrecurring | Packaging & Specialty Plastics [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Asset Impairment Charges			8		19
Fair Value, Measurements, Nonrecurring | Industrial Intermediates & Infrastructure [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Asset Impairment Charges			$ 73
Fair Value, Measurements, Nonrecurring | Manufacturing Facility | Packaging & Specialty Plastics [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Asset Impairment Charges					19
Fair Value, Measurements, Nonrecurring | Non-manufacturing Assets [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Asset Impairment Charges					30
Fair Value, Measurements, Nonrecurring | Non-manufacturing Assets [Member] | Performance Materials & Coatings [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Asset Impairment Charges					15
Fair Value, Measurements, Nonrecurring | Non-manufacturing Assets [Member] | Corporate Segment [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Asset Impairment Charges					15
Fair Value, Measurements, Nonrecurring | Fair Value, Inputs, Level 3 [Member] | Leased, Non-manufacturing Facilities [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets at fair value	110				110
Fair Value, Measurements, Nonrecurring | Fair Value, Inputs, Level 3 [Member] | Manufacturing Assets, Equity Method Investments, and Other Assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets at fair value	121				121
Fair Value, Measurements, Nonrecurring | Fair Value, Inputs, Level 3 [Member] | Non-manufacturing Assets [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets at fair value	11				11
Asset write-downs and write-offs [Member] | 2020 Restructuring Program [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Restructuring, Settlement and Impairment Provisions	196	$ 197			196
Asset write-downs and write-offs [Member] | Performance Materials & Coatings [Member] | 2020 Restructuring Program [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Restructuring, Settlement and Impairment Provisions	116				116
Asset write-downs and write-offs [Member] | Corporate Segment [Member] | 2020 Restructuring Program [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Restructuring, Settlement and Impairment Provisions	47				47
Asset write-downs and write-offs [Member] | Packaging & Specialty Plastics [Member] | 2020 Restructuring Program [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Restructuring, Settlement and Impairment Provisions	11				11
Asset write-downs and write-offs [Member] | Industrial Intermediates & Infrastructure [Member] | 2020 Restructuring Program [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Restructuring, Settlement and Impairment Provisions	$ 22				$ 22

VARIABLE INTEREST ENTITIES (Sch

VARIABLE INTEREST ENTITIES (Schedule of Consolidated Variable Interest Entities, Carrying Amounts of Assets and Liabilities) (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Variable Interest Entity [Line Items]
Cash and cash equivalents at end of year	$ 3,886	$ 2,988	$ 5,104
Other current assets	20,477	20,848
Net property	20,442	20,555	20,239
Other noncurrent assets	1,363	1,456
Total Assets	60,603	62,990	$ 61,470
Current liabilities	11,331	13,226
Long-term debt	14,698	14,280
Other noncurrent obligations	6,555	6,602
Variable Interest Entity, Primary Beneficiary
Variable Interest Entity [Line Items]
Cash and cash equivalents at end of year	17	40
Other current assets	36	40
Net property	157	184
Other noncurrent assets	17	15
Total Assets	227	279
Current liabilities	30	37
Long-term debt	0	3
Other noncurrent obligations	12	13
Liabilities	$ 42	$ 53

VARIABLE INTEREST ENTITIES (Non

VARIABLE INTEREST ENTITIES (Nonconsolidated Variable Interest Entity) (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Variable Interest Entity [Line Items]
Investment in nonconsolidated affiliates	$ 1,589	$ 2,045	$ 1,327
Silicon Inputs Joint Ventures [Member]
Variable Interest Entity [Line Items]
Investment in nonconsolidated affiliates	$ 113	$ 110

RELATED PARTY TRANSACTIONS - Na

RELATED PARTY TRANSACTIONS - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
The Dow Chemical Company | Dow Inc. [Member]
Related Party Transaction [Line Items]
Dividends declared and paid	$ 4,375	$ 3,264	$ 2,233

SEGMENTS AND GEOGRAPHIC REGIO_3

SEGMENTS AND GEOGRAPHIC REGIONS Geographic Region Information (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	$ 56,902	$ 54,968	$ 38,542
Net property	20,442	20,555	20,239
UNITED STATES
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	19,336	18,083	12,547
Net property	14,638	14,425	13,833
Europe, Middle East, Africa and India [Domain]
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	19,631	19,746	12,969
Net property	2,578	2,703	2,813
Rest of World [Domain]
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	17,935	17,139	13,026
Net property	$ 3,226	$ 3,427	$ 3,593

SEGMENTS AND GEOGRAPHIC REGIO_4

SEGMENTS AND GEOGRAPHIC REGIONS Segment Reporting Information (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Segment Reporting Information [Line Items]
Net sales	$ 56,902	$ 54,968	$ 38,542
Restructuring and asset related charges - net	118	6	708
Equity in earnings (losses) of nonconsolidated affiliates	268	975	(18)
Operating EBIT	6,590	9,533	2,715
Depreciation and amortization	2,758	2,842	2,874
Total Assets	60,603	62,990	61,470
Investment in nonconsolidated affiliates	1,589	2,045	1,327
Capital expenditures	1,823	1,501	1,252
Packaging & Specialty Plastics [Member]
Segment Reporting Information [Line Items]
Net sales	29,260	28,128	18,301
Restructuring and asset related charges - net	8	8	30
Equity in earnings (losses) of nonconsolidated affiliates	359	490	173
Operating EBIT	4,110	6,638	2,325
Depreciation and amortization	1,396	1,358	1,372
Total Assets	30,017	30,556	30,069
Investment in nonconsolidated affiliates	846	1,230	661
Capital expenditures	1,069	808	678
Industrial Intermediates & Infrastructure [Member]
Segment Reporting Information [Line Items]
Net sales	16,606	16,851	12,021
Restructuring and asset related charges - net	73	1	22
Equity in earnings (losses) of nonconsolidated affiliates	(91)	471	(166)
Operating EBIT	1,418	2,282	355
Depreciation and amortization	550	612	605
Total Assets	12,883	13,750	12,220
Investment in nonconsolidated affiliates	454	670	531
Capital expenditures	385	359	268
Performance Materials & Coatings [Member]
Segment Reporting Information [Line Items]
Net sales	10,764	9,672	7,951
Restructuring and asset related charges - net	6	10	192
Equity in earnings (losses) of nonconsolidated affiliates	10	7	6
Operating EBIT	1,328	866	314
Depreciation and amortization	789	842	870
Total Assets	13,028	13,810	13,915
Investment in nonconsolidated affiliates	115	111	108
Capital expenditures	369	334	306
Corporate Segment [Member]
Segment Reporting Information [Line Items]
Net sales	272	317	269
Restructuring and asset related charges - net	31	13	464
Equity in earnings (losses) of nonconsolidated affiliates	(10)	7	(31)
Operating EBIT	(266)	(253)	(279)
Depreciation and amortization	23	30	27
Total Assets	4,675	4,874	5,266
Investment in nonconsolidated affiliates	174	34	27
Capital expenditures	$ 0	$ 0	$ 0

SEGMENTS AND GEOGRAPHIC REGIO_5

SEGMENTS AND GEOGRAPHIC REGIONS EBIT Reconciliation (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Segment Reporting [Abstract]
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$ 4,640	$ 6,405	$ 1,294
Provision for income taxes	1,450	1,740	777
Income before income taxes	6,090	8,145	2,071
Interest income	173	55	38
Interest expense and amortization of debt discount	662	731	827
Other Nonrecurring (Income) Expense	(11)	(712)	145
Operating EBIT	$ 6,590	$ 9,533	$ 2,715

SEGMENTS AND GEOGRAPHIC REGIO_6

SEGMENTS AND GEOGRAPHIC REGIONS Significant Items (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Gain (loss) related to litigation settlement	$ 381	$ 54	$ 544
Charges related to separation, distribution and tax matters agreements	4	30	(21)
Gain (loss) on divestiture		16	717
Integration and separation costs			(239)
Restructuring, goodwill impairment and asset related charges - net	(40)	(69)	(718)
Loss on early extinguishment of debt	(8)	(574)	(149)
Standard and Extended Product Warranty Accrual, Increase (Decrease) for Preexisting Warranties			11
Other Nonrecurring (Income) Expense	(11)	(712)	145
Digitalization program costs	(230)	(169)
Russia and Ukraine Conflict Asset Related Charges	(118)
Packaging & Specialty Plastics [Member]
Gain (loss) related to litigation settlement	321	0	544
Charges related to separation, distribution and tax matters agreements	0	0	0
Gain (loss) on divestiture		16	52
Integration and separation costs			0
Restructuring, goodwill impairment and asset related charges - net	0	(8)	(30)
Loss on early extinguishment of debt	0	0	0
Standard and Extended Product Warranty Accrual, Increase (Decrease) for Preexisting Warranties			0
Other Nonrecurring (Income) Expense	313	8	566
Digitalization program costs	0	0
Russia and Ukraine Conflict Asset Related Charges	(8)
Industrial Intermediates & Infrastructure [Member]
Gain (loss) related to litigation settlement	0	54	0
Charges related to separation, distribution and tax matters agreements	0	0	0
Gain (loss) on divestiture		0	61
Integration and separation costs			0
Restructuring, goodwill impairment and asset related charges - net	0	(1)	(22)
Loss on early extinguishment of debt	0	0	0
Standard and Extended Product Warranty Accrual, Increase (Decrease) for Preexisting Warranties			0
Other Nonrecurring (Income) Expense	(73)	53	39
Digitalization program costs	0	0
Russia and Ukraine Conflict Asset Related Charges	(73)
Performance Materials & Coatings [Member]
Gain (loss) related to litigation settlement	0	0	0
Charges related to separation, distribution and tax matters agreements	0	0	0
Gain (loss) on divestiture		0	0
Integration and separation costs			0
Restructuring, goodwill impairment and asset related charges - net	0	(10)	(192)
Loss on early extinguishment of debt	0	0	0
Standard and Extended Product Warranty Accrual, Increase (Decrease) for Preexisting Warranties			0
Other Nonrecurring (Income) Expense	(6)	(10)	(192)
Digitalization program costs	0	0
Russia and Ukraine Conflict Asset Related Charges	(6)
Corporate Segment [Member]
Gain (loss) related to litigation settlement	60	0	0
Charges related to separation, distribution and tax matters agreements	4	30	(21)
Gain (loss) on divestiture		0	604
Integration and separation costs			(239)
Restructuring, goodwill impairment and asset related charges - net	(40)	(50)	(474)
Loss on early extinguishment of debt	(8)	(574)	(149)
Standard and Extended Product Warranty Accrual, Increase (Decrease) for Preexisting Warranties			11
Other Nonrecurring (Income) Expense	(245)	(763)	$ (268)
Digitalization program costs	(230)	$ (169)
Russia and Ukraine Conflict Asset Related Charges	$ (31)

VALUATION AND QUALIFYING ACCO_2

VALUATION AND QUALIFYING ACCOUNTS (Schedule of Valuation and Qualifying Accounts) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Accounts Receivable - Allowance for Doubtful Receivables
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
Balance at beginning of year	$ 54	$ 51	$ 45
Additions charged to expenses	61	16	22
SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction	(5)	(13)	(16)
Balance at end of year	110	54	51
Inventory - Obsolescence Reserve
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
Balance at beginning of year	14	23	35
Additions charged to expenses	50	3	2
SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction	(7)	(12)	(14)
Balance at end of year	57	14	23
Reserves for Other Investments and Noncurrent Receivables
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
Balance at beginning of year	2,033	2,093	2,215
Additions charged to expenses	17	19	7
SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction	(100)	(79)	(129)
Balance at end of year	1,950	2,033	2,093
Reserves for Other Investments and Noncurrent Receivables | Sadara Chemical Company
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction	(77)	(77)	(77)
Deferred Tax Assets - Valuation Allowance
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
Balance at beginning of year	1,391	1,302	1,262
Additions charged to expenses	120	201	313
SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction	(242)	(112)	(273)
Balance at end of year	$ 1,269	$ 1,391	$ 1,302